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Abstract 
The asymmetric approach to a range of substituted indolizidine templates (3) from non-
racemic substrates (1), based around the development of a diastereoselective 
N-acyliminium cyclisation strategy, is well established within our group. 
(1) (3) 
(i) [c!N-c9] 
(2) 
Scheme 1: Reagents; (i) NaBH4, 2 M HCl, EtOH, 20 h. 
The application of this novel methodology in target synthesis has been demonstrated by 
the manipulation of chiral building blocks such as (3). The removal of functional 
groups has allowed assess to therapeutically active natural products including 
(+)-crispine A (4) 1 and (+)-harmicine (5},2 whilst the exploitation of their existing 
functionality has been utilized to form complex {3-tum peptide mimics, such as (6). 
M~XJ>6 % 0 fPh N C02Me N H MeO ::::,... N N 0 H H 
(4) (5) (6) NR2 
The scope of this methodology has been extended with the novel N-acyliminium 
cyclisationlretro Diels-Alder tandem synthesis of the complex pentacyclic template 
(10), from the lactam precursor (9). Analogues of such templates are used as key 
intermediates in the synthesis of the cephalotaxus alkaloids. 
OH 
M eO~ 
~ ~H: MeO 2 
(7) 
(ii) 
(8) 
(ill) 
(9) 
Meo~0 I 0 N"':._ 
MeO ,, 
\ _ _g BF4 
(10) 
Scheme 2: Reagents; (ii) Keto-acid (8), PhMe, !:J., 24 h; (ill) BF3.0Et2, DCM, !:J., 15 h. 
1 Allin, S. M.; Gaskell, S. N.; Towler, J. M.; Page, P.C.; McKenzie, M. J. and Martin, W. P. J. Org. Chem. 2007, 72, 8972. 
2 Allin, S. M.; Gaskell, S. N.; Elsegood, M. J. and Martin, W. P. Tetrahedron Letl. 2007, 48, 5669. 
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CHAPTER ONE: 
INTRODUCTION 
1.1. N-Acyliminium Ions in Synthesis 
1.2. Cyclisations of N-Acyliminium Ion Intermediates 
1.3. Chiral Bicyclic Lactams as Precursors for Asymmetric Synthesis 
1.4. Applications of N-Acyliminium Ions in Alkaloid Synthesis 
1.1. N-Acyliminium Ions in Synthesis 
Advancement in chemo-, regio-, and stereoselectivity of both classical and newly 
developed reagents has been the basis for expansion of synthetic organic chemistry in 
recent history. An excellent example is the Mannich reagent (1) and the amidoalkylating 
reagent (2) in which the latter, also known as an N-acyliminium ion, had been initially 
designed for the purpose ofMannich-type condensations with primary amines. 1 
(1) (2) 
The cyclisations that proceed via iminium cations are well established, such as the 
Mannich reaction,2 the Bischler-Napieralski reaction3 and the Pictet-Spengler reaction,4 
and it soon became apparent that the applications of N-acyliminium ions would ·be 
significant due to its highly versatile reaction characteristics.5 These have been reviewed 
comprehensively, the majority being of the intermolecular reaction type.6•7 The study of 
intramolecular carbon-carbon forming reactions of N-acyliminium ions further enhances 
the emphasis on the reactivity and selectivity of amidoalkylative reagents. 
1.1.1. Structure and Reactivity of N-Acyliminium Ions 
It has been well established in recent decades that the presence of a strongly electron 
withdrawing group at nitrogen renders the imino carbon in the Mannich-intermediate 
(1) considerably more reactive by enhancing its cationic character. 
(1) R1 = H, alkyl 
(3) R1 =acyl 
(4) R1=COOR 
(5) R1 = CONR2 
(6) R1 = Tosyl 
(7) R1=NR2 
TheN-acyl derivative (3) and the carbamate (4) have been the most widely exploited of 
these modified cations, however the use of other electronegative substituents such as the 
amide (5) and N-tosyl (6) cations have also been explored. Depending on the identity of 
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R\ R2 and R3, numerous cyclic and linear forms can be distinguished and new 
variations such as the hydrazonium (7) have been added.8 
G:ppm 189.7 ppm 
(Ph .0 Ph~~.Me Ph~~)lMe 
I I 
H SbC16 H SbC16 
(8) (9) 
A 13C NMR study of the iminium salts (8) and (9) by Wiirthwein et al. showed that the 
substitution of an N-methyl by an N-acetyl group gave rise to a downfield shift of the 
imino carbon absorption of approximately 5 ppm.9 From this, one may anticipate that 
N-acyliminium ions are more electrophilic, i.e. more reactive than iminium ions. 10 
Boekelheide et al. have illustrated the difference in reactivity of intramolecular 
reactions in the results of olefin cyclisations obtained in the synthesis of Erythrina 
alkaloids as shown in Scheme 1.11 Both N-acyliminium ions (lla, llb) generated from 
their respective keto amides (lOa, lOb) proceeded to form the expected cyclisation 
products (12a, 12b) .. 
Scheme 1: 
(lOa) R1 = 0, R2 = H2 
(lOb) R 1 = H2, R2 = 0 
(13) R1 = H2, R2 = H2 
(lla) R1 = 0, R2 = H2 
(llb) R1 = H2, R2 = 0 
(12a) R1 = 0, R2 = H2 
(12b) R1 = H2, R2 = 0 
The corresponding ring closure of the iminium salt (13) however, led to unidentifiable 
products. It is important to note that these olefin cyclisations are in principle a reversible 
process, the reverse reaction being a Grob fragmentation. 12 The greater attribute of the 
N-acyliminium ion cyclisation is that the amide product of an N-acyliminium-olefin 
cyclisation is much less susceptible to fragmentation and hence more irreversible, in 
comparison to its amine counterpart from the corresponding iminium-olefin cyclisation. 
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1.1.2. Mechanistic Aspects of N-Acyliminium Ion Chemistry 
When applied to organic synthesis, N-acyliminium ions are almost always generated in 
situ, in view of their limited stability and high reactivity. The mechanistic scheme, 
which applies to most amidoalkylation reactions, is shown in Scheme 2. 13 
Scheme 2: 
Rl 
I 
R2 N R4 
R31 n 
X 0 
X= Cl, RC02, RS02 
N3,RO,RS 
(14) 
RI 
Acidic Catalyst R2 ~+ R4 Nucleophile Yn --~ 
R3 0 
(15) (16) 
The N-acyliminium ion (15) is formed in equilibrium with its precursor (14) through the 
influence of an acidic catalysis. The subsequent reaction of a nucleophile with the 
N-acyliminium ion yields the product (16) in an irreversible process. This scheme 
closely resembles that of an SN 1 process. A study by Zaugg and Martin distinguished 
two extreme kinetic situations: 6a 
1. The formation of the N-acyliminium ion is rate limiting, 
ii. The reaction with the nucleophile is rate limiting. 
The former case would suggest that a more stable N-acyliminium ion leads to a faster 
reaction, whereas in the latter the opposite is true. The rate of amidoalkylation is also 
influenced by the nature of the leaving group and the solvent, as well as the acidic 
catalyst structure., 
In N-acyliminium chemistry, an important side reaction is the formation of an enamide. 
This can be a reversible process when preformed in an acidic medium; however this is 
not always the case. The enamide formed can act as a nucleophile and further react with 
the N-acyliminium species still present, to give dimeric structures. These problems of 
enamide formation and subsequent side reactions arise if the N-acyliminium ion is not 
trapped fast enough by the nucleophile. This may occur if: 
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• The nucleophile is not very reactive, 
• There is too much steric hindrance, 
• Stereoelectronic factors are unfavourable (for intramolecular processes), 
• A medium-sized or large ring is to be formed. 13 
1.1.3. Generation of N-Acyliminium Ions and their Precursors 
Whereas iminium salts are frequently isolable, their N-acyliminium counterparts are far 
more reactive and seldom, if ever, isolated.5 There are five major synthetic pathways td 
form N-acyliminium ions in situ for applications in elaborate organic synthesis. 
1.1.3.1. Heterolysis of a-Oxygenated Amides 
Heterolysis of a-substituted amides is the most common method for the generation of 
synthetically useful N-acyliminium ions, the a-substituent being an oxygen moiety in 
the majority of cases, although a variety of other leaving groups have been employed, 
including bisamides, a-chloroalkyl amides and a-thioalkylamides; an example is the 
amidoalkylation outlined in Scheme 3. 14 
Scheme 3: 
0 0 
~NH2 + ~~~Ph 
(17) (18) (19) (20) 
Reagents: (i) MeS03H, P20 5, 35 ·c, 18 h. 
The addition of an amide (17) to an aldehyde (18) or ketone under conditions of acid 
catalysis can be used to prepare the a-oxygenated amides (19). Generally, Br6nsted or 
Lewis acids are used to generate the corresponding N-acyliminium ions (20) from the 
a-oxyalkyl amide precursors. 
The reduction of cyclic imides (21) in the presence of an alcohol affords the 
corresponding hydroxy lactam (22) and/or the alkoxy lactam (24), which are useful 
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precursors of cyclic N-acyliminium species (23) (Scheme 4). 15 Such reductions of 
imides are often highly regiospecific in the presence of other functionality. 16 
Scheme 4: 
0 0 
<N-R (i) QN-R 
0 OH 
0 0 
(5~-R (ii) QN-R 
OR 
(21) (22) (23) (24) 
Reagents: (i) NaBH4, H+; (ii) ROH. 
1.1.3.2 .. N-Acylation oflmines 
!mines are readily prepared in high yield by condensation of an aldehyde or ketone with 
a primary amine. In 1914, Jarnes and Judd reported the first acylation of an imine with a 
reactive carboxylic acid derivative such as an acid chloride or anhydride when they 
reacted benzaniline (25) with benzyl choride (26) (Scheme 5): 17 
Scheme 5: 
(25) (26) (27) (28) 
PhCHO + 
(30) (29) 
The crystalline precursor (27) was readily hydrolyzed in water to give benzanilide (29) 
and benzaldehyde (30). The !ability of the carbon-chlorine bond illustrates the 
propensity to N-acyliminium ion (28) formation in this system. 
Introduction 5 
1.1.3.3. Electrophilic Addition to Enamides 
Enamides (32) are easily formed via acylation of an imine (31) with an acid chloride or 
anhydride followed by elimination. Enamides are stable compounds under neutral or 
basic conditions. When reacted with Br6nsted acids they give rate-determining 
protonation at carbon, which leads to hydrolysis in aqueous medium (Scheme 6). The 
N-acyliminium ion (33) is the intermediate formed after protonation of the enamide. 13 
Scheme 6: 
(32) 
(33) 
1.1.3.4. N-Protonation of N-Acylimines 
N-acylimine protonation is in principle, a route to acyliminium ions, however it is more 
of mechanistic interest rather than a general synthetic method. This is due to the 
limitations in preparing N-acylimines (34) themselves and their relative instability. If 
possible they. tautomerise to the corresponding enamide (35) (Scheme 7), unless there 
are no a-hydrogen atoms available. 
Scheme 7: 
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.H 
3.-i NOR R~iY 
R RI 0 
(34) (35) 
6 
1.1.3.5. Oxidation of Amides 
The removal of a hydride from the a-carbon of an amide (36) formally leads to an 
· N-acyliminium ion (37). The most important way to effect this transformation has been 
established by many research groups as the electrochemical method, which involves 
two single-electron transfer steps as shown in Scheme 8. 7 
Scheme 8: 
0 
- e -e Jl+ MeOH R3 N~R1 --~ 
~2 -W 
(36)' (37) (38) 
This electrochemical oxidation is conducted in the presence of a nucleophile, usually 
methanol, in order to trap the N-acyliminium ion as soon as it is generated as the 
a-methoxyalkyl amide (38). This reaction is effective for a large variety of amides and 
carbamates and there are few reports of other methods for the formation of 
N-acyliminium ions via hydride abstraction of amides. 
1.1.4. Observation of N-Acyliminium Ions by NMR Spectroscopy 
It has been previously mentioned that N-acyliminium ions are almost always generated 
in situ due to their limited stability and high reactivity. Consequently, the observation of 
a transient N-acyliminium intermediate in dynamic NMR has been reported only twice. 8 
It has been shown in a specially designed experiment by Yamamoto et al., that 
alkoxycarbamate (39) at -55 ·c in the presence of triflic anhydride produced a clean 
13C NMR spectrum of the intermediate (40) shown in Scheme 9. 18 
Scheme 9: 
(39) (40) 
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More recently, it was discovered that treatment of the bis(homoallyl)hydroxylactam 
(41) with boran trifluoride diethyl etherate at 25 ·c produced the 13C NMR spectrum of 
the N-acyliminium species (42). 19 
(41) (42) (43) 
This int~rmediate was slowly (1 hour) converted to the fluoro compound (43). The· 
reasons for this unexpected stability are not entirely clear although the spectral data 
suggests that the greater electron withdrawing ability of the amide carbonyl group in 
comparison to carbamate could be a factor. 8 
1.2. Cyclisations of N-Acyliminium Ion Intermediates 
The reactions of N-acyliminium ions with tethered 7r-nucleophiles have been established 
as an excellent method for the preparation of complex nitrogen heterocycles. Since the 
introduction of N-acyliminium methodology as a versatile tool, the y-lactam derivatives 
have prominently featured in the field of intramolecular carbon-carbon bond formation. 
1.2.1. Reactions of Benzenoid N ucleophiles 
Intramolecular amidoalkylations have been applied to a wide variety of aromatic 
nucleophiles and have been shown to be highly effective with benzene rings, as well as 
derivatives substituted with moderate deactivating groups.20 The major breakthrough of 
N-acyliminium cyclisations with benzene nucleophiles came in the 1950's and was 
conducted by Belleau21 and Mondon,22 who both lead the pioneering work in the 
syntheses of the Erythrina isoquinoline alkaloids. 
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1.2.1.1. Synthesis of Erythrinanes 
Bell eau illustrated the enhanced reactivity of an N-acyliminium variant of the Mannich 
reaction in the formation of the erythrinane (45), as shown in Scheme 10 with a 
successful cyclisation from the N-acyliminium species (44). The corresponding iminium 
ion (46) had previously failed under "various conditions".Z3 
Scheme 10: 
::~. 
R=O 
R=H2 
(i) 
Reagents: (i) P20 5, PPA, 100 'C, 3 h (93 %). 
MeO~R 
A) ___ )< 
MeO tJ-1 
(44) R= 0 
(46) R= H2 
MeOmR 
. I 
~NN! MeO \._/--l 
(4S)R=O 
R=H2 
The alternative "Mondon-type" cyclisation; which differs only by the position of the 
lactam carbonyl as shown in Scheme 11, is similar to that of Bell eau as both modes are 
completely stereoselective for the cis-fused configuration. 
Scheme 11: 
(i) MeOm 
MeO ""O:ro 
Reagents: (i) H3P04, H20/MeOH, 6., 1 h (65 %). 
The stereochemical outcome is a result of the steric effects that arise in the orthogonal 
approach of the 1r-orbital of the arene nucleophile to the plane of the iminium ion23 and 
this pattern is general for a diverse range of substrates.20 
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1.2.1.2. Effects of Substituents on the Iminium Ion 
The nature of the substituent on the iminium unit does not have a great impact on the 
outcome of an N-acyliminium cyclisation. However more reactive intermediates, such 
as those bearing an electron-withdrawing group on carbon or those devoid of steric 
hindrance may lead to increased yields and/or allow milder conditions. 
Winn and Zaugg used various hydroxyisoindolinones as N-acyliminium precursors to 
determine the influence ofiminium carbon substituents on cyclisation (Scheme 12).24 
Scheme 12: 
~N 
.&HO Rb 
(47) R= Ph 
(48) R= H 
Reagents: (i) PP A, 135 'C, 4 h. 
(i) 
R= Ph (75 %) 
R=H (0%) 
With standard substituents such as phenyl or hydrogen, there were cases of differential 
reactivity. The more reactive N-acyliminium species bearing an electron withdrawing 
phenyl group (47) leads to enhanced cyclisation yields in comparison to those observed 
for its hydrogen group counterpart (48), which fails to cyclise. However, the ring strain 
exhibited during formation of the five-membered ring is also a contributing factor, as 
the corresponding cyclisations to six-membered derivatives occur with good yields for 
both phenyl (49) and hydrogen (50) substitution (Scheme 13). 
Scheme 13: 
~_rQ 
R OH 
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(49)R=Ph 
(SO) R= H 
(i) 
0 
R= Ph (65 %) 
R=H (84%) 
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1.2.1.3. Formation of Five and Seven-Membered Rings 
The formation of five-membered rings by N-acyliminium ion cyclisation onto arenes 
can be problematic in comparison to its six-membered equivalent due to considerable 
ring strain during formation, as demonstrated in the previous example. This difficulty is 
also illustrated by the preference for. cyclisation of the phenyl substituent of (51) to 
generate a new seven-membered system (52), in favour of the completing cyclisation of 
the more nucleophilic thiophene to form a 5,5-fused product (53) (Scheme 14).25 
Scheme 14: 
oFvs ~N- ~ 
~ ~h 
0 
(i) 
OH 
(51) (52) (53) 
Reagents: (i) TF A (80 %). 
Alternatively, five-membered rings are more readily formed from spirocyclisation of 
N-acyliminium intermediates as shown in Scheme 15.Z6 
Scheme 15: 
o~l'·re ~ 
OH 
(i) 
Reagents: (i) TFA, D. (69 %). 
The formation of seven-membered rings in arene cyclisations can also be troublesome, 
however there are a number of successful examples.20 One such example is the 
synthesis of an extremely potent inhibitor of angiotensin-converting enzyme (56) using 
an N-acyliminium intermediate generated from an N-acyl enamine (54) to construct the 
fused tricyclic core (55) (Scheme 16).27 
Introduction 11 
Scheme 16: 
r'n lfhth 
~0 
o···CO,M, 
(54) 
Reagents: (i) TfDH, DCM, 24 h (77 %). 
NPhth 
(i) &!JC~H 
(55) 
1.2.2. Reactions of Heterocyclic Nucleophiles 
c;o2H 
ffiY~Ph 
: 0 
,C02H 
' 
~ 
H 
(56) 
N-acyliminium ion cyclisations of heterocyclic nucleophiles for the most part, mirror 
that of their benzenoid counterparts. The 71"-rich heteroarenes, such as furan, pyrrole and 
indole are at the higher end of the reactivity spectrum comparable to phenyl derivatives, 
where as 7r-deficient compounds such as pyridine are significantly attenuated?0 
1.2.2.1. Cyclisations of Thiophenes and Furans 
Heterocyclic cyclisations that generate new six-membered rings are very tolerant and 
often proceed better than their phenyl counterparts (Scheme 17).28 
Scheme 17: 
~N)-<J 
OEt 
(li'1, 0 ~rf(Y + 
Ph 
zA 
0 ~
X= NMe 74:26 (96 %) 
X= S 96:4 (47 %) 
In comparing reactions of thiophene nucleophiles with its phenyl equivalent, it is found 
that the thiophene is more reactive when its a-position is involved. In cases when the 
heterocycle is linked to the N-acyliminium s~gment by its 3-position, regiochemistry of 
the cyclisation can be an issue. When the thiophene 2-position is available however, 
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regiospecific cyclisation readily occurs at this site as shown in Scheme 18 and in this 
case, allow access a seven-membered product (57)?9 
Scheme 18: 
0 
)l_ ~ F\ 
HN N ~S 
-t-ZoH · (i) 
(57) 
Reagents: (i) TFA, 6, I h (65 %). 
Tanis et· al. have explored furan-based N-acyliminium cyclisations extensively. The 
products obtained are highly dependent on the furan tether position, the tether length 
and the substituents on the furan 5-position as shown in Scheme 19.30 
Scheme 19: 
)N~ VOH 0 
0 
This outcome and the ability to form spirocycles reflects the lower nucleophility of the 
furan /3-position in comparison to the a-position and has been applied in a formal 
synthesis of (±)-perhydrohistrionicotoxin (63) (Scheme 20), which selectively binds to 
part of the cholinergic receptor that regulates the ion transport mechanism.30 
The desired spirocyclic intermediate (59) was formed upon treatment of the 
N-acyliminium precursor (58) with formic acid. Oxidative ring opening of the furan 
with m-chloroperoxybenzoic acid and subsequent reduction of the ene-dione gave the 
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target dione (60). Selective thioketalisation afforded (61), which was desulfurised under 
Raney nickel conditions to give the spirocyclic amide (62) and thus completed the 
formal synthesis of the target (±)-perhydrohistrionicotoxin (63). 
Scheme 20: 
OH 
(58) 
~ 
(63) 
(i) 
(59) 
0 
(62) 
(ii) 
(60) 
1 (fu1 
(iv) 
0 
(61) 
Reagents: (i) HC02H, cyclohexane (72 %); (ii) m-CPBA then Pd/C, H2, EtOAc (70 %); (iii) TMSOTf, 
TMSS(CH2hSTMS (67 %); (iv) Raney-nickel, EtOH, !). (78 %). 
1.2.2.2. Cyclisations of Pyrroles and Pyridines 
N-acyliminium ion precursors linked to an N-substituted pyrrole at the a-position react 
cleanly at the /3-position as previously shown in Scheme 17?8 However when linked to 
the pyrrole nitrogen, N-acyliminium ion cyclisation at the a-position can occur to form 
five, six, seven and eight-membered ring systems?0 Some examples are shown below. 
As previously discussed, the formation of five-membered rings by N-acyliminium ion 
cyclisation onto arenes can be problematic, however Scheme 21 shows a new, highly 
strained five-membered ring (65) produced, with difficultly as indicated by the low 
yield, via the N-acyliminium ion cyclisation of (64).31 
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Scheme 21: 
c<:o (i) 
(64) (65) 
Reagents: (i) HC02H, 3 d (27 %). 
In the case of (66) (Scheme 22), attack of the pyrrole over the competing phenyl group 
gives a new eight-membered ring (67) in excellent yield and under extremely mild 
conditions (1 hour, 23 ·q.32 Both examples highlight the high reactivity of the pyrrole 
nucleus for N-acyliminium cyclisations. 
Scheme 22: 
X 0 CC/ N:J 
Et OH 
(i) 
(66) (67) 
Reagents: (i) TF A, DCM, I h (92 %). 
In contrast, the pyridine ring is considerably less reactive toward electrophiles due to its 
electron-withdrawing nature and has received limited attention in cationic 7!"-cyclisation 
reactions, despite its prevalence in a variety of biologically active heterocycles. Pawda 
has reported the intramolecular cyclisation of activated pyridines of type (68) with 
tethered N-acyliminium ions as detailed in Scheme 23.33 
Scheme 23: 
0 
R = Donor Group 
(68) 
An example of such is the cyclisation of lactam (69) as shown in Scheme 24, which 
upon treatment with a variety of Lewis acids including BF3.0Et2, TiCl4, and SnCl4 
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resulted only in the recovery of starting materials. The synthesis of (70) was achieved 
however, with catalytic amounts of pro tic acid in refluxing benzene in 70 % yield. 
Scheme 24: 
0~ ~N_/ N=< ~· OMe 
OH 
(69) 
Reagents: (i) p-TsOH, benzene, 6. (70 %). 
1.2.2.3. · Cyclisations of lndoles 
M eO 
(i) 
0 
(70) 
The work of several research groups has illustrated the versatility of N-acyliminium 
cyclisations with indole nucleophiles and its applications in the total synthesis of 
various indole alkaloids. The highly reactive nature of the indole 71"-nucleophile allows 
these cyclisations to stand out as a unique collection of examples. 
Scheme 25: 
A~ 
~Ty~ HN NH2 
(71) 
(74) 
0 
A~ ~T]( J 0 HN HN- /:'... .. Jl lf 't1n -R 
0 
(72) 
(73) 
In the vast majority of cases, the essential step is the coupling of an oxo-carboxylic acid 
with tryptamine (71) and acid catalysed ring closure of the so formed oxo-amide (72) 
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into the desired template (74) via the N-acyliminium species (73) (Scheme 25). 13 As 
can be expected in cases where different stereoisomers may be formed, mixtures of both 
RC-N diastereoisomers are obtained, the composition dependent on the location of 
additional substituents in the N-acyliminium portion. 
Exceptions to this method are the indole alkaloids synthesised by Van Tamelen et a/.34 
and Wenkert et a/. 35 starting from indole-3-acetic acid (75) and an amine to form the 
amide precursor (76), which is cyclised by acid-catalysed formation of the 
N-acyliminium ion (77) and subsequent ring closure to (78) (Scheme 26). 
Scheme 26: 
Q:rc~H 
HN 
(75) 
qP~1 
I 
OHC 
(78) 
~~0 
(76) 
(77) 
Unlike the previous reaction, where bond formation is only observed at the 2-position of 
the indole ring, the greater stability of the y-lactam influences the cyclisation to yield 
the spiro-structure (78) as the more stable product via bond formation at the 3-position. 
The distinct difference in behaviour between the two N-acyliminium ions (73) and (77) 
is extremely useful for exerting regiocontrol in this type of bond formation and 
cyclisation. 13 Van Tamelen et cif. demonstrated this in an early example of an 
N-acyliminium ion cyclisation with an indole 7r-nucleophile as the key step in the total 
synthesis of (±)-yohimbine (Scheme 27).36 The precursor (80), a trapped dialdehyde 
Introduction 17 
-----------
formed by oxidation of (79) using sodium metaperiodate, reacts with phosphoric acid to 
yield the polycyclic lactam (81) in 60 % yield with high stereoselectivity.20 
Scheme 27: 
(i) (ii) 
~6 
HO 
(79) (81) 
1.2.3. Reactions of Alkenes and Related Species 
Although Belleau reported the first N-acyliminium cyclisation with an alkene 
nucleophile in 1957,37 it was two decades later when Speckamp pioneered the field, by 
capitalising on a diverse range of N-acyliminium precursors through imide partial 
reduction. The introduction of mild condition, such as formic acid at room temperature, 
was an important step forward in this area. 13 
1.2.3.1. Standard Alkenes 
With respect to the position of the tethered alkene 7r-nucleophile, three types of 
cyclisation can be distinguished as shown below. 13 
D RI R2 
0 +~- }=( 
\..J R3 
Ring closure of type A lead to high yields of single isomers, as exemplified in the 
synthesis of depentylperhydrogephyrotoxin (84) by Hart. The key step involved the 
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treatment of the N-acyliminium precursor (82) with formic acid, which gave the lactam 
core structure (83) as a single diastereoisomer, the observed stereochemistry being 
controlled by A(I,J) strain as shown below in Scheme 28.38 
Scheme 28: 
(i) 
cf;S 
0 
(82) 
Reagents: (i) HC02H, 30 min (85 %). 
~H 
0 
(83) 
HO 
(84) R= H 
(85) R = CH2CH=CHC=CH 
Depentylperhydrogephyrotoxin (84) is an analogue of gephyrotoxin (85); an alkaloid 
isolated from the skin extracts of the neotropical frog Dendrobates histrionicus which 
has shown some interesting pharmacological properties.39 
Scheme 29: 
0 N 
I 
Bn 
M-er (i) '+ N-Bn 
0 
(86) 
MoO;)e 
l~_OH ~~ H H 
(88) 
(ii) 
(iv) 
&OMe 
CO-oH 
Brl fi H 
(87) ! (ill) 
OMe 
~OMe 
V 
Reagents: (i) HC02H, 20 h; (ii) LiAIH4, THF, 6., 3 h; (iii) Pt02, H2, i-PrOH, 48 h (66 %); (iv) HC02H (50%). 
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In the second type of ring closure B, mixtures of diastereoisomers are expected, the 
composition of which is dependent on substituent R. 
Thus, in the synthesis of the mesembrine alkaloid d/-epi-di-hydromaritidine (88) by 
Speckamp and Wijnberg, shown above in Scheme 29, the cis-fused-ocatahydroindole 
isomer (87) resulting from transition state (86) is preferred, in which the bulky aromatic 
group occupies the equatorial position.40 
When an alkene is directly linked to the iminium carbon as in type C, N-acyliminium 
ion spirocyclisation can ensue. This reaction has been demonstrated in the 
stereoselective formal total synthesis ofperhydrohistrionicotoxin (63) (Scheme 30).41 
Scheme 30: 
y:o 
+BrMg~ 
0 
~ 
(63) 
(i) 
(89) 
(iii) 
s 
(91) 
Reagents: (i) THF, 20 h; (ii) HC02H, ~. 8 d (23 %); (iii) P2S5, benzene, ~. I h then NaOH, I h (88 %). 
(90) 
In the key step of the synthesis (89) to (90), three asymmetric centres are formed in a 
single operation via a 6-endo-trig, N-acyliminium-olefin cyclisation. The resulting spiro 
formate ester (90) was converted. to the spirothiolactam alcohol (91), which is a known 
precursor of perhydrohistrionicotoxin ( 63). 
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1.2.3.2. Vinyisilanes 
The N-acyliminium ion cyclisation of vinylsilane nucleophiles is directed toward the 
silicon-bearing alkene carbon because of the stabilisation of the resultant carbo cation by 
the "13-silyl effect". Although not as reactive as the analogous allylsi1anes and vinyl 
thioesters, vinylsilane nucleophiles have been utilised in the preparation of several 
nitrogen containing heterocycles.20 Early examples of silicon-directed cyclisations were 
conducted as an extension of the Mannich reaction in the synthesis of quinolizidines 
(93a) and indolizidines (93b) as shown in Scheme 31.42 
Scheme 31: 
r-{Yn 
O~N)-OH 
~R 
TMS 
(92) 
(i) 
an=2, R=H 
bn=l,R=H 
c n = 1, R= Br 
O~_,R 
u 
(ii) 
(93) 
Q_,Br !u 
(94)X=H, OH 
(95) X= 0 
Reagents: (i) TFA, 15 min; (ii) LiAIH4, Et20, 6., 2 h (67 %); (iii) s-BuLi, THF, -78 °C, butanal (86 %). 
The additional reactivity of the N-acyliminium ion was significant in cyclisations of 
electron-deficient vinylsilanes, which had failed to react with the corresponding 
iminium derivatives. Dissolution of the hydroxylactams (92a) and (92b) under acidic 
conditions produced clean cyclisation within 15 minutes at room temperature to afford 
the quinolizidine (93a) (91 %yield) and indolizidine (93b) (93 %yield), respectively. 
To demonstrate the synthetic opportunities presented by functionalised alkene 
cyclisation products, the bromoindolizidine intermediate (93c) was employed in the 
efficient synthesis of the Elaeocarpus alkaloids, elaeokanine B (94) and A (95). 
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Reduction of {93c) followed by treatment with sec-butyl lithium and butanal afforded 
elaeokanine B (94) as a 1:1 mixture of diastereoisomers in 86 % yield. Subsequent 
Swem oxidation provided racemic elaeokanine A (95) in 56 % yield.42 
1.2.3.3. Allylsilanes and Allylstannanes 
Allylsilanes are normally exemplary participants in N-acyliminium ion cyclisations, the 
13-effect of the silicon atom allowing excellent regiocontrol with electrophiles at the 
y-position. Diastereoselectivity of such reactions however, can be an issue. The use of 
terminal alkenes with nitrogen-linked allylsilanes has been useful in the synthesis of 
quinolizidines derivatives such as (+)-myrtine (98a) and (-)-epimyrtine (98b) as shown 
below in Scheme 32.43 
Scheme 32: 
IYOH 
'yNXII™s 
0 Me 
(96) 
(98a) (98b) 
(i) 
(ii)-(iii) 
l 
0:2i+ 0:2i 
Me Me 
(97a) 7:3 (97b) 
Reagents: (i) TFA, DCM, 0 oc 6 h (99 %); (ii) LiAIH4, THF, !:J., 2.5 h (99 %); (iii) Nai04, Os04, AcOH, 23 h (36 %). 
Treatment of the hydroxylactam (96) with trifluoroacetic acid gave the bicyclic 
compounds (97a) and (97b) as a 7:3 mixture of diastereoisomers in quantitative yield. 
Reduction of the lactam carbonyl followed by oxidation of the olefinic bond leads to a 
mixture of (+)-myrtine (98a) and (-)-epimyrtine (98b), which were separated by flash 
chromatography to give the optically pure natural alkaloids. 
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1.2.4. Reactions of Alkynes 
Participation of the alkyne function as a nucleophilic terminator for N-acyliminium ion 
cyclisations has been applied in a wide number of syntheses. Ring closure may proceed 
through an exo (99) or endo (100) vinyl cation intermediate, which is captured by 
solvent or an available anion as shown in Scheme 33. 
Scheme 33: 
,-fVn 
o-:::::(N)-ox R 
V 
n~ 
O- ·N~R + 
(99) (100) 
In view of the energy difference between these two possible intermediates, in general 
endo-dig cyclisation is strongly favoured even in the case of macrocyclic formation 
(102e) as shown in Scheme 34, by the ring closure of co-alkoxy lactams (101) bearing a 
terminal alkyne. 20 
Scheme34: 
o.J)-OEt 
~ 
(101) 
Reagents: (i) HC02H, Aqueous work up. 
a 
b 
c 
d 
e 
m 
0 
1 
2 
3 
10 
(i) 
Time 
?? 
3d 
5d 
14d 
20d 
Yield % 
0 
97 
90 
80 
82 
0~ 
·~0 
(102) 
Only in the case of electronically unbiased acetylenes such as (103) and (105), where 
ring strain effects influence the order of stability of linear and bent vinyl cations, do 
different results occur (Scheme 35). 
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Scheme 35: · 
rt 0 N OR Me 
~ 
(103) n =I 
(105) n= 2 
Reagents: (i) HC02H, 5 d. 
(i) on ,? + 
...--....N0Me 
(104a) n =I 
(106a) n = 2 
01:(' 
(104b) n =I 
(106b) n= 2 
Thus in the case of (103) (n = 1), N-acyliminium cyclisation in formic acid results in a 
10:90 mixture of products (104a) and (104b) in favour of the endo regioisomer. In 
contrast, the one-carbon homologue (105) generates mostly the exo product (106a) in a 
ratio ss:ls, presumably due to the reduced ring strain of the resulting indolizidine 
(106a) in comparison to the endo pyrrolizidine product (106b).44 
1.3. · Chiral Bicyclic Lactams as Precursors for Asymmetric Synthesis 
The chiral bicyclic lactam (107) has proven to be an exceptional building block for the 
formation of a wide variety of enantiomerically pure carbocycles and heterocycles. 
Scheme 36: 
0 
;}2, 
R3 Me\ ~OMe 
!IN~~ 
: OMe ~ 
R.3 
(107) n = 0, I 
/ 
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The ability of non-racemic bicyclic lactams to generate new quaternary carbon 
compounds with excellent control over the absolute stereochemistry, as well as access 
to a variety of other structural features has been widely utilised in total synthesis.45 
Two general methods have been developed for the synthesis ofbicyclic lactams.46 
Cyclodehydration of an optically pure amino alcohol (108) with a keto acid (109) has 
been used to generate lactams such as (110) as shown in Scheme 37. 
Scheme 37: 
.·£OH 
~ NH2 + 
(108) CA= Chiral Auxiliary 
0 
Jl,,../'-... JOH 
R' 1'1n If 
0 
(109)n= 1,2 
R 
c[V~ 
0 
(110)n=l,2 
The second route, which involves an N-acyliminium species, is related to the work by 
Speckamp (Scheme 38). 13'47 
Scheme 38: 
0 0 OH 0 
OH 0~ H')-I-! Ry HO~ (i) HO -H20 + R ~~ NH2 0 0 0 
(111) (112) (113) (114) 
l (iij 
-
Jo~ OH OEt OH):_ 
R Ny! )-·! (iii) H•)-N ! H' N 
R ~~ R ~~ 
0 0 0 
(117) (116) (115) 
Reagents: (i) PhMe, 6; (ii) NaBH4, 6 N HCI, EtOH, 6 h (82 %); (iii) Benzene,p-TsOH, 6, 2 h (73 %). 
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Condensation of an optically pure amino alcohol (111) with a cyclic anhydride (112) or 
dicarboxylic acid (113) afforded the imide (114). Addition of a hydride source in 
ethanol generated the corresponding ethoxylactam (115), which upon treatment with 
acid produced (117) via the N-acyliminium intermediate (116).46•48 
1.3.1. Construction of Pyrrolidines and Pyrrolidinones 
The addition of allylsilanes at the angular position of 5,5-bicyclic lactams (118) is 
possible under strong Lewis acid conditions to furnish the disubstituted pyrrolidinones 
(119) and (120) as illustrated below in Scheme 39.49 
Scheme 39: 
Ph~~ (i) 
R = alkyl, aryl 
0 
(118) 
(I)! R=H 
0 
(119) 
~ Ph;~ HOJ-~ 
0 
(120) 
R 
PhSe~ 
(122) 
(ii) 
(iv) 
! (iii) 
~ 
:K HN\..__} 
(121) 
Reagents: (i) Allyltrimethylsilane, TiCI4, DCM, -78 oc tort; (ii) Li, NH3, EtOH, -33 oc; (iii) LiAIH4; (iv) (PhSeh, 
(NH4)2S20s, MeCN, D.. 
When R was an alkyl or acyl group, the products (120) are formed with retention of 
configuration at the angular position due to the endo attack at the bicyclic lactam. 
Conversely, when the angular substituent was hydrogen, the observed stereochemistry 
results from exo entry to give an inversion of configuration in the product (119). 
Dissolving metal cleavage of the chiral auxiliary in (120) followed by further reduction 
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generates the pyrrolidine (121), which acts as a key cyclisation precursor to the 
backbone of the pyrrolizidine alkaloids (122).49b 
1.3.2. Construction of Piperidines 
Due to the success of 5,5-bicyclic lactams (118) in the preparation of enantiomerically 
pure pyrrolidines (121), it was felt this procedure could be applied to the related 
5,6-lactams (123) in the synthesis of2-substituted piperidines (124) (Scheme 40). 
Scheme 40: 
(i) (ii) RJ) 
('Ph 
Ph-)) 
0 
OH 
(123) (124) l (lii) 
RJ) 
H 
(125) R= CH3 
(126) R = CH2CH2CH3 
Reagents: (i) Red-AI, THF, 1'1; (ii) Ac20, DMAP, DCM; (iii) Pd(OH)2, H2, MeOH. 
Red-Al reduction of a variety of alkyl 5,6-bicyclic lactams (123) generated the 
piperidine derivatives (124) in good yield and with high diastereoselectivity, with 
retention of configuration at the angular substituent. The efficient and versatile nature of 
this piperidine synthesis has been exemplified in the total synthesis of (-)-pipecoline 
(125) and (+)-coniine (126).50 
1.3.3. Construction of Tetrahydroisoquinolines 
Similarly substituted tetrahydroisoquinolines, such as (-)-salsolidine (128), have been 
synthesised from the appropriately benzo-fused bicyclic lactams (127) (Scheme 41), 
following the previously described reduction protocol for piperidines.51 
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Scheme 41: 
MeO~O 
I b N 
MeO _)•••Ph 
Me 0 
(127) 
M eO~ 
MeO~NH 
Me 
(128) 
(i) 
(ill) 
MeO~O 
MeO~N'f'oH 
Me Ph 
I N Me OD? 
MeO -& 'f'oH 
Me Ph 
Reagents: (i) Red-AI, THF (85 %); (ii) LiAIH4 (50 %); (iii) Pd/C, H2, MeOH (97 %). 
1.3.4. Construction of Substituted Pyrroloisoquinolines 
The pyrroloisoquinoline ring system (129) has received significant interest in recent 
years as a major structural motif of the Erythrina alkaloids. Katritzky52 suggests that 
I 
there are three major routes reported for the synthesis of such systems (Scheme 42). 
Scheme 42: 
~ 0 a:& a ~ ?/ ~ 0)+ (129) ao 
(130) C02R (133) 
r noo D 
CO:- o:c en R-(yo 0 NH C02H 
(131) (132) (134) I a b c d e 
R Bt AcCH OH OEt SPh 
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Route A involves the carbon-nitrogen bond formation via reduction of the intermediate 
(130), obtained by the 1,3 cycloaddition of nitrones (131) with electron deficient 
alkenes. Burdisso et al. have extensively explored this method with studies into the 
steric interactions of nitrone cycloadditions with ethylenes, 53 whilst Huisgen and Seidl 
have investigated reactions . with various acetylenes to generate functionalised 
pyrroloisoquinolines. 54 Orito et al. reported the synthesis of these templates by 
intramolecular condensation of intermediate (132) with the elimination of water as 
shown in route B. 55 Katritzky et al. established novel methodology by utilising route C, 
which involved cyclisation of an N-acyliminium cation (133) generated by loss of a 
benzotriazolyl anion (134a) in the presence of titanium tetrachloride. 52 Other research 
groups have explored this route, involving carbon-carbon bond formation from 
cyclisation of N-acyliminium ions generated by protonation of an enamide (134b)56 or 
by elimination of a hydroxy (134c),57 ethoxy (134d)58 or phenylthio group (134e).59 
Padwa et al. have recently reported the synthesis of alkyl-thio-substituted 
five-membered lactams (136) by treatment of amido-substituted thioacetals (135) with 
dimethyl(methylthio)sulfonium tetrafluoroborate (DMTSF) as shown in Scheme 43.60 
Scheme 43: 
MoO m 
MoO "'-I Lo 
EtS SEt 
(i) 
(135) 
~N4:Mo 
SEt 
(136) 
OMe 
J<._r{j-oMo l_gN 
(137) 
Reagents: (i) DMTSF (2 equiv), DCM, 12 h (64 %). 
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M eO~ 
MoOA:J HNJo 
Mes,SJSEt 
Et 
-EtSSMe 
M eO~ 
A) IiN o MeO ~u·~ 
EtS~ 
I N MeOXX& 
MeO ~ 0 
(138) 
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Such lactams (136) act as transient intermediates and upon further reaction with 
DMTSF, generate an N-acyliminium ion (137) that undergoes subsequent cyclisation 
with the tethered aromatic ring to produce the pyrroloisoquinoline template (138). 
Additional methods include the stereoselective synthesis of pyrrolo[2, l-a ]isoquinolines 
(141) by Lete et al. via a tandem organolithium addition/N-acyliminium ion cyclisation 
as shown in Scheme 44. 61 
Scheme 44: 
0 Ae 
-{_A~~ OMe 
qN OTBDPS 
0 
(139) 
OH 
M eO 0 
(141) 
(i) 
R=Me,Bu 
Reagents: (i) RLi, THF, -78 °C, 6 h; (ii) BF3.0Et2, DCM, t1, 4 d. 
R 
The chiral succinimide (139) was reacted with organolithiums (methyl or butyllit~ium) 
to generate the corresponding oxoamide (140), which upon treatment under Lewis acid 
conditions undergoes stereoselective cyclisation to afford the trans-pyrroloisoquinolines 
(141) with no trace of the related cis-diastereoisomer. 
More recently, Allin et al. reported a novel, highly stereoselective approach to the 
tricyclic core of the erythrinane ring system in which the key step involved an 
asymmetric intramolecular N-acyliminium mediated cyclisation. 62 Treatment of the 
bicyclic lactam (142) with the Lewis acid activator titanium tetrachloride gave the target 
pyrroloisoquinoline ring system (144) as a single diastereoisomer, with inversion of 
stereochemistry at the ne.wly formed chiral centre (Scheme 45). 
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Scheme 45: 
(i) ~0 
(142) (143) (144) 
Reagents: (i) Lewis acid, DCM, -I 0 °(, 20 h. 
It is presumed that the cyclisation, to yield the product (144) proceeds via the 
N-acyliminium ion intermediate (143). 
1.4. Applications of N-Acyliminium Ions in Alkaloid Synthesis 
The formation of optically pure heterocyclic templates from non-racemic substrates is 
now a standard, and widely applied technique in the synthesis of a number of 
therapeutically active natural and unnatural compounds. The applications of 
functionalised chiral bicyclic lactams as useful precursors for asymmetric synthesis has 
been described in preceding sections, and the N-acyliminium cyclisation has been 
applied with excellent success in the synthesis of a wide range of both simple and 
complex chiral polycyclic alkaloids. 
1.4.1. Stereos elective Synthesis of the Isoindolinone Ring System 
0 
cCN 
(145) 
The isoindolinone ring system (145) is an interesting synthetic target due to actual and 
potential biological activities of many of its derivatives. 63 In addition, the fused 
heterocyclic isoindolinone moiety is present in several naturally occurring chiral 
alkaloids; including lennoxamine64 (147) and neuvamine65 (146), which was the first 
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isoindolisoquinoline isolated from the natural source, the Berberis Darwinii Hook found 
in Southern Chile. 
0 OMe 
OMe 
(146) (147) 
Heaney and Shuhaibar reported the use of ~methoxyisoindolones (150) as useful 
acylimin~um precursors in the synthesis of the isoindolinone template (151) 
(Scheme 46).66 The aminol lactone (149) was formed in quantitative yield from the 
reaction of ,8-phenylethylamine with 3-hydroxyphthalide (148), which upon treatment 
with thionyl chloride followed by methanol gave the methoxyisoindolone intermediate 
(150). Treatment of (150) with titanium tetrachloride in dichloromethane gave the 
expected isoindoloisoquinoline derivative (151) in quantitative yield and constitutes a 
novel synthesis of the nuevamine skeleton (146). 
Scheme 46: 
(i) ~0 HN_rQ 
(148) (149) 
l (il) 
0 (iii) ~N_rO 
OMe 
(151) (150) 
Reagents: (i) ,8-Phenylethylamine, PhMe, D., 4 h; (ii) SOCI2 then MeOH; (iii) TiCI4, DCM, -78 °C, 2 h. 
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Several other research groups have reported the synthesis of chiral ring-fused 
isoindolinone targets via N-acyliminium ion cyclisations, however few have addressed 
the issue of stereocontrol during the reaction. Allin et al. have recently developed a 
facile new two-step procedure for the synthesis of chiral ring-fused isoindolinones, with 
extremely high levels of diastereoselectivity, from readily available starting materials.67 
Condensation of enantiomerically pure amino alcohols phenylglycinol (152a/b) and 
phenylalaninol (153alb) with 2-formylbenzoic acid (154) produced the desired 
trans-tricyclic r-Iactams (155a/b) and (156a/b) respectively, with excellent 
diastereoselectivity (Scheme 47, Table 1).68 
Scheme~7: 
(152a) R= Ph 
(153a) R = CH2Ph 
(152b) R= Ph 
(153b) R= CH2Ph 
Reagents: (i) PhMe, b.. 
Table 1: 
Substrate 
(152a) 
(152b) 
(153a) 
(153b) 
R 
CCCO,H 
CHO 
(154) 
(i) 
Yield(%) 
70 
70 
72 
71 
cc5N+R 
H b_J 
(155a) R= Ph 
(1S6a) R = CH2Ph 
~NJH· 
H 0 
(155b) R= Ph 
(156b) R = CH2Ph 
Diastereoselectivity 
(155a), exclusive 
(155b ), exclusive 
(156a), exclusive 
(156b ), exclusive 
A mechanism has been proposed by Allin to explain the stereochemical outcome of the 
reaction outlined in Scheme 48.68 The hydroxyimine (157) could undergo a reversible 
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cyclisation to produce both the trans-(l58a) and cis-(158b) oxazolidines (referring to 
the stereochemistry at C-2 and C-5). Ring closure of (158a) with the loss of water 
yields the observed trans-tricyclic lactam (159a). The cyclisation to (159b) however, 
appears from. simple molecular modelling studies to be highly disfavoured due to the 
remote orientation of the reactive functional groups. 
Scheme 48: 
(157) 
o:C~H 
H17Y-R 
(158a) 
ojN+R 
H O.:J 
Trans-(159a) 
Cis-(159b) 
The potential of tricyclic lactam (160) to act as a suitable precursor for intramolecular 
N-acyliminium ion cyclisation was demonstrated upon treatment with a Lewis acid 
·activator. Nucleophilic attack of the aromatic substituent formed the desired tetracyclic 
isoindolinone target as a mixture of two diastereoisomers (16la/b) (Scheme 49).67 
Scheme 49: 
OH OH 
(i) + 0 
(160) (161a) (161b) 
Reagents: (i) Lewis acid, DCM, -10 °C, 20 h. 
An extremely high degree of diastereoselectivity can be achieved in this reaction as 
displayed in Table 2, particularly with trimethylsilyl triflate as the Lewis acid activator. 
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Table 2: 
Entry Activator Yield(%) (161a): (161b) 
a SnCl4 98 2:1 
b TiCl4 93 2:1 
c BF3.0Etz 99 3:1 
d HzS04 80 6:1 
e TMSOTf 97 ~49:1 
The stereochemical outcome of the reaction was rationalised by invoking the 
conformational models highlighted in Scheme 50. In transition state A, leading to the 
favoured diastereoisomer (161a), the carbonyl moiety would be "eclipsed" in a 
1,3-fashion by the hydrogen atom at the chiral centre. 
Scheme 50: 
! 
OH 
I '"H 
~bo 
(161a) 
A--fo_jr 
~Nv.:O-LA 
I = H 
u 
[[I 
! 
(16lb) 
In the alternative transition state B (leading to the minor diastereoisomer (16lb)) 
however; an unfavourable 1 ,3-interaction between the carbonyl group and the more 
bulky Lewis acid complexed oxymethyl group exists. The possibility of an additional 
seven-membered chelate generated from the amide oxygen atom and the alkoxy group 
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with a metal counter-ion, could make transition state B initially seem more favourable. 
However from consideration of the results shown in Table 2, it is clear that if chelation 
does occur, it leads to lower levels of diastereoselectivity probably due to an increased 
contribution of a chelated transition state similar in structure to B.67 
1.4.2. Stereoselective Synthesis of Benzoquinolizidine Derivatives 
o:cro 
(162) 
The benzo[a]quinolizidine ring system (162) is of considerable significance since this 
heterocyclic motif is present within a wide range of pharmacologically active 
compounds. Some examples include the protoberberine alkaloid xylopinine (163),69 
which has shown potential as an antimicrobial agent whilst (-)-protoemetinol (164)70 
and more recently alangine (165), 71 isolated from Alangium lamarckii act as potent 
inhibitors of HIV -1 reverse transcriptase. 
M eO 
M eO 
OMe 
OMe 
(163) 
M eO 
M eO 
OH 
(164) 
M eO 
M eO 
(165) 
Based on their stereoselective approach to the pyrroloisoquinoline62 and 
isoindoloinone67 ring systems, Allin at al. envisaged that a suitably bicyclic lactam 
(166) could act as a precursor toward the tetrahydroisoquinoline core (162) of such 
compounds. This approach involved the introduction of asymmetry during the key ring-
forming step via an N-acyliminium intermediate (Scheme 51).72 Synthesis of the 
desired bicyclic lactam (166) followed the method previously described by Amat.73 
Separation of the lactam diastereoisomers and subsequent cyclisation upon treatment 
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with titanium tetrachloride produced exclusively the trans-product (167) in both cases, 
evidence to support the proposed mechanism involving an N-acyliminium intermediate. 
Scheme 51: 
0 YY'(YOMe 
H O_j ~OMe 
OH 
M eO~ 
MeOAJ~(ro (i) 
(166) (167) 
Reagents: (i) TiCI4, DCM, -10 °C, 20 h (65 %). 
In collaboration with Amat, Allin et al. developed complimentary routes to 
functionalised benzoquinolizidine derivatives that allow the preparation of targets with 
complete control of relative stereochemistry.74 The first method is through conjugate 
addition to an a,,B-unsaturated tetrahydroisoquinoline substrate (169) (Scheme 52). 
Scheme 52: 
(i)-(iv) 
(167) 
M eO~ 
MoO~'>('''')'~ O 
H' 
~ 
(vii) 
(170) 
M eO~ 
MeoAJ;Oo 
(168) 
l (v)-(vi) 
M eO~ 
MeOA),,O''"''"'~ N 0 
. H 
.0 
(169) 
Reagents: (i) IBX, DMSO, 24 h (70 %); (ii) NaCI02, NaH2P04, MeCN, t-BuOH, H20, 18 h (86%); (iii) (PhSe)2, 
PBu3, DCM, 18 h (76 %); (iv) n-Bu3SnH, AIBN, PhMe, 80 °C, 2 h (81 %); (v) LDA, PhSeBr, THF, -78 °C, 24 h; 
(vi) Na104, NaHC03, MeOH, H20, 18 h (61 %); (vii) Vinyl MgBr, CuCN, TMSCI, THF, -78 °C, 24 h (67 %). 
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Removal of the hydroxymethyl substituent present in the~ tetrahydroisoquinoline 
skeleton (167) was accomplished in four steps via the acylselenide followed by radical 
decarbonylation (Scheme 52). Treatment of (168) with lithium diisopropylamine and 
phenylselenylbromide followed by oxidation, generated the a,/3-unsaturated substrate 
(169), which allowed conjugate addition of vinylmagnesium bromide to form the 
desired product as the single trans-diastereoisomer (170) as observed in alangine (165). 
Scheme 53: 
OH 
M eO~ 
Me04 k 2 
·(171) 
(i) 
(ii) 
MoC,\ ... y~OMo 
H O_l ~OMe 
(172a) (13 %) 
+ 
Me02C~0 
NJCtOMe 
--- I 
H 0 o OMe 
(172b) (67 %) 
Reagents: (i) PhMe, 6, 24 h (80 %); (ii) TiCI4, DCM, -78 °C, 3 d (36%). 
The alternative route that incorporates functionality at an earlier stage, involved the 
stereoselective cyclocondensation of a chiral amino alcohol (171) with the prochiral 
glutarate as shown in Scheme 53. This approach lead to the formation of separable 
functionalised bicyclic lactams (172a/b ). The major N-acyliminium precursor (172b ), 
on treatment with titanium tetrachloride gave the benzoquinolizidine derivative (173) 
containing cis relative stereochemistry as required in protoemetinol (164).74 
1.4.3. Stereoselective Synthesis of the Erythrina Alkaloids 
(174) 
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The genus Erythrina is common in tropical and sub-tropical regions and the alkaloids 
have been used in indigenous medicine. 75 Members of the Erythrina family have shown 
·curare-like and hypnotic activity, and a number of pharmacological effects including 
sedative, hypotensive, neuromuscular blocking and central nervous system activity have 
been associated with its tetracyclic template (174)/6 examples of which include 
(-)-3-demethoxyerythratidinone (175), erysotramidine (176) and erythraline (177). 
0 
(176) (177) 
Recently, Allin et al. have extended their initial methodology toward the pyrrolo 
isoquinoline ring system, a key structural subunit of the Erythrina alkaloids, towards a 
functionalised tetracyclic core (179) in a highly stereoselective manner (Scheme 54).77 
Scheme 54: 
OH 
M eO~ 
MeOJl) k 2 
(171) 
OH 
M eO 
M eO 0 
_c:Yl(YOMe 
({Jo_; ~OMe 
(178) 
!(il) 
0&0Me 
+ ~. /; OMe 
;,N 
0 
\ 
LA 
Reagents: (i) PhMe, ~. 48 h (63%); (ii) TiCI4, DCM, -78 °C, 20 h (92 %). 
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The formation of the required tricyclic lactam (178) followed similar methodology to 
that previously described by All in et a!, 62 with the condensation of a suitable {3-amino 
alcohol (171) and the required keto-acid substrate under Dean-Stark conditions in 63 % 
yield. Treatment of the lactam (178) with an excess of titanium tetrachloride at low 
temperature produced the key tetracyclic product (179) with deprotection of the ketal 
protecting group in 92 % yield and with excellent diastereoselectivity. 
Removal of the pendant hydroxymethyl auxiliary from template (179) was achieved in a 
three-step procedure by initial oxidation of the primary alcohol with Dess-Martin 
periodinane to provide aldehyde (180) (Scheme 55). The aminoketone (181) was then 
completed by a rhodium-catalysed decarbonylation protocol to access the corresponding 
enamide· and its subsequent reduction by catalytic hydrogenation.77 
Scheme 55: 
OH 0 
M eO M eO 
H (i) 
M eO 0 M eO 0 
(179) (180) ! (il)-( ill) 
M eO 
0 (iv) M eO 0 
(182) (181) 
Reagents: (i) Dess-Martin periodinane, DCM (93 %); (ii) Rh(PPh3h(CO)CI, dppp;p-xylene, 6., 4 d (61 %); (iii) Pd/C, 
H2, EtOH (79 %); (iv) Ethylene glycol,p-TsOH, PhMe, 6.. 
The formal asymmetric synthesis of (-)-3-demethoxyerythratidinone (175), the natural 
enantiomer isolated from Erythrina lithosperman in 1973 by Barton, 78 was completed. 
by re-protection of the ketone using ethylene glycol to give intermediate (182) 77 which 
had been converted by others to the natural product in a four-step sequence. 79 
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1.4.4. Stereos elective Synthesis of Indole Alkaloids 
0 
(183) 
The indolo[2,3-a]quinolizine ring system (183) is of great interest smce this 
heterocyclic skeleton is found within a plethora of highly bioactive indole alkaloids, 
including geissoschizine (184),80 vellosimine (185)81 and ajmalicine (186).82 
CHO 
(184) (185) (186) 
Recent approaches to the construction of this heterocyclic target system by other groups 
have included the Mannich reaction,83 Bischler-Napieralski reaction,84 Fi~cher indole 
synthesis85 and the Pictet-Spengler reaction.86 Allin et al. have recently developed a 
stereoselective synthesis of the indolo[2,3-a] quinolizine ring system (183),87 based on 
the general approach to a range of non-racemic heterocycles, as detailed in this section. 
Synthesis of the required bicyclic lactam (188) followed the method previously used by 
Allin. Dean-Stark condensation of (S)-tryptophanol (187) with an appropriate keto-ester 
for 48 hours, which under these reaction conditions generated the expected bicyclic 
lactam in 69 % yield as a 5:1 mixture of diastereoisomers (188) (Scheme 56). 
Treatment of the mixture of isomers (188) with hydrochloric acid in ethanol at room 
temperature for 20 hours gives an excellent 95 % yield of the expected trans-cyclic 
product (189) as a single diastereoisomer. 87 
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Scheme 56: 
Qy2H 
HN NHz 
(187) 
(190) 
CHO 
~C02 Me 
(i) 
Reagents: (i) PhMe, 11, 48 h (69 %); (ii) 2 M HCI, EtOH, 20 h (95 %). 
C}~ 
H 0 NH 
(188) 
!(h1 
f\~JH 
~_[~~yo 
HH~ 
(189) 
From this structure (189) the key building block (190) is easily generated, which due to 
the presence of the lactam carbonyl allows several avenues for functionalisation en 
route to natural product targets (Scheme 57). 
Scheme 57: 
(i)-(ili) 
(190) 
! 
(\__I~ ~Jt0 .. ~ N 0 Bocf H ~ (i)-(ii) 
(192) 
........ C02 Me 
(193) 
(\___/'-... 
'-=\.]. .~ N 'Dv,N HH 
~ 
(191) 
(194) 
Reagents: A (i) LDA, MeCHO, THF, -78 °C, 24 h; (ii) Et3N, MsCI, DCM, 3 h; (iii) DBN, THF, 16 h (65 %); 8 (i) 
Methyl-1,3-dithiolane-2-carboxylate, n-BuLi, THF, -78 °C, 24 h (47 %); (ii) NiCI2, NaBH4, THF/MeOH, 4 h (73 %). 
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Route A utilises the formation of a lithium enolate to introduce an ethylidene substituent 
at the 3-position via a three-step aldol/elimination procedure. This has been applied in 
the total asymmetric synthesis of (R)-(+)-deplancheine (191), an alkaloid isolated from 
the New Caledonian plant Alstonia deplanchei, with an e. e. >95 %.88 
Alternatively, the introduction of a,/1-unsaturatiori to give (192) allows access to the 
2-position via Michael addition, as demonstrated in route B with the asymmetric 
synthesis ofthe indole alkaloid derivative (+)-12b-epidevinylantirhine (194).89 Upon the 
addition of lithiated methyl 1,3-dithiolane-2-carboxylate to substrate (192), the 
exclusive formation of the addition product (193) was observed as a single 
diastereoisomer in 47 % yield. Further transformation involving desulfurisation, 
deprotection and reduction completed the desired target (194) displaying cis relative 
stereochemistry at positions 2 and 12b. 
1.4.5. Stereo selective Synthesis of the Cephalotaxus Alkaloids 
R= 
0 
HO~~ 
' OH I 
C02 Me 
(196) Harringtonine 
OMe 
(195) R = H Cephalotaxine 
0 
X 
' OH I 
C02 Me 
(197) Deoxyharringtonine 
0 
HO, /'-... ~-- jl__~ /<.,_ "-" ,Xo~ 
I 
C02 Me 
(198) Homoharringtonine 
We recognised that an extension of the methodology used in the construction of the 
isoindolinone, benzoquinolizidine, erythrinane and indolo[2,3-a]quinolizine ring 
systems would be its application toward the synthesis of (-)-caphalotaxine (195), the 
parent compound of the Cephalotaxus alkaloids. 
Interest in the members of the Cephalotaxus alkaloids has remained high since their 
isolation in 1963 by Paudler90 and subsequent characterisation in the 1960s and 1970s.91 
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The evergreen plum-yews of the genus Cephalotaxus, which are indigenous to 
south-east Asia, produce a range of structurally related polycyclic homoerythrina 
alkaloids of which (-)-cephalotaxine (195) is the most abundant member.92 Whilst 
cephalotaxine itself is largely biologically inactive, significant interest has been paid to 
its ester derivatives, especially harringtonine (196), deoxyharringtonine (197) and 
homoharringtonine (198), which have been found to be highly effective for the 
treatment of acute human leukemia and are currently undergoing advanced clinical 
trials.93 More recently, homoharringtonine (198) has shown potential as a potent agent 
against strains of the chloroquinine-resistant Plasmodium f malaria parasite. 94 
The natural source of this alkaloid remains limited and some species of the Asian shrub 
from which ·it is extracted are now endangered. For these reasons, this structurally 
unique class of alkaloids, of which a 1-azaspiro[ 4.4]-nonane moiety fused to a 
benzazepine system is a common feature, have stimulated a large number of studies 
directed towards the total synthesis of these compounds. 
Scheme 58: 
~=Ud~ 
OH 
(199) R=O 
(201) R= H2 
(200) R= 0 
(202) R=H2 
Over the last 40 years, a number of racemic synthetic approaches to the core pentacyclic 
ring system of cephalotaxine (195) have been developed. However, to date it is 
surprising to find that only six syntheses of optically pure (-)-cephalotaxine (195)95 
have been reported in which the polycyclic core alkenes (200) and (202) are common 
intermediates. The most significant work in this area has focused on the formation of 
the spirocyclic allylic alcohols (199) and (201) as key intermediates, followed by 
subsequent intramolecular cyclisation as shown in Scheme 58, which was initially 
applied by Kuehne et al. in the synthesis of (±)-cephalotaxine (195).96 
Introduction 44 
Treatment of the key allylic alcohol intermediate (199) with stannic chloride in 
dichloromethane and nitromethane resulted in cyclisation to the desired tetracyelic 
lactam core (200) in quantitative yield. With this core olefin· (200) in hand, 
' 
furictionalisation toward cephalotaxine (195) was achieved by oxidation with osmium 
tetraoxide to the corresponding diol (203), followed by further oxidation with dimethyl 
sulfide, N-chlorosuccinimide and triethylamine at -42 ·c to the lactam diketone (204) in 
89 % yield (Scheme 59). 
Scheme 59: 
~=Vd~ 
OH 
(199) 
0 
·~ 
(iv) 
<0 
0 
OMe 
(205) 
(i) 
0 
(204) 
(v) 
~=ccg:t 
(ii) 
(200) 
(iii) 
OMe 
(195) 
~~::( 
. :0.1) 
OH 
(203) 
Reagents: (i) SnCI4, MeN02, DCM, -78 ·c, I h (lOO%); (ii) Os04, NMO, THF, 24 h (99 %); (iii) Me2S, NCS, Et3N, 
DCM, -42 ·c, 2.5 h (89 %); (iv) TMSOMe, TfOH, DCM, 24 h (97 %); (v) LiAIH4, THF, !:>, I h (88 %). 
Finally, the sterically less hindered ketone was converted to the enol ether (205) with 
trimethylsilyl methyl ether and triflic acid, followed by reduction with lithium 
aluminium hydride to provide racemic cephalotaxine (195) in 88 % yield. This 
pioneering methodology has since been utilised in three of the six reported total 
asymmetric syntheses of (-)-cephalotaxine (195) using optically active spirocyclic 
allylic alcohol substrates.95a-c 
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To the best of our knowledge, only one formal total synthesis of (±)-cephalotaxine (195) 
based on N-acyliminium ion chemistry has been achieved to date. The key steps in the 
synthesis reported by Nagasaka et al. 97 include the formation of pyrroloisoquinoline 
(207), the ring-expansion to pyrrolobenzazepine (209) and the construction of the 
cyclopentapyrrolobenzazepine ring system (212), a key intermediate in Hanaoka's 
. synthesis,98 all derived from sequential N-acyliminium ion intermediates (Scheme 60). 
Scheme 60: 
0 
0 ;=<-/ 
~1__r\fo 
HO-iOMo 
R 
(206) 
(209) 
(i) 
(ii) 
(208) 
<0 
0 
(210) 
0 
(212) 
l 
o=g:& ~ I .0 N 0 
HO 
R 
(207) 
l (ill) OBn 
0 
<0 
0 
~ OBn 
0 Ho) 
(211) 
Reagents: (i) BF3.0Et2, DCM, --45 'C (80 %); (ii) S02C12, Et3N, CHC13, py, -78 'C (76 %); (iii) TiC14, DCM (71 %). 
The synthesis of building block (207) as a tertiary N-acyliminium ion equivalent from 
the methoxylactam (206) proceeded smoothly under Lewis acid conditions to afford the 
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pyrroloisoquinoline (207) in excellent yield as a 2:1 mixture of diastereoisomers. 
Chlorosulfonylation of the crude mixture, followed by migration of the aromatic ring 
allowed the successful ring-expansion to pyrrolobenzazepine (209) via the acyliminium 
ion (208) in 76 % yield. The final key step, the intramolecular cyclisation of 
,8-keto-ester (210) occurred upon exposure with titanium tetrachloride through the 
formation of intermediate (211). Subsequent debenzylation completed the formal 
synthesis and gave the target pentacyclic ketone (212) in a 1 :4;3 ratio (cis:trans). 
In 2003, an interesting novel synthesis of (±)-cephalotaxine (195) involving a similar 
pentacyclic intermedia~e (216) was detailed by Li and Wang (Scheme 61),99 which was 
based on the postulated biogenesis of cephalotaxine (195) reported by Parry et al. 100 
Scheme 61: 
(213) 
0 
(216) 
10 Steps 
4 steps 
Reagents: (i) Zn, AcOH, I 00 ·c (65 %). 
<0 
0 
.. 
<0 
0 
0 
(214) 
• 
OMe 
(195) R= H 
(i) 
<0 
0 
HO 
(215) 
The synthesis commenced with the Bischler-Napieralski cyclisation of the 
phenylethylamine (213) followed by structural modification over a further nine steps to 
form the key intermediate pentacyclic amino enone (214) in good yield. Upon exposure 
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to zinc dust in warm acetic acid, amino enone (214) underwent a transannular reductive 
skeletal rearrangement via the transient bridged aziridinium species (215) to generate 
the unique fused benzazepine system (216), which was easily converted to 
cephalotaxine (195) in four additional steps. This key transformation may be regarded 
as a novel biomimetic synthesis in terms of its unique pentacyclic ring construction and 
offers a new and efficient formation of this class of alkaloid. 
We envisage an asymmetric route to the key homo-erythrinane (214) described by Li 
and Wang, or derivative of such, via a stereoselective N-acyliminium cyclisation from a 
suitable polycyclic lactam precursor. Thus, subsequent skeletal rearrangement and 
structural modification would allow a non-racemic entry toward (-)-cephalotaxine 
(195). The progress toward the proposed synthesis of this highly desirable structural 
unique template is reported in the proceeding sections. 
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CHAPTER TWO: 
RESULTS AND DISCUSSION 
2.1. Asymmetric Cyclisations of Chiral N-Acyliminium Ion Precursors 
2.2. Application in the Synthesis of Naturally Occurring Alkaloids 
2.3. Application as Potential Building Blocks for Peptide Mimics 
2.4. Application Toward the Synthesis of Cephalotaxine 
2.1. Asymmetric Cyclisations of Chiral N-Acyliminium Ion Precursors 
As detailed in Section 1, the high versatility exhibited by N-acyliminium species is well 
documented and has created an active interest in these compounds as useful synthetic 
intermediates to access various chiral fused-ring targets. The methodology developed by 
Allin et al, in which substituted bicyclic lactams act as N-acyliminium ion precursors in 
the synthesis of enantiomerically pure heterocyclic templates, is also well established. 1 
Scheme 1: 
(2) (1) (3) 
Our initial investigations focused on the construction and manipulation of substituted 
chiral indolizidines (1), a key structural subunit present in both the pyrroloisoquinoline 
(2)1b and the indolizino[8,7-b]indoles (3)2 model systems (Scheme 1). 
2.1.1. Stereoselective Synthesis ofPyrrolo[2,1-a]isoquinolines 
Interest in the pyrroloisoquinoline ring system of general structure (4) is well 
documented as a skeletal motif for the Erythrina alkaloids. However its core structure is 
not restricted to just one class of alkaloid and has been utilised as intermediates in the 
synthesis ofvarious compounds, including cephalotaxine as detailed in Section 1.4.5. 
As previously mentioned, it was recognised by Allin and James that a duly substituted 
bicyclic lactam could act as a precursor for the stereoselective synthesis of the 
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pyrroloisoquinoline template (10). This short reaction sequence detailed in Scheme 4 
was used as an experimental introduction to the concept of N-acyliminium chemistry. 
The synthesis of the pyrroloisoquinoline ring system (10) by Allin and James required 
the initial preparation of an optically pure amino alcohol (6). This was generated in 
quantitative yields by reduction of the corresponding amino acid, L-phenylalanine (5) 
with lithium borohydride and trimethylsilylchloride, as shown in Scheme 2.3 
Scheme 2: 
uiOH (i) {)C,OH 
(5) (6) 
Reagents: (i) LiBH4, TMSCI, THF, 24 h (99 %). 
The reaction is believed to proceed through a borane-tetrahydrofuran complex (7) in 
which borane exists as a Lewis acid-base species with the ether oxygen (Scheme 3). In 
the presence of excess trimethylsilylchloride, it is this complex which is envisaged to 
act as the required reducing agent. 
Scheme 3: 
THF 
(7) 
Scheme 4 outlines the stereoselective synthesis of the pyrroloisoquinoline ring system 
(10) from the N-acyliminium precursor (8), which is formed by condensation of the 
.B-amino alcohol (6) with succinic anhydride in the presence of triethylamine. Following 
reduction of the imide (8) with sodium borohydride in ethanol, the intermediate ethoxy 
lactam (9), which exhibited no sign of direct N-acyliminium cyclisation under the protic 
acid conditions, was treated with titanium tetrachloride to undergo clean conversion to 
the cyclic template (10). The desired heterocycle (10) was obtained as a single 
diastereoisomer in 44 % yield, which is very respectful when compared to the literature 
value of 53 %, previously published by Allin and James. 1b 
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Scheme 4: 
OH 
~ (i) ~N-c9 
0 
(6) (8) 
(ill) 
OEt 
(10) (9) 
Reagents: (i) Succinic anhydride, Et3N, PhMe, 1:!., 18 h (62 %); (ii) NaBH4, 2 M HCI, EtOH, 20 h; (iii) TiCI4, DCM, 
-78 octo rt, 20 h (44 %). 
This methodology has since been applied in the synthesis of a range of substituted 
pyrroloisoquinoline derivatives 1b and the indolizino[8,7-b]indole ring system? 
2.1.2. Stereos elective Synthesis of lndolizino[S, 7-b]indoles 
(11) 
The initial applications of this chemistry allowed access to the pyrroloisoquinoline 
system (10) by a stereoselective attack of an electron-rich aromatic nucleophilic at the 
planar N-acyliminium ion intermediate. By substitution of the aromatic ring with an 
increasing electronegative indole 7!"-nucleophile, it was envisaged that the tetracyclic 
core of a new class of physiologically active compounds (11), could be accessed in 
novel fashion.2 
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Indolizino[8, 7 -b ]indoles of general structure (11) have attracted great interest as 
synthetic intermediates in the pharmaceutical industry. Indeed, a number of these 
indoles are known to exhibit analgesic and anti-inflammatory activity in their own 
right,4 however they have been widely used as a core building block for more complex 
alkaloids which possess diuretic properties. 5 
A typical method for the preparation of indolizino[8,7-b]indole derivatives (11) is the 
condensation of a tryptamine derivative (12) with a keto-acid or keto-ester species. An 
example of such is the diverse range of tetrahydro-,8-carbolines (14) prepared by a 
modified Pictet-Spengler reaction demonstrated in Scheme 5. The resulting secondary 
amine (13) formed during condensation then reacts intramolecularly with loss of water 
and subsequent ring closure to give the desired indolizino[8,7-b]indole (14).6 
Alternatively, tryptamine (15) can be converted to the corresponding imide (16) by 
reaction with succinate esters and cyclisation to the ,B-carboline derivative (17), 
accomplished under Bischler-Napieralski conditions as shown in Scheme 6.7 
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Scheme 6: 
Qn 
N NH2 
H 
(15) 
R 
R 
Our approach to the indolizino[8,7-b]indole template (21) shown in Scheme 7, mirrors 
the synthesis of the pyrroloisoquinoline equivalent (10) previously applied by our 
group, with excellent levels of stereo control. 
Scheme 7: 
~N 0 (i) ~N 
0 OEt 
(18) (19) 
1 
0 
eN 
rL~JH 
~NJ'Xk~o 
HHL_j 
(21) (20) 
Reagents: (i) NaBH4, 2 M HCI, EtOH, 20 h (85 %). 
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Subjecting imide (18) to the typical sodium borohydride reduction conditions as 
described earlier in Scheme 4, en route to the expected ethoxylactam precursor (19), 
resulted in direct cyclisation via the N-acyliminium ion (20) to the target ~-carboline 
(21) as a 9:1 mixture of diastereoisomers and in an excellent 85 %yield. To date the 
ethoxy lactam intermediate (19) has not been isolated.2 
Presumably, under the acidic reaction conditions, the increased nucleophilicity of the 
indole ring is able to attack the N-acyliminium ion generated in situ and cyclise directly. 
The major isomer (21) was isolated from the mixture by recystallisation and the relative 
stereochemistry was confirmed by X-ray crystallography, with the hydrogen atoms at 
positions 5 and 11 b situated in a trans relationship (Figure 1 ). 
Figure 1: Single Crystal X-Ray Structure of (21). 
OH 
coxo 
HHLJ 
(21) 
An approach to the analogous indolizino[8,7-b]indole ring system (25) has also been 
investigated that proceeds via the bicyclic lactam (23), which acts as an N-acyliminium 
ion precursor (Scheme 8).2 The ~-amino alcohol (22) of L-tryptophan was reacted under 
Dean-Stark conditions with levulinic acid for 48 hours. Under these reaction conditions 
the expected bicyclic lactam (23) was only isolated in 3 % yield, the major product 
being the target indolizino[8,7-b]indole derivative (25) formed as a single 
diastereoisomer in 55 % yield. 
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Scheme 8: 
0 
(i) (/;l 
Me 'o 
(22) (23) 
! 
~N 
Me 
(25) (24) 
Reagents: (i) Levulinic acid. PhMe, ,1, Dean-Stark, 48 h (55 %). 
The stereochemistry of the heterocyclic product (25) has been confirmed as the anti 
configuration with respect to the angular methyl substituent and the hydroxymethyl 
auxiliary by X-ray crystallography as shown in Figure 2. Effectively, retention of 
configuration at the methyl-bearing chiral centre is observed if one considers the 
bicyclic lactam (23) as an intermediate. 2 
Figure 2: Single Crystal X-Ray Structure of (25). 
C' 
(25) 
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One could however, envisage an alternate mechanism to explain the formation of (25) 
which avoids the intermediacy of the bicyclic lactam (23); a stereoselective 
Pictet-Spengler condensation of the ,6-amino alcohol and keto-acid substrate that results 
in the initial formation of a tetrahydro-,6-carboline derivative and then undergoes lactam 
formation to yield (25) in the final step. 8 To date, no intermediates have been observed 
by us that would support this hypothesis with our substrates. 
2.1.3. Cyclisations Involving Indole - Proposed Mechanism 
The chemistry of indole is, in many ways that of a reactive pyrrole ring with a relatively 
unreactive benzene ring attached, in that electrophilic substitution almost always occurs 
on the pyrrole ring. However, indole and pyrrole differ in one important aspect, that is 
electrophilic substitution is preferred in the 3-position with almost all reagents. 
Examples include halogenation, nitration, sulfonation, Friedel-Crafts acylation and 
alkylation which all occur cleanly at this position. 
A simple explanation is that reaction at the 3-position involves the isolated enamine 
system in the five-membered ring and hence does not disturb the aromaticity of the 
benzene ring (Scheme 9). 
Scheme 9: 
+ 
~~ 
H 
H 
00~ 
H 
E 
00 
H 
The positive charge in the intermediate is, of course, delocalised round the benzene ring, 
however its main stabilisation is from the nitrogen atom. It is not possible to get 
reaction at the 2-position without seriously disturbing the aromaticity of the benzene 
ring (Scheme 10). 
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Scheme 10: 
+ 
qfE---~ ~H 
vt£'E 
H 
~E v--r 
H 
If the 3-position is blocked, reaction will occur at the 2-position, which seems to 
suggest that electrons can be taken the 'wrong way' round the five-membered ring. An 
intramolecular Friedel-Crafts alkylation experiment involving a tritium (radioactive 3H) 
labelled substrate next to the ring has shown that this is not so simple (Scheme 11). 
Scheme 11: 
(i) 
OH 
Reagents: (i) BF3• 
The resulting product showed exactly 50 % of the label where it is expected and 50 % 
where it is not, which indicates the reaction must have a symmetrical intermediate for 
this result to occur. The obvious candidate arises from attack at the 3-position, the s·o 
called spiro compound, in which the five-membered ring is at a right angle to the indole 
ring with each CH2 group having an equal chance of migrating as shown in Scheme 12. 
Scheme 12: 
Qx) 
H 
The migration is a pinacol-like rearrangement; it is thought that most substituent's in the 
2-position occur via this migration, but some attack directly with disruption of the 
aromatic ring. 9 
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The condensation reaction to produce the target ,B-carboline product (25) is envisaged to 
initially proceed via the bicyclic lactam intermediate (23), as its presence in the reaction 
mixture would suggest (Scheme 13). 
Scheme 13: 
JN -
\_( -oH 
Me 
(23) (24) 
-w 
0 
(25) (26) 
Rotation about the iminium bond in the resultant N-acyliminium species (24) to the 
more favourable conformation is then assumed, which is followed by stereoselective 
intramolecular attack of the indole, initially occurring at the 3-position to generate the 
spiro compound (26). Bond migration to the 2-position followed, resulting in the target 
heterocycle (25). 
2.1.4. Rationalisation of the Observed Stereochemical Outcome 
The stereochemistry observed in the cyclised products (10), (21) and (25) has been 
rationalised by invoking the conformational models detailed in Figure 3, in which 
formation of the ethoxy lactam (19) and bicyclic lactam (23) leads to the formal 
N-acyliminium ion intermediates (20) and (24) respectively. 10 
Results and Discussion 63 
Figure 3: Proposed Conformational Models. 
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(25a) R= Me 
(2la) R = H Anti product 
(25) R=Me 
In conformation A (R = H), leading to the favoured syn-isomer (21), the carbonyl 
moiety is "eclipsed" in a 1,3-fashion by the hydrogen atom at the P-amino alcohol chiral 
centre. The angular hydrogen atom at the iminium carbon provides no significant steric 
bulk to interfere with the steric positioning of the large indole (Ar) or hydroxymethyl 
substituents. Rotation about the extra-annular C-N bond leads to the alternative 
conformation B (R = H), which would form the minor diastereoisomer (21a). In this 
scenario an unfavourable 1,3-interaction exists between the carbonyl and 
hydroxymethyl groups. 
With the N-acyliminium species (24), the steric influence exercised by the angular 
methyl substituent (R =Me) at the iminium carbon over-rides the conformational effect 
previously noted and leads to the major diastereoisomer (25) of opposite relative 
stereochemistry. Steric interactions between the angular methyl and the indole moiety 
(A, R =Me) can be envisaged, however bond rotation about the extra-annular C-N bond 
leads to conformation B (R = Me) with minimised steric interactions from the iminium 
carbon substituent, which generate the observed diastereoisomer (25) exclusively, with 
retention of stereochemistry. 1b 
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2.2. Application in the Synthesis of Naturally Occurring Alkaloids 
Having demonstrated the potential for N-acyliminium cyclisation chemistry in the 
construction of both the pyrrolo[2, l-a ]isoquinoline and indolizino[8, 7 -b ]indole ring 
systems, we aimed to establish the synthetic utility of this methodology in target 
synthesis. The tetracyclic skeleton of both these chiral building blocks is present in the 
structures of several interesting heterocyclic targets, examples of which include 
(+)-jamtine (27) 11 and (-)-subincanadine B (28) 12 as illustrated below. 
M eO~ 
Moo~?.() 
Me02Co 
(27) (28) 
However, conditions to remove both the pendent hydroxymethyl moiety and the lactam 
carbonyl from the respective chiral templates are essential to achieve such targets. This 
section outlines the methodology adopted by us to perform these transformations and 
the application toward some simple, therapeutically interesting alkaloids. 
2.2.1. Removal of the Hydroxymethyl Auxiliary 
Methodology for the successful removal of the hydroxymethyl auxiliary has received 
. . 
extensive attention in our group due to its application in the synthesis of both the 
Erythrina 13 and indole14 alkaloids. The initial work in this area focused on the 
decarbonylation of aldehydes using complexes of rhodium, as developed by Tsuji and 
Ohno in their studies with chlorotris(triphenylphosphine)rhodium (29), more commonly 
known as Wilkinson's catalyst (Scheme 14). 15 
Scheme 14: 
RCHO + 
PPh3 
I 
Ph3P-Rh-PPh3 
I 
Cl 
(29) 
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Typically, the decarbonylation reaction requires stoichiometric quantities of rhodium in 
refluxing benzene, toluene or p-xylene, however the same research group discovered 
that at temperatures in excess of 200 ·c, the decarbonylation of aldehydes proceeds 
smoothly with the chlorocarbonylbis(trisphenylphosphine)rhodium complex (30) in 
only catalytic amounts. 
Kruse and Meyer investigated a further modification of this procedure on the 
decarbonylation of indole-2-carboxaldehydes (31) under mild conditions, whereby 
chlorobis[ 1 ,2-bis( diphenylphoshino )propane ]rhodium was prepared in situ from 
catalytic (30) and 1 ,3-bis( diphenylphosphino )propane ( dppp) without the usual 
requirement for high temperatures (Scheme 15). 16 
Scheme 15: 
(i) 
Reagents: (i) Rh(PPh3)2(CO)CI, dppp, p-xylene, 6., 24 h. 
This route was initially applied by Allin et al. using the aldehyde derivative (32) formed 
by mild oxidation of the indolizino[8,7-b]indole template (25) with o-iodoxybenzoic 
acid (IBX) in dimethyl sulfoxide (Scheme 16).2 
Scheme 16: 
H (i) + 
0 0 0 
(32) (33) (34) 
Reagents: (i) Rh(PPh3h(CO)CI, dppp,p-xylene, 6., 5 d. 
The subsequent decarbonylation procedure under the conditions described by Kruse and 
Meyer16 resulted in a mixture of products, which required catalytic hydrogenation to 
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convert the unwanted enamine (34) to the target lactam (33). Due to the additional steps, 
extended reaction times (8 days) and evidence for some degree of racemisation when 
applied to indolo[2,3-a]quinolizine templates, 17 an alternate procedure for the removal 
of the hydroxymethyl auxiliary was sought. 
A large number of radical chain decarbonylation reactions are reported in the literature, 
of which the trialkylstanne-induced decarbonylation of phenyl seleno esters appeared 
advantageous to our group. 18 Allin and eo-workers have since applied this procedure in 
the synthesis of several complex indole alkaloids, and is highlighted in Scheme 17. td 
Scheme 17: 
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0 
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Reagents: (i) IBX, DMSO; (ii) Di-t-butyl dicarbonate, Et3N, DMAP, THF; (iii) NaCI02• NaH2P04, 1-methyl-1-
cyclohexene, MeCN, t-BuOH, H20; (iv) (PhSe)2, PBu3, DCM; (v) n-Bu3SnH, AIBN, PhMe, 80 °C. 
Compound (35) was oxidised to the carboxylic acid derivative (37) via the 
corresponding aldehyde (36), from which the acylselenide (38) was generated and 
subsequently underwent a tin-mediated deacylation to yield the indolo[2,3-a ]quinolizine 
ring system (39) with a high level of enantiomeric purity. 
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However a more direct route reported by Krafft, 19 which was highly appealing to us due 
to its simplicity, was that in the presence of Raney nickel in refluxing toluene, primary 
alcohols gave rise to new deoxygenated compounds containing one less carbon. For 
example, heating a solution of methyl 12-hydroxydodecanoate (40) with Raney nickel 
for 3.5 hours provided a 73 %isolated yield of methyl undecanoate (41) (Scheme 18). 
Scheme 18: 
0 
MeO~OH 
(40) 
Reagents: (i), Raney-nickel, PhMe, 1'1, 3.5 h (73 %). 
(i) 0 11 Me 
Meo-' 't19 
(41) 
Krafft proposed that the dehydroxymethylation procedure involves a reversible 
dehydrogenation (i.e. oxidation) of the alcohol to the aldehyde, followed by an 
irreversible decarbonylation. Martin has since applied this procedure developed by 
Krafft to remove a superfluous hydroxymethyl group during a formal synthesis of 
pumiliotoxin 251D (44) (Scheme 19).20 Heating a mixture of (42) and Raney nickel 
(W-2) in refluxing toluene produced the bicyclic lactam (43), a known precursor to the 
allopumiliotoxin alkaloid, in 71 % yield. 
Scheme 19: 
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(i) 
Reagents: (i) Raney-nickel, PhMe, 1'1, 4 h (71 %). 
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The quality of Raney nickel was critical to the successful removal of the pendant 
hydroxymethyl group. The use of commercially available catalyst failed to promote the 
reaction to completion, even after prolonged heating. Alternatively, freshly prepared 
catalyst effected the conversion in 4 hours.21 
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Our application of these reaction conditions with a range of heterocyclic substrates 
developed within our group began with the formation of (48) from the 
tetrahydroisoquinoline building block (45) (Scheme 20). The target lactam (48) had 
previously been synthesised in our group via route A as . an inseparable mixture 
containing the enamide (47) using the rhodium catalysed decarbonylation method 
described earlier in this section from aldehyde (46). 
Scheme 20: 
OH 0 
eX 0 oXH HDO ~::t H (i) (ii) 
(45) (46) (47) 
+ 
(i) 
Reagents: A (i) Dess-Martin periodinane, DCM, 20 h; (ii) Rh(PPh3h(CO)CI, dppp, p-xylene, 6., 72 h; B (i) Raney-
nickel, PhMe, 6., 4 h (44%). 
This was seen as a suitable test reaction for the new methodology and upon subjecting 
compound (45) to freshly prepared Raney nickel (W-2) in refluxing toluene for 4 hours 
under Dean-Stark conditions, the desired compound (48) was isolated in 44% yield 
with no trace of the corresponding enamide (47). With this encouraging result, we 
proceeded to broaden the scope of this technique toward the more complex 
indolizino[8, 7 -b ]indole substrate (25) in order to investigate its diversity and potential 
use in natural product synthesis. 
Our initial attempts represented the most direct route to the desired free indole 
decarbonylation product (33) from the indolizino[8,7-b]indole building block (25) as 
outlined in Scheme 21. 
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Scheme 21: 
(i) 
0 
(25) (33) 
Reagents: (i) Raney-nickel, PhMe, !:1. 
Treatment of alcohol (25) under the Raney nickel conditions however, liberated only 
starting material after prolonged heating for 24 hours. With the mechanism proposed by 
Krafft in mind/9 we attempted to gain more insight into this process by subjecting the 
corresponding aldehyde (32), fonned by oxidation of (25) with IBX, to the analogous 
reaction conditions (Scheme 22). 
Scheme 22: 
(i) 
(ii) 0 0 
(25) (32) (33) 
Reagents: (i) IBX, DMSO, 24 h (49%); (ii) Raney-nickel, PhMe, !:1. 
Upon treatment of aldehyde (32) with Raney nickel in refluxing toluene, it was perhaps 
unsurprising to us to isolate exclusively the reduction product (25), as the 
dehydrogenation step is a reversible process under these conditions. This result does 
however indicate that it was the rate-determining decarbonylation step that failed to 
proceed and not the initial dehydrogenation. 
Our next approach was to attempt the Raney-nickel induced decarbonylation on various 
N-protected indolizino[8,7-b]indole derivatives to prevent any co-ordination between 
the nickel catalyst and indole nitrogen, which may potentially hinder the process 
(Scheme 23). The first candidate was the tert-butyloxycarbonyl (Boc) protected 
carbamate (50), which was considered due to the ease of its removal. The hydroxyl 
group was initially converted to the silyl ether (49) to avoid any unwanted side 
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reactions, which allowed protection of the indole with di-tert-butyl dicarbonate, 
triethylamine and catalytic dimethylaminopyridine in 92 % yield. Subsequent removal 
of the silyl group in the presence of tetrabutylammonium fluoride (TBAF) afforded the 
desired substrate (50) after 5 minutes, which when subjected to Raney-nickel, resulted 
only in a mixture of starting material and the free indole (25). 
Scheme 23: 
(i) 
0 0 
(25) (iv) (49) 
1 (ll)-(UI) 
I (v) 
N ' ~Me''' 0 0 
(52) (50) R= Boc 
(51) R= Bn 
Reagents: (i) TBSCI, imidazole, DMAP, DCM, 4 h (81 %); (ii) Di-t-butyl dicarbonate, Et3N, DMAP, THF, 24 h, 
(92 %); (iii) TBAF, THF, 5 min (97 %); (iv) NaH, BnBr, DMF, 3 h (62 %); (v) Raney-nickel, PhMe, tJ., 4 h (77 %). 
In view of this result, we utilised the more stable benzyl-protected derivative (51), 
formed directly from (25) by deprotonation with sodium hydride and treatment with 
benzyl bromide, which to our delight successfully decarbonylated to the target amide 
(52) in the presence ofRaney-nickel under reflux in a respectable 77% yield. 
From these initial studies, we aimed to demonstrate the potential application of this 
methodology toward a range of simple natural products, which would significantly 
decrease the reaction time and increase efficiency when compared to previous 
procedures detailed in this section. 
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2.2.2. Total Synthesis of (R)-(+)-Crispine A 
MeOro I 
MeO ~ ~U 
(53) 
The pyrrolo[2, 1-a ]isoquinoline alkaloid (R)-( + )-crispine A (53), isolated in 2002 by .. 
Zhao and eo-workers from the welted thistle Carduus crispus Linn, has been applied in 
Chinese folk medicine for the treatment of cold, stomach ache and rheumatism since 
ancient times. More recently, pharmacological screening has revealed a cytotoxic 
activity against SKOV3, KB and HeLa human cancer celllines.22 
Due to the renewed interest in this molecule, three total syntheses of (±)-crispine A (53) 
have been published to date.23 The first of these by Kn6lker and Agarwal, utilised a 
novel three-step pyrrole synthesis from the isoquinoline (54) (Scheme 24)?3a 
Scheme 24: 
MeOro 
I N MeO ~ ..-: 
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(53) 
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(iv) 
M eO 
TMS 
M eO'(() 
M eO~ 
(57) 
(56) 2% 
Reagents: (i) BF3.0Et2, THF; (ii) AgOAc, DCM; (iii) AgOAc, acetone, L\; (iv) Rh/C, H2, AcOH/MeOH, 8 d (66 %). 
The Lewis addition promoted addition of 3-trimethylsilylpropargylmagnesium bromide 
to (54) afforded the propargy1 compound (55) and allene (56) in 61 % and 2 %yields 
respectively. The silver(l)-promoted oxidative cyclisation of the homopropargylamine 
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(55) in dichloromethane at room temperature and subsequent chemoselective 
hydrogenation of the pyrrole ring (57) provided (±)-crispine A (53) in 66% yield. 
In 2006, Meyer and Opatz reported a facile one-pot synthesis of (±)-crispine A (53) 
based on the conjugate addition of a deprotonated a-amino nitrile to an a,/3-unsaturated 
carbonyl compound (Scheme 25).23b Deprotonation of amino nitrile (58) with potassium 
hexamethyldisilazide (KHMDS), followed by 1 ,4-addition to acrolein and reduction of 
the resulting unstable intermediate with sodium cyanoborohydride in acidic solution, 
furnished racemic crispine A (53) in a relatively low 13 % yield. 
Scheme 25: 
M eO~ 
MeO~NH 
CN 
(58) 
(i)-(iv) 
Reagents: (i) KHMDS; (ii) Acrolein; (iii) AcOH/EtOH; (iv) NaCNBH3• 
MeO[I(Jr 
M eO~ 
(53) 
The first enantioselective synthesis of this alkaloid was reported in 2005 by Czamocki 
and eo-workers, in which the key synthetic step involved an asymmetric transfer 
hydrogenation of enamine (60) generated from the iminium salt (59), to introduce 
chirality (Scheme 26).24 
Scheme 26: 
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Reagents: (i) y-butyrolactone,p-xylene,!;,. (95 %); (ii) POCI3,!;,. (95 %); (iii) Hydroxide (67 %); 
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The successful synthesis of (+)-crispine A was concluded to be enantiomeric~lly pure 
within the detection limits of a 1H NMR spectroscopic method using (R)-(+)-tert-
butylphenylphosphinothiolic acid (61) as a chiral additive (Figure 4). 
Figure 4: Structure of (R)-(+)-tert-butylphenylphosphinothiolic acid (61). 
0 
11 
Ph•••P ~ 'SH 
t-Bu 
(61) 
Our approach to (+)-cri spine A (53) involved the asymmetric synthesis of the 
pyrroloi~oquinoline derivative (64) via an N-acyliminium ion cyclisation as the key step 
(Scheme 27). Imide (63), prepared as previously reported from ,8-amino alcohol (62) 
and succinic anhydride was subjected to a sodium borohydride reduction that resulted in 
direct cyclisation to the tricyclic lactam (64) as a single diastereoisomer. 
Scheme 27: 
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(53) 
Reagents: (i) LiBH4, TMSCI, THF, 24 h (91 %); (ii) Succinic anhydride, Et3N, PhMe, 11, 18 h (71 %); (iii) Na8H4, 
2 M HCI, EtOH, 20 h, (78 %); (iv) Raney-nickel, PhMe, 11, 4 h (98 %); (v) LiAIH4, THF, 11, 3 h, then rt, 12 h (76 %). 
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Presumably, under the acidic reaction conditions, the electron rich methoxy-substituted 
aryl ring is able to cyclise directly onto the N-acyliminium intermediate generated in 
situ. The relative stereochemistry of this advanced intermediate has been confirmed as 
the expected trans-diastereoisomer by single crystal X-ray analysis and is consistent 
with the conformation models previously rationalised on template systems. 1b With this 
cyclic template in hand, we applied the method developed by Kraft, 19 and tested by us, 
involving a Raney nickel induced decarbonylative removal of the hydroxymethyl 
functionality. The quality of the Raney nickel in this approach is known to be a critical 
factor in its success and in our hands, the decarbonylation of (64) proceeded smoothly 
in an impressive 98 % yield to give the corresponding lactam (65). Reductive removal 
of the lactam carbonyl group was achieved using lithium aluminium hydride, thus 
completing the synthesis of crispine A (53). 
The enantiomeric excess of (53) was determined using the 1H NMR spectroscopic 
method detailed by Czamocki and Drabowicz,24 who kindly furnished us with an 
amount of the chiral shift reagent (R)-(+)-tert-butylphenylphosphinothiolic acid (61), 
and was shown to be a disappointingly low value of 50% e. e. (Figure 5). 
Figure 5: 
&.~s ~-l~ & • .s &.~o 6.35 
~r ¥ 
The diagnostic signal in the 1H NMR spectrum used in the determination was the 
aromatic C(lO) proton which, in the presence of the chiral shift reagent, shows distinct, 
well separated singlet peaks for the enantiomers at 6.27 and 6.45 ppm. In our case, 
although the level of product e. e. was moderate, the major enantiomer was confirmed as 
the desired (R)-crispine A (53). 
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Although the use of Raney nickel allows for a rapid and high yielding access to 
crispine A (53) from lactam (64), epimerisation of the benzylic stereocentre was 
occurring at some point in the two-step sequence and thus compromising the 
enantiomeric purity of the final product. 
As an alternative approach, we chose to reverse the order of synthetic transformation 
and firstly removed the lactam carbonyl to yield amine (66) (Scheme 28). No 
epimerisation was evident during this step within the limits of 1H NMR spectroscopy, 
however subsequent attempts to remove the hydroxymethyl group to form (53) using 
Raney-nickel resulted only in decomposition of the starting material. 
Scheme.28: 
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M eO~ 
MooAJ;~o 
(64) 
MeOY"''(yR 
MooAJ;&o 
(. )I (67) R= CHO IV~ (65) R=H 
(i) 
(v) 
Reagents: (i) LiAIH4, THF, tJ., 3 h, then rt, 12 h (97 %); (ii) Raney-nickel, PhMe, tJ., 4 h; (iii) IBX, EtOAc, tJ., 4 h 
(99 %); (iv) Rh(PPh3h(CO)CI, dppp,p-xylene, tJ., 10 d (46 %); (v) LiAIH4, THF, t!., 3 h, then rt, 12 h (58%). 
This issue was ultimately overcome in collaboration with a colleague through the 
application of a rhodium-induced decarbonylation sequence (Scheme 28) previously 
applied by our group in the work on the Erythrina alkaloid series. 13 The template 
compound (64) was oxidised to aldehyde (67) in excellent yield using IBX in ethyl 
acetate under reflux, followed by a rhodium-induced decarbonylation over 10 days to 
give the amide (65). The target (R)-(+)-crispine A (53) was achieved following lactam 
reduction using lithium aluminium hydride in 58 % yield. Compound (53) was shown to 
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have an e.e. greater than 95 %using the 1H NMR spectroscopic technique previously 
described, as shown in Figure 6. 
Figure 6: 
The optical rotation of our product was determined to be+ 95.2 (c 1.5, MeOH) and was 
comparable to that reported byZhao of the natural product isolate[+ 91.0 (MeOH)].22 
2.2.3. Total Synthesis of (R)-(+)-Harmicine 
~~ ~JI,xh< 
H H \__/ 
(68) 
Leishmaniasis, a disease spread by the bite of the sand fly, is found in tropical and sub-
tropical regions, affecting some 12 million people in 88 countries. Symptoms of this 
disease vary from skin sores to fever, anaemia and damage to the spleen and liver. 
Common therapies have included the use of antimony containing drugs, although less 
toxic treatments are currently in development.25 Preliminary screening of the leaf 
extracts from the Malaysian plant Kopsia griffithii by Kam and Sim showed strong 
anti-leishmania activity, which was ascribed to the basic fractions containing the 
indolizidino[8,7-b]indole alkaloid, harmicine (68).26 
Ohsawa and eo-workers previously reported the asymmetric synthesis of ent-harmicine 
(68) (Scheme 29) and assigned the absolute configuration of the natural product as R..27 
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Scheme 29: 
~ ~N~~ 
R 
R = (S)-N-(9-anthracenylmethyl)-
pyroglutaminyl 
[a.]n -108.31 (c = 0.10, CHC13) 
(i)-(iii) 
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~ ! (iv)-(v) 
OH 
(vi) I R 1 = C02CH2CCI3 
~R1 =H 
Reagents: (i) Bu3SnCH2CH=CH2, CIC02CH2CCI3; (ii) NaOH, THF/H20; (iii) Et3SiH, TFA (91 %); (iv) BH3, 2 h; (v) 
NaOH, H20 2 (79 %); (vi) Zn, AcOH, I h (77 %); (vii) PPh3, DEAD, DCM, 3 h (84 %). 
Knolker and Agarwal have also generated harmicine in racemic form, by utilising the 
same three-step pyrrole synthesis described for the preparation of the 
pyrroloisoquinoline alkaloid crispine A (53) (Scheme 30).28 
Scheme 30: 
~ ~N~h 
H 
(68) 
(i) 
TMS 
(iii) 
Reagents: (i) TMSC =CCH2MgBr, BF3.0Et2, THF 15 h (68 %); (ii) AgOAc, DCM, 14 h (77 %); (iii) Rh/C, H2, 
AcOH/MeOH, 8d (88 %). 
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Our approach to (+)-harmicine (68) began with the highly stereoselective synthesis of 
the indolizidino[8,7-b ]indole framework (21) as previously described in Section 2.1.2. 
via application of an N-acyliminium cyclisation (Scheme 31). 
With the cyclic template in hand, our synthesis again required the removal of the 
hydroxymethyl auxiliary group. Due to the potential epimerisation at the benzylic 
stereocentre experienced with both the Raney nickel and rhodium induced 
decarbonylation techniques when applied to indole derivatives, we opted for a 
tin-mediated deacylation route that has been successfully utilised by our group in recent 
natural product syntheses, with no signs ofracemisation. 
Scheme.31: 
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[a]o+ll8.2 (c= 1.6, CHC13) 
Reagents: (i) IBX, DMSO, 24 h (72 %); (ii) Di-t-butyl dicarbonate, Et3N, DMAP, THF, 18 h (98 %); (iii) NaC102• 
NaH2P04, cyclohexene, MeCN, t-BuOH, H20, 17 h (79%); (iv) (PhSe)2, PBu3, DCM, 24 h (66 %); (v) n-Bu3SnH, 
AIBN, PhMe, 80 °C, 4 h (90 %); (vi) TBAF, THF, D., 2 h (69 %); (vii) LiAIH4, THF, D., 3h, then rt, 12 h (80 %). 
Compound (21) was oxidised to the carboxylic acid derivative (71) via the aldehyde 
(70); from (71) we generated the acyl selenide (72) and successfully performed a 
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deacylation in the presence of tri-n-butyl tin hydride and azobisisobutyronitrile to give 
the core indolizidino[8, 7 -b ]indole ring system (73). Deprotection of the indole nitrogen 
gave (74), from which reductive removal of the lactam carbonyl group completed the 
synthesis of the natural product (R)-(+)-harmicine (68), in 80% yield by treatment with 
lithium aluminium hydride.29 The optical rotation of our target compound was 
determined to be+ 118.2 (c 1.6, CHC13) and was comparable to that reported by Kam 
and Sim for the natural product isolate[+ 119 (c 0.086, CHCh)].26 
2.3. Application as Potential Building Blocks for Peptide Mimics 
oJ? ~~ CO,H 
N ~~N)===-0 
HH ~ 
NHZ 
(75) 
Having successfully demonstrated the . application of our novel N-acyliminium 
chemistry toward simple natural product targets by the removal of functionality from 
chiral indolizidine templates, we envisaged the elaboration of these core building blocks 
toward more complex targets, through exploitation of the carbonyl group reactivity. 
Functionalised indolizino[8,7-b]indoles such as (75), have displayed the ability to 
mimic /j-turn activity and shown high binding affinity and selectivity for CCK1 
receptors, due to the constrained framework of the lactam backbone. 30 
Considerable attention has been paid toward peptide and protein secondary structure 
mimics, in particular the /j-turn motif that describes an amino acid chain in which the 
two central residues function to reverse the direction of chain propagation. Due to the 
frequent appearance of the reverse turns on the external surface of protein molecules, 
they have been postulated as loci for receptor binding and antibody recognition.31 
However, most biologically active peptides are highly flexible molecules and the 
number of possible conformations complicates attempts to relate structu_ral parameters 
and activities. Due to these problems, major efforts in recent years have been devoted to 
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the development of templates that mimic or stabilise these secondary structural features, 
several of which are shown below in Figure 7.32 
Figure 7: 
Extensive research in this field has been conducted by Gonzalez-Mufiiz et al. with the 
synthesis and molecular-dynamic studies of the 2-amino-3-oxohexahydroindolizino 
[8,7-b]indole-5-carboxylate (IBTM) derivatives (76) and (77), which have displayed a 
conformational behaviour similar to that of the bicyclic turned dipeptide (BTD) (78), a 
competent type-II' {3-tum mimic (Figure 8). Their findings indicate that the ability to fix 
the desired torsion angles within the bicyclic framework is highly dependent on the 
stereochemistry at the 11 b chiral centre, with the (R)-isomer (77) showing fewer 
variations and hence a greater ability to adopt a reverse turn when compared to its 
(S)-counterpart (76).33 
Figure 8: 
(76) 
In order to investigate whether a turn-like conformation was adopted at the CCK 
receptor site, a new series of constrained depeptoid derivatives (81) and (82) was 
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developed by incorporation of the IBTM skeleton into the known receptor antagonists 
(79) and (80) (CCK2 and CCK1 selective, respectively) (Figure 9). 34 
Figure 9: 
(79) (PD-140547) (*, S) 
(80) (PD-140548) ( *, R) 
NHR 
(81) R=Z 
(82) R= Boc 
Cholecystokinin (CCK) is a peptide hormone and neurotransmitter, which has been 
implicated in the regulation of gastrointestinal functions and behaviour by interaction 
with specific receptors. Two CCK receptor subtypes have been characterised: CCK1 
receptors that predominate in the periphery and CCK2 receptors located in the central 
nervous system (CNS). Changes in CCK levels found in the tissues and sera of patients 
with various disease states, including schizophrenia and eating disorders, models of 
Parkinson's disease, cancer, anxiety and pain, indicate the potential utility of CCK 
receptor ligands as therapeutic agents. 30 
The results of this investigation demonstrated that compounds (81) and (82) containing 
an 11 bR configuration showed a higher CCK1 binding potency of one to two orders of 
magnitude compared to the corresponding 11 bS isomers. Due to the greater ability of 
11 bR conformers to mimic a type II' reverse turn, these results indicate that a turn-like 
conformation within the dipeptoid backbone is favourable for CCK1 receptor 
recognition, and that the high degree of constraint imposed by the IBTM framework is 
not tolerated by CCK2 receptor binding sites, making them highly selective. 
2.3.1. Enolate Addition Studies 
The presence of the lactam carbonyl group within the structural building blocks (21) 
and (25) provides a handle for regiospecific derivatisation through the exploitation of 
enolate addition chemistry. It was envisaged that the presence of asymmetry in the 
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molecule could also exhibit some level of stereocontrol for the incorporation of an 
N-terminal moiety and provide a novel route to constrained peptides such as (75) with 
the ability to adopt a /J-tum conformation. 
An initial study was undertaken involving the alkylation of the indolizine[8,7-b]indole 
template (25) using simple electrophiles of varying steric bulk, in order to evaluate the 
effects on the stereoselective outcome. The procedure is outlined in Scheme 32. 
Scheme 32: 
(i) I ov 
0 N ' 0 .,& ~Me''' 
(25) (83) 
1 (li)
ou 
0 .,& + 
ov 
0 .,& 
R R 
(84a) (84b) 
Reagents: (i) NaH, BnBr, DMF, 3 h (72 %); (ii) LDA, RX, THF, -78 octo rt, 16 h. 
Protection of the acidic protons present on the indole nitrogen and the hydroxyl group 
was initially required to avoid any unwanted side-reactions at either position during 
treatment with the hindered base. Deprotonation of (25) with sodium hydride followed 
by treatment with benzyl bromide afforded the his-protected compound (83) in 72 % 
yield. With the protected indolizine[8,7-b]indole (83) in hand, we turned our attention 
toward the proposed functionalisation of our substrate. Enolisation of (83) was achieved 
with lithium diisopropylamine (LDA), which upon addition of the desired electrophile 
produced the target compound (84) as a mixture of diastereoisomers, the ratio of which 
was determined from the crude 1 H NMR spectrum. 
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The results are summarised below in Table 1: 
Entry R X Product Yield Ratio 
(%) (a: b) 
1 Me I 85a/b 67 4:1 
2 Et I 86alb 70 1:8 
3 i-Pr I 87 a/b 79 1:10 
4 Bn Br 88a/b 52 1:2 
From the results, it was evident that reactions of substrate (83) with alkyl iodides 
(Entries 1-3) show an increase in stereoselectivity with increasing steric bulk of the 
electrophile. It was surprising to discover that the stereoselectivity of the alkylation with 
benzyl bromide (Entry 4) was significantly reduced in this case. This could be due to 
the planar nature of the benzyl electrophile decreasing the steric interactions at this 
angle of electrophilic attack. The increased reactivity of the electrophile could also lead 
to lower selectivity for alkylation, as is the case with the alkylation of pyridinones. 35 
The relative stereochemistry at the newly formed chiral centre was determined by single 
crystal X-ray analysis for the major isomers from the methyl, isopropyl and benzyl 
alkylation reactions (Figure 10, 11 and 12 respectively). 
Figure 10: Single Crystal X-Ray Structure of (85a). 
(85a) 
Interestingly, the major diastereoisomer from the methyl alkylation was formed in a 4:1 
ratio in favour of the anti isomer with respect to the angular methyl substituent and the 
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C-2 alkyl group (85a) (Figure 10). When the steric bulk of the electrophile was 
increased to isopropyl, the diastereoisomeric ratio increased to 10:1, however the major 
product of the reaction was that fonned from electrophilic attack at the opposite face, 
displaying syn relative stereochemistry (87b) (Figure 11). 
Figure 11: Single Crystal X-Ray Structure of (87b). 
C!91 
C!291 
(87b) 
This trend continued in the benzyl alkylation in which the syn isomer (88b) was again 
favoured as the major product (Figure 12), however the stereoselectively was greatly 
reduced to a 2:1 ratio in this case, as previously stated. 
Figure 12: Single Crystal X-Ray Structure of (88b). 
C!181 
(88b) 
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This trend was also evident in the ethyl alkylation where ID nOe studies suggest the 
presence of a syn relationship between the alkyl groups at positions 2 and 11 b of the 
favoured product (86b) formed in an 8:1 ratio (Figure 13). 
Figure 13: lD nOe Interactions for (86b). 
;-
H 
(86b) 
The presence of a nOe between the protons situated on the methyl group at position 11 b 
and the ethyl group at position 2 was consistent with the proposed structure. As we were 
unable to isolate the minor diastereoisomer we were unable to carry out a comparative 
nOe study. 
It is assumed that the stereochemical outcome of these alkylation reactions is due to the 
"concave" nature of the chiral indolizidine ring structure. The sterically smaller methyl 
electrophile is able to manoeuvre into this space and attack at the top face of the 
molecule. As the steric bulk of the electophile increase, the interaction with the bicyclic 
ring structure consequently increases and retards attack from the top face of the 
molecule, as is the case for the ethyl, isopropyl and benzyl electrophiles. 
' 
With potential ,B-turn polypeptide targets such as (75) in mind,30 we turned our attention 
toward the electrophilic a-amination of our indolizine[8, 7 -b ]indole enolate precursor 
(83) . The introduction of an amine functionality adjacent to a carbonyl group using 
electrophilic aminating agents is a topical area of research, particular with respect to the 
synthesis of a-amino acids, 36 and the formation of a new chiral C-N bond is key to our 
synthesis of enantiomerically pure ,B-turn mimetics. 
The initial choice of aminating agent was a commercially available diazene 
dicarboxylate due to the high reactivity and large steric bulk. It was intended that, in 
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tandem with the asymmetry present in our substrates, the steric size would induce high 
levels of stereoselectivity as shown in Scheme 33. 
Scheme 33: 
I (i) 
N , (YMe''' 
(83) 
Reagents: (i) LDA, DBAD, THF, -78 octo rt, 16 h, (82 %). 
I 
. N ,, (YMe'' 
(89) 
,NBoc 
NHBoc 
Treatment of the his-protected indolizine[8,7-b]indole derivative (83) with LDA at 
-78 OC and subsequent addition of di-tert-butyl azodicarboxylate (DBAD) formed 
exclusively the target a-aminocarbonyl compound (89) as a single diastereoisomer. A 
nOe study was conducted to confirm the relative stereochemistry present at the newly 
·formed chiral centre generated from a-amination (Figure 14). 
Figure 14: 1D nOe Interactions for (89). 
(89) 
0~ 
oV 
As with the major product of the ethyl alkylation (86b ), the absence of a nOe between 
the protons situated on the methyl group and position 2 suggests the amine moiety 
adopts a syn conformation with respect to the 11 b methyl group. As we were unable to 
isolate the minor diastereoisomer we were unable to carry out a comparative nOe study. 
It should be noted that the observation of syn relative stereochemistry is consistent with 
the trend previously observed for the alkylation of (83) with large electrophiles. 
Following these initial investigations into the a-addition of precursor (25), we deemed it 
would be interesting to observe the effect, if any, on diastereoselectivity and face 
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selectivity of the enolate addition using the analogous syn-indolizine[8, 7 -b ]indole 
template (21) (Scheme 34). 
Scheme 34: 
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(91a) (91b) 
Reagents: (i) NaH, BnBr, DMF, 3 h (97 %); (ii) LDA, RX, THF, -78 octo rt, 16 h. 
Protection of the indole nitrogen and the primary alcohol group was again necessary to 
avoid any unwanted side-reactions at either position during treatment with base. 
Protection of (21) with sodium hydride followed by benzyl bromide afforded the 
his-protected compound (90) in quantitative yield. Treatment of the indolizine[8,7-b] 
indole derivative (90) with LDA and the desired electrophile under the standard 
protocol generated compound (91) as a mixture of diastereoisomers, the ratio of which 
was again determined from the crude 1H NMR spectra. 
The results are summarised below in Table 2: 
Entry R X Product Yield Ratio 
{%} {a: b) 
5 i-Pr I 92 a/b 58 3:1 
6 Bn Br 93 a/b 58 1:1 
7 DBAD 94 a/b 57 6:1 
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As we expected, the diastereoselectivities observed for both the alkylation and 
amination procedures of (90) were lower in comparison to their 11 b methyl counterpart 
(83). It is reasonable to propose that this is due to the reduction of steric bulk provided 
by the angular methyl substituent, hence decreasing the interaction with the attacking 
electrophile. The relative stereochemistry of the major isomer formed from the 
isopropyl alkylation (Entry 5) was determined by ID nOe studies (Figure 15). 
Figure 15: 1D nOe Interactions for (92a). 
(Qyo~ 
N -~r~ v (YH h 
(92a) 
The absence of a nOe between the protons situated at positions 2 and 11 b of product 
(92a) is consistent with the proposed trans relationship. As we were unable to isolate 
the minor diastereoisomer we were unable to carry out a comparative nOe study. 
In conclusion, we have discovered that the electrophilic addition of the indolizine[8,7-b] 
indole template is a highly stereoselective process which increases significantly with the 
size of the electrophile. The relative stereochemistry of these addition products is highly 
dependent on the stereochemistry present at the 11 b asymmetric centre, with the enolate 
addition of sterically large carbophiles forming products containing a syn relative 
stereochemistry between the newly introduced a-substituent and the group at ring 
junction 11 b. In addition, we have also found that the steric bulk of the 11 b substituent 
exerts some influence on the diastereoselective ratio of the enolate addition. 
2.3.2. Manipulation of the Hydroxymethyl Auxiliary 
To determine the potential of the a-aminated compounds (89) and (94) as {3-tum 
mimics, the C-terminal hydroxyl group required modification to be consistent with the 
known IBTM {3-tum mimic (75) reported by Gonz:Hez-Mufiiz et a/.30 However the poor 
resolution of these compounds in the 1H NMR, due to the slow rotation about the planar 
carbamate groups made assignment difficult. For this reason, a test study was carried 
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out on the core indolizine[8,7-b]indole derivative (83); as shown in Scheme 35, to avoid 
the need for elevated temperature 1 H NMR experiments and give a detailed 
understanding of the conversion required. 
Scheme35: 
I 
N ' ~Me''' 
(83) 
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N , 
~Me''' 
(96) 
OH 
0 
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(ill) 
I 
N ' ~Me''' 0 
(51) ! (li) 
I H 
N , 
~Me''' 0 
(95) 
Reagents: (i) Pd/C, H2, EtOH, 50 psi, 4 d (78 %); (ii) IBX, DMSO, 24 h, (65 %); (iii) NaCI02• NaH2P04, 1-methyl-1-
cyclohexene, MeCN, t-BuOH, H20, I 7 h (75 %). 
Initial selective debenzylation of the hydroxymethyl auxiliary ·was achieved under 
standard hydrogenolysis conditions in the presence of a palladium catalyst to yield the 
desired alcohol (51). A variety of methods have previously been attempted within our 
group for the direct oxidation of indolizine[8,7-b]indole alcohol derivatives to the 
corresponding carboxylic acid which include, Jones oxidation, pyridinium dichromate 
and treatment with potassium permanganate, however all have failed to produce the 
target carboxylic acid. Due to these previous difficulties, we utilised the more 
established two-step procedure involving formation of the aldehyde (95) by mild 
oxidation of (51) with IBX followed by further oxidation to the carboxylic acid 
derivative (96) using sod~um chlorite. 
An appropriate coupling reaction between the indolizine[8,7-b]indole acid derivative 
(96) and an amino ester was then envisaged which allows control of the new 
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asymmetric centre by consideration of the substrate chirality. This is an important 
consideration as the stereochemistry at this position has shown significant influence 
towards receptor selectivity, as seen in the known antagonists (79) and (80) (CCK2 and 
CCK1 selective, respectively) shown in Figure 9.34 In this case, (S)-phenylalanine 
methyl ester hydrochloride (97) was coupled to the carboxylic acid (96) in the presence 
of 1-ethyl-3-[(dimethylamino)propyl] carbodiimide hydrochoride (EDCI) with 
1-hydroxyazabenzotriazole acting as a racemisation suppressant, to generate the desired 
dipeptide compound (98) as shown in Scheme 36. 
Scheme36: 
I 
N , 
~Me''' 
(96) 
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0 
0 
(i) I 
N , 
Q!Me''' 
(98) 
Reagents: (i) £-Phenylalanine methyl ester hydrochloride (97), EDCI, HOABt, NMM, DCM, -15 °C, 3 h (77 %). 
With an established procedure in place to modify the hydroxymethyl auxiliary to a 
dipeptide moiety, we aimed to demonstrate the synthetic potential of this methodology 
towards a range of chiral a-aminated lactams and allow a highly controlled synthesis of 
a range of potential .B-turn mimics. 
2.3.3. The Anti-Indolizino[8,7-b]indole Polypeptide 
Before the derivativation of the anti-aminated template (89) was attempted, the initial 
protecting group strategy of the tetracyclic template (25) was revised. It was felt that the 
4 day reaction time required to successfully remove the benzyl ether and the harsh 
conditions necessary to deprotect a benzylic indole group could be optimised with an 
improved choice of protecting group. 
The hydroxyl moiety was initially protected as the tert-butyldimethylsilyl ether (49) 
upon treatment of the template (25) with imidazole, catalytic 4-dimethylaminopyridine 
and tert-butyldimethylsilylchloride, which was successful in 81 % yield (Scheme 37). 
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Subsequent Boc protection of the indole was achieved in near quantitative yield by 
treatment with triethylamine, 4-dimethylaminopyridine and di-tert-butyl dicarbonate to 
form the his-protected substrate (99), which could be selectively deprotected at either 
position under the appropriate conditions. The enolate of (99), formed upon treatment 
with LDA, was then reacted with the DBAD under the standard protocol to provide the 
a-aminated compound (100) exclusively as a single diastereoisomer in 89% yield. 
Scheme 37: 
(i) 
0 0 
(25) (49) ! (ij) 
(ill) 
0 0 
NBoc 
' NHBoc 
(lOO) (99) 
Reagents: (i) TBSCI, imidazole, DMAP, DCM, 4 h (81 %); (ii) Di-t-butyl dicarbonate, Et3N, DMAP, THF, 18 h, 
(92 %); (iii) LDA, DBAD, THF, -78 °C tort, 16 h, (89 %). 
The nOe interactions displayed by the isolated product (100) were consistent with the 
trends previously observed for the a-substitution of (83) and indicated the expected syn 
relative stereochemistry between the angular methyl and hydrazine groups (Figure 16). 
Figure 16: 1D nOe Interactions for (100). 
(lOO) 
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Treatment of (100) with TBAF in tetrahydrofuran efficiently formed the free alcohol 
(101) in quantitative yield as shown in Scheme 38. The free hydroxyl (101) was then 
oxidised to the aldehyde (102) in 94 % yield by treatment with IBX in refluxing ethyl 
acetate, a protocol successfully established by Finney and More.37 
Scheme 38: 
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Reagents: (i) TBAF, THF, 5 min (98 %); (ii) IBX, DMSO, 20 h (97 %); (iii) NaCI02, NaH2P04, 1-methyl-
cyclohexene, MeCN, t-BuOH, H20, 17 h (83 %); (iv) £-Phenylalanine methyl ester hydrochloride (97), EDCI, 
HOABt, NMM, DCM, -15 °C, 3 h (46 %). 
Oxidation to the carboxylic acid (103) was achieved with sodium chlorite, which was 
consequently reacted with the amine moiety of the (L)-phenylalanine methyl ester (97) 
in the presence ofEDCI and 1-hydroxyazabenzotriazole to generate the peptide (104). 
The Boc protecting groups present in (104) were easily removed in the presence of 
trifluoroacetic acid as shown in Scheme 39; however purification of the resultant amine 
derivative (105) proved difficult. 
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Scheme 39: 
B N C02Me H (i) 
0 
NBoc 
I 
NHNHz 
NHBoc 
(104) (105) 
Reagents: (i) TF A, DCM, 30 min. 
The (2R,5S,11 bS,3'S) constrained dipeptoids (104) and (105) still represent a novel 
stereochemical configuration to the reported IBTM frameworks probed by Gonzalez-
Muiiiz for type-II and type-II' IJ-tum activity,30 and have the potential to exhibit a 
turn-like conformation and perhaps display affinity for the CCK receptor subtype. 
2.3.4. The Syn-lndolizino[8,7-b]indole Polypeptide 
As detailed earlier in this section, extensive studies conducted by Gonzalez-Muiiiz and 
co:-workers have shown that the 11 bR IBTM skeletons, such as (75) have a greater 
ability to adopt a type-II' {J-tum conformation and exhibit a higher binding affinity for 
CCKt receptors by one or two orders of magnitude when compared to- their 11 bS 
counterparts. With this in mind, we attempted to apply the methodology shown 
previously to the llbR-indolizino[8,7-b]indole building block (21), in the hope of 
generating a functionalised polypeptide which displays the stereochemical requirements 
of the known type-II' {J-tum IBTM mimic and selective CCK1 receptor antagonist (75), 
constructed by Gonzalez-Muiiiz et a/.30 
With the core indolizino[8,7-b]indole (21) prepared in asymmetric fashion as detailed in 
Section 2.1.2, the next step was protection of the hydroxymethyl auxiliary as the 
tert-butyldimethylsilyl ether (106) (Scheme 40). An initial problem was the poor 
solubility of our substrate (21) in the reaction solvent, dichloromethane. For this reason, 
the silyl protection was performed under analogous conditions replacing the solvent 
with N ,N-dimethylformamide, a common medium for this style of protection. 
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Scheme 40: 
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Reagents: (i) TBSCl, imidazole, DMAP, DCM, 24 h; (ii) TIPSCl, imidazole, DMF, 6.5 h (98 %); (iii) Di-t-butyl 
dicarbonate, Et3N, DMAP, THF, 16 h, (73 %). 
Under these revised conditions, the silyl protection proved unsuccessful on numerous · 
attempts, with only starting material recovered. An alternate triisopropylsilyl protecting 
agent was then attempted under similar basic conditions in N ,N-diinethylformamide, 
which successfully formed the corresponding triisopropylsilyl ether· (107) in excellent 
98 % yield as shown in Scheme 40. 
With a silyl protected indolizino[8,7-b]indole (107) in hand, protection of the indole 
was achieved as previously detailed using a Boc protecting group formed by treatment 
with di-tert-butyl dicarbonate to give the his-protected compound (108) in 92 % yield. 
Substrate (108) was then subjected to the amination conditions previously applied to its 
llbS-methyl-counterpart as described in Section 2.3.3, however only starting material 
was isolated from the reaction (Scheme 41). The reaction was repeated several times 
with increased levels of base and electrophile, with all attempts proving unsuccessful. 
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Scheme 41: 
(108) 
Reagents: (i) LDA,.DBAD, THF, -78 octo rt, 16 h. 
(i) # r .. 
(109) 
We reasoned that this unexpected lack of reactivity was due to the increased steric 
influence of the triisopropylsilyl group. From the trends displayed in our alkylation 
studies detailed in Section 2.3.1, we envisage that the sterically large DBAD 
electrophile would attack from the top face of our substrate (108) as it is unable to 
manoeuvre within the concave lactam. It is possible that this alternate protecting group 
is hindering this mode of attack and thus preventing the formation of the product (109). 
Scheme 42: 
(i) 
(108) 
(iii) 
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Reagents: (i) TBAF, THF, 10 min (72 %); (ii) TBSCl, imidazole, DMAP, DCM, 4 h, (85 %); (iii) LDA, DBAD, 
THF, -78 octo rt, 16 h, (86 %). 
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To consolidate this theory, the triisopropylsilyl derivative (108) was converted to the 
corresponding tert-butyldimethylsilyl ether (111) by means of TBAF induced 
deprotection to restore the alcohol (110), and subsequent treatment with 
tert-butyldimethylsilylchloride under basic conditions (Scheme 42). The tert-butyl 
dimethylsilyl ether (111) was then treated with LDA at -78 ·c to generate the desired 
enolate and upon addition of the DBAD electrophile, to our delight formed the target 
a-aminocarbonyl as a 6:1 mixture of diastereoisomers. A nOe study was conducted on 
the major diastereoisomer (112) to confirm the relative stereochemistry present at the 
newly formed a-aminated chiral centre (Figure 17). 
Figure 17: 1D nOe Interactions for (112). 
OTBS ~0 
Bod H ~,.., 
:: NBoc H I 
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(112) 
The absence of a nOe between the hydrogen atoms situated at positions 2 and 11 b 
suggests they are situated in a trans relationship. As we were unable to isolate the minor 
diastereoisomer we were unable to carry out a comparative nOe study. This result 
continues the trend of the expected syn addition of sterically large carbophiles with 
respect to the substituent at the 11 bring junction. 
With the desired aminated compound in hand, (112) was then subjected to the same 
derivatisation methodology detailed earlier. The silyl protecting group was efficiently 
removed in the presence of TBAF at room temperature and the resultant hydroxyl 
moiety (113) was successfully oxidised to the carboxylic acid (115) via the aldehyde 
(114) upon treatment with IBX followed by sodium chlorite (Scheme 43). Coupling of 
the acid substrate (115) with the (S)-amino ester (97) was achieved in 64 % yield with 
the carbodiimide coupling agent EDCI to complete the formation of polypeptide (116). 
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Scheme43: 
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Reagents: (i) TBAF, THF, 20 min (72 %); (ii) IBX, EtOAc, .6., 5 h (94 %); (iii) NaCI02, NaH2P04, 1-methyl-1-
cyclohexene, MeCN, t-BuOH, H20, I 7 h (85 %); (iv) L-Phenylalanine methyl ester hydrochloride (97), EDCI, 
HOABt, NMM, DCM, -15 °C, 3 h (64 %). 
This synthesis demonstrates the versatility of the indolizino[8,7-b] indole building block 
(21) with a stereoselective a-amination and subsequent manipulation to produce the 
constrained polypeptoid (116), which incorporates all the stereochemical requirements 
displayed by the known type II' ,8-tum mimetic (75). It has been shown that the type of 
,8-tum is critical for maintaining good selectivity for the CCK1 receptor.30 Thus the 
restricted dipeptoid analogue (116), containing a type II' ,8-tum backbone, is apparently 
devoid of affinity for the CCK2 receptor and therefore could represent a new potent and 
selective CCK1 receptor antagonist. 
2.3.5. The Syn-Pyrrolo[2,1-a]isoquinoline Polypeptide 
To the best of our knowledge, the application of substituted chiral pyrroloisoquinoline 
derivatives as potential CCK receptor antagonists has not been explored, which is 
surprising due to the structural similarities with the indolizino[8,7-b]indole ring system. 
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The pyrroloisoquinoline (10) contains the necessary bicyclic framework responsible for 
the type 11' /3-tum activity possessed by the IBTM derivatives utilised by Gonzalez-
Mufiiz and in theory, could act as a potent and selective CCK1 receptor antagonist.30 
With this in mind, we envisaged a stereoselective synthesis of a new type of constrained 
polypeptide, which incorporates the pyrroloisoquinoline framework (10) and has the 
potential to mimic a /3-tum conformation and show selective affinity for the CCK 
receptor subtype. 
The pyrrolo[2,1-a]isoquinoline building block (10), which is formed in an asymmetric 
fashion as detailed in Section 2.1.1. was converted to the silyl ether (117) in the 
presence of imidazole, 4-dimethylaminopyridine and tert-butyldimethylsilylchloride in 
quantitative yield as shown in Scheme 44. 
Scheme 44: 
(10) 
~H 
U;~o 
NBoc 
' NHBoc 
(119) 
(i) 
(117) 
l (H) 
(iii) ~s 
NBoc 
' NHBoc 
(118) 
Reagents: (i) TBSCI, imidazole, DMAP, DCM, 4 h (99 %); (ii) LDA, DBAD, THF, -78 octo rt, 16 h (88 %); (iii) 
TBAF, THF, 5 min (40 %). 
Subsequent ex-amination upon enolisation of (117) with LDA and treatment with DBAD 
at -78 ·c successfully generated the desired product as a 15:1 mixture of 
diastereoisomers within the limits of 1H NMR spectroscopy. The nOe interactions 
displayed by the major product (118) shown in Figure 18, were consistent with the 
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trends observed for the syn-indolizino[8,7-b]indole analogue (112), indicating a syn 
addition product with respect to the substituent's at positions 2 and lOb. 
Figure 18: 1D nOe Interactions for (118). 
OTBS 
I 
,, IObN 
~----·'p=-0 
H~ .... 
= NBoc H I NHBoc 
(118) 
Deprotection of the silyl ether (118) was achieved upon treatment with TBAF at room 
temperatUre to generate the free alcohol derivative (119), which was subsequently 
oxidised to the aldehyde (120) in the presence ofiBX as detailed in Scheme 45. 
Scheme 45: 
Ofto 
NBoc 
' NHBoc 
(119) 
OE C2t~ C~Mo 
NBoc 
' NHBoc 
(122) 
(i) 
(iii) 
0 
~H lJ~~o 
NBoc 
' NHBoc 
(120) 
0 
~OH lJ~~o 
NBoc 
' NHBoc 
(121) 
Reagents: (i) IBX, DMSO, 24 h (61 %); (ii) NaCI02,NaH2P04, I-methyl-1-cyclohexene, MeCN, t-BuOH, H20, 17 h 
(80 %); (iii) L-Phenylalanine methyl ester hydrochloride (97), EDCI, HOABt, NMM, DCM, -15 cc, 3 h (57%). 
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Oxidation to the carboxylic acid (121) was achieved usmg sodium chlorite in 
acetonitrile and tert-butanol and isolated by column chromatography in 80 % yield, 
which was then utilised in the EDCI induced coupling process with (S)-phenylalanine 
methyl ester hydrochloride (97) in the presence of a racemisation suppressant to form 
the polypeptide (122). 
This synthesis represents the development of a novel constrained dipeptoid (122) which 
effectively incorporates the pyrroloisoquinoline framework into the known receptor 
antagonists (79) and (80) shown in Figure 9,34 in a highly stereoselective fashion. This 
(2S,5S,llbR,3'S) peptide derivative (122) also displays the required stereochemistry 
properties necessary for {3-tum activity and is comparable to the known type 11' {3-tum 
IBTM mimetic (75). The construction of this new phenyl derivative (122) could also 
give some insight into the effects of the aromatic substituent on receptor affinity and 
selectivity when compared to its indole analogue (116). 
2.4. Application Toward the Synthesis of Cephalotaxine 
OMe 
(123) 
The application of N-acyliminium ion cyclisations toward a range of heterocyclic 
templates has been described in detail throughout this thesis. We have demonstrated the 
diverse nature of these key building blocks toward both simple natural products and 
more complex rigid polypeptides with potential {3-tum activity. In our ongoing attempts 
to extend this novel methodology toward new polycyclic ring systems, we undertook 
the asymmetric synthesis of the pentacyclic enone (127), a key precursor in the 
synthesis of cephalotaxine (123) by Li and Wang detailed earlier in Section 1.4.5. 38 
Allin et al. had previously reported the formation of a cyclic ketone (125) as a key 
structural template in the synthesis of (-)-3-demethoxyerythratidinone (126), from a 
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ketal protected lactam (124) as shown below in Scheme 46. 13b In this synthesis, the 
required {J-amino alcohol (62), prepared quantitatively from the readily available amino 
acid, was subjected to condensation with a cyclic keto-acid under Dean-Stark conditions 
in toluene for 48 hours to generate the desired lactam (124) as a single diastereoisomer. 
Scheme 46: 
OH 
MeOm I , 
MeO .o NH2 
(62) 
OH 
M eO M eO 
M eO M eO 0 
(125) 
Reagents: (i) PhMe, 6, Dean-Stark, 48 h (63 %); (ii) TiCI4, DCM, -78 °C, 48 h (92 %). 
The exclusive formation of this isomer from the racemic keto-acid requires the 
epimerisation of the stereogenic centre adjacent to the ketone, and this fact has been 
noted in the preparation of similar polycylic lactams for use as N-acyliminium 
precursors. On treating lactam (124) with excess titanium tetrachloride at low 
temperatures, the tetracyclic product (125) was isolated in an excellent 92 % yield, and 
perhaps not unexpectedly, had been accompanied by the concomitant deprotection of 
the ketal protecting group. 
As shown in the retrosynthetic Scheme 47, we envisaged a similar route toward the 
structural related tetracyclic system (128) in which the tricyclic lactam (129) could be 
generated by cyclocondensation of the chiral amino alcohol with the pro-chiral 
functionalised keto-acid. 
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Scheme 47: 
<0~ 0~~ 
0 
(127) 
OH 
M eO~ I = 
MeO .o NHz 
+ 
L__ _ > 
OH 
I MeOl(Y'l,,'' O 
MoO~p=> 
0 
(128) 
il 
(129) 
We believed this chiral lactam (129) could act as a suitable N-acyliminium ion 
precursor in the asymmetric synthesis of building block (128), which under these acidic 
conditions would also liberate the carbonyl group in the same step, as previously seen in 
the synthesis of (-)-3-demethoxyerythratidinone (126). 13b This ketone functionality 
could then be easily manipulated to form the target amino enone (127) and onward 
towards a novel synthesis of(-)-cephalotaxine (123). 
2.4.1. Stereoselective Synthesis of a Tetracyclic Model System 
OH 
M eO 
M eO 
(130) 
In order to determine the potential of our N-acyliminium chemistry towards the 
synthesis of the cyclic ketone (128) and hence (-)-cephalotaxine (123), it was first 
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deemed necessary to investigate if the formation of this particular tetracyclic ring 
system (130) was favoured using our methodology. Our synthesis mirrored that of the 
Erythrina alkaloids by Allin et al. described in Section 1.4.3. in which condensation of 
a chiral amino alcohol with a racemic cyclic keto-acid substrate provided a tricyclic 
lactam with high levels of diastereoselectivity. 13 
The desired keto-ester (132) required for condensation had previously been synthesised 
by Stork et al. and employed the. alkylation of an appropriate enamine (131). 39 As 
shown in Scheme 48, this was used to great effect by treatment of pyrrolidine enamine 
(131) and methyl acrylate in refluxing dioxane to yield the target keto-ester (132) in 
79 % yield. Hydrolysis of the ester (132) with lithium hydroxide gave the corresponding 
target keto-acid (133) in quantitative yield. 
Scheme 48: 
Q 0 0 6 (i) ~CO, Me (ii) ~CO,H 
(131) (132) (133) 
Reagents: (i) Methyl acrylate, dioxane,/',., 3.5 h (79 %); (ii) LiOH, THF/H20, 20 h (99 %). 
Condensation of the amino alcohol (62) and racemic keto-acid (133) in toluene for 48 
hours under Dean-Stark conditions generated the desired tricyclic lactam (134) as a 
single diastereoisomer in an excellent 76% yield as illustrated in Scheme 49. 
Exposure of the lactam (134) to the Lewis acid activator, titanium tetrachloride, in 
dichloromethane over 48 hours generated the reactive N-acyliminium ion intermediate 
(135), which then underwent intramolecular cyclisation to exclusively afford the 
tetracyclic model template (130) in 68 % yield as a single diastereoisomer. 
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cheme 49: 
OH 
MeOm 
I NH 
MeO ./:/ 2 
(62) 
OH 
M eO 
M eO 
(130) 
0 
~co,H 
(133) 
(i) 
(134) 
g~clOM• OH OMe 
(135) 
Reagents: (i) PhMe, 11, Dean-Stark, 48 h (76 %); (ii) TiC4, DCM, - 78 °C, 48 h (68 %). 
The relative stereochemistry of the pentacyclic tetrahydroisoquinoline skeleton (130) 
was confirmed by single crystal X-ray crystallograpby (Figure 19). 
Figure 19: Pentacyclic Template (130). 
OH 
M eO 
M eO 
(130) 
We were pleased to observe that the stereochemical outcome of the cyclisation could be 
rationalised using the same conformational models previously proposed for the related 
synthesis of the pyrroloisoquinoline and indolizino[8,7-b ]indoles ring systems. As 
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highlighted in Figure 20, Lewis acid activation of the tricyclic lactam substrate (134) 
leads to the formation of a fonnal N-acyliminiurn species (135) . 
Figure 20: Proposed Conformational Models. 
0 g H OH -N ... ,; H••• ;, 
- ~I 
::::,.... OMe 
OMe 
(135) 
0 
11 
HI OH 
!J 
R = alkyl 
OH 
MeOxxi I o ~ ,,x-N---\. 
MeO 
(130a) Syn Product 
OH 
M eO 
M eO 
(130) Anti Product 
In the proposed conformation A, one can envisage steric interactions between the 
angular alkyl group, R, and the benzyl moiety, which may disfavour the formation of 
the syn-product (130a). This steric influence exercised by the angular alkyl substituent 
at the iminium carbon atom over-rides the unfavourable 1 ,3-interaction that exists 
between the carbonyl and hydroxyl groups in conformation B and leads to the observed 
anti-diastereoisomer (130) with retention of stereochemistry. The presence of the 
additional chiral centre within the N-acyliminium species may also contribute to this 
stereochemical outcome, as it has been shown that the related erythrinane systems 
exhibit high levels of stereoselectivity for a cis-fused configuration. 
The cyclised compound (130) obtained from 3-(3 ,4-dimethoxyphenyl)-L-alanine 
possesses the opposite stereochemistry to that of naturally occurring (-)-cephalotaxine 
(123) . For this reason, the process was repeated using the D-amino alcohol (136) in 
order to ensure the transfer of chirality and afford enantiomer (138), which contained 
the relative stereochemistry required for (- )-cephalotaxine (123) (Scheme 50) . 
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cheme 50: 
MeOmOH 
I : 
MeO .-0 NH2 
(136) 
OH 
MeOm~ ,) 0 _o,,xN~ 
MeO ~
(138) 
0 
~co,H 
(133) 
(i) 
(137) l (H) 
g~-0{-0Me '-OH OMe 
Reagents: (i) PhMe, , Dean-Stark, 48 h (71 %); (ii) TiCI4, DCM, - 78 °C, 48 h (73 %). 
The procedure was repeated under the exact conditions as previously stated with the 
tricyclic lactam (137) formed exclusively as a single diastereoisomer in 71 %yield and 
the cyclised product (138) isolated in 73 % yield. The relative stereochemistry of (138) 
was again confirmed by X-ray crystallography (Figure 21). 
Figure 21: Pentacyclic Template (138). 
OH 
I Me0~,,,, 0 MeO~c;=s 
(138) 
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2.4.2. Synthesis of an Appropriate Keto-Acid Substrate 
With the successful application of our N-acyliminium methodology with the model 
tetracyclic skeletons (130) and (138), we turned our attention to the formation of a more 
functionalised ketone derivative that was suitable for a ring expansion/contraction 
procedure. Our initial focus was on the preparation of a protected keto-acid derivative 
such as (140), which could undergo cyclocondensation with an amino alcohol to 
generate the lactam precursor (129), described previously in Scheme 47. 
0 
CrC~H 
0 0 
\_j 
(139) (140) 
The related keto-acid (139) utilised in the synthesis of (-)-3-demethoxyerythratidinone 
(126) (Scheme 46) was prepared by the enolate addition of methyl bromo acetate to the 
1,4-protected cyclohexanone (141), which posed no problem of regioselectivity due to 
the symmetrical nature of the substrate (Scheme 51). 13b 
Scheme 51: 
-
0 
(i) Q 
\_j 
(141) 
Reagents: (i) KHMDS, THF, methyl bromoacetate, -78 °C tort, 16 h. 
0 Crco2Me 
0 0 
\_j 
The electrophilic alkylation of the 1,3-cyclopentadione derivative (142) however, is 
more problematic, as .shown in Scheme 52, due to the potential formation of multiple 
regioisomers (143) and (144). 
Results and Discussion 108 
Scheme 52: 
0 
(i) 0~ ~0 
0~ ~0 
(ii) 
(143) 
(142) 0~ ~0 (ii) 
0 er:: eo, M, 
0~ 
(144) 
Reagents: (i) LDA, THF, -78 °C; (ii) Methyl-3-bromopropionate, rt. 
With this in mind, our initial approach was to substitute the protected 1 ,3-cyclopentene 
dione (145) regioselectively at the 4-position using a Baylis-Hillman procedure 
(Scheme 53). This also had the advantage of incorporating a,,B-unsaturation into 
substrate (146), which is a feature of the target enone (127). This could however, be 
removed if the additional functionality proved problematic during condensation with the 
amino alcohol. 
Scheme 53: 
0 p 
0 
(i) 
o!;J 
~0 
(145) 
(ii) # r,.. 
Reagents: (i) Ethylene glycol,p-TsOH, PhMe, 1:1, 15 h (64 %); (ii) DABCO, methyl acrylate, THF. 
(146) 
Treatment of the mono-protected cyclopentene dione (145) with methyl acrylate in the 
presence of catalytic 1 ,4-diazabicyclo[2.2.2]octane (DABCO) however, produced only 
starting materials after vigorous stirring for 7 days at room temperature. The reaction 
was repeated under more extre!Jle conditions including stoichiometric quantities of 
Results and Discussion 109 
DABCO, elevated temperatures, extended reaction times and microwave conditions,40 
which all failed to generate the desired compound. 
After this initial setback, an alternate approach was attempted using the vinyl ether 
derivative of 1 ,3-cyclopentadione (148), in which the 2-position is effectively blocked, 
allowing substitution at the desired 4-position (Scheme 54). The vinyl ether (148) was 
readily obtained from 1,3-cyclopentanedione (147) following the procedure described 
by Chandrasekhar and Reddy in 72 % yield.41 Alkylation of the protected ketone (148) 
was then achieved using LDA and methyl-3-bromopropionate at -78 ·c to generate the 
ester (149) as part of a complex mixture. 
Scheme 54: 
0 
op (i) 
(147) 
0 p 
M eO 
(148) 
(ii) 
0 
~COzMe 
M eO 
(149) 
Reagents: (i) Trimethyl orthoformate, p-TsOH, MeOH, PhMe, ~. 80 min (72 %); (ii) LDA, methyl-3-bromo 
propionate, THF, -78 °C tort, 16 h, (22 %). 
Isolation of the desired compound was eventually achieved by column. chromatography 
in 22 % yield while monitoring the isolated fractions by LC-MS. The complex mixture 
generated in this reaction highlights the problems associated with alkylation's involving 
methyl-3-bromopropionate due to the potential side-reactions including; alkylation at 
the ester carbonyl and possible enolisation of the ester electrophile. Hydrolysis of the 
isolated methyl ester (149) was subsequently achieved with lithium hydroxide to form 
the desired carboxylic acid (150) in 55 % yield, as shown in Scheme 55. 
Scheme 55: 
0 
~COzMe 
M eO 
(149) 
Reagents: (i) LiOH, THF/H20, 20 h (55%). 
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2.4.3. Attempted Synthesis of the Tricyclic Ketone 
With the desired substrate (150) in hand, we attempted the formation of the 
functionalised tricyclic lactam (151), which would act as our N-acyliminium precursor 
(Scheme 56). The condensation was performed with amino alcohol (62) and the 
keto-acid (150) substrates under the Dean-Stark conditions previously applied in our 
test study, detailed in Section 2.5.1. 
Scheme 56: 
NJ(XOMe 
- I b ~ OMe 
0 
(150) (151) 
Reagents: (i) L-Dimethoxyphenylalaninol (62), PhMe, tl, Dean-Stark, 48 h. 
However to our disappointment, no trace of the desired lactam (151) was evident, with 
only starting materials recovered after prolonged heating in toluene. Attempts to 
increase the reaction temperature with the use of xylene and mesitylene also proved 
fruitless, as did attempts to condense the keto-ester precursor (149). 
We propose that under these conditions the amino alcohol (62) favours attack in a 
1,4-fashion over the desired 1,2-additio:ri, and is then immediately eliminated to revert 
back to the starting materials, which is supported by trace amounts of what appeared to 
be a conjugate addition product in the LC-MS, however this was not isolated. 
2.4.4. An Alternate Approach Towards a Tetracyclic Diol 
Due to the problems associated with condensation of the amino alcohol (62) and a 
1,3-diketo-acid equivalent (150), we designed a different approach to overcome the 
problem of 1 ,4-addition whilst still providing a functionalised substrate (154) 
(Scheme 57). As a solution to the previous problems associated with 1,4-addition to the 
1,3-diketone substrates, we focused our efforts on the formation of an analogous 
1 ,3-keto-alcohol, which could be oxidised to the ketone at a later stage. We reasoned 
Results and Discussion 
that a suitable condensation precursor (154) could be generated through a kinetically 
controlled enolate alkylation of the protected diol (153) formed by an asymmetric 
dihydroxylation of the readily available 2-cyclopentene-1-one (152). 
Scheme 57: 
0 
0 _______ QL ____ ~ )<o,,,~ o···lJ 
(152) 
M eO 
M eO 
Hcf 
(156) 
(153) 
OH 
(ii) 
--------------~ 
0 
)<Q,,.~ jCOzR 0'''~ 
(154) R = Me, H 
I 
I 
I 
:(ill) 
I 
I y 
•------<!!)______ (i~OMo U<?· OMe 
: 0 
0~ 
(155) 
Reagents: (i) AD-mix-,8, t-BuOHIH20; (ii) LDA, methyl-3-bromopropionate, THF, -78 °C tort; (iii) L-Dimethoxy 
phenylalaninol (62), PhMe, fi, Dean-Stark; (iv) TiCI4, DCM, -78 °C. 
Cyclocondensation of this keto-acid (154) with amino alcohol (62) in refluxing toluene 
could generate the highly functionalised N-acyliminium ion precursor (155). We 
envisaged that upon treatment of (155) with a Lewis acid activator such as titanium 
tetrachloride, the heterocyclic template (156) could be generated via a stereoselective 
N-acyliminium ion cyclisation with probable removal of the ketal protecting group 
under the acidic conditions. 
With a suitable protecting group strategy to prepare the mono-protected diol (157) and 
subsequent oxidation to generate the enone derivative (158) as shown in Scheme 58, we 
could incorporate the required chiral hydroxyl group present in the ( + )-cephalotaxine 
target (159) with complete stereocontrol and present a novel introduction of this 
asymmetric centre. 
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Scheme 58: 
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To the best of our knowledge the dihydroxylation of 2-cyclopentene-1-one (152) to diol 
(160) had not previously been reported in the literature, and it was perhaps unsurprising 
to us when this conversion failed under various conditions including AD-mix,42 
ruthenium tetraoxide,43 and potassium permanganate 44 (Scheme 59). 
Scheme 59: 
0 
6 
(152) 
(i) # H0-6 
HO 
(160) 
The lack of success of this reaction was put down to the reduced reactivity of the olefin 
moiety in the presence of a conjugated ketone. With this in mind, the protected analogue 
2-cyclopenten-1-one ethylene ketal (161) was subjected to the same conditions and 
successful afforded the diol (162) in both a racemic (potassium permanganate)44 and 
asymmetric fashion (AD-mix) in 41 and 94 % yields respectively (Scheme 60). With 
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the free dial (162) in hand we attempted to remove the acetal protecting group and 
subsequently protect the dial to obtain the desired substrate (153). 
Scheme 60: 
n 
0 (i) 
(161) 
n 
0 0 HO·.,o 
Hcf 
(162) 
(ill) l 
oil 
Xo.,,Ao o···l} 
(164) 
0 
(ii) H0--6 
(163) 
(iv) .# Xo.,,~ o···l) 
(153) 
Reagents: (i) AD-mix-(3, t-BuOH/H20, 25 h (94%); (ii) Perchloric acid, acetone!H20; (iii) Dimethoxypropane, 
BF3.0Et2, 30 min (79 %); (iv) Perchloric acid, acetone/H20. 
However, exposure of (162) to protic acid conditions including both p-tosic acid and 
perchloric acid at various temperatures only generated the elimination product (163). An 
alternate route reported by Cocu detailed the protection of diol (162) with 
dimethoxypropane to give·(164) followed by treatment with perchloric acid in acetone 
to selectively remove the ketone-protecting group and generate (153),44 however this 
was unsuccessful in our hands. 
Synthesis of the target ketone (153) was achieved however, by an alternate strategy 
involving an epoxide intermediate (167) as shown in Scheme 61. 2-Cyclopentene-1-ol 
(166) was formed from the readily available oxirane (165) as described by Mordini et 
al. in the presence of LDA and potassium tert-butoxide in an excellent 88 % yield.45 
The allylic alcohol (166) was significantly more reactive than its enone counterpart 
(152) and successfully underwent epoxidation in the presence ofm-CPBA to form (167) 
in 68 % yield. 
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Scheme 61: 
OH 
(i) 6 (ii) 
(165) (166) (167) 
1 (iU) 
(iv) x:xr 
(153) (168) 
Reagents: (i) LDA, t-BuOH, -78 °C to 0 °C, 90 min (88 %); (ii) m-CPBA, DCM, 2 h (68 %); (iii) BF3.0Et2, acetone, 
I h (81 %); (iv) Dess-Martin periodinane, DCM, 3 h (90 %). 
Treatment of the epoxide (167) with Lewis acid in acetone quickly produced the desired 
1,3-dioxolane (168),46 which was then transformed into the target ketone (153) upon 
oxidation with Dess-Martin periodinane. It was expected that treatment of the ketone 
(153) with the hindered base LDA at low temperatures would generate the kinetic 
enolate (169) and allow regioselective alkylation to yield substrate (154) (Scheme 62). 
To our disappointment however, only a complex mixture was obtained which was 
inseparable by chromatography methods. 
Scheme 62: 
(169) (154) 
(153) 
0 x:xYCO,Me 
(154) 
Reagents: (i) LDA, THF, -78 °C, then methyl-3-bromopropionate, rt, 16. h; (ii) Pyrrolidine, Dean-Stark, then methyl 
acrylate, PhMe, 6., 15 h. 
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It has been shown by Stork that enamines derived from unsymmetrical ketones lead to 
substitution on the less substituted carbon when reacted with alkyl halides.39 With this 
in mind we attempted to generated enamine (170) by reaction of (153) with pyrrolidine, 
and undergo a Michael addition to methyl acrylate, however this was also unsuccessful. 
2.4.5. Manipulation of the Keto-ester Test Substrate 
Having spent a significant amount of time investigating the enolate addition of 
. functionalised cyclopentanes with little success, it seemed advantageous at this point to 
attempt to manipulate substrate (132), previously used in our model systems, in a 
similar fashion to that shown in Scheme 63. This keto-ester (132) already incorporates 
the desired propionate side chain and hence avoids the problems associated with its 
introduction via enolate chemistry. This approach had previously been avoided due to 
the additional steps required to generate the allylic alcohol (172) from (132), and the 
potential for several regioisomers when introducing a,,B-unsaturation. 
Scheme 63: 
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r--------
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I 
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""11(--------------
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I 
: (ii) 
I 
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t 
Reagents: (i) Unsaturation method; (ii) NaBH4, CeCI3, EtOH; (iii) m-CPBA, DCM; (iv) BF3.0Et2, acetone (v) Dess-
Martin periodinane, DCM. 
To achieve our desired enone product (171) in favour of the other potential compounds, 
we utilised a palladium (H)-catalysed dehydrosilylation of the silyl enol ether (175).47 It 
was reasoned that regioselective formation of the desired enolate could be achieved 
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under kinetically controlled conditions as shown in Scheme 64. To our delight, 
deprotonation of the keto-ester (132) with LDA at low temperature and trapping of the 
enolate with chlorotrimethylsilane afforded exclusively the kinetic product (173), which 
was then converted to the desired a,,B-unsaturated regioisomer (171) in the presence of 
palladium (II) acetate in a modest 39% yield with trace amounts of the keto-ester (132). 
Scheme 64: 
0 
~co2Me 
(132) 
OH 
0co2Me 
(172) 
(i) 
(ill) 
OTMS 
~co2Me 
(173) 
0 
~CO, Me 
(171) 
Reagents: (i) LOA, THF, TMSCI, -78 octo rt, 4 h (99 %); (ii) Pd(OAc)2, 1,4-benzoquinone, MeCN, 4 h (39%); (iii) 
NaBH4, CeCI3, EtOH. 
However upon subjecting enone (171) to the Luche reduction conditions, a 1:1 mixture 
of products was obtained which appeared to be consistent with the allylic alcohol (172) 
and the analogous alcohol. Due to the difficulties encountered when separating these 
compounds, together with the low yields and high expense associated with the 
dehydrosilylation of (173), we turned our attentions to an alternate strategy. 
2.4.6. Synthesis of a Tetracyclic Olefin via a Diels-Alder Strategy 
OH 
M eO 
M eO 
(174) 
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Lete and eo-workers recently reported an interesting synthesis of polyfunctionalised 
a,/3-unsaturated lactams oftype (178) in which a masked olefin moiety was contained in 
the imide precursor (175), in the form of a Diels-Alder adduct (Scheme 65).48 
Scheme 65: 
OMe 
(i) fitt-{_rQ-oMe 
~OH 
R 
(175) (176) 
MeOX2r 
' I N 
MeO '" 0 
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(iii) M eO 
0 M eO 
(178) (177) 
Reagents: (i) RLi, -78 °C, 6 h; (ii) TFA, DCM, L'1, 24 h; (iii) L'1, !mm Hg, 10 min. 
Treatment of the protected imide (175) with n-butyl lithium or methyl lithium at low 
temperatures afforded the corresponding hydroxy lactams (176) as diastereomeric 
mixtures, in good yields. Subsequent N-acyliminium cyclisation of (176) under protic 
acid conditions formed the respective lactams (177), which when heated at 500 ·c under 
reduced pressure, afforded the a,/3-unsaturated pyrroloisoquinolinones (178) in almost 
quantitative yields, by a retro Diels-Alder reaction. With all previous attempts to 
introduce a protected diol moiety into our keto-acid substrate proving unsuccessful, it 
was felt that this masked alkene strategy could be used to our advantage. 
The endo ketone (179) had previously been prepared in quantitative yields by Little et 
al. via a Diels-Alder cycloaddition of cyclopentadiene with cyclopentenone (152) in the 
presence of a boron· trifluoride diethyl etherate.49 With this cycloadduct (179) readily 
accessible to us, we attempted to introduce the necessary propionate side chain (Scheme 
66). 
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Scheme 66: 
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Reagents: (i} Cyclopentadiene, BF3.0Et2, Et20, 24 h (99 %}; (ii} LDA, THF, methyl-3-bromopropionate, -78 °C to 
rt, 16 h (66 %); (iii} LiOH, THF/H20, 90 min (99 %}. 
To our delight, treatment of (179) with LDA at -78 ·c followed by the addition of the 
methyl-3-bromopropionate electrophile, resulted in the formation of our desired 
keto-ester (180) in a respectable 66 % yield as a single diastereoisomer. Subsequent 
hydrolysis to the corresponding carboxylic acid (181) was achieved quantitatively in the 
presence of lithium hydroxide, to yield the target condensation substrate. 
The protected polycyclic lactam (182) was then successfully prepared as a single 
diastereoisomer by cyclocondensation of the racemic keto-acid (181) and chiral amino 
alcohol (62) under Dean-Stark conditions, as shown in Scheme 67. 
Scheme 67: 
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Reagents: (i} L-Dimethoxyphenylalaninol (62}, PhMe, 6, Dean-Stark, 48 h (45 %}; (ii} TiCI4, DCM; (iii} 6, !mm Hg. 
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With our functionalised lactam (182) in hand, we visualised an asymmetric 
N-acyliminium ion cyclisation upon treatment with Lewis acid at low temperature to 
form (183) bearing a masked olefin, that could be released in the final step by a retro 
Diels-Alder reaction to give the alkene building block (184). 
However, treatment of the N-acyliminium ion precursor (182) with titanium 
tetrachloride at -78 ·c failed to produce the desired product (183) and resulted only in 
the degradation of the starting materials. Attempts to generate the N-acyliminium 
intermediate with an alternate Lewis acid, boron trifluoride diethyl etherate, was also 
unsuccessful at low temperatures with only starting materials recovered. In a further 
attempt to drive this synthesis, the temperature was elevated by performing the reaction 
in refluxing dichloromethane, which after 24 hours under these revised conditions, 
produced the unexpected alkene iminium salt (186) shown in Scheme 68. 
Scheme 68: 
OMe 
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(182) (185) 
! 
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Reagents: (i) BF3.0Et2, DCM, t'l, 15 h (91 %). 
The complete structure of the iminium salt (186) was determined by single crystal X-ray 
crystallography and also confirmed the relative stereochemistry of this highly 
functionalised intermediate, which followed the trends observed in the model tetracyclic 
system with effective retention of configuration (Figure 22). 
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Figure 22: Single Crystal X-Ray Structure of (186): 
M eO 
M eO 
(186) 
We propose that in the presence of excess Lewis acid and at moderately elevated 
temperatures, this unexpected tandem reaction is likely to occur via the stabilised 
N-acyliminium intermediate (185) shown in Scheme 68. The formation of (185) is 
possible by two mechanistic pathways, however to date, the intermediate alkene (188) 
generated in route B has not been observed at any point in the reaction (Scheme 69). 
cheme 69: 
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;, OH 
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We believe that an initial ring opening of the bicyclic lactam occurs via route A to 
generate N-acyliminium ion (187), which in turn triggers a retro Diels-Alder reaction 
under the Lewis acid catalysed conditions, to form the conjugated N-acyliminium ion 
intermediate (185). Subsequent nucleophilic attack of the aromatic moiety at the 
N-acyliminium species would lead to the expected tetracyclic alkene (184), however it 
appears that in the presence of excess boron trifluoride diethyl etherate, the free 
hydroxyl group undergoes a further 1 ,2-addition at the lactam carbonyl to generated the 
isolated oxazolidine-iminium salt (186) (Scheme 68). 
The final step outlined in Scheme 70, involved the reduction of the iminium species 
(186), which was achieved in the presence of two equivalents of diisobutylaluminium 
hydride (DIBAL) to furnish the target chiral amine (174) in 65 %yield. 
Scheme 70: 
OH 
(i) 
M eO 
(186) (174) 
Reagents: (i) DIBAL, DCM, t1, 5 h (65 %). 
2.4.7. Future Work 
We are confident that the alkene building block (17 4), which is accessible in excellent 
yields over 6 steps and in a highly stereoselective fashion, can act as a key intermediate 
towards the target product (+)-cephalotaxine (159). As demonstrated in Scheme 71, we 
envisage that the olefin moiety displayed by (174) can be converted to the enone (192) 
through the application of standard literature methodology, and would act as a suitable 
intermediate for the transannular rearrangement reported by Li and Wan g. 38 
Dihydroxylation of the alkene function (174), under the conditions reported by 
Sharpless,42 would generate the dial (189) in an asymmetric fashion and allow a 
stereocontrolled introduction of the hydroxyl group present in ( + )-cephalotaxine (159). 
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Reagents: (i) AD-mix, t-BuOH/H20; (ii) Benzaldehyde dimethyl acetal, p-TsOH, DMF; (iii) DIBAL, DCM; (iv) 
Dess-Martin periodinane, DCM; (v) LOA, THF, PhSeBr, -78 octo rt; (vi) Nal04, NaHC03; (vii) Zn/AcOH, 100 °C; 
(viii) 8Br3, CH2Br2; (ix) Raney-nickel, PhMe, ~; (x) Pd/C, H2 EtOH; (xi) Trimethyl orthoformate, PhMe, ~. 
Protection of the diol (189) as the benylidene ketal (190) in the presence of 
benzaldehyde dimethyl acetal and p-tosic acid under reflux followed by selective 
cleavage with DIBAL,50 which we believe would occur at the least hindered position, 
forms the mono-benyl ether (191). Oxidation of the secondary hydroxyl group followed 
by a-selenylation and syn elimination, a conversion examined extensively by Reich et 
a/.51 and employed by Allin,52 would then afford the target enone intermediate (192). 
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A transannular reductive skeletal rearrangement of (192), as reported by Li and Wang 
for a structurally related enone upon exposure to zinc dust in hot acetic acid, would 
allow transformation to the pyrrolobenzazepine (193). We envisage the presence of the 
hydroxymethyl auxiliary may act as a chiral handle during this rearrangement and could 
contribute some degree of stereocontrol. With (193) in hand, removal ·of the 
hydroxymethyl group with Raney nickel and construction of the methylenedioxy group 
in the usual manner would then generate (194),53 which followed by hydrogenolysis and 
formation of the vinyl ether with methyl orthoformate would complete a highly 
stereocontrolled novel synthesis of the target ( + )-cephalotaxine (159) in a total of 16 
steps. This synthesis could also be easily transferred to the construction of naturally 
occurring enantiomer, (-)-cephalotaxine (123), through the use of D-phenylalaninol as 
the starting amino alcohol and the appropriate asymmetric dihydroxylation reactants. 
2.5. Conclusions 
In summary, we have developed a highly stereoselective approach to a variety of 
enantiomerically pure heterocyclic templates from readily available non-racem1c 
substrates via the application of novel N-acyliminium ion methodology (Scheme 72). 
Scheme 72: 
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The potential application of this novel methodology in target synthesis and the diverse 
nature of these key building blocks has been demonstrated by the removal of 
functionality using complementary procedures to access the biologically active natural 
alkaloids (+)-crispine A and (+)-harmicine (Scheme 73).29 
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Reagents: (i) Rh(PPh3)2(CO)CI, dppp,p-xylene, ti, 10 d (46 %); (ii) n-Bu3SnH, AIBN, PhMe, 80 oc (90 %). 
We have also demonstrated the manipulation of existing functionality associated with 
these heterocyclic building blocks through the application of enolate addition chemistry, 
which was achieved with excellent levels of stereocontrol and allows access to a new 
range of potential CCK receptors antagonists (Scheme 74). 
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Finally, we have taken this methodology forward through the development of a novel 
N-acyliminium cyclisationlretro Diels-Alder tandem reaction to generate a highly 
functionalised pentacyclic template, which we envisage as the key intermediate toward 
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a novel stereoselective synthesis of the interesting target compound cephalotaxine 
(Scheme 75). 
Scheme 75: 
(i)-(ii) 
Reagents: (i) BF3.0Et2, DCM, tJ., 15 h (91 %); (ii) DIBAL, DCM, tJ., 5 h (65 %). 
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CHAPTER THREE: 
EXPERIMENTAL 
3.1. General Information 
3.2. Asymmetric Cyclisations of Chiral N-Acyliminium Ion Precursors 
3.3. Application in the Synthesis of Naturally Occurring Alkaloids 
3.4. Application as Potential Building Blocks for Peptide Mimics 
3.5. Application Toward the Synthesis of Cephalotaxine 
3.1. General Information. 
Commercial dry solvents were used in all reactions except for light petroleum and ethyl 
acetate, which was distilled from CaCh and dichloromethane, which was distilled over 
phosphorus pentoxide. Light petroleum refers to the bp 40-60 ·c fractions. Sodium 
hydride was obtained as 60 % dispersion in oil, and was washed with light petroleum, 
and a 2.5 M solution of n-butyl lithium in hexane was used in all stated cases. Melting 
points were determined on a Stuart Scientific SMP3 melting point apparatus and are 
uncorrected. Elemental analyses were determined on a Perkin Elmer 2400 CHN 
Elemental Analyser in conjunction with a Perkin Elmer AD-4 Autobalance. Infrared 
spectra were recorded on a Perkin-Elmer Paragon 1000 FT-IR spectrophotometer on 
NaCl pl~tes. 1H (400 MHz) and 13C (100 MHz) NMR spectra were recorded on a 
Broker DPX-400 spectrometer as solutions of CDCb with tetramethylsilane as the 
internal standard for 1H NMR spectra and CDCb the standard for 13C NMR spectra 
unless otherwise specified. Chemical shifts are given in parts per million (ppm) and J 
values in hertz (Hz). Mass spectra were recorded on a Jeol JMS-SX102 quadrupole 
high-resolution mass spectrometer or carried out by the EPSRC MS service at the 
University of Wales, Swansea. TLC using silica gel as absorbent was carried out with 
aluminium backed plates coated with silica gel (Merck Kieselgel 60 F254). Silica gel 
(Merck Kieselgel 60 H silica) was used for column chromatography unless otherwise 
specified. 
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3.2. Asymmetric Cyclisations of Chiral N-Acyliminium Ion Precursors 
3.2.1. Stereoselective Synthesis of Pyrroloisoquinolines 
(S)-2-Amino-3-phenyl-1-propanol (6). 3 
OH 
~ 
Trimethylsilylchloride (13.2 g, 15.4 ml, 121.1 mmol) was added to lithium borohydride 
(1.32 g, .60.5 mmol) in tetrahydrofuran (80 ml) over a 5 min period under nitrogen. 
L-Phenylalanine (5.0 g, 30.3 mmol) was added to the resultant mixture and the mixture 
stirred at room temperature for 24 h. Methanol (50 ml) was cautiously added and the 
volatiles were removed by evaporation. The residue was treated with 20 % potassium 
hydroxide solution and extracted with dichloromethane (3 x 50 ml). The organic 
extracts were combined, dried over anhydrous magnesium sulfate, filtered and solvent 
was evaporated under reduced pressure to yield the target compound as a colourless 
crystalline solid (4.35 g, 95 %), Mp 92-94 ·c, Lit: Mp 92-94 ·c; [a]o- 18.5 [c = 1.08 in 
CH2Ch], Lit [a]0 - 22.8 [c = 1.20 in 1 N HCl]; Vmax (thin film, CH2C}z)/cm-1 3356 
(NH) and 3659 (OH); oH (400 MHz, CDCh) 2.50 (1 H, dd, J 8.8, 13.6 Hz, 
ArCH(H)CHNH2), 2.79 (1 H, dd, J 5.2, 13.6 Hz, ArCH(H)CHNH2), 3.10 (1 H, m, 
ArCH2CHNH2), 3.39 (1 H, dd, J7.2, 10.8 Hz, CH(H)OH), 3.62 (1 H, dd, J 4.0, 10.8 Hz, 
CH(H)OH) and 7.18-7.32 (5 H, m, ArH); oc (100 MHz, CDCh) 41.1 (CH2), 54.6 (CH), 
66.5 (CH2), 126.8 (CH), 129.0 (CH), 129.0 (CH), 126.6 (CH), 126.6 (CH) and 139.1 
(C); MS (FAB) m/z 152 [MH+, 100 %] (MH+, 152.1075. C9H13NO requires 152.1075). 
1-(2S)-(1-Hydroxymethyl-2-phenyl-ethyl)-pyrrolidine-2,5-dione (8). 1b 
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Succinic anhydride (5.29 g, 52.9 mmol) and (S)-2-amino-3-phenyl-1-propanol (6) 
(8.0 g, 52.9 mmol) was stirred in toluene (100 ml) under a nitrogen atmosphere. 
Triethylamine (8 ml) was added to the resultant solution and the mixture heated under 
reflux for 18 h after which, the reaction was cooled to room temperature and solvent 
removed by evaporation to yield a yellow oil. The crude product was adsorbed onto 
silica gel and chromatographed using silica gel as absorbent and 3: 1 ethyl acetate/light 
petroleum as eluent to produce a colourless solid (7.65 g, 62 %), Mp 130-131 ·c, Lit: 
Mp 130-131 ·c; [a]o- 89.2 [c = 0.50 in CHzClz], Lit [a]o- 89.8 [c = 0.48 in CHzClz]; 
Vmax (thin film, CH2Clz)/cm-1 1682 (NCO), 2972 (aliphatic CH) and 3419 (OH); OH (400 
MHz, CDCh) 2.50-2.63 (4 H, m, COCH2CH2CO), 3.05-3.20 (2 H, m, ArCH2CHN), 
3.82 (1 H, dd, J 3.5, 11.9 Hz, CH(H)OH), 4.01 (1 H, dd, J 7.6, 11.9 Hz, CH(H)OH), 
4.47-4.54 (1 H, m, ArCH2CHN) and 7.16-7.28 (5 H, m, ArH); oc (100 MHz, CDCh) 
27.8 (Clh), 27.8 (CH2), 33.7 (CH2), 55.7 (CH), 62.1 (CHz), 126.8 (CH), 128.5 (CH), 
128.5 (CH), 129.0 (CH), 129.0 (CH), 137.2 (C), 178.2 (CO) and 178.2 (CO); MS (El) 
m/z 233 [M+, 2.5 %] (M+, 233.1055. C13H15N03 requires 233.1052). 
(5S,1 ObR)-5-(Hydroxymethyl)-1,2,3,5,6,1 0 b-hexahydropyrrolo [2,1-a] isoq uinolin-3-
one (10). 1b 
qio 
1-(2S)-3-Hydroxy-2-(phenylmethyl)ethyl-tetrahydro-1H-pyrrole-2,5-dione (8) (5.0 g, 
21.4 mrnol) was dissolved in absolute ethanol (100 ml) and cooled to 0 ·c. Sodium 
borohydride (8.11 g, 214.4 mmol) was then added with stirring. HCl (2 M solution in 
absolute ethanol, 10.7 ml, 21.4 rnrnol) was then slowly added via syringe over a 3 h 
period. The resultant solution was acidified to pH 1-3 with HCl (2 M solution in 
absolute ethanol) over a 15 min period. This afforded a white suspension, which was 
stirred for a further 20 h. The reaction was quenched with sodium hydrogen carbonate 
and extracted with dichloromethane (3 x 75 ml). The dichloromethane layers were then 
combined and dried over anhydrous magnesium sulfate and solvent removed by rotary 
evaporation to yield the ethoxy lactam intermediate as a colourless oil ( 4.34 g). The 
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intermediate ethoxy lactam ( 4.34 g, 16.5 mmol) was dissolved in dry dichloromethane 
(100 ml) under nitrogen. The solution was cooled to -78 OC and titanium tetrachloride 
(4.69 g, 2.71 ml, 24.7 mmol) was added dropwise. After stirring at -78 OC for 10 min, 
the reaction was allowed to warm to room temperature and stirred for 20 h. The reaction 
mixture was quenched with saturated aqueous ammonium chloride (75 ml), extracted 
with dichloromethane (3 x 75 ml) and dried over anhydrous magnesium sulfate. The 
solvent was removed by evaporation to yield the target compound as a single 
diastereoisomer, which was purified by column chromatography using silica gel 
absorbent and 10 % methanol/dichloromethane as eluent to yield a green solid (2.04 g, 
44 %), Mp 110-111 oC, Lit: Mp 110-111 OC; [a]0 + 13.7 [c = 0.54 in CH2Clz], Lit [a]o 
+ 13.3 [c = 0.08 in CHzClz]; Vmax (thin film, CHzClz)/cm·1 1643 (NCO), 2985 (aliphatic 
CH) and 3374 (OH); oH (400 MHz, CDCh) 1.92-2.07 (1 H, m, CH(H)CH2CO), 2.41-
2.51 (1 H, m, CH2CH(H)CO), 2.59-2.70 (2 H, m, CH(H)CHzCO and CHzCH(H)CO), 
2.74 (1 H, dd, J3.6, 16.4 Hz, ArCH(H)CHN), 3.04 (1 H, dd, J 6.4, 16.4 Hz, 
ArCH(H)CHN), 3.59-3.73 (2 H, m, CH20H), 4.14 (1 H, br, s, OH), 4.43-4.49 (1 H, m, 
ArCH2CHN), 4.83 (1 H, t, J7.6 Hz, NCHAr) and 7.09-7.31 (4 H, m, ArH); oc (100 
MHz, CDCh) 26.6 (CI-iz), 29.6 (CH2), 31.7 (CHz), 49.5 (CH), 54.5 (CH), 62.8 (CHz), 
124.3 (CH), 126.9 (CH), 127.2 (CH), 128.7 (CH), 132.3 (C), 136.7 (C) and 175.2 (CO); 
MS (El) m/z 217 [M+, 8.3 %] (M+, 217.1105. C13H1sN02 requires 217.1103). 
3.2.2. Stereoselective Synthesis of lndolizino[8,7-b]indoles 
(2S)-2-Amino-3-(1H-indol-3-yl) propan-1-ol (22). 
Trimethylsilylchloride (12.4 ml, 97.9 mmol) was added to lithium borohydride (1.07 g, 
49.0 mmol) in tetrahydrofuran (80 ml) over a 5 min period under nitrogen. L-tryptophan 
(5.0 g, 24.5 mniol) was cautiously added to the resultant mixture and the reaction stirred 
at room temperature for 24 h. Methanol (50 ml) was cautiously added and the volatiles 
were removed by rotary evaporation. The red residue was treated with 20 % potassium 
hydroxide solution and extracted with ethyl acetate (3 x 50 ml). The organic extracts 
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were combined, dried over anhydrous magnesium sulfate, filtered and solvent was 
evaporated under reduced pressure resulting in a crude yellow solid ( 4.6 g, 99 %), Mp 
72-76 ·c, Lit: Mp 73-77 ·c; [a]0 - 19.9 [c = 1.01 in MeOH], Lit [a:]0 - 20.5 [c = 1.00 
in MeOH]; Vmax (thin film, CHzClz)/cm"1 3282 (NH) and 3350 (OH); OH (400 MHz, 
DMSO) 2.57 (1 H, dd, J7.3, 14.5 Hz, ArCH(Jf}CHNH2), 2.81 (1 H, dd, J6.0, 14.1 Hz, 
ArCH(H)CHNHz), 2.95-3.02 (1 H, m, ArCH2CHNH2), 3.24 (1 H, dd, J5.3, 15.9 Hz, 
CH(H)OH), 3.40 (1 H, dd, J 4.5, 10.1 Hz, CH(lf)OH), 6.99 (1 H, t, J 6.8 Hz, ArH), 7.08 
(1 H, t, J 7.3 Hz, ArH), 7.14 (1 H, s, CHNH), 7.35 (1 H, d, J7.2 Hz, ArH) and 7.55 
(1 H, d, J 7.7 Hz, ArH); oc (100 MHz, DMSO) 29.6 (CHz), 53.6 (CH), 66.0 (CHz), 
111.3 (CH), 111.7 (C), 118.1 (CH), 118.5 (CH), 120.8 (CH), 123.3 (CH), 127.6 (C) and 
136.2 (C); MS (El) m/z 190 [M\ 3.0 %] (M+, 190.1102. C11H14N20 requires 190.1106). 
1-[ (1S)-1-Hydroxymethyl-2-(1H-indol-3-yl)-ethyl]-pyrrolidine-2,5-dione (18). 2 
~N 
OHO 
(2S)-2-Amino-3-(1H-indol-3-yl)propan-1-ol (22) (4.90 g, 26.0 mmol) and succinic 
anhydride (2.60 g, 26.0 mmol) were stirred in toluene (100 ml) under a nitrogen 
atmosphere. Triethylamine (4 m1) was added to the resultant solution and the mixture 
heated at reflux for 18 h after which, the reaction was cooled to room temperature and 
solvent removed by rotary evaporator to yield a dark brown oil. The crude product was 
adsorbed onto silica gel and chromatographed using silica gel as absorbent and 3: 1 ethyl 
acetate/hexane as eluent to produce a colourless solid (3.54 g, 72 %), Mp 144-148 ·c; 
[a]o - 74.0 [c = 1.00 in CHzClz] (Found: C, 66.27; H, 5.82; N, 10.32. C1sHI6Nz03 
requires C, 66.16; H, 5.92; N, 10.29 %); Vmax (thin film, CH2Clz)/cm"1 1674 (NCO), 
2946 (aliphatic CH), 3408 (OH) and 3426 (NH); oH (400 MHz, CDCh) 2.39-2.56 (4 H, 
m, COCH2CH2CO), 3.18 (1 H, ddd,J0.6, 8.7, 14.6 Hz, ArCH(lf)CHN), 3.28 (1 H, ddd, 
J0.6, 8.7, 14.6 Hz, ArCH(H)CHN), 3.66 (1 H, br, s, OH), 3.79 (1 H, dd, J 4.0, 11.7 Hz, 
CH(H)OH), 4.11 (1 H, dd, J 8.5, 11.7 Hz, CH(H)OH), 4.55-4.61 (1 H, m, ArCH2CHN), 
7.01 (1 H, d, C=CH), 7.04-7.08 (1 H, m, ArH), 7.10-7.13 (1 H, m, ArH), 7.31-7.34 
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(1 H, m, ArH), 7.57-7.58 (1 H, m, ArH) and 9.24 (1 H, br, s, NH); oc (100 MHz, 
CDCh) 23.7 (CHz), 28.0 (CH2), 28.0 (CHz), 55.6 (CH), 61.5 (CHz), 111.0 (C), 111.3 
(CH), 118.4 (CH), 119.0 (CH), 121.6 (CH), 122.9 (CH), 127.3 (C), 136.2 (C), 178.3 
(CO) and 178.3 (CO); MS (El) m/z 272 [M+, 13.9 %] (M+, 272.1162. C 15H16Nz03 
requires 272.1161). The product was recrystallised from dichloromethane/hexane via 
vapour diffusion to produce a colourless crystalline solid. 
(5S,llbR)-5-Hydroxymethyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b]indol-3-one 
(21).2 
Qn}H 
N ')('N)::::O 
HH LJ 
1-[(1S)-1-Hydroxymethyl-2-(1H-indol-3-yl)-ethyl]-pyrrolidine-2,5-dione (18) (500 mg, 
1.84 mmo1) was dissolved in absolute ethanol (25 ml) at room temperature under a 
nitrogen atmosphere. The solution was then cooled to 0 oc and sodium borohydride 
(700 mg, .18.4 mmol) was added with stirring. The reaction mixture was warmed to 
room temperature and HCI (2 M solution in absolute ethanol, 0.92 ml, 1.84 mmol) was 
added with stirring over a 3 h period. The resultant solution was acidified (pH 1-3) with 
HCl (2 M solution in absolute ethanol) over a 15 min period. This afforded a white 
suspension, which was stirred for a further 20 h. The reaction was quenched with 
saturated sodium hydrogen carbonate (30 ml) and extracted with dichloromethane (3 x 
30 ml). The dichloromethane layers were then combined and dried over anhydrous 
magnesium sulfate. The organic phase was then filtered and volatiles removed on the 
rotary evaporator to yield the target compound as a crude 9:1 mixture of 
diastereoisomers (400 mg, 85 %). The crude mixture was recrystallised from absolute 
ethanol, which precipitated the major isomer only as clear colourless needles (202 mg, 
43 %), Mp 266-267 oC; [a]0 + 144.8 [c = 0.48 in EtOH] (Found: C, 70.57; H, 6.31; N, 
10.74. C1sHI6NzOz requires C, 70.29; H, 6.29; N, 10.93 %); Vmax (KBr disc)/cm-1 1666 
(NCO), 2968 (aliphatic CH) and 3269 (NH); oH (400 MHz, DMSO) 1.77-1.85 (1 H, m, 
CH(H)CHzCO), 2.25-2.31 (1 H, m, CHzCH(H)CO), 2.50-2.58 (2 H, m, CH(H)CH2CO 
and CHzCH(H)CO), 2.73 (1 H, dd, J 2.1, 6.6 Hz, ArCH(H)CHN), 2.82 (1 H, d, 
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J 15.8 Hz, ArCH(H)CHN), 3.38 (2 H, t, J 7.96, CH20H), 4.47-4.52 (1 H, m, 
ArCH2CHN), 4.84-4.88 (2 H, m, NCHAr and OH), 6.95-6.99 (1 H, m, ArH), 7.04-7.07 
(1 H, m, ArH), 7.31-7.34 (1 H, m, ArH), 7.38-7.40 (1 H, m, ArH) and 11.02 (1 H, s, 
NH); oc (100 MHz, DMSO) 21.1 (Cfh), 25.5 (CHz), 31.1 (CHz), 48.0 (Cfl), 50.7 (CH), 
60.1 (CH2), 104.1 (C), 111.1 (CH), 117.7 (CH), 118.4 (CH), 120.9 (CH), 126.9 (C), 
133.4 (C), 136.1 (C) and 172.6 (CO); MS (El) m/z 256 [M+, 86.8 %] (M+, 256.1215. 
C1sHI6N20 2 requires 256.1212). The relative stereochemistry at C-5 and C-1lb was 
determined by single crystal X-ray analysis. 
(5S,11 bS)-5-Hydroxymethyl-11 b-methyl-1,2,5,6,11,11 b-hexahydro-indolizino 
[8,7-b]indol-3-one (25).2 
(2S)-2-Amino-3-(1H-indol-3-yl)propan-1-ol (22) (4.80 g, 25.2 mmol) and levulinic acid 
(2.93 g, 25.2 mmol) were added to toluene (150 ml) and refluxed under Dean-Stark 
conditions for 48 h. The reaction was cooled to room temperature and solvent removed 
by rotary evaporation. The crude product was adsorbed onto silica and chromatographed 
using silica gel as absorbent and 4:1 ethyl acetate/light petroleum as eluent to produce a 
colourless solid (3.75 g, 55%), Mp 212-214 ·c; [a] 0 - 229.8 [c = 1.24 in CHzCh]; Vmax 
(thin film, CH2Ch)/cm·1 1651 (NCO), 2970 (aliphatic CH), 3057 (aromatic CH), 3265 
(OH) and 3269 (NH); oH (400 MHz, CDCi]) 1.65 (3 H, s, CH3), 2.25-2.32 (2 H, m, 
CH2CH2CO), 2.49 (1 H, ddd, J3.1, 9.3, 17.0, Hz, CHzCH(fflCO), 2.70-2.78 (2 H, m, 
CHzCH(H)CO and ArCH(Ff)CHN), 3.05 (1 H, dd, J 11.7, 15.4 Hz, ArCH(H)CHN), 
3.66-3.70 (1 H, m, ArCH2CHN), 4.17-4.19 (2 H, m, CH20H), 5.29 (1 H; br, s, OH), 
7.11-7.15 (1 H, m, ArH), 7.17-7.21 (1 H, m, ArH), 7.33-7.35 (1 H, m, ArH), 7.46-7.48 
(1 H, m, ArH) and 8.37 (1 H, br, s, NH); oc (100 MHz, CDCi]) 24.3 (CHz), 25.4 (Cfl3), 
31.3 (CH2), 32.7 (CH2), 55.5 (CH), 62.3 (C), 62.7 (CHz), 107.1 (C), 111.1 (CH), 118.5 
(CH), 120.0 (CH), 122.3 (CH), 126.5 (C), 136.3 (C), 137.2 (C) and 174.6 (CO); MS 
(El) mlz 270 [M+, 3.4 %] (M\ 270.1364. C16H1sN20 2 requires 270.1368). The product 
was recrystallised from dichloromethane to produce clear, colourless needles. 
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3.3. Application in the Synthesis Of Naturally Occurring Alkaloids 
3.3.1. Removal of the Hydroxymethyl Auxiliary 
(11 bR)-1,2,3,6, 7,11 b-Hexahydro-pyrido [2,1-a] isoq uinolin-4-one ( 48). 
Raney nickel (W-2) (2.50 g) was washed with water (3 x 10 ml) followed by 2-propanol 
(2 x 10 ml). 2-Propanol was decanted and the Raney nickel was taken up in toluene 
(20 ml) and the residual water and 2-propanol were azeotropically removed using a 
Dean-Stark trap. A solution of (6S,llbR)-6-hydroxymethyl-1,2,3,6,7,11b-hexahydro-
pyrido[2,1-a]isoquinolin-4-one (45) (500 mg, 2.16 mmol) in toluene (10 ml) was added 
and the reaction was refluxed under Dean-Stark conditions for 4.5 h. The resulting 
solution was filtered through a celite pad, washed with methanol and evaporated under 
reduced pressure to yield the target compound as a colourless oil (186 mg, 44 %), Vmax 
(thin film, CHCh)/cm·1 1619 (NCO) and 2930 (aliphatic CH); oH (400 MHz, CDCh) 
1.65-1.76 (1 H, m, CH(JOCH2CH2CO), 1.80-2.00 (2 H, m, CH2CH2CH2CO), 2.30-2.45 
(1 H, m, CH2CH2CH(JOCO), 2.49-2.63 (2 H, m, CH(H)CH2CH2CO and 
CH2CH2CH(H)CO), 2.70-2.79 (1 H, m, ArCH(H)CH2N), 2.83-2.89 (1 H, m, 
ArCH(H)CH2N), 2.91-3.03 (1 H, m, ArCH2CH(fON), 4.61-4.69 (1 H, m, NCHAr), 
4.76-4.85 (1 H, m, ArCH2CH(H)N) and 7.08-7.30 (4 H, m, ArH); oc (100 MHz, CDCh) 
20.0 (CHz), 29.3 (CH2), 31.1 (CH2), 32.6 (CHz), 40.0 (CHz), 57.3 (CH), 125.3 (CH), 
126.9 (CH), 127.0 (CH), 129.4 (CH), 135.5 (C), 137.7 (C) and 169.7 (CO); MS (El) m/z 
201 [M+, 100 %] (M+, 201.1156. C13H 15NO requires 201.1136). 
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(5S,11bS)-11b-Methyl-3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole-
5-carbaldehyde (32). 
H 
0 
a-Iodoxybenzoic acid (2.78 g, 10.0 mmol) was added to a solution of (5S,11bS)-5-
hydroxymethyl-11b-methyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b]indol-3-one (25) 
(1.36 g, 5.00 mmol) in dimethyl sulfoxide (15 ml) and the reaction stirred for 24 h at 
room temperature. The resulting mixture was added to a solution of ethyl acetate/water 
and product extracted with ethyl acetate (3 x 50 ml). The organic layer was washed with 
water (5 x 50 ml), dried over anhydrous magnesium sulfate, filtered and evaporated to a 
crude yellow solid. The crude product was adsorbed onto silica and chromatographed 
using silica gel as absorbent and ethyl acetate as eluent to isolate the target compound as 
a colourless solid (666 mg, 49 %), Mp 170-171 ·c; [a]0 - 91.9 [c = 1.30 in CH2Ch]; 
Ymax {thin film, CHzCh)/cm"1 1670 (NCO), 1670 (CHO), 2969 (aliphatic CH) and 3307 
(NH); OH (400 MHz, CDCh) 1.68 (3 H, s, CH3), 2.16-2.35 (2 H, m, CH(H)CH2CO and 
CHzCH(H)CO), 2.46-2.56 (2 H, m, CH(H)CH2CO and CH2CH(H)CO), 2.99 (1 H, dd, 
J5.2, 15.6 Hz, ArCH(H)CHN), 3.11 (1 H, dd, J 11.2, 16.0 Hz, ArCH(H)CHN), 3.84 
(1 H, dd, J 4.8, 10.8 Hz, ArCH2CHN), 7.05-7.09 (1 H, m, ArH), 7.12-7.16 (1 H~ m, 
ArH), 7.28-7.31 (1 H, m ArH), 7.42-7.44 (1 H, m, ArH), 9.29 (1 H, br, s, NH) and 10.08 
(1 H, s, CHO); oc (100 MHz, CDCh) 21.3 (CHz), 27.2 (CH3), 29.5 (CHz), 32.4 (CHz), 
58.8 (CH), 61.6 (C), 106.5 (C), 111.4 (CH), 118.4 (CH), 119.8 (CH), 122.4 (CH), 126.6 
(C), 136.5 (C), 137.2 (C), 178.4 (CO) and 196.2 (CHO); MS (El) m/z 268 [M\ 0.60 %] 
(M\ 268.1206. Ct6Ht6Nz0z requires 268.1212). 
(5S,11 bS)-5-(tert-Butyl-dimethyl-silanyloxyrnethyl)-11 b-rnethyl-1,2,5,6,11,11 b-
hexahydro-indolizino[8, 7-b]indol-3-one (49). 
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Imidazole (1.37 g, 20.2 mmol) and 4-dimethylaminopyridine (0.21 g, 1.68 mmol) 
followed by (5S, 11 bS)-5-hydroxymethyl-11 b-methyl-1 ,2,5,6, 11,11 b-hexahydro-
indolizino[8,7-b]indol-3-one (25) (4.54 g, 16.8 mmol) was dissolved in anhydrous 
dichloromethane (60 ml) under a nitrogen atmosphere. To this solution, 
tert-butyldimethylsilylchloride (2.78 g, 18.5 mmol) was added and the solution stirred 
at room temperature for 4 h. The resulting mixture was filtered to remove the solid 
phase and concentrated under reduced pressure. The crude product was 
chromatographed using silica gel as absorbent and 2:1 ethyl acetate/light petroleum as 
eluent to isolate the target compound as a colourless solid (5.2 g, 81 %), Mp 221-
223 "C; [a]o- 172.8 [c = 1.00 in CH2Clz]; Vmax (thin film, CH2Clz)/cm"1 1669 (NCO), 
2950 (aliphatic CH) and 3279 (NH); oH (400 MHz, CDCi)) 0.11 (3 H, s, SiCH3), 0.13 
(3 H, s, SiCH3), 0.93 (9 H, s, SiC(CH3) 3), 1.65 (3 H, s, CH3), 2.20-2.33 (3 H, m, 
CH2CH2CO and CH2CH(H)CO), 2.48-2.59 (1 H, m, CH2CH(H)CO), 2.81 (1 H, dd, 
J 11.0, 15.2 Hz, ArCH(H)CHN), 3.06 (1 H, dd, J 3.9, 15.2 Hz, ArCH(H)CHN), 3.57-
3.64 (1 H, m, ArCH2CHN), 4.46-4.54 (2 H, m, CH20Si), 7.10-7.20 (2 H, m, ArH), 
7.29-7.33 (1 H, m, ArH), 7.49-7.51 (1 H, m, ArH) and 8.01 (1 H, br, s, NH); oc (100 
MHz, CDCl)) -5.2 (SiCH3), -5.2 (SiCH3), 18.2 (C), 24.9 (CH2), 25.7 (SiC(CH3)3), 26.6 
(CH3), 30.7 (CH2), 32.6 (CH2), 55.5 (CH), 62.0 (C), 64.0 (CH2), 108.8 (C), 111.0 (CH), 
118.5 (CH), 119.8 (CH), 122.2 (CH), 126.9 (C), 136.1 (C), 137.7 (C) and 175.8 (CO); 
MS (El) m/z 385 [MH+, 6.5 %] (MH+, 385.2311. C22H32N202Si requires 385.2318). 
(SS,11 bS)-5-Hydroxymethyl-11 b-methyl-3-oxo-1 ,2,3,5,6,11 b-hexahydro-indolizino 
[8,7-b]indole-11-carboxylic acid tert-butyl ester (50). 
To a solution of the (5S, 11 bS)-5-(tert-butyl-dimethyl-silanyloxymethyl)-11 b-methyl-3-
oxo-1,2,3,5,6,11b-hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester 
(99) (1.05 g, 2.17 mmol) in tetrahydrofuran (15 ml) was added tetrabutylammonium 
fluoride (1 M solution in tetrahydrofuran, 2.17 ml, 2.17 mmol) and the reaction stirred 
for 5 min at room temperature. The resultant solution was concentrated and 
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chromatographed through a pad of silica gel using 2:1 light petroleum/ethyl acetate as 
eluent to yield the target compound as a colourless solid (769 mg, 97 %), Mp 96-99 ·c; 
[a]o- 215.8 [c = 1.01 in CH2Ch]; Ymax (thin film, CH2Ch)/cm-1 1665 (NCO), 2950 
(aliphatic CH) and 3265 (OH); oH (400 MHz, CDCI)) 1.71 (9 H, s, C02C(CH3)3), 1.84 
(3 H, s, CH3), 2.19-2.23 (1 H, m, CH(H)CH2CO), 2.42-2.66 (3 H, m, CH(fflCH2CO and 
CH2CH2CO), 2.75-2.79 (1 H, m, ArCH(fflCHN), 3.04 (1 H, dd, J 4.0, 15.4 Hz, 
ArCH(H)CHN), 3.59-3.66 (1 H, m, ArCH2CHN), 4.45-4.50 (2 H, m, CH20H), 7.22-
7.29 (2 H, m, ArH), 7.41-7.45 (1 H, m, ArH) and 7.94-7.99 (1 H, m, ArH); oc (100 
MHz, CDCI)) 25.1 (CH3), 25.5 (CH2), 28.3 (C02C(CH3)3), 30.5 (CH2), 32.2 (CH2), 53.6 
(CH), 63.8 (CH2), 65.0 (C), 84.1 (C), 116.0 (CH), 116.3 (C), 118.4 (CH), 122.7 (CH), 
124.5 (CH), 128.6 (C), 135.7 (C), 139.3 (C), 149.9 (CO) and 173.8 (CO); MS (El) m/z 
371 [MH+, 10.2 %] (MH+, 371..1888. C21H26N204 requires 371.1893). 
(SS,ll bS)-11-Benzyl-5-hydroxymethyl-11 b-methyl-1,2,5,6,11,11 b-hexahydro-
indolizino[8,7-b]indol-3-one (51). 
Anhydrous N,N-dimethylformamide (8 ml) was added to sodium hydride (14 mg, 
3.70 mmol) in a dry three-necked round bottom flask under nitrogen and cooled to 0 ·c 
with an ice bath. (5S,llbS)-5-Hydroxymethyl-llb-methyl-1,2,5,6,11,11b-hexahydro-
indolizino[8,7-b]indol-3-one (25) (1.00 g, 3.70 .mmol) m anhydrous 
N,N-dimethylformamide (8 ml) was added and stirred for 30 min at room temperature. 
Benzyl bromide (696 mg, 0.47 ml, 4.07 mmol) was added and the reaction stirred at 
room temperature for 3 h under nitrogen. Ice and water were added to quench and the 
product extracted with ethyl acetate (3 x 1 0 ml). Organic phases were combined and 
washed with saturated brine, dried over anhydrous magnesium sulfate, filtered and 
evaporated to a crude green solid. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 2 % methanol/ethyl acetate as eluent 
to isolate the target compound as a green solid (830 mg, 62 %), Mp 82-86 ·c; [a]0 
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- 174.1 [c = 0.27 in CH2Clz]; Vmax (thin film, CH2Cl2)/cm-1 1660 (NCO), 2927 (aliphatic 
CH) and 3389 (OH); oH (400 MHz, CDCh) 1.60 (3 H, s, CH3), 2.18-2.33 (2 H, m, 
CH2CH2CO), 2.42 (1 H, ddd, J 2.0, 9.6, 16.8 Hz, CH2CH(lf)CO), 2.61-2.81 (2 H, m, 
CH2CH(lf)CO and ArCH(H)CHN), 3.09 (1 H, dd, J 11.6, 15.2 Hz, ArCH(H)CHN), 
3.65-3.71 (1 H, m, ArCH2CHN), 4.18 (2 H, d, J3.2 Hz, CH20H), 4.99 (1 H, br, s, OH), 
5.39 (1 H, d, J 17.8 Hz, NCH(H)Ph), 5.44 (1 H, d, J 17.8 Hz, NCH(H)Ph), 6.75-6.81 
(2 H, m, ArH), 7.05-7.08 (1 H, m, ArH), 7.12-7.19 (2 H, m, ArH), 7.22-7.28 (3 H, m, 
ArH) and 7.50-7.54 (1 H, m, ArH); oc (100 MHz, CDCh) 24.5 (Cl-h), 25.2 (CH3), 31.2 
(CH2), 32.5 (CH2), 47.7 (CH2), 55.3 (CH), 62.3 (CH2), 63.3 (C), 107.7 (C), 110.0 (CH), 
118.6 (CH), 120.0 (CH), 122.4 (CH), 125.4 (CH), 125.4 (CH), 126.3 (C), 127.5 (CH), 
128.9 (CH), 128.9 (CH), 137.2 (C), 137.2 (C), 138.0 (C) and 173.8 (CO); MS (FAB) 
m/z 361 [MH\ 60.4 %] (MH+, 361.1916. C23H24N202 requires 361.1916). 
(llbS)-11-Benzyl-llb-methyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b]indol-3-
one (52). 
Raney nickel (W-2) (3.0 g) was washed with water (3 x 10 ml) followed by 2-propanol 
(2 x 10 ml). 2-Propanol was decanted and the Raney nickel was taken up in toluene and 
the residual water and 2-propanol were azeotropically removed using a Dean-Stark trap. 
A solution of (5S,1lbS}-11-benzyl-5-hydroxymethyl-11b-methyl-1,2,5,6,11,11b-hexa 
hydro-indolizino[8,7-b]indol-3-one (51) (500 mg, 1.39 mmol) in toluene (30 ml) was 
added and the reaction was refluxed under Dean-Stark conditions for 4 h. The resulting 
solution was filtered through a celite pad, washed with methanol and evaporated under 
reduced pressure to yield the target compound as a colourless oil (353 mg, 77 %), Mp 
130-131 "C; [a]o- 134.2 [c = 0.28 in CH2Clz]; Vmax (thin film, CH2Clz)/cm-1 1682 
(NCO) and 2970 (aliphatic CH); oH (400 MHz, CDCh) 1.54 (3 H, s, CH3), 2.15 (1 H, 
dd, J 11.2, 21.6 Hz, CH(H)CH2CO), 2.30 (1 H, ddd, J 1.6, 8.8, 12.0 Hz, 
CH(H)CH2CO), 2.44 (1 H, ddd, J 1.6, 9.6, 12.0 Hz, CH2CH(H)CO), 2.57-2.66 (1 H, m, 
CH2CH(lf)CO), 2.86-2.95 (2 H, m, ArCH2CH2N), 3.08-3.16 (1 H, m, ArCH2CH(lf)N), 
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4.50 (1 H, ddd, J 3.2, 4.4, 13.2 Hz, ArCH2CH(J:ON), 5.39 (1 H, d, J 17.4 Hz, 
NCH(H)Ph), 5.45 (1 H, d, J 17.4 Hz, NCH(f:OPh), 6.88-6.90 (2 H, m, ArH), 7.05-7.08 
(1 H, m, ArH), 7.11-7.15 (2 H, m, ArH), 7.21-7.29 (3 H, m, ArH) and 7.51-7.55 (1 H, 
m, ArH); oc (100 MHz, CDCh) 21.4 (CI-lz), 25.2(CH3), 30.5 (CH2), 32.5 (CHz), 34.5 
(CHz), 47.7 (CHz), 60.0 (C), 107.3 (C), 110.0 (CH), 118.6 (CH), 119.8 (CH), 122.3 
(CH), 125.5 (CH), 125.5 (CH), 126.6 (C), 127.4 (CH), 128.9 (CH), 128.9 (CH), 137.0 
(C), 137.3 (C), 138.7 (C) and 171.9 (CO); MS (El) mlz 330 [M+, 26.6 %] (M+, 
330.1737. CzzHzzNzO requires 330.1732). 
3.3.2. Total Synthesis of (R)-{+)-Crispine A 
(2S)-2-Amino-3-(3,4-dimethyloxy)phenyl)propan-1-ol (62). 
OH MeOm 
I NH MeO .o 2 
Trimethylsilylchloride (3.85 g, 4.50 ml, 35.5 mmol) was added under nitrogen to a 
solution of lithium borohydride (2.0 M solution in tetrahydrofuran, 8.88 ml, 17.8 mmol) 
in anhydrous tetrahydrofuran (10 ml) over a 2 min period. 3-(3,4-Dimethoxyphenyl)-L-
alanine (2.00 g, 8.88 mmol) was cautiously added to the resultant mixture over a 5 min 
period and the reaction stirred at room temperature for 24 h. Methanol (20 ml) was 
cautiously added and volatiles were removed by rotary evaporation. The residue was 
treated with 20 % potassium hydroxide sol~tion and extracted with dichloromethane (3 
x 20 ml). The organic extracts were combined, dried over anhydrous magnesium 
sulfate, filtered and solvent was evaporated under reduced pressure resulting in a 
colourless crystalline solid (1.70 g, 91 %), Mp 81-82 "C, Lit: Mp 78-79 "C; [a]0 - 21.6 
[c = 1.00 in EtOH], Lit: [a]o- 21.5 [c = 8.0 in EtOH]; Vrnax {thin film, CHzCh)/cm-1 
2933 (aliphatic CH) and 3348 (OH); oH (400 MHz, CDCh) 2.46 (1 H, dd, J 8.8, 
13.6 Hz, CH(f:OCHNHz), 2.62 (3 H, br, s, OH and NH2), 2.74 (1 H, dd, J 4.9, 13.5 Hz, 
CH(H)CHNHz), 3.09-3.11 (1 H, m, CHNHz), 3.41 (1 H, dd, J7.1, 10.6 Hz, CH(H)OH), 
3.63 (1 H, dd, J 3.6, 10.7 Hz, CH(H)OH), 3.85 (3 H, s, OCH3), 3.86 (3 H, s, OC5f3), 
6.72-6.74 (2 H, m, ArH) and 6.79-6.81 (1 H, m, ArH); oc (100 MHz, CDCh) 40.0 
(CHz), 54.3 (CH), 55.8 (OCH3), 55.9 (OCH3), 65.9 (CHz), 111.2 (CH), 112.2 (CH), 
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121.1 (CH), 131.2 (C), 147.5 (C) and 148.9 (C); MS (El) m/z 211 [M+, 6.5 %] (M+, 
211.1211. C11H17N03 requires 211.1208). 
l-(2S)-[2-(3,4-Dimethoxy-phenyl)-1-hydroxymethyl-ethyl]-pyrrolidine-2,5-dione 
(63).lb 
Succinic, anhydride (2.56 g, 25.6 mmol) and (2S)-2-amino-3-(3,4-dimethyloxy)pheny1) 
propan-1-ol (62) (4.92, 23.3 mmol) was stirred in toluene (100 ml) under nitrogen. 
Triethylamine ( 4 ml) was added to the resultant solution and the mixture heated under 
reflux for 18 h. After 18 h, the reaction was cooled to room temperature and solvent 
removed by rotary evaporator to yield a yellow oil. The crude product was adsorbed 
onto silica gel and chromatographed using silica gel as absorbent and ethyl acetate as 
eluent to produce a colourless solid (4.87 g, 71 %), Mp 124-125 ·c, [a.] 0 - 73.2 [c = 
1.01 in CHzClz]; Vmax (thin film, CHzClz)/cm-1 1700 (NCO), 2938 (aliphatic CH) and 
3447 (OH); oH (400 MHz, CDCi]) 2.51-2.61 (4 H, m, COCH2CH2CO), 3.04 (2 H, ddd, 
J 6.8, 14.0, 20.8 Hz, ArCH2CHN), 3.79 (1 H, dd, J3.6, 11.6 Hz, CH(H)OH), 3.83 (3 H, 
s, OCH3), 3.84 (3 H, s, OCH3), 4.03 (1 H, dd, J 8.0, 11.6 Hz, CH(H)OH), 4.47-4.52 
(1 H, m, ArCH2CHN) and 4.47-4.52 (3 H, m, ArH); oc (100 MHz, CDCh) 27.8 (CHz), 
27.8 (CHz), 33.1 (CH2), 55.6 (CH), 55.8 (OCH3), 55.8 (OCH3), 61.8 (CH2), 111.0 (CH), 
111.9 (CH), 121.0 (CH), 129.6 (C), 147.6 (C), 148.7 (C), 178.3 (CO) and 178.3 (CO); 
MS (FAB) m/z 294 [MH\ 4.0 %] (MH\ 294.1344. C1sH19NOs requires 294.1342). 
(SS,lObR)-5-Hydroxymethyl-8,9-dimethoxy-1,5,6,10b-tetrahydro-2H-pyrrolo 
[2,1-a]isoquinolin-3-one (64). 1b 
OH 
Meom· 
I . . 
.//·.xcrN 0 MeO ' 
H 
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1-(2S)-[2-(3,4-Dimethoxy-phenyl)-1-hydroxymethyl-ethyl]-pyrrolidine-2,5-dione (63) 
(4.09 g, 13.9 mmol) was dissolved in absolute ethanol (100 ml) and cooled to 0 ·c. 
Sodium borohydride (5.28 g, 139.4 mmol) was then added with stirring. HCl (2 M 
solution in absolute ethanol, 6.97 ml, 13.9 mmol) was then slowly added via syringe 
over a 3 h period. The resultant solution was acidified to pH 1-3 with HCl (2 M solution 
in absolute ethanol) over a 15 min period. This afforded a white suspension, which was 
stirred for a further 20 h. The reaction was quenched with sodium hydrogen carbonate 
and extracted with dichloromethane (3 x 40 ml). The dichloromethane layers were then 
combined and dried over anhydrous magnesium sulfate and solvent removed by rotary 
evaporation to yield the target cyclised compound as a single diastereoisomer, which 
was purified by column chromatography using silica gel as absorbent and 5 % 
methanol/dichloromethane as eluent to yield a colourless solid (3.01 g, 78 %), Mp 177-
179 ·c, [a.]o + 133.6 [c = 1.03 in CH2Ch]; Vmax (thin film, CH2Ch)/cm-1 1666 (NCO), 
2939 (aliphatic CH) and 3369 (OH); oH (400 MHz, CDC13) 1.91-1.98 (1 H, m, 
CH(fflCH2CO), 2.46-2.52 (1 H, m, CH2CH(fflCO), 2.61-2.69 (3 H, m, CH(H)CH2CO, 
CH2CH(fflCO and ArCH(H)CHN), 3.00 (1 H, dd, J 6.8, 16.0 Hz, ArCH(H)CHN), 3.62-
3.73 (2 H, m, CH20H), 3.87 (3 H, s, OCH3), 3.88 (3 H, s, OCH3), 4.47-4.50 (1 H, m, 
ArCH2CHN), 4.76 (1 H, t, J 7.6 Hz, NCHAr), 6.59 (1 H, s, ArH) and 6.63 (1 H, s, 
ArH); oc (100 MHz, CDCb) 27.1 (CH2), 29.1 (Cfh), 31.7 (CH2), 49.5 (CH), 54.2 (CH), 
55.9 (OCH3), 56.1 (OCH3), 63.2 (Cl-h), 107.3 (CH), 111.7 (CH), 124.1 (C), 128.4 (C), 
·148.0 (C), 148.2 (C) and 175.1 (CO); MS (FAB) m/z 278 [MH\ 27.5 %] (MH+, 
278.1395. C1sH19N04 requires 278.1392). 
(1 0 bR)-8,9-Dimethoxy-1 ,5,6,1 Ob-tetrahydro-2H-pyrrolo [2,1-a] isoq uinolin-3-one 
(65). 
Raney nickel (W-2) (7.08 g) was washed with water (3 x 20 ml) followed by 2-propanol 
(2 x 20 ml). 2-Propanol was decanted and the Raney nickel was taken up in toluene·and 
the residual water and 2-propanol were azeotropically removed using a Dean-Stark trap. 
A solution of (SS, 1 ObR)-5-hydroxymethyl-8,9-dimethoxy-1 ,5,6, 1 Ob-tetrahydro-2H-
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pyrrolo[2,1-a]isoquinolin-3-one (64) (1.18 g, 6.49 mmol) in toluene (60 ml) was added 
and the reaction was refluxed under Dean-Stark conditions for 4 h. The resulting 
solution was filtered through a celite pad, washed with methanol and evaporated under 
reduced pressure to yield the target compound as a.yellow oil (1.03 g, 98 %),. [a]o 
+ 175.8 [c = 3.09 in CHCh]; Vmax (thin film, CHCh)/cm"1 1681 (NCO) and 2934 
(aliphatic CH); OH (400 MHz, CDCh) 1.82-1.90 (1 H, m, CH(H)CHzCO), 2.45-2.71 
( 4 H, m, CH(H)CHzCO, CH2CH2CO and ArCH(.H)CHzN), 2.85-2.93 (1 H, m, 
ArCH(H)CH2N), 2.99-3.06 (1 H, m, ArCHzCH(H)N), 3.87 (3 H, s, OCH3), 3.88 (3 H, s, 
OCH3), 4.31 (1 H, ddd, J 2.4, 6.0, 12.8 Hz, ArCHzCH(H)N), 4.74 (1 H, t, J 8.0 Hz, 
NCHAr), 6.58 (1 H, s, ArH) and 6.63 (1 H, s, ArH); oc (100 MHz, CDCh) 27.8 (CHz), 
28.1 (CHz), 31.8 (CH2), 37.1 (CH2), 55.9 (OCH3), 56.0 (OCH3), 56.6 (CH), 107.6 (CH), 
111.6 (CH), 125.5 (C), 129.3 (C), 147.9 (C), 148.0 (C) and 173.4 (CO); MS (FAB) mlz 
248 [MH\ 31.3 %] (MH\ 248.1287. C14H17N03 requires 248.1287). 
(R)-(+)-Crispine A (53).Z2 
Lithium aluminium hydride (1 M solution in tetrahydrofuran, 4.5 ml, 4.49 mmol) was 
added to a pre-dried flask fitted with a reflux condenser under a nitrogen atmosphere . 
. Anhydrous tetrahydrofuran (100 ml) was added and the solution cooled to 0 ·c. (10bR)-
8,9-Dimethoxy-1,5,6,10b-tetrahydro-2H-pyrrolo[2,1-a]isoquinolin-3-one (65) (1.05 g, 
4.49 mmol) in anhydrous tetrahydrofuran (50 ml) was added dropwise to the hydride 
solution at 0 ·c and the resulting solution heated under reflux for 3 h, then stirred for a 
further 12 h at room temperature. Diethyl ether (50 ml) was added and reaction was 
quenched by the careful addition of saturated sodium potassium tartate. The mixture 
was stirred for a further 1 h before the addition of anhydrous magnesium sulfate prior to 
filtrate through a celite pad. The filtrate was evaporated under reduced pressure and the 
resultant yellow solid was purified by column chromatography using silica gel as 
absorbent and 10:1 chloroform/methanol as eluent to yield a colourless solid (752 mg, 
76 %), Mp 87-89 ·c, Lit: Mp 87-89 ·c; [a]o + 43.9 [c = 1.14 in MeOH], Lit [a]o + 91.0 
[MeOH]; Vmax (thin film, CHCl3)/cm·1 2927 (aliphatic CH); OH (400 MHz, CDCh) 1.72-
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1.79 (1 H, m, CH(H)CHzCH2N), 1.86-1.96 (2 H, m, CHzCH2CHzN), 2.31-2.37 (1 H, m, 
CH(H)CHzCHzN), 2.60-2.79 (3 H, m, CHzCHzCH(H)N, ArCH(H)CH2N and 
ArCHzCH(H)N), 2.98-3.11 (2 H, m, CHzCH2CH(H)N and ArCH(H)CH2N), 3.18 (1 H, 
ddd, J 2.8, 5.6, 10.8 Hz, ArCH2CH(H)N), 3.50 (1 H, t, J 8.4 Hz, NCHAr), 3.84 (3 H, s, 
OCH3), 3.85 (3 H, s, OCH3), 6.57 (1 H, s, ArH) and 6.61 (1 H, s, ArH); oc (100 MHz, 
CDCh) 22.3 (CHz), 27.9 (CH2), 30.6 (CHz), 48.3 (CH2), 53.2 (CH2), 55.9 (OCH3), 56.0 
(OCH3), 62.9 (CH), 108.8 (CH), 111.3 (CH), 126.1 (C), 130.5 (C), 147.3 (C) and 147.4 
(C); MS (FAB) m/z 232 [M+, 66.6 %j (M+, 233.1419. C14H19NOz requires 233.1416). 
(SS,lObR)-(8,9-Dimethoxy-1,2,3,5,6,10b-hexahydro-pyrrolo[2,1-a]isoquinolin-5-yl)-
methanol (66). 
OH 
M eO~ 
Moo)__);0 
Lithium aluminium hydride (1 M solution in tetrahydrofuran, 3.61 ml, 3.61 mmol) was 
added to a pre-dried flask fitted with a reflux condenser under nitrogen. Anhydrous 
tetrahydrofuran (50 ml) was added and the solution cooled to 0 ·c. (5S,10bR)-5-
Hydroxymethyl-8,9-dimethoxy-1 ,5,6, 1 Ob-tetrahydro-2H-pyrrolo[2, 1-a] isoquinolin-3-
one (64) (500 mg, 1.80 mmol) in anhydrous tetrahydrofuran (20 ml) was added 
dropwise to the hydride solution at 0 ·c and the resulting solution heated under reflux 
for 3 h, then stirred for a further 12 h at room temperature. Diethyl ether (20 ml) was 
added and reaction was quenched by the careful addition of saturated sodium potassium 
tartate. The mixture was stirred for a further 1 h before the addition of anhydrous 
magnesium sulfate prior to filtrate through a celite pad. The filtrate was evaporated 
under reduced pressure and the, resultant yellow solid was purified by column 
chromatography using silica gel as absorbent and 10:1 chloroform/methanol as eluent to 
yield a colourless solid (460 mg, 97 %), [a]0 + 79.1 [c = 1.83 in CHCh]; Vmax (thin film, 
neat)/cm·1 2934 (aliphatic CH) and 3374 (OH); oH (400 MHz, CDCi]) 1.78-1.89 (3 H, 
m, CH2CHzCHzN and CHzCH(H)CHzN), 2.41-2.46 (2 H, m, CH2CH(H)CH2N and -
ArCH(H)CHN), 2.76-2.81 (1 H, m, CHzCHzCH(H)N), 2.96 (I H, dd, J 5.2, 16.0 Hz, 
ArCH(H)CHN), 3.05-3.09 (1 H, m, CHzCHzCH(H)N), 3.13-3.16 (1 H, m, ArCH2CHN), 
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3.22 (1 H, br, s, OH), 3.42 (1 H, dd, J 8.0, 10.4 Hz, CH(H)OH), 3.52 (1 H, dd, J 5.2, 
10.4 Hz, CH(H)OH), 3.85 (3 H, s, OCH3), 3.85 (3 H, s, OCH3), 4.22 (1 H, t, J 6.4 Hz, 
NCHAr) and 6.56 (2 H, s, ArH); oc (100 MHz, CDCh) 24.0 (Cfh), 26.3 (CHz), 33.5 
(CH2), 51.9 (CHz), 55.6 (CH), 55.8 (OCH3), 56.0 (OCH3), 56.4 (CH), 62.6 (CHz), 109.0 
(CH), 111.2 (CH), 124.9 (C), 130.9 (C), 147.3 (C) and 147.6 (C); MS (FAB) mlz 264 
[MH+, 14.2 %] (MH+, 264.1596. C,sH21N03 requires 264.1600). 
(5S,1 ObR)-8,9-Dimethoxy-3-oxo-1 ,2,3,5,6,1 Ob-hexahydro-pyrrolo [2,1-a] 
isoquinoline-5-carbaldehyde (67). 
o-Iodoxybenzoic acid ( 4.48 g, 16.1 mmol) was added to a solution of (SS, 1 ObR)-5-
hydroxymethyl-8,9-dimethoxy-1 ,5,6, 1 Ob-tetrahydro-2H-pyrrolo[2, 1-a ]isoquinolin-3-
one (64) (1.49 g, 5.37 mmol) in ethyl acetate (75 ml) and the reaction was heated under 
reflux for 4 h. The resulting mixture was cooled to room temperature, filtered through a 
sinter funnel and evaporated to a crude brown residue. The crude product was adsorbed 
onto silica and chromatographed using silica gel as absorbent and 3: 1 light 
petroleum/ethyl acetate as eluent to isolate the target compound as •a yellow foam 
(1.46 g, 99 %), [a] 0 + 66.5 [c = 1.3 in CHCh]; Vmax (thin film, CH2Ch)/cm-1 1672 
(NCO) and 2937 (aliphatic CH); oH (400 MHz, CDCh) 1.85-1.93 (1 H, m, 
CH(H)CH2CO), 2.47-2.55 (1 H, m, CH2CH(H)CO), 2.68-2.75 (2 H, m, CH(J:OCHzCO 
and CH2CH(H)CO), 3.06 (1 H, dd, J 7.2, 16.0 Hz, ArCH(H)CHN), 3.22 (1 H, dd, J2.4, 
16.4 Hz, ArCH(H)CHN), 3.85 (3 H, s, OCH3), 3.86 (3 H, s, OCH3), 4.91 (1 H, t, 
J 6.8 Hz, NCHAr), 5.01 (1 H, dd, J 2.4, 7.2 Hz, ArCH2CHN), 6.53 (1 H, s, ArH), 6.65 
(1 H, s, ArH) and 9.62 (1 H, s, CHO); oc (100 MHz, CDCh) 26.5 (CHz), 28.2 (CHz), 
31.4 (CHz), 54.7 (CH), 55.7 (CH), 56.0 (OCH3), 56.1 (OCH3), 107.5 (CH), 111.5 (CH), 
122.3 (C), 128.1 (C), 148.2 (C), 148.5 (C), 174.4 (CO) and 198.9 (CHO); MS (FAB) 
m/z 276 [MH+, 22.2 %] (MH+, 276.1240. C1sH17N04 requires 276.1236). 
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3.3.3. Total Synthesis of (R)-(+)-Harmicine 
(SS,llbR)-3-0xo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b]indole-5-
carbaldehyde (69). 
o-Iodoxybenzoic acid (148 mg, 0.531 mmol) was added to a solution of (5S,11bR)-5-
hydroxymethyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b]indol-3-one (21) (68 mg, 
0.265 mmol) in dimethyl sulfoxide (3 ml) and the reaction stirred for 24 h at room 
temperature. The resulting mixture was added to a solution of ethyl acetate/water and 
the product extracted with ethyl acetate (3 x 8 ml). The organic layer was washed with 
water, dried over anhydrous magnesium sulfate, filtered and evaporated to a crude 
yellow solid. The crude product was adsorbed onto silica and cl].romatographed using 
silica gel as absorbent and ethyl acetate as eluent to isolate the target compound as a 
brown oil (49 mg, 72 %), [a]o + 112.4 [c = 1.01 in CHCh]; Vmax (thin film, CH2Clz)/ 
cm·
1 1668 (NCO), 2915 (aliphatic CH) and 3271 (NH); oH (400 MHz, CDCh) 1.84-1.98 
(1 H, m, CH(H)CHzCO), 2.45-2.60 (2 H, m, CH(H)CH2CO and CH2CH(H)CO), 2.65-
2.74 (1 H, m, CHzCH(H)CO), 3.05 (1 H, ddd, J2.4, 8.0, 16.0 Hz, ArCH(H)CHN), 3.39 
(1 H, d, J 16.0 Hz, ArCH(H)CHN), 5.07-5.11 (1 H, m, NCHAr), 5.20 (1 H, d, J7.2 Hz, 
ArCHzCHN), 7.06-7.16 (2 H, m, ArH), 7.26 (1 H, d, J 8.0 Hz, ArH), 7.45 (1 H, d, 
J7.6 Hz, ArH), 7.91 (1 H, s, NH) and 9.52 (1 H, s, CHO); oc (100 MHz, CDCh) 19.0 
(CHz), 25.4 (CHz), 30.4 (CH2), 51.2 (CH), 55.0 (CH), 104.3 (C), 110.1 (CH), 117.4 
(CH), 119.1 (CH), 121.6 (CH), 125.4 (C), 131.5 (C), 135.3 (C), 173.1 (CO) and 197.6 
(CHO); MS (El) m/z 254 [M+, 66.0 %] (M+.254.1055. C15H14Nz02 requires 254.1059). 
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(5S,11 bR)-5-Formyl-3-oxo-1,2,3,5,6,11 b-hexahydro-indolizino[8, 7 -b ]indole-11-
carboxylic acid tert-butyl ester (70). 
Qc!H 
N ''XN~o 
BoJ H L_/ 
(SS, 11 bR)-3-0xo-2,3,5,6, 11,11 b-hexahydro-1H-indolizino[8,7-b ]indole-5-carbaldehyde 
(69) (1.24 g, 4.88 mmol) was dissolved in anhydrous tetrahydrofuran (35 ml) under a 
nitrogen atmosphere. To this solution was added triethylamine (988 mg, 1.36 ml, 
9.16 mmol), 4-dimethylaminopyridine (119 mg, 0.976 mmol) and di-tert-butyl 
dicarbonate (1.28 g, 5.86 mmol) successively and the resultant mixture was stirred 
overnight. The volatiles were removed by evaporation and the orange residue dissolved 
in ethyl acetate and washed successively with saturated ammonium chloride (2 x 
50 ml), saturated sodium bicarbonate (2 x 30 ml) and saturated brine (30 ml). The 
organic phase was then dried over anhydrous magnesium sulfate and the solvent 
removed under pressure to yield a colourless solid, which was chromatographed using 
silica gel as absorbent and 3:1light petroleum/ethyl acetate as eluent to isolate the target 
compound as an orange oil (1.73 g, 98 %), [a.]0 + 248.2 [c = 1.02 in CHCb]; Vmax (thin 
film, CHzCh)/cm-1 1691 (NCO), 1730 (CO) and 2977 (aliphatic CH); DH (400 MHz, 
.CDCb) 1.69 (9 H, s, COzC(CH3)3), 1.81-1.92 (1 H, m, ·cH(H)CH2CO), 2.51 (1 H, ddd, 
J 1.6, 9.6, 16.8 Hz, CHzCH(H)CO), 2.70-2.77 (1 H, m, CHzCH(H)CO), 2.95-3.01 (2 H, 
m, CH(H)CHzCO and ArCH(H)CHN), 3.40 (1 H, d, J 16.4 Hz, ArCH(H)CHN), 5.27 
(1 H, d, J 7.2 Hz, ArCH2CHN), 5.42-5.46 (1 H, m, NCHAr), 7.24-7.34 (2 H, m, ArH), 
7.45-7.47 (1 H, m, ArH), 8.01 (1 H, d, J 8.0 Hz, ArH) and 9.63 (1 H, s, CHO); De (100 
MHz, CDCb) 22.4 (CHz), 27.6 (CHz), 28.2 (COzC(cth)J), 31.1 (CH2), 54.6 (CH), 55.4 
(CH), 84.7 (C), 112;6 (C), 115.6 (CH), 118.4 (CH), 123.1 (CH), 124.9 (CH), 128.4 (C), 
134.2 (C), 135.7 (C), 149.7 (CO), 175.0 (CO) and 198.8 (CHO); MS (FAB) m/z 355 
[MH+, 21.9 %] (MH+, 355.1651. C2oH22Nz04 requires 355.1658). 
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(5S,11 bR)-3-0xo-1,2,3,5,6,11 b-hexahydro-indolizino [8, 7 -b ]indole-5,11-dicarboxylic 
acid 11-tert-butyl ester (71). 
C(c/oH 
N ''XN~o 
Bod H. LJ 
A solution of (5S,11bR)-5-formyl-3-oxo-1,2,3,5,6,11b-hexahydro-indolizino[8,7-b] 
indole-11-carboxylic acid tert-butyl ester (70) (1.68 g, 4.74 mmol) in acetonitrile 
(22 ml), tert-butanol (87 ml) and cyclohexene (44 ml) was stirred rapidly as it cooled to 
0 ·c. A solution of sodium chlorite ( 4.13 g, 36.5 mmol) and sodium dihydrogen 
phosphate (3.98 g, 33.2 mniol) in water (87 ml) was added dropwise over a 10 min 
period and the reaction stirred at room temperature for 17 h. The reaction mixture was 
added to a solution of saturated brine/ethyl acetate (1: 1) (70 ml) and product extracted 
with ethyl acetate (3 x 70 ml). Organics were combined and washed with a 1 M solution 
of sodium hydrosulfite, dried over anhydrous magnesium sulfate, filtered and 
evaporated to a crude green oil. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 2:1 ethyl acetate/light petroleum as 
eluent to produce a green solid (1.37 g, 79 %), Mp 111-112 ·c; [a] 0 + 194.0 [c = 1.00 
in CHCh]; Vrnax (thin film, CHzClz)/cm-1 1668 (NCO), 1732 (CO), 2977 (aliphatic CH) 
and 3290 (OH); oH (400 MHz, CDCb) 1.68 (9 H, s, COzC(CH3)3), 1.74-1.85 (1 H, m, 
CH(H)CHzCO), 2.46 (1 H, dd, J 8.4, 17.2 Hz, CH2CH(H)CO), 2.62-2.71 (1 H, m, 
CHzCH(H)CO), 2.90-3.03 (2 H, m, CH(H)CH2CO and ArCH(H)CHN), 3.38 (1 H, d, 
J 16.0 Hz, ArCH(H)CHN), 5.38 (1 H, d, J 6.8 Hz, ArCH2CHN), 5.44-5.48 (1 H, m, 
NCHAr), 7.21-7.31 (2 H, m, ArH), 7.41-7.43 (1 H, m, ArH) and 7.99 (1 H, d, J8.0 Hz, 
ArH); oc (100 MHz, CDCh) 23.8 (CHz), 27.5 (CH2), 28.2 (COzC(CH3)3), 31.2 (CH2), 
48.6 (CH), 54.7 (CH), 84.6 (C), 112.7 (C), 115.6 (CH), 118.5 (CH), 123.0 (CH), 124.7 
(CH), 128.5 (C), 134.0 (C), 135.7 (C), 149.8 (CO), 174.2 (CO) and 178.8 (CO); MS 
(El) m/z 370 [M+, 23.3 %] (M+, 370.1534. C2oH22N20s requires 370.1529). 
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(5S,11 bR)-3-0xo-5-phenylselanylcarbonyl-1,2,3,5,6,11 b-hexahydro-indolizino 
[8,7-b]indole-11-carboxylic acid tert-butyl ester (72). 
0 Qc{s~h 
N I 'X N )::::::0 
Bod H. L_} 
To a flask containing (5S,11bR)-3-oxo-1,2,3,5,6,11b-hexahydro-indo1izino[8,7-b] 
indole-5, 11-dicarboxylic acid 11-tert-butyl ester (71) ( 481 mg, 1.30 mmol) under a 
nitrogen atmosphere was added anhydrous dichloromethane (3 ml) followed by 
dephenyldiselenide (609 mg, 1.95 mmol). The resulting mixture was cooled to 0 ·c and 
tributylphospine (526 mg, 0.64 ml, 2.60 mmol) was added dropwise. The solution was 
allowed to warm to room temperature and stirring continued for a further 24 h at room 
temperature. Dichloromethane (10 ml) and water (10 ml) were added and the aqueous 
layer was extracted further with dichloromethane (2 x 10 ml). The combined organic 
extracts were washed with brine (10 ml), dried over anhydrous magnesium sulfate and 
evaporated to a crude yellow oil. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 4:1 light petroleum/ethyl acetate as 
eluent to produce a colourless solid (438 g, 66 %), Mp 76-80 ·c; [a]0 + 70.3 [c = 1.03 
in CHCh]; Vmax (thin film, CH2Clz)/cm"1 1700 (NCO), 1729 (CO) and 2977 (aliphatic 
CH); oH (400 MHz, CDCh) 1.71 (9 H, s, C02C(CH3)3), 1.85-1.92 (1 H, m, 
CH(H)CH2CO), 2.56 (1 H, ddd, J 0.8, 8.8, 16.8 Hz, CH2CH(H)CO), 2. 74-2.83 (1 H, m, 
CH2CH(H)CO), 2.91 (1 H, ddd, J2.4, 7.2, 16.4 Hz, ArCH(H)CHN), 3.02-3.07 (1 H, m, 
CH(J:OCH2CO), 3.53 (1 H, dd, J 0.8, 16.4 Hz, ArCH(H)CHN), 5.47 (1 H, d, J 6.8 Hz, 
ArCH2CHN), 5.63-5.70 (1 H, m, NCHAr), 7.22-7.36 (5 H, m, ArH), 7.43-7.45 (3 H, m, 
ArH) and 7.99 (1 H, d, J 8.0 Hz, ArH); oc (100 MHz, CDCh) 22.3 (Cl-h), 28.0 (CH2), 
28.2 (C02C(CH3)3), 31.2 (CH2), 54.4 (CH), 58.9 (CH), 84.6 (C), 112.8 (C), 115.5 (CH), 
118.5 (CH), 123.0 (CH), 124.8 (CH), 125.2 (C), 128.5 (C), 129.1 (CH), 129.3 (CH), 
129.3 (CH), 133.5 (C), 135.6 (C), 136.0 (CH), 136.0 (CH), 149.9 (CO), 175.3 (CO) and 
200.1 (CO); MS (FAB) m/z 511 [MH+, 4.8 %] (MH+, 511.1127. C26H26N204Se requires 
511.1136). 
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(11 bR)-3-0xo-1,2,3,5,6,11 b-hexahydro-indolizino [8, 7-b ]indole-11-carboxylic acid 
tert-butyi ester (73). 
C{Q~o 
Bod H. L_j 
A three-necked round bottom flask fitted with a reflux condenser, glass stopper and 
suba seal was flushed with nitrogen. A solution of (5S,11bR)-3-oxo-5-phenylselanyl 
carbonyl-! ,2,3,5,6, 11 b-hexahydro-indolizino[8, 7-b ]indole-11-carboxylic acid tert-butyl 
ester (72) (300 mg, 0.588 mmol) in dry toluene ( 4 ml) was added via cannula. The 
solution 'was then degassed with nitrogen for 15 min before adding tri-n-butyltin 
hydride (684 mg, 0.63 ml, 2.35 mmol). The resulting mixture was heated to 80 ·c 
whereupon azobisisobutyronitrile (19 mg, 0.118 mmol) was added portionwise over a 
2 h period. After an additional 2 h stirring at 80 ·c, the mixture was cooled to room 
temperature and concentrated under reduced pressure. The resultant oily residue was 
adsorbed onto silica and chromatographed using silica gel as absorbent and 100 % light 
petroleum to 50 % light petroleum/ethyl acetate as eluent to produce a green solid 
{172 mg, 90 %), Mp 127-131 ·c; (a]o + 324.4 (c = 1.09 in CHCh]; Vmax (thin film, 
CH2Ch)/cm'1 1693 (NCO), 1731 (CO) and 2977 (aliphatic CH); oH (400 MHz, CDCh) 
1.70 (9 H, s, C02C(CH3)3), 1.80-1.86 (1 H, m, CH(lf)CH2CO), 2.43 (1 H, ddd, J 1.6, 
9.6, 16.4 Hz, CH2CH(H)CO), 2.55-2.64 (1 H, m, CH2CH(lf)CO), 2.77-2.87 (3 H, m, 
CH(H)CH2CO and ArCH2CH2N), 2.96-3.02 (1 H, m, ArCH2CH(H)N), 4.54 (1 H, ddd, 
J2.4, 4.4, 12.8 Hz, ArCH2CH(H)N), 5.22-5.26 (1 H, m, NCHAr), 7.24-7.33 (2 H, m, 
ArH), 7.42-7.44 (1 H, m, ArH) and 8.04 (1 H, d, J 8.4 Hz, ArH); oc (1 00 MHz, CDCh) 
21.6 (Cl-h), 27.0 ( CH2), 28.2 (C02C( CH3)3), 31.3 ( CH2), 36.8 ( CH2), 56.4 (CH), 84.4 
(C), 115.5 (C), 115.5 (CH), 118.4 (CH), 123.0 (CH), 124.5 (CH), 128.8 (C), 135.1 (C), 
135.7 {C), 150.0 (CO) and 173.7 (CO); MS {FAB) m/z 327 [MH+, 2.0 %] (MH+, 
327.1703. C19H22N203 requires 327.1709). 
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(llbR)-1,2,5,6,11,11b-Hexahydro-indolizino[8,7-b]indol-3-one (74). 
~~0 
H H LJ 
(11 bR)-3-0xo-1 ,2,3,5,6, 11 b-hexahydro-indolizino[8, 7 -b ]indole-11-carboxylic acid tert-
butyl ester (73) (100 mg, 0.306 mmol) was dissolved in tetrahydrofuran (10 ml) under 
an atmosphere of nitrogen. To this was added tetrabutylammonium fluoride (1 M 
solution in tetrahydrofuran, 3.06 ml, 3.06 mmol) and the reaction heated under reflux 
for 2 h. The resultant solution was cooled to room temperature and water added. The 
crude product was extracted with ethyl acetate (3 x 10 ml), dried over anhydrous 
magnesium sulfate and evaporated under reduced pressure. The compound was purified 
by chromatography using silica gel as absorbent and ethyl acetate as eluent to produce a 
green solid (51 mg, 69 %), Mp 250-252 "C; [a]0 + 188.4 [c = 0.55 in CHCh]; Vmax (thin 
film, CH2Ch)/cm-1 1668 (NCO), 2921 (aliphatic CH) and 3253 (NH); oH (400 MHz, 
CDCb) 1.90-2.02 (1 H, m, CH(H)CH2CO), 2.44-2.68 (3 H, m, CH(H)CH2CO and 
CH2CH2CO), 2.80-2.92 (2 H, m, ArCH2CH2N), 3.01-3.08 (1 H, m, ArCH2CH(H)N), 
4.54 (1 H, ddd, J 2.0, 5.0, 12.8 Hz, ArCH2CH(H)N), 4.93-4.96 (1 H, m, NCHAr), 7.13 
(1 H, dt, J 1.2, 7.6 Hz, ArH), 7.19 (1 H, dt, J 1.2, 7.6 Hz, ArH), 7.35 (1 H, d, J 8.0 Hz, 
ArH), 7.50 (1 H, d, J 8.0 Hz, ArH) and 8.16 (1 H, br, s, NH); oc (100 MHz, CDCb) 
21.0 (Cl-h), 25.7 (Cl-h), 31.7 (CH2), 37.6 (CH2), 54.3 (CH), 108.3 (C), 111.0 (CH), 
118.5 (CH), 119.9 (CH), 122.3 (CH), 126.8 (C), 133.2 (C), 136.2 (C) and 173.3 (CO); 
MS (FAB) m/z 226 [MH+, 11.5 %] (MH+, 226.1106. C14H14N20 requires 226.1110) .. 
(R)-(+)-Harmicine (68).29 
CO:J, 
H H LJ 
Lithium aluminium hydride (2 M solution in tetrahydrofuran, 0.12 ml, 0.230 mmol) was 
added to a pre-dried flask fitted with a reflux condenser under a nitrogen atmosphere. 
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Anhydrous tetrahydrofuran (3 ml) was added and the solution cooled to 0 ·c. (11 bR)-
1,2,5,6,11,11b-Hexahydro-indolizino[8,7-b]indol-3-one (74) (37 mg, 0.153 mmol) in 
anhydrous tetrahydrofuran (2 ml) was added dropwise to the hydride solution at 0 ·c 
and the resulting solution heated under reflux for 3 h, then stirred for a further 12 h at 
room temperature. Diethyl ether (10 ml) was added and reaction was quenched by the 
careful addition of saturated sodium potassium tartate. The mixture was stirred for a 
further 1 h before the addition of anhydrous magnesium sulfate prior to filtrate through 
a celite pad. The filtrate was evaporated under reduced pressure and the resultant yellow 
solid was purified by column chromatography using silica gel as absorbent and 10: 1 
dichloromethane/methanol as eluent to yield a yellow solid (28 mg, 80 %), Mp 161-164 
·c; [a]o + 118.2 [c = 1.6 in CHCh]; Vmax (thin film, CH2Clz)/cm-1 2925 (aliphatic CH) 
and 3253 (NH); oH (400 MHz, CDCh) 1.77-2.05 (3 H, m, CHCH(H)CH2CH2N and 
CHCH2CH2CH2N), 2.35-2.44 (1 H, m, CHCH(lf)CH2CH2N), 2.74-2.77 (1 H, m, 
ArCH(lf)CH2N), 2.88-2.96 (2 H, m; CHCH2CH2CH(H)N and ArCH(H)CH2N), 3.07-
3.19 (2 H, m, CHCH2CH2CH(H)N and ArCH2CH(H)N), 3.31 (1 H, ddd, J 2.0, 5.2, 
12.8 Hz, ArCH2CH(lf)N), 4.46-4.49 (1 H, m, NCHAr), 7.06 (1 H, dt, J 1.2, 7.6 Hz, 
ArH), 7.12 (1 H, dt, J 1.2, 7.6 Hz, ArH), 7.36 (1 H, d, J 7.2 Hz, ArH), 7.43 (1 H, d, 
J7.2 Hz, ArH) and 9.35 (1 H, br, s, NH); oc (100 MHz, CDCh) 17.4 (CH2), 23.1 (CH2), 
29.7 (CH2), 45.9 (CH2), 49.5 (CH2), 57.6 (CH), 106.6 (C), 111.3 (CH), 118.0 (CH), 
119.3 (CH), 121.6 (CH), 126.7 (C), 133.1 (C) and 136.4 (C); MS (El) m/z 212 [M+, 
75.0 %] (M+, 212.1184. C14H16N2 requires 212.1181). 
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3.4. Application as Potential Building Blocks for Peptide Mimics 
3.4.1. Enolate Addition Studies 
(SS,llbS)-ll~Benzyl-5-benzyloxymethyl-llb-methyl-1,2,5,6,11,11b-hexahydro­
indolizino [8, 7-h ]indol-3-one (83). 
I 
N , 
~Me''' 
0~ 
oV 
Anhydrous N,N-dimethylformamide (30 ml) was added to sodium hydride (890 mg, 
22.2 mmol) in a dry three-necked round bottom flask under nitrogen and cooled to 0 ·c 
with an ice bath. (5S,11bS)-5-Hydroxymethyl-11b-methyl-1,2,5,6,11,11b-hexahydro-
indolizino[8,7-b]indol-3-one (25) (2.0 g, 7.40 mmol) in N,N-dimethylformamide 
(20 ml) was added and stirred for 30 min at room temperature. Benzyl bromide (4.18 g, 
2. 79 ml, 24.4 mmol) was added and the reaction stirred at room temperature for 3 h 
under nitrogen. Ice and water were added and product extracted with diethyl ether (3 x 
50 ml). Ether phases were combined and washed with saturated brine, dried over 
anhydrous magnesium sulfate, filtered and evaporated to a yellow oil. The crude 
product was adsorbed onto silica and chromatographed using silica gel as absorbent and 
3:2 hexane/ethyl acetate as eluent to isolate the target compound as a colourless solid 
(2.42 g, 72 %), Mp 139-140 ·c; [a] 0 - 163.2 [c = 1.01 in CH2Ch] (Found: C, 79.76; H, 
6.83; N, 6.36. C3oH3oN202 requires C, 79.97; H, 6.71; N, 6.22 %); Vmax (thin film, 
CH2Ch)/cm-1 1684 (NCO), 2855 (aliphatic CH) and 2928 (aromatic CH); oH (400 MHz, 
CDCh) 1.60 (3 H, s, CH3), 2.16-2.30 (3 H, m, CH2CH2CO and CH2CH(H)CO), 2.43-
2.50 (1 H, m, CH2CH(Jf)CO), 2.94 (1 H, dd, J 11.1, 15.2 Hz, ArCH(Jf)CHN), 3.13 
(1 H, dd, J 4.0, 15.2 Hz, ArCH(H)CHN), 3.77-3.82 (1 H, m, ArCH2CHN), 4.35 (1 H, 
dd, J 8.7, 9.4 Hz, CH(Jf)OBn), 4.50 (1 H, dd, J 4.6, 9.6 Hz, CH(Jf)OBn), 4.65 (1 H, d, 
J 11.9 Hz, OCH(Jf)Ph), 4.68 (1 H, d, J 11.9 Hz, OCH(H)Ph), 5.40 (2 H, s, NCH2Ph), 
6.82-6.84 (2 H, m, ArH), 7.02-7.05 (1 H, m, ArH), 7.10-7.12 (2 H, m, ArH), 7.21-7.25 
(3 H, m, ArH), 7.26-7.31 (1 H, m, ArH), 7.34-7.41 (4 H, m, ArH) and 7.52-7.54 (1 H, 
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m, ArH); oc (100 MHz, CDCh) 25.8 (CH2), 26.5 (CH3), 30.8 (CH2), 32.2 (CH2), 47.7 
(CH2), 52.8 (CH), 62.6 (C), 71.1 (CH2), 73.4 (CH2), 108.9 (C), 110.0 (CH), 118.7 (CH), 
119.9 (CH), 122.3 (CH), 125.4 (CH), 125.4 (CH), 126.6 (C), 127.4 (CH), 127.6 (CH), 
127.8 (CH), 127.8 (CH), 128.4 (CH), 128.4 (CH), 128.9 (CH), 128.9 (CH), 137.2 (C), 
137.4 (C), 138.5 (C), 138.6 (C) and 174.7 (CO); MS (El) m/z 450 [M\ 50.1 %] (M+, 
450.2303. C3oH3oN202 requires 450.2307). The product was recrystallised from ethyl 
acetate/hexane to produce a colourless crystalline solid. 
(2S,5S,llbS)-11-Benzyl-5-benzyloxymethyl-2,1lb-dimethyl-1,2,5,6,11,11b-
hexahydro-indolizino[8, 7-b ]indol-3-one (85a). 
I 
N , 
~Me''' 
Me 
0~ 
oV 
n-Butyl lithium (1.11 ml, 2.77 mmol) was added dropwise to a stirred solution of 
diisopropylamine (281 mg, 0.40 ml, 2.77 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The resulting solution was stirred at 0 ·c for 15 min then cooled to 
-78 ·c. (5S,11bS)-11-Benzyl-5-benzyloxymethyl-11b-methyl-1,2,5,6,11,11 b-hexahydro 
indolizino[8,7-b]indol-3-one (83) (500 mg, 1.11 mmol) in anhydrous tetrahydrofuran 
(10 ml) was added dropwise and the reaction stirred for 15 min at -78 ·c. Methyl iodide 
(315 mg, 0.14 ml, 2.22 mmol) was added dropwise at -78 ·c and the reaction allowed 
to warm to room temperature overnight. The reaction mixture was then quenched with 
saturated ammonium chloride and product extracted with diethyl ether (3 x 50 ml). 
Ether phases were combined and washed with saturated brine (50 ml) and dried over 
anhydrous magnesium sulfate. Ether phase was then filtered and solvent removed on the 
rotary evaporator to yield the target compound as a 4:1 mixture of diastereoisomers, 
which were separated. by column chromatography using silica gel as absorbent and 4:1 
hexane/ethyl acetate as eluent to yield a colourless solid (345 mg, 67 %), Mp 117-118 
"C; [a] 0 - 176.0 [c = 1.02 in CH2CbJ (Found: C, 79.90; H, 6.92; N, 5.94. C31H32N202 
requires C, 80.14; H, 6.94; N, 6.03 %); Vmax (thin film, CH2Cb)/cm·1 1688 (NCO) and 
2928 (aliphatic CH); oH (400 MHz, CDCh) 1.05 (3 H, d, J 7.0 Hz, CH(CH3)CO), 1.54 
(3 H, s, CH3), 1.83 (1 H, dd, J 10.6, 11.8 Hz, CH(J:OCHCO), 2.53 (1 H, dd, J 8.6, 
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12.0 Hz, CH(H)CHCO), 2.58-2.68 (1 H, m, CH2CHCO), 2.84 (1 H, dd, J 11.1, 15.2 Hz, 
ArCH(fOCHN), 3.16 (1 H, dd, J 3.8, 15.2 Hz, ArCH(fOCHN), 3.77-3.84 (1 H, m, 
ArCH2CHN), 4.33 (1 H, dd, J 8.8, 9.4 Hz, CH(H)OBn), 4.54 (1 H, dd, J 4.7, 9.6 Hz, 
CH(fOOBn), 4.64 (1 H, d, J 11.9 Hz, OCH(H)Ph), 4.69 (1 H, d, J 11.9 Hz, OCH(H)Ph), 
5.37 (2 H, s, NCH2Ph), 6.86-6.88 (2 H, m, ArH), 7.02-7.04 (1 H, m, ArH), 7.10-7.12 
(2 H, m, ArH), 7.22-7.30 (4 H, m, ArH), 7.33-7.41 (4 H, m, ArH) and 7.51-7.55 (1 H, 
m, ArH); oc (100 MHz, CDCh) 15.8 (CH3), 25.4 (CH3), 26.2 (CH2), 35.7 (CH), 41.6 
(CHz), 47.7 (CHz), 52.8 (CH), 59.9 (C), 70.8 (CHz), 73.3 (CHz), 107.9 (C), 110.0 (CH), 
118.7 (CH), 119.8 (CH), 122.1 (CH), 125.5 (CH), 125.5 (CH), 126.5 (C), 127.4 (CH), 
127.6 (CH), 127.7 (CH), 127.7 (CH), 128.4 (CH), 128.4 (CH), 128.8 (CH), 128.8 (CH), 
137.1 (C), 137.3 (C), 138.5 (C), 139.3 (C) and 175.5 (CO); MS (El) m/z 464 [M+, 10.6 
%] (M\ 464.2472. C31H32N20 2 requires 464.2464). The product was recrystallised from· 
ethyl acetate/hexane via vapour diffusion to produce clear, colourless crystals. 
Stereochemistry at C-2, C-5 and C-llb was determined by single crystal X-ray analysis. 
(2R,SS,llbS)-11-Benzyl-5-benzyloxymethyl-2-ethyl-llb-methyl-1,2,5,6,11,11b-
hexahydro-indolizino [8, 7 -b ]indol-3-one (86b ). 
I I 
N ' ~Me''' 
N , 
~Me''' 
n-Butyl lithium (0.55 ml, 1.37 mmol) was added dropwise to a stirred solution of 
diisopropylamine (139 mg, 0.19 ml, 1.37 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The resulting solution was stirred at 0 ·c for 15 min then cooled to 
-78 ·c. (5S,11bS)-11-Benzyl-5-benzyloxymethyl-11b-methyl-1,2,5,6,11,11 b-hexahydro 
indolizino[8,7-b]indol-3-one (83) (516 mg, 1.11 mmol) in anhydrous tetrahydrofuran 
(10 ml) was added dropwise and the reaction stirred for 15 min at -78 ·c. Iodoethane 
(268 mg, 0.14 ml, 1.72 mmol) was added dropwise at -78 ·c and the reaction allowed 
to warm to room temperature overnight. The reaction mixture was quenched with 
saturated ammonium chloride and product extracted with diethyl ether (3 x 50 ml). 
Ether phases were combined and washed with saturated brine (50 ml) and dried over 
anhydrous magnesium sulfate. Ether phase was then filtered and solvent removed on the 
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rotary evaporator to yield the target compound as an 8:1 mixture of diastereoisomers, 
which were separated by column chromatography using silica gel as absorbent and 7:1 
hexane/ethyl acetate as eluent to yield a colourless solid (381 mg, 70 %), Mp 54:56 ~C; 
[a]o- 134.0 [c = 1.01 in CH2Ch]; Vmax (thin film, CH2Ch)/cm"1 1686 (NCO) and 2986 
(a1iphatic CH); oH (400 MHz, CDCh) 0.69 (3 H, t, J 7.4 Hz, CH(CH2CH3)CO), 1.26-
1.33 (1 H, m, CH(CH(H)CH3)CO), 1.64-1.69 (1 H, m, CH(lf)CHCO), 1.66 (3 H, s, 
CH3), 1.74-1.82 (1 H, m, CH(CH(H)CH3)CO), 1.97-2.04 (1 H, m, CH2CHCO), 2.56 
(1 H, dd, J9.0, 12.7 Hz, CH(lf)CHCO), 3.05 (2 H, m, ArCH2CHN), 3.74-3.81 (1 H, m, 
ArCH2GHN), 4.40 (1 H, dd, J 4.3, 9.6 Hz, CH(H)OBn), 4.49 (1 H, dd, J 8.3, 9.6 Hz, 
CH(H)OBn), 4.66 (2 H, s, OCH2Ph), 5.36 (1 H, d, J 17.6 Hz, NCH(lf)Ph), 5.46 (1 H, d, 
J 17.6 Hz, NCH(lf)Ph), 6.79-6.81 (2 H, m, ArH), 7.03-7.05 (1 H, m, ArH), 7.07-7.12 
(2 H, m, 'ArH), 7.20-7.31 (4 H, m, ArH), 7.34-7.41 (4 H, m, ArH) and 7.49-7.52 (1 H, 
m, ArH); oc (100 MHz, CDCb) 11.4 (CH3), 24.1 (CH2), 25.1 (CH2), 28.5 (CH3), 37.4 
(CH2), 43.1 (CH), 47.7 (CH2), 52.9 (CH),61.2 (C), 72.1 (CH2), 73.4 (CH2), 109.8 (CH), 
110.2 (C), 118.6 (CH), 119.8 (CH), 122.3 (CH), 125.3 (CH), 125.3 (CH), 126.7 (C), 
127.5 (CH), 127.6 (CH), 127.8 (CH), 127.8 (CH), 128.4 (CH), 128.4 (CH), 128.9 (CH), 
128.9 (CH), 137.3 (C), 137.6 (C), 138.6 (C), 139.6 (C) and 179.9 (CO); MS (El) m/z 
478 [M+, 24.8 %] (M+, 478.2626. C32H34N202 requires 478.2620). The Stereochemistry 
at C-2, C-5 and C-11 b was determined by nOe studies. 
(2S,5S,llbS)-11-Benzyl-5-benzyloxymethyl-2-isopropyl-llb-methyl-1,2,5,6,11, llb-
hexahydro-indolizino [8, 7 -b ]indol-3-one (87b ). 
I 
N , 
~Me''' 
n-Butyl lithium (0.55 ml, 1.37 mmo1) was added dropwise to a stirred solution of 
diisopropylamine (139 mg, 0.19 ml, 1.37 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The resulting solution was stirred at 0 ·c for 15 min then cooled to 
-78 ·c. (5S,11bS)-11-Benzyl-5-benzyloxymethyl-llb-methyl-1,2,5,6,11,11b-hexahydro 
indolizino[8,7-b]indol-3-one (83) (516 mg, 1.11 mmol) in anhydrous tetrahydrofuran 
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(10 ml) was added dropwise and the reaction mixture stirred for 15 min at -78 ·c. 
2-Iodo-propane (268 mg, 0.14 ml, 1.72 mmol) was added dropwise at -78 ·c and the 
reaction was allowed to warm to room temperature overnight. Saturated ammonium 
chloride was added to quench the reaction mixture and product extracted with diethyl 
ether (3 x 50 ml). Ether phases were combined and washed with saturated brine (50 ml) 
and dried over anhydrous magnesium sulfate. Ether phase was then filtered and solvent 
removed on the rotary evaporator to yield the target compound as an 10:1 mixture of 
diastereoisomers, which were separated by column chromatography using silica gel as 
absorbent and 7:1 hexane/ethyl acetate as eluent to yield a colourless solid (432 mg, 
79 %), Mp 121-122 ·c; [a] 0 - 114.8 [c = 1.01 in CH2C}z] (Found: C, 80.24; H, 7.44; N, 
5.73. c33H36Nz0z requires C, 80.45; H, 7.37; N, 5.69 %); Yrnax (thin film, CHzClz)/cm-1 
1693 (NCO) and 2955 (aliphatic CH); oH (400 MHz, CDCh) 0.69 (3 H, d, J 6.7 Hz, 
CH(CHCH3(CH3))CO), 0.75 (3 H, d, J 6.7 Hz, CH(CHCH3(CH3))CO), 1.67 (3 H, s, 
CH3), 1.74 (1 H, dd, J 10.3, 12.7 Hz, CH(H)CHCO), 2.02-2.09 (2 H, m, 
CH(CH(CH3)z)CO and CH2CHCO), 2.36 (1 H, dd, J 8.8, 12.8 Hz, CH(H)CHCO), 3.00-
3.12 (2 H, m, ArCH2CHN), 3.73-3.79 (1 H, m ArCH2CHN), 4.39 (1 H, dd, J 4.2, 
9.6 Hz, CH(H)OBn), 4.50 (1 H, dd, J 8.2, 9.6 Hz, CH(H)OBn), 4.66 (2 H, s, OCH2Ph), 
5.36 (1 H, d, J 17.7 Hz, NCH(H)Ph), 5.48 (1 H, d, J 17.7 Hz, NCH(H)Ph), 6.78-6.80 
(2 H, m, ArH), 7.03-7.05 (1 H, m, ArH), 7.08-7.11 (2 H, m, ArH), 7.20-7.26 (3 H, m, 
ArH), 7.28-7.30 (1 H, m, ArH), 7.33-7.41 (4 H, m, ArH) and 7.50-7.51 (1 H, m, ArH); 
oc (100 MHz, CDCh) 17.7 (CH3), 20.3 (CH3), 24.8 (CH2), 27.3 (CH), 28.4 (CH3), 32.8 
(CHz), 47.2 (CH), 47.7 (CH2), 52.9 (CH), 60.9 (C), 72.3 (CH2), 73.4 (CH2), 109.8 (CH), 
110.4 (C), 118.6 (CH), 119.8 (CH), 122.3 (CH), 125.3 (CH), 125.3 (CH), 126.7 (C), 
127.5 (CH), 127.6 (CH), 127.8 (CH), 127.8 (CH), 128.4 (CH), 128.4 (CH), 128.9 (CH), 
128.9 (CH), 137.3 (C), 137.6 (C), 137.8 (C), 138.6 (C) and 179.8 (CO); MS (El) m/z 
492 [M+, 24.4 %] (M\ 492.2781. C33H36N20 2 requires 492.2777). The product was 
recrystallised from ethyl acetate/hexane via vapour diffusion to produce clear, 
colourless crystals. Stereochemistry at C-2, C-5 and C-llb was determined by single 
crystal X-ray analysis. 
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(2R,5S,llbS)-2,11-Dibenzyl-5-benzyloxymethyl-llb-methyl-1,2,5,6,11,11b-hexa 
hydro-indolizino [8, 7 -b] indol-3-one (88b ). 
I I 
N , 
~Me''' 
N , 
~Me''' 
n-Butyl lithium (0.62 ml, 1.55 mmol) was added dropwise to a stirred solution of 
diisopropylamine (157 mg, 0.22 ml, 1.55 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The resulting solution was stirred at 0 ·c for 15 min then cooled to 
-78 ·c. (5S,11 bS)-11-Benzyl-5-benzyloxymethyl-11b-methyl-1,2,5,6,11,11 b-hexahydro 
indolizino[8,7-b]indol-3-one (83) (500 mg, 1.11 mmol) in anhydrous tetrahydrofuran 
(10 ml) was added dropwise and the reaction stirred for 15 min at -78 ·c. Benzyl 
bromide (247 mg, 0.16 ml, 1.44 mmol) was added dropwise at -78 ·c and reaction 
allowed to warm to room temperature overnight. Saturated ammonium chloride was 
added to quench the reaction mixture and the product was extracted with diethyl ether (3 
x 50 ml). Ether phases were combined and washed with saturated brine (50 ml) and 
dried over anhydrous magnesium sulfate. Ether phase was then filtered and solvent 
removed on the rotary evaporator· to yield the target compound as an 2:1 mixture of 
diastereoisomers, which were separated by column chromatography using silica gel as 
absorbent and 7:1 hexane/ethyl acetate as eluent to yield a colourless solid (313 mg, 
52%), Mp 145-146 ·c; [a]o- 96.9 [c = 1.02 in CH2Clz] (Found: C, 81.81; H, 6.67; N, 
5.16. c37H36N202 requires c, 82.19; H, 6.71; N, 5.18 %); Vmax (thin film, CH2Clz)/cm·1 
1694 (NCO) and 2930 (aliphatic CH); oH (400 MHz, CDCh) 1.52 (3 H, s, CH3), 1.74 
(1 H, dd, J 8.3, 11.7 Hz, CH(lf)CHCO), 2.43-2.52 (2 H, m, CH(H)CHCO and 
CH2CHCO), 2.60-2.66 (1 H, m, CH(CH(H)Ph)CO), 3.05-3.08 (2 H, m, ArClhCHN), 
3.14 (1 H, dd, J 3.6, 13.8 Hz, CH(CH(Jf)Ph)CO), 3.75-3.79 (1 H, m, ArCH2CHN), 
4.43-4.52 (2 H, m, CH20Bn), 4.69 (2 H, s, OCH2Ph), 5.28 (1 H, d, J 17.6 Hz, 
NCH(lf)Ph), 5.36 (1 H, d, J 17.6 Hz, NCH(H)Ph), 6.70-6.72 (2 H, m, ArH), 6.95-7.00 
(3 H, m, ArH), 7.07-7.18 (8 H, m, ArH), 7.30-7.42 (5 H, m, ArH) and 7.49-7.51 (1 H, 
m, ArH); oc (100 MHz, CDCh) 25.1 (Cl-h), 28.4 (CH3), 37.0 (CH2), 37.1 (CH2), 42.8 
(CH), 47.6 (CH2), 53.0 (CH), 61.3 (C), 71.9 (CH2), 73.4 (CH2), 109.9 (CH), 110.0 (C), 
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118.5 (CH), 119.8 (CH), 122.3 (CH), 125.2 (CH), 125.2 (CH), 126.2 (CH), 126.6 (C), 
127.4 (CH), 127.6 (CH), 127.8 (CH), 127.9 (CH), 128.4 (CH), 128.4 (CH), 128.4 (CH), 
128.4 (CH), 128.7 (CH), 128.7 (CH), 128.8 (CH), 128.8 (CH), 137.2 (C), 137.2 (C), 
137.8 (C), 138.5 (C), 138.9 (C) and 178.8 (CO); MS (El) m/z 540 [M+, 14.1 %] (M+, 
540.2777. C37H36Nz02 requires 540.2784). The product was recrystallised from 
dich1oromethane/hexane via vapour diffusion to produce clear, colourless crystals. 
Stereochemistry at C-2, C-5 and C-11 b was determined by single crystal X-ray analysis. 
(2R,5S,11 bS)-2-N ,N'-Bis-(3,3-tert-butyl ester)-hydrazino-11-benzyl-5-benzyloxy 
methyl-11 b-methyl-:-1,2,5,6,11,11b-hexahydro-indolizino [8, 7 -b ]indol-3-one (89). 
I 
NBoc 
N , 
~Me''' 
' NHBoc 
n-Butyl lithium (2.93 ml, 7.32 mmol) was added dropwise to a stirred solution of 
diisopropylamine (741 mg, 1.03 ml, 7.32 mmol) in anhydrous tetrahydrofuran (15 ml) 
at 0 ·c under nitrogen. The resulting solution was stirred at 0 ·c for 15 min then cooled 
to -78 ·c. (5S,1lbS)-11-Benzyl-5-benzyloxymethyl-11b-methyl-1,2,5,6,11,11 b-hexa 
hydro-indolizino[8,7-b]indol-3-one (83) (1.65 g, 3.66 mmol) in anhydrous 
tetrahydrofuran (20 ml) was added dropwise and the reaction stirred for 15 min at 
-78 ·c. Di-tert-butyl azodicarboxylate (1.27 g, 5.49 mmol) in anhydrous 
tetrahydrofuran (15 ml) was added dropwise at -78 ·c and the reaction allowed to warm 
to room temperature overnight. The reaction was quenched with saturated ammonium 
chloride and product was extracted with diethyl ether (3 x 75 ml). Ether phase was dried 
over magnesium sulfate and solvent removed on the rotary evaporator to yield the target 
compound as a single diastereoisomer, which was purified by column chromatography 
using silica gel as absorbent and 4:1 light petroleum/ethyl acetate as eluent to yield a 
colourless solid (2.04 g, 82 %), Mp 103-105 ·c; [a] 0 - 82.4 [c = 1.02 in CHzCh]; Vmax 
(thin film, CHzCh)/cm·' 1709 (NCO), 1709 (CO), 2976 (aliphatic CH) and 3284 (NH); 
OH ( 400 MHz, DMSO, 80 ·c) 1.36 (9. H, s, COzC(CH3)3), 1.3 7 (9 H, s, COzC(CH3)3), 
1.67 (3 H, s, CH3), 2.30 (1 H, dd, J 9.2, 12.8 Hz, CH(H)CHCO), 2.78 (1 H, dd, J 9.6, 
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13.2 Hz, CH(mCHCO), 2.85-'3.00 (2 H, m, ArCH2CHN), 3.79-3.84 (1 H, m, 
ArCH2CHN), 4.29-4.35 (2 H, m, CH2CHCO and CH(mOBn), 4.47 (1 H, dd, J 5.2, 
10.0 Hz, CH(lf)OBn), 4.63 (1 H, d, J 12.0 Hz, OCH(H)Ph), 4.67 (1 H, d, J 12.0 Hz, 
OCH(mPh), 5.48 (1 H, d, J 17.6 Hz, NCH(H)Ph), 5.54 (1 H, d, J 17.6 Hz, NCH(mPh), 
6.91 (2 H, d, J7.2 Hz, Arll), 7.02-7.09 (3 H, m, Arll), 7.19-7.30 (4 H, m, ArH), 7.34-
7.41 (4 H, m, Arll), 7.46-7.49 (1 H, m, Arll) and 8.27 (1 H, br, s, NH); oc (100 MHz, 
DMSO, 80 "C) 24.1 (CH2), 27.1 (CH3), 27.3 (C02C(CH3)3), 27.4 (C02C(CH3)3), 34.1 
(CH2), 46.8 (CH2), 52.1 (CH), 58.8 (C), 58.9 (CH), 70.3 (CH2), 71.9 (CH2), 79.1 (C), 
80.1 (C), 108.3 (C), 109.7 (CH), 117.6 (CH), 118.8 (CH), 121.2 (CH), 124.9 (CH), 
124.9 (CH), 125.8 (C), 126.4 (CH), 126.6 (CH), 126.8 (CH), 126.8 (CH), 127.5 (CH), 
127.5 (CH), 127.9 (CH), 127.9 (CH), 136.7 (C), 137.3 (C), 137.7 (C), 138.3 (C), 153.3 
(CO), 154.8 (CO) and 171.6 (CO); MS (FAB) mlz 680 [M+, 52.4 %] (M+, 680.3580. 
C4oH4sN406 requires 680.3574). Stereochemistry at C-2, C-5 and C-11b was determined 
by nOe studies. 
(SS,llbR)-11-Benzyl-5-benzyloxymethyl-1,2,5,6,11,11b-hexahydro-indolizino 
[8,7-b]indol-3-one (90). 
Qxyo~ 
N 'X N'):::::O V crHLJ 
Anhydrous N,N-dimethylformamide (50 ml) was added to sodium hydride (940 mg, 
23.4 mmol) in a dry three-necked round bottom flask under nitrogen and cooled to 0 ·c 
with an ice bath. (5S,11bR)-5-Hydroxymethyl-1,2,5,6,11,11b-hexahydro-indolizino 
' [8,7-b]indol-3-one (21) (2.0 g, 7.80 mmol) in anhydrous N,N-dimethylformamide 
(65 ml) was added and stirred for 30 min at room temperature. Benzyl bromide (4.40 g, 
2.94 ml, 25.8 mmol) was added and the reaction was stirred at room temperature for 3 h 
under nitrogen. Ice and water were added to quench and the product extracted with ethyl 
acetate (3 x 60 ml). The organic phases were combined and washed with saturated 
brine, dried over anhydrous magnesium sulfate, filtered and evaporated to a crude green 
oil. The crude product was adsorbed onto silica and chromatographed using silica gel as 
absorbent and 3:2 ethyl acetate/hexane as eluent to isolate the target compound as a 
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yellow solid (3.30 g, 97 %), Mp 76-80 ·c; [a]0 + 74.7 [c = 0.68 in CHCh]; Vmax (thin 
film, CHC13)/cm-1 1690 (NCO) and 2855 (aliphatic CH); oH (400 MHz, CDCh) 1.76-
1.86 (1 H, m, CH(I-f)CHzCO), 2.36-2.57 (3 H, m, CH(I-f)CHzCO and CH2CH2CO), 2.88 
(1 H, d, J 16.0 Hz, ArCH(H)CHN), 3.04 (1 H, ddd, J2.3, 6.7, 15.8 Hz, ArCH(H)CHN), 
3.45 (2 H, d, J 7.5 Hz, CH20Bn), 4.39 (1 H, d, J 12.0 Hz, OCH(I-f)Ph), 4.54 (1 H, d, 
J 12.0 Hz, OCH(I-f)Ph), 4.60 (1 H, br, t, J 7.9 Hz, NCHAr), 5.02 (1 H, dd, J 7.2, 
14.0 Hz, ArCHzCHN), 5.23 (1 H, d, J 17.3 Hz, NCH(I-f)Ph), 5.32 (1 H, d, J 17.3 Hz, 
NCH(H)Ph), 6.85-6.89 (2 H, m, ArH), 7.13-7.29 (11 H, m, ArH) and 7.51-7.55 (1 H, m, 
ArH); oc (100 MHz, CDCh) 22.4 (CHz), 26.9 (CHz), 31.7 (CH2), 45.7 (CH), 47.3 
(CHz), 51.6 (CH), 68.6 (CH2), 72.7 (CH2), 106.5 (C), 109.5 (CH), 118.6 (CH), 119.8 
(CH), 122.2 (CH), 125.6 (CH), 125.6 (CH), 127.0 (C), 127.6 (CH), 127.7 (CH), 127.8 
(CH), 127.8 (CH), 128.4 (CH), 128.4 (CH), 129.0 (CH), 129.0 (CH), 133.4 (C), 137.2 
(C), 137.4 (C), 138.0 (C) and 173.5 (CO); MS (FAB) m/z 436 [M+, 7.7 %] (M\ 
436.2156. CzgHzsNz02 requires 436.2151). 
(2R,5S,11 bR)-11-Benzyl-5-benzyloxymethyl-2-isopropyl-1,2,5,6,11,11 b-hexahydro-
indolizino[8,7-b]indol-3-one (92a). 
n-Butyl lithium (0.85 ml, 2.12 mmol) was added dropwise to a stirred solution of 
diisopropylamine (214 mg, 0.30 ml, 2.12 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The reaction was stirred at 0 ·c for 15 min then cooled to -78 ·c. 
(5S,11bR)-11-Benzyl-5-benzyloxymethyl-1,2,5,6,11,11 b-hexahydro-indolizino[8,7-b] 
indol-3-one (90) (616 mg, 1.41 mmol) in anhydrous tetrahydrofuran (10 ml) was added 
dropwise and the reaction stirred for 15 min at -78 ·c. 2-Iodo-propane (312 mg, 0.18 
ml, 1.70 mmol) was added dropwise at -78 ·c and reaction allowed to warm to room 
temperature overnight. The reaction was quenched with saturated ammonium chloride 
and product was extracted with diethyl ether (3 x 50 ml). Ether phases were combined 
and washed with saturated brine (50 ml) and dried over anhydrous magnesium sulfate. 
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Ether phase was then filtered and solvent removed by evaporation to yield the target 
compound as an 3: 1 mixture of diastereoisomers, which were separated by column 
chromatography using silica gel as absorbent and 5:1 light petroleum/ethyl acetate as 
eluent (448 mg, 66 %), Mp 68-72 ·c; [a]o + 21.6 [c = 1.10 in CH2Clz]; Vmax (thin film, 
CH2Clz)/cm·1 1704 (NCO) and 2959 (aliphatic CH); DH (400 MHz, CDCh) 0.83 (3 H, d, 
J 6.8 Hz, CH(CHCH3(CH3))CO), 0.95 (3 H, d, J 6.8 Hz, CH(CHCH3(CH3))CO), 1.95-
2.03 (1 H, m, CH(H)CHCO), 2.12-2.18 (1 H, m, CH(CH(CH3)2)CO), 2.27 (1 H, ddd, 
J 1.8, 7.3, 12.6 Hz, CH(H)CHCO), 2.47 (1 H, ddd, J 1.9, 4.3, 10.1 Hz, CH2CHCO), 
2.81 (1 H, d, J 15.9, ArCH(H)CHN), 3.06 (1 H, ddd, J 2.3, 6.7, 15.9 Hz, 
ArCH(H)CHN), 3.45 (2 H, d, J 7.6 Hz, CH20Bn), 4.40 (1 H, d, J 11.8 Hz, OCH(H)Ph), 
4.50 (1 H, d, J 11.8 Hz, OCH(H)Ph), 4.58 (1 H, br, t, J 8.1 Hz, NCHAr), 5.05 (1 H, dd, 
J 7.4, 14.4 Hz, ArCH2CHN), 5.23 (1 H, d, J 17.0 Hz, NCH(H)Ph), 5.39 (1 H, d, 
J17.0Hz, NCH(H)Ph), 6.90-6.95 (2 H, m, ArH), 7.13-7.30 (11 H, m, ArH) and 7.50-
7.55 (1 H, m, ArH); De (100 MHz, CDC13) 18.3 (CH3), 20.7 (CH3), 22.2 (CH2), 28.2 
(CH2), 29.6 (CH), 45.5 (CH), 47.5 (CH2), 48.9 (CH), 50.8 (CH), 68.5 (CH2), 72.7 
(CH2), 106.5 (C), 109.5 (CH), 118.5 (CH), 119.7 (CH), 122.1 (CH), 125.8 (CH), 125.8 
(CH), 127.0 (C), 127.6 (CH), 127.7 (CH), 127.8 (CH), 127.8 (CH), 128.3 (CH), 128.3 
(CH), 128.9 (CH), 128.9 (CH), 134.1 (C), 137.2 (C), 137.4 (C), 137.9 (C) and 175.2 
·(CO); MS (El) m/z 478 [M+, 25.8 %] (M+, 478.2614. C32H34N202 requires 478.2620). 
(5S,11 bR)-2,11-Dibenzyl-5-benzyloxymethyl-1,2,5,6,11,11 b-hexahydro-indolizino 
[8,7-h]indol-3-one (93). 
n-Butyl lithium (0.79 ml, 1.98 mmol) was added dropwise to a stirred solution of 
diisopropylamine (201 mg, 0.30 ml, 1.98 mmol) in arihydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The reaction was stirred at 0 ·c for 15 min then cooled to -78 ·c. 
(5S,11bR)-11-Benzyl-5-benzyloxymethyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b] 
indol-3-one (90) (577 mg, 1.32 mmol) in anhydrous tetrahydrofuran (10 ml) was added 
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dropwise and the reaction stirred for 15 min at -78 ·c. Benzyl bromide (294 mg, 
0.20 ml, 1.50 mmol) was added dropwise at -78 ·c and the reaction allowed to warm to 
room temperature overnight. The reaction was quenched with saturated ammonium 
chloride and the product extracted with diethyl ether (3 x 50 ml). Ether phases were 
combined and washed with saturated brine (50 ml) and dried over anhydrous 
magnesium sulfate. Ether phase was then filtered and solvent removed on the rotary 
evaporator to yield the target compound as an 1: 1 mixture of diastereoisomers, which 
were separated by column chromatography using silica gel as absorbent and 5:1 light 
petroleum/ethyl acetate as eluent (404 mg, 58%), Mp 83-85 ·~; [a]0 + 35.6 [c = 1.05 in 
CH2Cb] (Found: C, 82.27; H, 6.60; N, 5.60. C36H34N202 requires C, 82.10; H, 6.51; N, 
5.32 %); Vmax (thin film, CH2Ch)/cm"1 1699 (NCO) and 2930 (aliphatic CH); oH (400 
MHz, CDCh) 1.42-1.51(1 H, m, CH(H)CHCO), 2.28-2.35 (1 H, m, CH(H)CHCO), 2.43 
(1 H, dd, J 10.5, 13.7 Hz, CH(CH(J:OPh))CO, 2.78-2.89 (2 H, m, ArCH(J:OCHN and 
CH2CHCO), 3.04 (1 H, ddd, J 2.2, 6.7, 15.9 Hz, ArCH(H)CHN), 3.33 (1 H, dd, J 3.8, 
13.7 Hz, CH(CH(H)Ph)CO), 3.45 (2 H, d, J 7.5 Hz, CH20Bn), 4.39 (1 H, d, J 12.0 Hz, 
OCH(J:OPh), 4.53 (1 H, d, J 12.0 Hz, OCH(J:OPh), 4.48-4.52 (1 H, m, NCHAr), 5.04 
(1 H, dd, J7.2, 14.1 Hz, ArCH2CHN), 5.18 (2 H, s, NCH2Ph), 6.73-6.79 (2 H, m, ArH), 
6.97-6.99 (2 H, m, ArH), 7.14-7.24 (14 H, m, ArH) and 7.52-7.54 (1 H, m, ArH); oc 
(100 MHz, CDCh) 22.4 (CH2), 33.9 (CH2), 36.9 (CH2), 44.7 (CH), 45.9 (CH), 47.2 
(CH2), 49.9 (CH), 68.6 (CH2), 72.7 (CH2), 106.4 (C), 109.4 (CH), 118.6 (CH), 119.8 
(CH), 122.3 (CH), 125.6 (CH), 125.6 (CH), 126.3 (CH), 127.0 (C), 127.5 (CH), 127.7 
(CH), 127.7 (CH), 127.7 (CH), 128.4 (CH), 128.4 (CH), 128.5 (CH), 128.5 (CH), 128.8 
(CH), 128.8 (CH), 128.9 (CH), 128.9 (CH), 133.2 (C), 137.3 (C), 137.5 (C), 138.0 (C), 
139.3 (C) and 174.4 (CO); MS (El) mlz 526 [M+, 11.3 %] (M+, 526.2612. C36H34N202 
requires 526.2619). 
Mp 83-85 ·c; [a]o + 23.4 [c = 1.04 in CH2Ch]; Vmax (thin film, CH2Ch)/cm"1 1696 
(NCO) and 2929 (aliphatic CH); oH (400 MHz, CDC13) 1.90 (1 H, dt, J 9.2, 18.4 Hz, 
CH(H)CHCO), 2.20 (1 H, ddd, J 1.3, 6.7, 12.4 Hz, CH(H)CHCO), 2.71 (1 H, dd, J9.0, 
13.4 Hz, CH(CH(H)Ph)CO), 2.80-2.85 (1 H, m, CH2CHCO), 2.89 (1 H, d, J 15.9 Hz, 
ArCH(H)CHN), 2.98-3.06 (2 H, m, ArCH(J:OCHN and CH(CH(J:OPh)CO), 3.29 (2 H, 
dd, J 3.4, 7.5 Hz, CH20Bn), 4.12-4.17 (1 H, m, NCHAr), 4.36 (1 H, d, J 11.9 Hz, 
OCH(H)Ph), 4.49 (1 H, d, J 11.9 Hz, OCH(H)Ph), 4.97 (1 H, dd, J 7.0, 13.8 Hz, 
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ArCH2CHN), 5.06 (1 H, d, J 17.1 Hz, NCH(H)Ph), 5.24 (1 H, d, J 17.1 Hz, 
NCH(H)Ph), 6.75-6.82 (2 H, m, ArH), 7.09-7.29 (16 H, m, ArH) and 7.50-7.54 (1 H, m, 
ArH); De (100 MHz, CDCh) 22.3 (CHz), 30.7 (CH2), 36.6 (CHz), 44.4 (CH), 45.7 (CH), 
47.3 (CHz), 50.2 (CH), 68.5 (CHz), 72.7 (CHz), 106.6 (C), 109.3 (CH), 118.6 (CH), 
119.7 (CH), 122.2 (CH), 125.8 (CH), 125.8 (CH), 126.6 (CH), 127.0 (C), 127.7 (CH), 
127.7 (CH), 127.7 (CH), 127.7 (CH), 128.4 (CH), 128.4 (CH), 128.5 (CH), 128.5 (CH), 
128.9 (CH), 128.9 (CH), 129.2 (CH), 129.2 (CH), 133.3 (C), 137.2 (C), 137.5 (C), 
138.0 (C), 138.6 (C) and 175.0 (CO); MS (El) m/z 526 [M+, 15.6 %] (M+, 526.2615. 
C36H34N202 requires 526.2619). 
(2S,5S,11 bR)-2-N ,N'-Bis-(3,3-tert-butyl ester)-hydrazino-11-Benzyl-5-benzyloxy 
methyl-1,2,5,6,11,11 b-hexahydro-indolizino [8, 7-b]indol-3-one (94a). 
Qxro~ 
N ~0 V ~ H NBoc 
I 
NHBoc 
n-Butyl lithium (0.92 ml, 2.29 mmo1) was added dropwise to a stirred solution of 
diisopropylamine (232 mg, 0.32 ml, 2.29 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The reaction was stirred at 0 ·c for 15 min then cooled to -78 ·c. 
(5S,11bR)-11-Benzyl-5-benzyloxymethyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b] 
indol-3-one (90) (500 mg, 1.15 mmol) in anhydrous tetrahydrofuran (10 ml) was added 
dropwise and the reaction stirred for 15 min at -78 ·c. Di-tert-butyl azodicarboxylate 
(396 mg, 1.72 mmol) in anhydrous tetrahydrofuran (5 ml) was added dropwise at 
-78 ·c and the reaction allowed to warm to room temperature overnight. The reaction 
was quenched with saturated ammonium chloride and product was extracted with 
diethyl ether (3 x 40 ml). Ether phases were combined and washed with saturated brine 
(50 ml) and dried over anhydrous magnesium sulfate. Ether phase was then filtered and 
solvent removed on the rotary evaporator to yield the target compound as an 6:1 
mixture of diastereoisomers, which were separated by column chromatography using 
silica gel as absorbent and 4:1 light petroleum/ethyl acetate as eluent (439 mg, 57 %), 
Mp 93-96 ·c; [a]o + 63.5 [c = 1.01 in CHzClz]; Vmax (thin film, CH2C}z)/cm-1 1701 
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(NCO), 1701 (CO), 2980 (aliphatic CH) and 3286 (NH); oH (400 MHz, DMSO, 100 "C) 
1.34 (9 H, s, C02C(CH3)3), 1.42 (9 H, s, COzC(CH3)3), 2.16-2.25 (1 H, m, 
CH(H)CHCO), 2.71-2.76 (1 H, m, CH(H)CHCO), 2.89(1 H, ddd, J 2.1, 6.3, 15.8 Hz, 
ArCH(fflCHN), 2.95-3.00 (1 H, m, ArCH(fflCHN), 3.39-3.51 (2 H, m, CH20Bn), 4.43 
(1 H, d, J 12.4 Hz, OCH(H)Ph), 4.48 (1 H, d, J 12.4 Hz, OCH(fflPh), 4.61 (1 H, d, 
J7.7 Hz, CH2CHCO), 4.80 (1 H, dd, J 6.5, 13.0 Hz, ArCH2CHN), 4.87 (1 H, t, J 7.3 
Hz, NCHAr), 5.27 (1 H, d, J 17.2 Hz, NCH(H)Ph), 5.43 (1 H, d, J 17.2 Hz, 
NCH(H)Ph), 6.92-6.94 (1 H, m, ArH), 7.06-7.11 (2 H, m, ArH), 7.21-7.28 (10 H, m, 
ArH), 7.49-7.53 (1 H, m, ArH) and 8.47 (1 H, br, s, NH); oc (100 MHz, DMSO, 
100 "C) 22.6 (CHz), 28.4 (OC(CH3)3), 28.4 (OC(CH3)3), 31.4 (CHz), 46.9 (CH), 47.4 
(CHz), 50.7 (CH), 60.1 (CH), 69.3 (CH2), 72.8 (CH2), 80.2 (C), 81.1 (C), 106.2 (C), 
110.4 (CH); 118.7 (CH), 119.7 (CH), 122.1 (CH), 126.3 (CH), 126.3 (CH), 127.5 (C), 
127.6 (CH), 127.7 (CH), 127.7 (CH), 127.7 (CH), 128.5 (CH), 128.5 (CH), 129.0 (CH), 
129.0 (CH), 134.0 (C), 134.6 (C), 137.8 (C), 138.3 (C), 154.5 (CO), 156.0 (CO) and 
168.9 (CO) ; MS (El) m/z 666 [M\ 6.4 %] (M\ 666.3414. C39H46N406 requires 
666.3417). 
3.4.2. Manipulation of the Hydroxymethyl Auxiliary 
(SS,llbS)-11-Benzyl-5-hydroxymethyl-llb-methyl-1,2,5,6,11,11b-hexahydro-
indolizino[8,7-b]indol-3-one (51). 
(5S,11bS)-11-Benzyl-5-benzyloxymethyl-11b-methyl-1,2,5,6,11,11b-hexahydro-
indolizino[8,7-b]indol-3-one (83) (1.82 g, 2.67 mmol) was dissolved in ethanol (150 ml) 
under nitrogen at room temperature. To this was added 10 % Pd/C (200 mg) and 
reaction hydrogenated at room temperature under pressure (50 psi) for 4 days. The 
reaction mixture was then filtered through a celite pad and evaporated down to a crude 
colourless solid, which was adsorbed onto silica and chromatographed using silica gel 
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as absorbent and 3:1 light petroleum/ethyl acetate as eluent to produce a colourless solid 
(1.14 g, 78 %), which had identical spectral properties to the compound prepared as 
previous discussed. 
(SS,ll bS)-11-Benzyl-11 b-methyl-3-oxo-2,3,5,6,11,11 b-hexahydro-lH-indolizino 
[8,7-b]indole-5-carbaldehyde (95). 
H 
0 
a-Iodoxybenzoic acid (2.43 g, 8.74 mmol) was added to a solution of (5S,11bS)-11-
benzyl-5-hydroxymethyl-11b-methyl-1,2,5,6,11 ,11 b-hexahydro-indolizino[8,7-b ]indol-
3-one (51) (2.10 g, 5.83 mmol) in dimethyl sulfoxide (40 ml) and the reaction stirred for 
24 h at room temperature. The resulting mixture was added to a solution of ethyl 
acetate/water and product extracted with ethyl acetate (3 x 50 ml). The organic layer 
was washed with water (3 x 50 ml), dried over anhydrous magnesium sulfate, filtered 
and evaporated to a crude yellow solid. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 2:1 ethyl acetate/light petroleum as 
eluent to isolate the target compound as a colourless solid (1.36 g, 65 %), Mp 81-85 ·c; 
[a]o- 184.3 [c = 1.02 in CH2Clz]; Vmax (thin film, CH2Ch)/cm"1 1682 (NCO), 1732 
(CHO), 2928 (aliphatic CH) and 3057 (aromatic CH); oH (400 MHz, CDC13) 1.71 (3 H, 
s, CH3), 2.23-2.33 (2 H, m, CH(H)CH2CO and CH(H)CO), 2.40-2.55 (2 H, m, 
CH(H)CH2CO and CH(H)CO), 3.12 (1 H, dd, J 5.2, 15.8 Hz, ArCH(H)CHN), 3.21 
(1 H, dd, J 10.8, 15.8 Hz, ArCH(H)CHN), 3.93 (1 H, dd, J 5.2, 10.8 Hz, ArCHi~HN), 
5.41 (1 H, d, J 17.4 Hz, N<;H(H)Ph), 5.47 (1 H, d, J 17.4 Hz, NCH(H)Ph), 6.84-6.86 
(2 H, m, ArH), 7.05-7.07 (1 H, m, ArH), 7.13-7.16 (2 H, m, ArH), 7.24-7.29 (3 H, m, 
ArH), 7.54-7.57 (1 H, m, ArH) and 10.11 (1 H, s, CHO); oc (100 MHz, CDCh) 21.0 
(CH2), 27.3 (CH3), 29.1 (Clh), 32.2 (CH2), 47.7 (CH2), 58.3 (CH), 61.4 (C), 107.6 (C), 
110.0 (CH), 118.7 (CH), 120.2 (CH), 122.7 (CH), 125.3 (CH), 125.3 (CH), 126.4 (C), 
127.6 (CH), 129.0 (CH), 129.0 (CH), 137.1 (C), 137.3 (C), 137.4 (C), 176.2 (CO) and 
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195.8 (CHO); MS (El) m/z 358 [M+, 33.4 %] (M+, 358.1681. Cz3HzzN20 2 requires 
358.1681). 
(SS,llbS)-11-Benzyl-llb-methyl-3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino 
[8,7-b]indole-5-carboxylic acid (96). 
I 
N , 
~Me''' 
OH 
0 
A solution of (5S,llbS)-ll-benzyl-llb-methyl-3-oxo-2,3,5,6,11,11b-hexahydro-lH-
indolizino[8,7-b]indole-5-carbaldehyde (95) (1.79 g, 4.99 mmol) in acetonitrile (70 ml), 
tert-butanol (220 ml) and 1-methyl-1-cyclohexene (70 ml) was stirred rapidly as it 
cooled to 0 ·c. A solution of sodium chlorite (4.35 g, 38.5 mmol) and sodium 
dihydrogen phosphate (4.19 g, 35.0 mmol) in water (150 ml) was added dropwise over a 
10 min period and the reaction stirred at room temperature for 17 h. The resulting 
mixture was added to a solution of saturated brine/ethyl acetate (1:1) (50 ml) and the 
product extracted with ethyl acetate (3 x 50 ml). The organics were combined and 
washed with a 1 M solution of sodium hydrosulfite, dried over anhydrous magnesium 
sulfate, filtered and evaporated to a crude brown residue. The crude product was 
adsorbed onto silica and chromatographed using silica gel as absorbent and 1: 1 ethyl 
acetate/light petroleum as eluent to produce a yellow solid (1.41 g, 75 %), Mp 98-101 
"C; [a]o- 136.7 [c = 1.20 in CHzClz]; Ymax (thin film, CH2Clz)/cm"1 1681 (NCO), 1731 
(CO) and 3440 (OH); oH ( 400 MHz, CDCb) 1.69 (3 H, s, CH3), 2.21-2.31 (2 H, m, 
CH(fflCHzCO and CHzCH(mco), 2.37-2.56 (2 H, m, CH(H)CH2CO and 
CHzCH(H)CO), 3.10 (1 H, dd, J 4.7, 15.7 Hz, ArCH(H)CHN), 3.41 (1 H, dd, J 11.0, 
15.7 Hz, ArCH(fflCHN), 4.22 (1 H, dd, J 4.7, 11.0 Hz, ArCHzCHN), 5.39 (1 H, d, . 
J17.7 Hz, NCH(H)Ph), 5.45 (1 H, d, J 17.7 Hz, NCH(fflPh), 6.83-6.85 (2 H, m, ArH), 
7.04-7.06 (1 H, m, ArH), 7.10-7.14 (2 H, m, ArH), 7.22-7.28 (3 H, m, ArH) and 7.53-
7.56 (1 H, m, ArH); oc (100 MHz, CDCb) 23.2 (CH2), 27.3 (CH3), 29.8 (CH2), 31.8 
(CHz), 47.7 (CHz), 52.7 (CH), 62.8 (C), 108.2 (C), 110.0 (CH), 118.7 (CH), 120.1 (CH), 
122.6 (CH), 125.4 (CH), 125.4 (CH), 126.4 (C), 127.6 (CH), 129.0 (CH), 129.0 (CH), 
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137.2 (C), 137.3 (C), 137.6 (C), 172.5 (CO) and 176.4 (CO); MS (El) m/z 374 [M+, 
9.2 %] (M+, 374.1637. C23H22N203 requires 374.1630). 
L-Phenylalanine methyl ester hydrochloride (97). 
0 
·~oMe u k2 •HCI 
Methanol (70 ml) was cooled to 0 ·c with an ice bath and acetyl chloride (3.2 ml) was 
added dropwise whilst maintaining the temperature below 5 ·c. L-Phenylalanine (2.0 g, 
12.11 mmol) was added in one portion and the solution heated under reflux for 3 h. The 
solvent was removed under reduced pressure to yield the target compound as a 
colourless solid (2.97 g, 72 %), Mp 160-162 ·c; [a]0 + 38.2 [c = 1.05 in EtOH]; Vmax 
(thin film, CH2Cl2)/cm"1 1732 (CO) and 3410 (NH); oH (400 MHz, DMSO) 3.11 (1 H, 
dd, J7.6, 14.0 Hz, ArCH(I-f)CHNH2), 3.23 (1 H, dd, J 5.6, 13.6 Hz, ArCH(H)CHNH2), 
3.65 (3 H, s, OCH3), 4.23 (1 H, dd, J 5.6, 7.2 Hz, ArCH2CHNH2), 7.24-7.36 (5 H, m, 
ArH) and 8.81 (2 H, br, s, NH1); oc (100 MHz, DMSO) 35.8 (CH2), 52.5 (CH3), 53.2 
(CH), 127.2 (CH), 128.6 (CH), 128.6 (CH), 129.4 (CH), 129.4 (CH), 134.7 (C) and 
169.3 (CO); MS (FAB) mlz 180 [MH+, 100 %] (MH+, 180.1026. C10H13N02 requires 
180.1025). 
(5S,llbS,3'S)-2-[(11-Benzyl-llb-methyl-3-oxo-2,3,5,6,11,11b-hexahydro-1H-
indolizino [8, 7-b ]indole-5-carbonyl)-amino ]-3 '-phenyl-propionic acid methyl ester 
(98). 
I 
N . ~Me''' 
(5S,11bS)-11-Benzyl-llb-methyl-3-oxo-2,3,5,6,11,11b-hexahydro-1H-indolizino[8,7-b] 
indole-5-carboxylic acid (96) (250 mg, 0.668 mmol) was dissolved in anhydrous 
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dichloromethane (10 ml) and cooled to -15 ·c. 1-Hydroxyazabenzotriazole '(lOO mg, 
0. 734 mmol) and 1-ethyl-3-[( dimethylamino )propyl]carbodiimide hydrochoride 
(141 mg, 0.734 mmol) were added and the reaction stirred for 20 min at -15 ·c. 
N-methyl morpholine (74 mg, 0.08 ml, 0.734 mmol) and £-phenylalanine methyl ester 
hydrochloride (97) (155 mg, 0.734 mmol) were added and the reaction stirred for a 
further 3 h at -15 ·c. An ice cold 1 M solution of HCl (2 ml) was added and the 
reaction extracted with dichloromethane (3 x 10 ml). The organic phase was washed 
with saturated sodium bicarbonate, dried over anhydrous magnesium sulfate, filtered 
and solvent removed by rotary evaporation to yield a crude yellow residue. The crude 
product was adsorbed onto silica and chromatographed using silica gel as absorbent and 
2:1 ethyl acetate/light petroleum as eluent to isolate the target compound as a colourless 
solid (275 mg, 77 %), Mp 84-86 ·c; [a]0 - 76.8 [c = 1.11 in CH2Clz]; Vmax (thin film, 
CHzClz)/cm·1 1682 (NCO), 1738 (CO), 3418 (NH); oH (400 MHz, CDCb) 1.65 (3 H, s, 
CH3), 2.05-2.20 (2 H, m, CH(H)CH2CO and CH2CH(H)CO), 2.33-2.46 (2 H, m, 
CH(H)CHzCO and CH2CH(H)CO), 3.06-3.16 (2 H, m, ArCH(H)CHN and 
CHCH(H)Ph), 3.22 (1 H, dd, J 5.3, 13.6 Hz, ArCH(H)CHN), 3.43 (1 H, dd, J 10.0, 
15.9 Hz, CHCH(H)Ph), 3.68 (3 H, s, OCH3), 4.17 (1 H, dd, J 5.2, 9.9 Hz, CHC02CH3), 
4.93-4.97 (1 H, m, ArCHzCHN), 5.39 (1 H, d, J 17.6 Hz, NCH(H)Ph), 5.47 (1 H, d, 
J 17.6 Hz, NCH(H)Ph), 6.44 (1 H, br, d, J 7.6 Hz, NH), 6.78-6.81 (2 H, m, ArH), 7.06-
7.23 (11 H, m, ArH), and 7.55-7.59 (1 H, m, ArH); oc (100 MHz, CDCb) 21.8 (CHz), 
27.6 (CH3), 29.6 (CHz), 31.7 (CHz), 38.1 (CHz), 47.7 (CHz), 52.2 (OCH3), 53.3 (CH), 
53.7 (CH), 62.5 (C), 109.3 (C), 109.9 (CH), 118.8 (CH), 120.2 (CH), 122.7 (CH), 125.2 
(CH), 125.2 (CH), 126.5 (C), 127.0 (CH), 127.5 (CH), 128.4 (CH), 128.4 (CH), 129.0 
(CH), 129.0 (CH), 129.5 (CH), 129.5 (CH), 136.0 (C), 137.0 (C), 137.2 (c), 137.4 (C), 
169.4 (CO), 172.2 (CO) and 177.4 (CO); MS (El) m/z 535 [M+, 46.7 %] (M+, 535.2465. 
C33H33N304 requires 535.2471). 
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3.4.3. The Anti-Indolizino[8,7-b]indole Polypeptide 
( 5S,11 bS)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-11 b-methyl-3-oxo-1,2,3,5,6,11 b 
hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (99). 
(SS, 11 bS)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-11 b-methyl-1 ,2,5,6, 11,11 b-
hexahydro-indolizino[8,7-b]indol-3-one (49) (5.2 g, 13.5 mmol) was dissolved in 
anhydrous tetrahydrofuran (50 ml) under a nitrogen atmosphere. Triethylamine (2. 74 g, 
3.77 ml, 27.0 mmol), 4-dimethylaminopyridine (0.33 g, 2.70 mmol) and di-tert-butyl 
dicarbonate (3.54 g, 16.2 mmol) were added successively and the resultant solution was 
stirred overnight. The volatiles were removed by evaporation and the orange residue 
dissolved in ethyl acetate and washed successively with saturated ammonium chloride 
(2 x 50 ml), saturated sodium bicarbonate (2 x 50 ml) and saturated brine (50 ml). The 
organic phase was then dried over anhydrous magnesium sulfate and the solvent 
removed under pressure to yield a colourless solid, which was chromatographed using 
silica gel as absorbent and 4:1 light petroleum/ethyl acetate as eluent to isolate the target 
compound as a colourless solid (6.0 g, 92 %), Mp 49-51 ·c; [a] 0 - 194.2 [c = 1.04 in 
CHzCh]; Vmax (thin film, CHzClz)/cm-1 1697 (NCO), 1736 (CO) and 2951 (aliphatic 
CH); oH (400 MHz, CDCh) 0.12 (3 H, s, SiCH3), 0.13 (3 H, s, SiCH3), 0.93 (9 H, s, 
SiC(CH3)3), 1.71 (9 H, s, C02C(CH3)3), 1.86 (3 H, s, CH3), 2.19-2.25 (1 H, m, 
CH(If)CHzCO), 2.41-2.64 (3 H, m, CH(H)CHzCO and CHzCH2CO), 2.77 (1 H, dd, 
J 11.1, 15.7 Hz, ArCH(If)CHN), 3.02 (1 H, dd, J 4.0, 15.7 Hz, ArCH(H)CHN), 3.59-
3.66 (1 H, m, ArCHzCHN), 4.45-4.56 (2 H, m, CH20Si), 7.22-7.32 (2 H, m, ArH), 
7.42-7.45 (1 H, m, ArH) and 7.97-8.00 (1 H, m, ArH);. oc (100 MHz, CDCh) -5.2 
(SiCH3), -5.2 (SiCH3), 18.3 (C), 25.3 (CH3), 25.5 (CHz), 26.0 (SiC(CH3)3), 28.3 
(COzC(CH3)3), 30.5 (CHz), 32.2 (C1-h), 53.9 (CH), 64.0 (CH2), 65.0 (C), 84.3 (C), 116.0 
(CH), 116.4 (C), 118.4 (CH), 122.8 (CH), 124.6 (CH), 128.7 (C), 135.7 (C), 139.3 (C), 
149.8 (CO) and 175.1 (CO); MS (El) m/z 485 [MH+, 42.8 %] (MH+, 485.2842. 
Cz7H4oN204Si requires 485.2836). 
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(2R,5S,1 0 bS)-2-N ,N'-Bis-(3,3-tert-bu tyl ester)-hydrazino-(5-(tert-bu tyl-dimethyl-
silanyloxymethyl)-11 b-methyl-3-oxo-1,2,3,5,6,11 b-hexahydro-indolizino[8, 7-b] 
indole-11-carboxylic acid tert-butyl ester (100). 
NBoc 
I 
NHBoc 
n-Butyl lithium (0.65 ml, 1.64 mmol) was added dropwise to a stirred solution of 
diisopropylamine (166 mg, 0.23 ml, 1.64 mmol) in anhydrous tetrahydrofuran (5 ml) at 
0 ·c under nitrogen. The reaction was stirred at 0 ·c for 20 min then cooled to -78 ·c. 
(SS, 11 bS)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-11 b-methyl-3-oxo-1 ,2,3,5,6, 11 b-
hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (99) (563 mg, 
1.17 mmol) in anhydrous tetrahydrofuran (1 0 ml) was added dropwise and reaction 
stirred for 20 min at -78 ·c. Di-tert-butyl azodicarboxylate (350 mg, 1.52 mmol) in 
anhydrous tetrahydrofuran (5 ml) was added dropwise at -78 ·c and reaction allowed to 
warm to room temperature overnight. The reaction was quenched with saturated 
ammonium chloride and product was extracted with ethyl acetate (3 x 30 ml). Organic 
phase was then dried over anhydrous magnesium sulfate and solvent removed on the 
rotary evaporator to yield the target compound as a single diastereoisomer, which was 
purified by column chromatography using silica gel as absorbent and 2:1 light 
petroleum/ethyl acetate as eluent (742 mg, 89 %), Mp 99-110 ·c; [a.] 0 - 97.5 [c = 1.12 
in CHzClz]; Vmax (thin film, CHzCh)/cm·1 1697 (NCO), 1732 (CO), 2855 (aliphatic CH) 
and 3277 (NH); OH (400 MHz, DMSO, 80 ·q 0.11 (3 H, s, SiCH3), 0.11 (3 H, s, 
SiCH3), 0.95 (9 H, s, SiC(CH3)3), 1.41 (9 H, s, COzC(CH3)3), 1.45 (9 H, s, 
COzC(CH3)3), 1.71 (9 H, s, C02C(CH3)3), 1.88 (3 H, s, CH3), 2.43 (1 H, dd; J 8.8, 
14.0 Hz, CH(H)CHCO), 2.75 (1 H, dd, J 11.6, 16.0 Hz, ArCH(H)CHN), 2.89-2.94 (1 H, 
m, ArCH(lf)CHN), 3.04 (1 H, dd, J 10.0, 14.4 Hz, CH(H)CHCO), 3.62-3.69 (1 H, m, 
ArCHzCHN), 4.29-4.31 (1 H, m, CH2CHCO), 4.50 (2 H, d, J 7.2 Hz, CH20Si), 7.22-
7.26 (1 H, m, ArH), 7.30-7.34 (1 H, m, ArH), 7.45 (1 H, d, J7.6 Hz, ArH), 8.02 (1 H, d, 
J 8.4 Hz, ArH) and 8.25 (1 H, br,. s, NH); oc (100 MHz, DMSO, 80 ·c) -4.8 (SiCH3), 
-4.8 (SiCH3), 18.4 (C), 25.0 (CHz), 26.3 (SiC(CH3)3), 27.4 (CH3), 28.3 (COzC(CH3)3), 
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28.4 (COzC(CH3)3), 28.4 (C02C(CH3)3), 36.0 (CHz), 54.3 (CH), 61.7 (CH), 61.7 (C), 
64.3 (CHz), 80.1 (C), 81.0 (C), 85.3 (C), 116.1 (CH), 116.8 (C), 118.8 (CH), 123.3 
(CH), 125.1 (CH), 128.6 (C), 136.2 (C), 139.2 (C), 150.0 (CO), 154.5 (CO), 156.0 (CO) 
and 172.1 (CO); MS (ES) m/z 715 [MH+, 50.0 %] (MH\ 715.4099. C31HssN40sSi 
requires 715.4102). 
(2R,5S,10bS)-2-N,N'-Bis-(3,3-tert-butyl ester)-hydrazino-5-hydroxymethyl-11 b-
methyl-3-oxo-1,2,3,5,6,11 b-hexahydro-indolizino[S, 7-b ]indole-11-carboxylic acid 
tert-butyl ester (101). 
NBoc , 
NHBoc 
To a solution of the (2R,5S,10bS)-2-N,N'-bis-(3,3-tert-butyl ester)-hydrazino-(5-(tert-
butyl-dimethyl-silanyloxymethyl)-11 b-methyl-3-oxo-1 ,2,3,5,6, 11 b-hexahydro-
indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (100) (435 mg, 0.608 mmol) 
in tetrahydrofuran (10 ml) was added tetrabutylammonium fluoride (1 M solution in 
tetrahydrofuran, 0.61 ml, 0.608 mmol) and the reaction stirred for 5 min at room 
temperature. The resultant solution was concentrated and chromatographed through a 
pad of silica gel using 2:1 light petroleum/ethyl acetate as eluent to yield the target 
compound as a colourless solid (358 mg, 98 %), Mp 95-97 ·c; [a]0 - 112.0 [c = 1.10 in 
CHCh]; Vmax (thin film, CH2Clz)/cm-1 1697 (NCO), 1734 (CO), 2977 (aliphatic CH), 
3289 (NH) and 3401 (OH); oH (400 MHz, DMSO, 80 ·c) 1.42 (9 H, s, COzC(CH3)3), 
1.46 (9 H, s, COzC(CH3)3), 1.72 (9 H, s, COzC(CH3)3), 1.87 (3 H, s, CH3), 2.47-2.51 
(1 H, m, CH(lf)CHCO), 2.80 (2 H, d, J 8.0 Hz, ArCH2CHN), 2.95 (1 H, t, J 13.6 Hz, 
CH(H)CHCO), 3.74-3.77 (1 H, m, ArCH2CHN), 4.12-4.19 (2 H, m, CH20H), 4.43-4.53 
(1 H, br, m, CH2CHCO), 4.69 (1 H, br, s, OH), 7.25 (1 H, t, J7.4 Hz, ArH), 7.32 (1 H, 
t, J 7.4 Hz, ArH), 7.48 (1 H, d, J 7.6 Hz ArH), 8.01 (1 H, d, J 8.4 Hz, ArH) and 8.66 
(1 H, br, s, NH); oc (100 MHz, DMSO, 80 ·c) 24.4 (CH2), 27.5 (CH3), 28.3 
(COzC(CH3)3), 28.4 (COzC(CH3)3), 28.5 (COzC(CH3)3), 35.9 (CHz), 54.1 (CH), 62.1 
(CH), 62.4 (CH2), 62.4 {C), 79.4 (C), 80.1 (C), 81.0 (C), 116.2 (CH), 116.4 (C), 118.8 
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(CH), 123.3 (CH), 125.1 (CH), 128.6 (C), 136.1 (C), 139.1 (C), 149.9 (CO), 153.8 
(CO), 156.1 (CO) and 171.5 (CO); MS (ES) m/z 601 [MH\ 100 %] (MH+, 601.3233. 
C31H44N40s requires 601.3237). 
(2R,5S,10bS)-2-N,N'-Bis-(3,3-tert-butyl ester)-hydrazino-5-formyl-11b-methyl-3-
oxo-1,2,3,5,6,11 b-hexahydro-indolizino[8, 1-b ]indole-11-carboxylic acid tert-butyi 
ester (102). 
H 
0 
NBoc 
' NHBoc 
a-Iodoxybenzoic acid (700 mg, 2.50 mmo1) was added to a solution of(2R,5S,10bS)-2-
N ,N-bis-(3,3-tert-butyl ester)-hydrazino-5-hydroxymethyl-11 b-methyl-3-oxo-1 ,2,3,5,6, 
11b-hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (101) (1.00 g, 
1.66 mmol) in dimethyl sulfoxide (30 ml) and the reaction stirred for 20 h at room 
temperature. The reaction mixture was added to a solution of ethyl acetate/water and 
product extracted with ethyl acetate (3 x 40 ml). The organic layer was washed with 
water (3 x 50 ml), dried over anhydrous magnesium sulfate, filtered and evaporated to a 
crude yellow solid. The crude product was adsorbed onto silica and chromatographed 
using silica gel as absorbent and 1:1 ethyl acetate/light petroleum as eluent to isolate the 
target compound as a colourless solid (964 mg, 97 %), Mp 112-114 ·c; [a] 0 - 121.2 
[c = 1.00 in CHCh]; Vmax (thin film, CH2Ch)/cm"1 1697 (NCO), 1736 (CO), 2977 
(aliphatic CH) and 3299 (NH); oH (400 MHz, DMSO, 80 "C) 1.41 (9 H, s, 
C02C(CH3)3), 1.45 (9 H, s, C02C(CH3)3), 1.74 (9 H, s, C02C(CH3)3), 1.98 (3 H, s, 
CH3), 2.50-2.58 (1 H, m, CH(H)CHCO), 2.83-2.95 (2 H, m, ArCH2CHN), 3.06-3.14 
(1 H, m, CH(H)CHCO), 4.31 (1 H, dd, J 5.6, 10.8 Hz, ArCH2CHN), 4.39-4.49 (1 H, br, 
m, CH2CHCO), 7.23-7.35 (2 H, m, ArH), 7.53 (1 H, d, J 7.6 Hz ArH), 8.02 (1 H, d, 
J8.4 Hz, ArH), 8.79 (1 H, br, s, NH) and 9.96 (1 H, s, CHO); oc (100 MHz, DMSO, 
80 "C) 20.0 (CH2), 26.5 (CH3), 27.4 (C02C(CH3)3), 27.5 (C02C(CH3)3), 27.6 
(C02C(CH3)3), 35.8 (CH2), 56.3 (CH), 59.2 (CH), 60.0 (C), 78.5 (C), 79.3 (C), 80.3 (C), 
114.3 (C), 115.3 (CH), 118.1 (CH), 122.4 (CH), 124.3 (CH), 127.7 (C), 135.2 (C), 
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137.8 (C), 149.0 (CO), 153.5 (CO), 155.2 (CO), 171.6 (CO) and 195.2 (CHO); MS (El) 
mlz 598 [M+, 1.6 %] (M+, 598.3013. C31H4zN40s requires 598.3003). 
(2R,5S,1 ObS)-2-N ,N'-Bis-(3,3-tert-butyl ester )-hydrazino-11 b-methyl-3-oxo-1,2,3,5, 
6,11 b-hexahydro-indolizino [8, 7-b ]indole-5,11-dicarboxylic acid 11-tert-butyl ester 
(103). 
OH 
0 
NBoc 
' NHBoc 
A solution of (2R,5S,10bS)-2-N,N-bis-(3,3-tert-butyl ester)-hydrazino-5-formyl-11b-
methyl-3-oxo-1 ,2,3,5,6, 11 b-hexahydro-indolizino[8, 7 -b ]indole-11-carboxylic acid tert-
butyl ester (102) (6.80 g, 11.3 mmol) in acetonitrile (150 ml), tert-butanol (400 ml) and 
1-methyl-1-cyclohexene (100 ml) was stirred rapidly as it cooled to 0 ·c. A solution of 
sodium chlorite (9.89 g, 87.5 mmol) and sodium dihydrogen phosphate (9.54 g, 79.5 
mmol) in water (300 ml) was added dropwise over a 10 min period and the reaction 
stirred at room temperature for 17 h. The reaction mixture was added to a solution of 
saturated brine/ethyl acetate (1:1) (200 ml) and product extracted with ethyl acetate (3 x 
150 ml). Organics were combined and washed with a 1 M solution of sodium 
hydrosulfite, dried over anhydrous magnesium sulfate, filtered and evaporated to a 
crude brown residue. The crude product was adsorbed onto silica and chromatographed 
using silica gel as absorbent and 3:1 ethyl acetate/light petroleum as eluent to produce 
an orange solid (5.79 g, 83 %), Mp 147-149 ·c; [a.] 0 - 86.7 [c = 1.02 in CHzClz]; Vmax 
(thin film, CH2Clz)/cm-1 1699 (NCO), 1733 (CO), (aliphatic CH), 3283 (NH) and 3401 
(OH); oH (400 MHz, DMSO, 80 ·c) 1.39 (9 H, s, COzC(CH3)3), 1.41 (9 H, s, 
COzC(CH3)3), 1.69 (9 H, s, COzC(CH3)3), 1.89 (3 H, s, CH3), 2.34-2.43 (1 H, m, 
CH(H)CHCO), 2.83 (1 H, dd, J 8.0, 16.0 Hz, ArCH(H)CHN), 3.04 (1 H, dd, J 12.0, 
16.0 Hz, ArCH(H)CHN), 3.13 (1 H, dd, J8.0, 12.0 Hz, CH(H)CHCO), 4.18-4.30 (2 H, 
m, ArCHzCHN and CH2C~CO), 7.21-7.32 (2 H, m, ArH), 7.49 (1 H, d, J 8.0 Hz ArH), 
7.99 (1 H, d, J 8.0 Hz, ArH) and 8.47 (1 H, br, s, NH); oc (100 MHz, DMSO, 80 ·c) 
23.0 (CHz), 27.3 (CH3), 28.3 (COzC(CH3)3), 28.4 (COzC(CH3)3), 28.5 (COzC(CH3)3), 
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36.0 (Gh), 51.2 (CH), 61.3 (CH), 61.3 (C), 80.2 (C), 81.2 (C), 85.4 (C), 116.2 (CH), 
116.6 (C), 118.9 (CH), 123.3 (CH), 125.2 (CH), 128.6 (C), 136.3 (C), 138.4 (C), 150.0 
(CO), 154.5 (CO), 155.9 (CO), 170.4 (CO) and 171.7 (CO); MS (ES) mlz 615 [MH+, 
100 %] (MH+, 615.3058. C31H42N409 requires 615.3030). 
(2R,5S,11 bS, 1 'S)-2-N ,N'-Bis-(3,3-tert-butyl ester )-hydrazino-5-(1-methoxycarbonyl 
-2-phenyl-ethylcarbamoyl)-11 b-methyl-3-oxo-1,2,3,5,6,1 J b-hexahydro-indolizino 
[8,7-b]indole-11-carboxylic acid tert-butyl ester (104). 
NBoc 
' NHBoc 
(2R,5S,10bS)-2-N,N'-Bis'-(3,3-tert-butyl ester)-hydrazino-11b-methyl-3-oxo-1,2,3,5,6, 
11b-hexahydro-indolizino[8,7-b]indole-5,11-dicarboxylic acid 11-tert-butyl ester (103) 
(1.00 g, 1.64 mmol) was dissolved in anhydrous dichloromethane (35 ml) and cooled to 
-15 ·c under nitrogen. 1-Hydroxyazabenzotriazole (245 mg, 1.80 mmol) and 1-ethyl-3-
[(dimethylamino)propyl]carbodiimide hydrochoride (345 mg, 1.80 mmol) were added 
and the reaction stirred for 20 min at -15 ·c. N-methy1 morpholine (82 mg, 0.20 ml, 
1.80 mmol) and £-phenylalanine methyl ester hydrochloride (97) (388 mg, 1.80 mmol) 
were added and the reaction stirred for a further 3 hat -15 ·c. An ice cold 1 M solution 
of HCl (6 ml) was added and the reaction extracted with dichloromethane (3 x 30 ml). 
The organic phase was washed with saturated sodium bicarbonate, dried over anhydrous 
magnesium sulfate, filtered and solvent removed by rotary evaporation to yield a crude 
orange residue. The crude product was adsorbed onto silica and chromatographed using 
silica gel as absorbent and 1: 1 ethyl acetate/light petroleum as eluent to isolate the target 
compound as a colourless solid (584 mg, 46 %), Mp 135-137 ·c; [a.]0 - 70.4 [c = 1.04 
in CHCh]; Vmax (thin film, CH2Clz)/cm"1 1693 (NCO), 1745 (CO), (aliphatic CH) and 
3345 (NH); oH (400 MHz, DMSO, 80 ·c) 1.42 (9 H, s, COzC(CH3)3), 1.47 (9 H, s, 
COzC(CH3)3), 1.72 (9 H, s, C02C(CH3)3), 1.93 (3 H, s, CH3), 2.50-2.52 (1 H, m, 
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CH(H)CHCO), 2.89 (1 H, dd, J 4.8, 16.4 Hz, CHCH(H)Ph), 3.00-3.18 (4 H, m, 
CH(H)CHCO, CHCH(H)Ph and ArCH2CHN), 3.58 (3 H, s, OCH3), 4.29 (2 H, m, 
CHC02CH3 and CH2CHCO), 4.68-4.69 (1 H, m, ArCH2CHN), 7.22-7.35 (7 H, m, 
ArH), 7.51 (1 H, d, J 7.8 Hz ArH), 7.99 (1 H, d, J 7.8 Hz, ArH) and 8.52 (1 H, br, s, 
NH); oc (100 MHz, DMSO, 80 ·c) 22.5 (CHz), 27.1 (CH3), 28.3 (C02C(CH3)3), 28.4 
(COzC(CHJ)J), 28.5 (COzC(CH3)3), 36.0 (CHz), 38.0 (CH2), 51.9 (OCH3), 52.2 (CH), 
54.4 (CH), 59.8 (CH), 61.8 (C), 80.4 (C), 81.7 (C), 85.4 (C), 116.2 (CH), 116.5 {C), 
118.9 (CH), 123.3 (CH), 125.2 (CH), 126.9 (CH), 128.6 (C), 128.7 (CH), 128.7 (CH), 
129.5 (CH), 129.5 (CH), 136.2 (C), 137.6 (C), 138.8 (C), 150.0 (CO), 154.5 (CO), 
154.5 (CO), 168.6 (CO), 172.0 (CO) and 172.1 (CO); MS (ES) m/z 776 [MH+, 100 %] 
(MH+, 776.3909. C41Hs3Ns010 requires 776.3871). 
3.4.4. The Syn-Indolizino[8,7-b]indole Polypeptide · 
(5S,11 bR)-5-Triisopropylsilanyloxymethyl-1,2,5,6,11,11 b-hexahydro-indolizino 
[8,7-b]indol-3-one (107). 
OTIPS 
Ox(o 
HH\_/ 
Imidazole (529 mg, 7.76 mmol) followed by (5S,11bR)-5-hydroxymethyl-1,2,5,6,11, 
~ 
11b-hexahydro-indolizino[8,7-b]indol-3-one (21) (995 mg, 3.88 mmol) was dissolved in 
anhydrous N,N-dimethylformamide (30 ml) under nitrogen. To this solution, 
triisopropylsilylchloride (1.12 g, 1.25 ml, 5.82 mmol) was added and the solution was 
stirred at room temperature for 6.5 h. The resulting mixture was filtered to remove the 
solid phase and concentrated under reduced pressure. The green residue was then 
dissolved in dichloromethane (20 ml) and washed with water (3 x 30 ml), dried over 
anhydrous magnesium sulfate and evaporated to a blue oil. The crude product was 
chromatographed using silica gel as absorbent and 2:1 ethyl acetate/light petroleum as 
eluent to isolate the target compound as a blue oil (1.57 g, 98 %), [a] 0 + 80.4 [c = 1.06 
in CHzCb]; Ymax (thin film, CHzCh)/cm-1 1674 (NCO), 2941 (aliphatic CH) and 3262 
(NH); oH (400 MHz, CDCh) 0.94-1.03 (18 H, m, Si(CH(CH3)z)3), 1.05 (3 H, s, 
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Si(CH(CH3)z)3), 1.90-1.98 (1 H, m, CH(H)CHzCO), 2.48-2.65 (3 H, m, CH(H)CH2CO 
and CH2CH2CO), 2.87 (1 H, d, J 15.6 Hz, ArCH(lf)CHN), 2.96 (1 H, ddd, J 2.4, 6.8, 
16.0 Hz, ArCH(.fflCHN), 3.74 (2 H, d, J7.6 Hz, CH20Si), 4.83 (1 H, dd, J 6.8, 14.0 Hz, 
ArCHzCHN), 4.89-4.93 (1 H, m, NCHAr), 7.12 (1 H, dt, J 1.2, 7.8 Hz, ArH), 7.18 (1 H, 
dt, J 1.2, 7.8 Hz, ArH), 7.34 (1 H, d, J 7.8 Hz, ArH), 7.49 (1 H, d, J 7.8 Hz, ArH) and 
8.23 (1 H, br, s, NH); oc (100 MHz, CDCb) 11.9 (Si(CH(CH3)2) 3), 17.9 
(Si(CH(CHJ)z)J), 21.5 (CHz), 25.9 (CHz), 31.8 (CHz), 48.3 (CH), 51.6 (CH), 62.6 
(CHz), 106.7 (C), 111.0 (CH), 118.5 (CH), 119.8 (CH), 122.1 (CH), 127.2 (C), 132.2 
(C), 136.4 {C) and 173.5 (CO); MS (El) m/z 412 [M+, 32.6 %] (~, 412.2544. 
Cz4H36NzOzSi requires 412.2546). 
(5S,11 bR)-3-0xo-5-triisopropylsilanyloxymethyl-1,2,3,5,6,11 b-hexahydro-
indolizino[8,7-h]indole-11-carboxylic acid tert-butyl ester (108). 
OTIPS COo: a 
Bocf H LJ 
(5S,11 bR)-5-Triisopropylsilanyloxymethyl-1 ,2,5,6, 11 ,11b-hexahydro-indolizino[8,7-b] 
indol-3-one (107) (1.76 g, 4.27 mmol) was dissolved in anhydrous tetrahydrofuran 
(50 ml) under nitrogen. Triethylamine (863 mg, 1.19 ml, 8.53 mmol), 
4-dimethylaminopyridine (104 mg, 0.853 mmol) and di-tert-butyl dicarbonate (1.12 g, 
5.13 mmol) were added successively and the resultant solution was stirring overnight. 
The volatiles were removed by evaporation and the orange residue was dissolved in 
ethyl acetate, which was washed successively with saturated ammonium chloride (2 x 
20 ml), saturated sodium bicarbonate (2 x 20 ml) and saturated brine (20 ml). The 
organic phase was then dried over anhydrous magnesium sulfate and the solvent 
removed under pressure to yield a green residue, which was chromatographed using 
silica gel as absorbent and 3:1 light petroleum/ethyl acetate as eluent to isolate the target 
compound as a green oil (1.60 g, 73 %), [a.]o + 91.2 [c = 1.11 in CHzClz]; Vmax (thin 
film, CHzClz)/cm·1 1698 (NCO), 1731 (CO), 2938 (aliphatic CH); oH (400 MHz, 
CDCl3) 0.92-0.99 (21 H, m, Si(CH(CH3)z)3 and Si(CH(CH3)z)3), 1.70 (9 H, s, 
COzC(CH3)3), 1.79-1.85 (1 H, m, CH(lf)CHzCO), 2.43 (1 H, ddd, J 1.6, 9.6, 16.8 Hz, 
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CH2CH(H)CO), 2.54-2.64 (1 H, m, CH2CH(H)CO), 2.85-2.92 (3 H, m, CH(H)CH2CO 
and ArCH2CHN), 3.77 (2 H, d, J 6.8 Hz, CH20Si), 4.82-4.85 (1 H, m, ArCH2CHN), 
5.17-5.21 (1 H, m, NCHAr), 7.25 (1 H, dt, J 1.2, 7.4 Hz, ArH), 7.31 (1 H, dt, J 1.2, 
7.4 Hz, ArH), 7.43 (1 H, d, J 8.0 Hz, ArH) and 8.04 (1 H, d, J 8.0 Hz, ArH); oc 
(100 MHz, CDCh) 11.9 (Si(CH(CH3)2)3), 17.9 (Si(CH(CH3)2)3), 21.9 (CH2), 27.3 
(CH2), 28.2 (C02C(CH3)3), 31.4 (CH2), 47.3 (CH), 54.1 (CH), 62.6 (CH2), 84.3 (C), 
113.6 (C), 115.5 (CH), 118.4 (CH), 122.9 (CH), 124.5 (CH), 129.2 (C), 134.0 (C), 
135.8 (C), 150.0 (CO) and 174.0 (CO); MS (El) m/z 512 [M+, 6.1 %] (M+, 512.3078. 
C29H44N204Si requires 512.3070). 
(5S,11 bR)-5-Hydroxymethyl-3-oxo-1,2,3,5,6,11 b-hexahydro-indolizino[S, 7-b] 
indole-11-carboxylic acid tert-butyl ester (110). 
Clf.!H 
N , 'X N 'J::::::O 
Bod H. LJ 
To a solution of the (5S,11bR)-3-oxo-5-triisopropy1silanyloxymethyl-1,2,3,5,6,11b-
hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (108) (1.0 g, 
1.95 mmol) in tetrahydrofuran (30 ml) was added tetrabutylammonium fluoride (1 M 
solution in tetrahydrofuran, 1.95 ml, 1.95 mmol) and the reaction stirred for 10 min at 
room temperature. The resultant solution was concentrated and chromatographed 
through a pad of silica gel using ethyl acetate as eluent to yield the target compound as a 
green solid (502 mg, 72 %), Mp 77-78 ·c; [a]o + 264.0 [c = 1.05 in CHCh]; Vmax (thin 
film, CH2Ch)/cm-1 1673 (NCO), 1732 (CO), 2976 (aliphatic CH) and 3368 (OH); oH 
(400 MHz, CDC13) 1.70 (9 H, s, C02C(CH3) 3), 1.79-1.88 (1 H, m, CH(H)CH2CO), 2.47 
(1 H, ddd, J 1.6, 9.6, 16.8 Hz, CH2CH(H)CO), 2.62-2.72 (1 H, m, CH2CH(H)Cq), 2.77 
(1 H, dd, J 1.6, 16.8 Hz, ArCH(H)CHN), 2.89-2.97 (2 H, m, CH(H)CH2CO and 
ArCH(H)CHN), 3.67-3.70 (2 H, m, CH20H), 4.85 (1 H, dd, J 7.2, 15.6 Hz, 
ArCH2CHN), 5.23-5.27 (1 H, m, NCHAr), 7.23-7.27 (1 H, m, ArH), 7.30-7.34 (1 H, m, 
ArH), 7.41-7.43 (1 H, m, ArH) and 8.03 (1 H, d, J 8.4 Hz, ArH); oc (100 MHz, CDCh) 
22.1 (CH2), 27.1 (CH2), 28.2 (C02C(CH3)3), 31.4 (CH2), 48.0 (CH), 53.7 (CH), 61.6 
(CH2), 84.5 (C), 113.2 (C), 115.5 (CH), 118.4 (CH), 123.0 (CH), 124.7 (CH), 128.9 (C), 
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133.6 (C), 135.8 {C), 149.9 (CO) and 175.3 (CO); MS (El) m/z 356 [M+, 1.1 %] (M+, 
356.1729. CzoH24N204 requires 356.1736). 
(5S,11 bR)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-3-oxo-1,2,3,5,6,11 b-hexahydro-
indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (111). 
QdTBS 
N ')('N')::::::O 
Bocf H LJ 
Imidazole (472 mg, 6.94 mmol) and 4-dimethylaminopyridine (65 mg, 0.534 mmol) 
followed by (5S, 11 bR)-5-hydroxymethyl-3-oxo-1 ,2,3,5,6, 11 b-hexahydro-indolizino 
[8,7-b]indole-11-carboxylic acid tert-butyl ester (110) (1.90 g, 5.34 mmol) was 
dissolved in anhydrous dichloromethane (20 ml) under a nitrogen atmosphere. To this 
solution, tert-butyldimethylsilylchloride (1.01 g, 6.67 mmol) was added and the solution 
stirred at room temperature for 4 h. The resulting mixture was filtered to remove the 
solid phase and concentrated under reduced pressure. The crude product . was 
chromatographed using silica gel as absorbent and 3:1 light petroleum/ethyl acetate as 
eluent to isolate the target compound as a green solid (2.14 g, 85 %), Mp 75-76 ·c; [a] 0 
+ 102.3 [c = 1.00 in CHCb]; Vmax (thin film, CHzClz)/cm·1 1697 (NCO), 1731 (CO) and 
2951 (aliphatic CH); oH (400 MHz, CDCb) -0.03 (3 H, s, SiCH3), -0.02 (3 H, s, 
SiCH3), 0.80 (9 H, s, SiC(CH3) 3), 1.70 (9 H, s, C02C(CH3)3), 1.79-1.84 (1 H, m, 
CH(H)CHzCO), 2.38-2.43 (1 H, m, CH2CH(H)CO), 2.52-2.62 (1 H, m, CH2CH(H)CO), 
2.80-2.92 (3 H, m, ArCH2CHN and CH(H)CH2CO), 3.67 (2 H, d, J 6.8 Hz, CH20Si), 
4.76-4.83 (I H, m, ArCH2CHN), 5.14-5.20 (1 H, m, NCHAr), 7.23-7.33 (2 H, m, ArH), 
7.42-7.44 (1 H, m, ArH) and 8.03 (1 H, d, J 8.0 Hz, ArH); oc (100 MHz, CDCb) -5.5 
(SiCH3), -5.5 (SiCH3), 18.0 {C), 22.0 (CH2), 25.7 (SiC(CH3) 3), 27.2 (CH2), 28.2 
(COzC(CH3)3), 31.4 (CHz), 47.1 (CH), 54.1 (CH), 62.2 (CHz), 84.3 (C), 113.6 (C), 
115.4 (CH), 118.3 (CH), 122.9 (CH), 124.5 (CH), 129.2 (C), 134.0 (C), 135.8 (C), 
150.0 (CO) and 173.9 (CO); MS (El) m/z 470 [M+, 7.3 %] (M+, 470.2609. 
Cz6H3sN204Si requires 470.2601). 
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(2S,5S,11bR)-2-N,N'-Bis-(3,3-tert-butyl ester)-hydrazino-5-(tert-butyl-dimethyl-
silany loxymethyl)-3-oxo-1,2,3,5,6,11 b-hexahydro-indolizino [8, 7 -b] indole-11-
carboxylic acid tert-butyl ester (112). 
OTBS ~0 
BoJ H ~ 
NBoc 
I 
NHBoc 
n-Butyl lithium (1.67 ml, 4.17 mmol) was added dropwise to a stirred solution of 
diisopropylamine (0.42 mg, 0.58 ml, 4.17 mmol) in anhydrous tetrahydrofuran (15 ml) 
at 0 ·c under nitrogen. The reaction was stirred at 0 ·c for 20 min then cooled to 
-78 ·c. (5S,11bR)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-3-oxo-1,2,3,5,6,11b-hexa 
hydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (111) (1.40 g, 2.98 
mmol) in anhydrous tetrahydrofuran (15 ml) was added dropwise and reaction stirred 
for 20 min at -78 ·c. Di-tert-butyl azodicarboxylate (891 mg, 3.87 mmol) in anhydrous 
tetrahydrofuran (10 ml) was added dropwise at -78 ·c and reaction allowed to warm to 
room temperature overnight. The reaction was quenched with saturated ammonium 
chloride and product was extracted with ethyl acetate (3 x 40 ml). Organic phase was 
then dried over anhydrous magnesium sulfate and solvent removed on the rotary 
evaporator to yield the target compound as a 6:1 mixture of diastereoisomers, which 
were purified by column chromatography using silica gel as absorbent and 7:2 light 
petroleum/ethyl acetate as eluent (1.79 g, 86 %), Mp 74-75 ·c; [a]0 + 78.1 [c = 1.05 in 
CHCh]; Vmax (thin film, CH2Ch)/cm-.1 1708 (NCO), 1732 (CO), 2929 (aliphatic CH) and 
3261 (NH); oH (400 MHz, DMSO, 100 ·c) -0.07 (3 H, s, SiCH3), -0.04 (3 H, s, SiCH3), 
0.58 (9 H, s, SiC(CH3)3), 1.44 (9 H, s, C02C(CH3)3), 1.46 (9 H, s, C02C(CH3)3), 1.67 (9 
H, s, C02C(CH3)3), 2.14-2.28 (1 H, m, CH(H)CHCO), 2.80-2.86 (2 H, m, ArCH2CHN), 
2.90-3.00 (1 H, m, CH(mCHCO), 3.72-3.80 (2 H, m, CH20Si), 4.46-4.56 (1 H, m, 
CH2CHCO), 4.57-4.65 (1 H, m, ArCthCHN), 5.21 (1 H, t, J 6.8 Hz, NCHAr), 7.23 (1 
H, t, J7.6 Hz, ArH), 7.30 (1 H, t, J7.2 Hz, ArH), 7.45 (1 H, d, J7.2 Hz, ArH), 8.01 (1 
H, d, J 8.0 Hz, ArH) and 8.39 (1 H, br, s, NH); oc (100 MHz, DMSO, 100 ·c) -5.27 
(SiCH3), -5.25 (SiCH3), 18.0 (C), 22.2 (CH2), 26.0 (SiC(CH3)3), 28.2 (C02C(CH3)3), 
28.4 (C02C(CH3)3), 28.5 (C02C(CH3)3), 31.0 (Cfh), 48.0 (CH), 52.7 (CH), 60.1 (CH), 
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63.6 (CH2), 80.3 (C), 81.1 (C), 84.9 (C), 113.9 (C), 115.5 (CH), 118.6 (CH), 123.2 
(CH), 124.7 (CH), 129.3 (C), 134.8 (C), 136.2 (C), 149.8 (CO), 154.5 (CO), 156.0 (CO) 
and 169.6 (CO); MS (FAB) mlz 701 [MH+, 7.8 %] (MH+, 701.3936. C36Hs6N40sSi 
requires 70 1.3946). 
(2S,5S,11 bR)-2-N ,N'-Bis-(3,3-tert-butyl ester)-hydrazino-5-hydroxymethyl-3-oxo-
1,2,3,5,6,11 b-hexahydro-indolizino [8, 7-b ]indole-11-carboxylic acid tert-butyl ester 
(113). 
OH ~0 
BoJ H ~ 
NBoc 
I 
NHBoc 
To a solution of the (2S,5S,llbR)-2-N,N-bis-(3,3-tert-butyl ester)-hydrazino-5-(tert-
butyl-dimethyl-silanyloxyrnethyl)-3-oxo-1,2,3,5,6,11b-hexahydro-indolizino[8,7-b] 
indole-11-carboxylic acid tert-butyl ester (112) (1.65 g, 2.35 lnmol) in tettahydrofuran 
( 40 ml) was added tetrabutylammonium fluoride (1 M solution in tetrahydrofuran, 
2.53 ml, 2.59 mmol) and the reaction stirred for 20 min at room temperature. The 
resultant solution was concentrated and chromatographed through a pad of silica gel 
using 3: 1 ethyl acetate/light petroleum as eluent to yield the target compound as a 
yellow solid (994 mg, 72 %), Mp 129-131 ·c; [a]o + 117.6 [c = 1.01 in CHCh]; Vmax 
(thin film, CH2Ch)/cm-1 1704 (NCO), 1732 (CO), 2931 (aliphatic CH), 3261 (NH) and 
3404 (OH); oH (400 MHz, DMSO, 80 ·c) 1.44 (9 H, s, C02C(CH3)3), 1.47 (9 H, s, 
C02C(CH3)3), 1.68 (9 H, s, C02C(CH3)3), 2.14-2.29 (1 H, m, CH(H)CHCO), 2.70-2.78 
(1 H, m, ArCH(H)CHN), 2.86-2.95 (2 H, m, CH(H)CHCO and ArCH(H)CHN), 3.46-
3.58 (2 H, m, CH20H), 4.45-4.60 (3 H, m, ArCH2CHN, CH2CHCO and OH), 5.15 (1 H, 
t, J 6.8 Hz, NCHAr), 7.23-7.27 (1 H, m, ArH), 7.30-7.34 (1 H, m, ArH), 7.48 (1 H, d, 
J 8.0 Hz, ArH), 8.02 (1 H, d, J 8.0 Hz, ArH) and 8.66 (1 H, br, s, NH); oc (100 MHz, 
DMSO, 80 . ·c) 21.9 (CH2), 28.2 (C02C(CH3)3), 28.4 (C02C(CH3)3), 28.5 
(C02C(CH3)3), 30.9 (CH2), 48.6 (CH), 51.9 (CH), 60.4 (CH), 60.4 (CH2), 80.2 (C), 80.9 
(C), 85.0 (C), 113.7 (C), 115.5 (CH), 118.9 (CH), 123.2 (CH), 124.8 (CH), 129.3 (C), 
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134.6 (C), 136.1 (C), 149.8 (CO), 154.5 (CO), 156.0 (CO) and 169.7 (CO); MS (FAB) 
mlz 587 [MH+, 20.1 %] (MH+, 587.3087. C3oH42N40s requires 587.3081). 
(2S,5S, 11 bR)-3-N ,N'-Bis-(3,3-tert-butyl ester)-hydrazino-5-formyl-3-oxo-1,2,3,5,6, 
11b-hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester (114). 
COi: 
Bocl H ~ 
NBoc 
I 
NHBoc 
o-Iodoxybenzoic acid (964 mg, 3.47 mmo1) was added to a solution of(2S,5S,11bR)-2-
N ,N-bis-(3 ,3-tert-butyl ester)-hydrazino-5-hydroxymethyl-3-oxo-1 ,2,3,5,6, 11 b-hexa 
hydro-indolizino[8,7-b]indole-11-carboxy1ic acid tert-butyl ester (113) (678 mg, 
1.16 mmol) in ethyl acetate (30 ml) and the reaction was heated under reflux for 5 h. 
The resulting mixture was cooled to room temperature, filtered through a sinter funnel 
and evaporated to a crude brown residue. The crude product was adsorbed onto silica 
and chromatographed using silica gel as absorbent and 3:1light petroleum/ethyl acetate 
as eluent to isolate the target compound as a yellow solid (633 mg, 94 %), Mp 127-129 
·c; [a]o + 663.3 [c = 1.20 in CHCh]; Ymax (thin film, CH2Clz)/cm-1 1700 (NCO), 1731 
(CO), 2931 (aliphatic CH) and 3279 (NH); oH (400 MHz, DMSO, 80 "C) 1.46 (9 H, s, 
COzC(CH3)3), 1.48 (9 H, s, COzC(CH3)3), 1.68 (9 H; s, C02C(CH3)3), 2.23-2.31 (1 H, 
m, CH(H)CHCO), 2.87 (1 H, ddd, J 2.4, 7.2, 16.4 Hz, ArCH(H)CHN), 2.95-3.02 (1 H, 
m, CH(H)CHCO), 3.33 (1 H, d, J 16.4 Hz, ArCH(lf)CHN), 4.44-4.63 (1 H, m, 
CHzCHCO), 5.22 (1 H, d, J 6.8 Hz, ArCH2CHN), 5.35 (1 H, t, J 8.0Hz, NCHAr), 7.27 
(1 H, dt, J 0.8, 7.6 Hz, ArH), 7.33 (1 H, dt, J 1.2, 7.2 Hz, ArH), 7.54 (1 H, d, J 7.6 Hz, 
ArH), 8.01 (l H, d, J 8.4 Hz, ArH), 8.74 (1 H, br, s, NH) and 9.64 (1 H, s, CHO); oc 
(100 MHz, DMSO, 80 "C) 20.3 (CHz), 28.2 (COzC(CH3)3), 28.4 (COzC(CH3)3), 28.5 
(COzC(CH3)3), 31.1 (CHz), 52.7 (CH), 56.0 (CH), 72.5 (CH), 80.3 (C), 81.1 (C), 85.2 
(C), 113.4 (C), 115.5 (CH), 119.0 (CH), 123.3 (CH), 125.1 (CH), 128.7 (C), 128.7 (C), 
134.6 (C), 149.7 (CO), 149.7 (CO), 149.7 (CO), 170.6 (CO) and 200.1 (CHO); MS 
(FAB) m/z 585.[MH+, 4.2 %] (MH+, 585.2911. C3oH4oN40s requires 585.2924). 
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(2S,5S,11 bR)-2-N ,N'-Bis-(3,3-tert-butyl ester)-hydrazide-3-oxo-1,2,3,5,6,11 b-hexa 
hydro-indolizino[8, 1-b ]indole-5,11-dicarboxylic acid 11-tert-butyl ester (115). 
Cif/oH 
N 'X'NpO 
BoJ H ~ 
NBoc 
. 
NHBoc 
A solution of (2S,5S,11bR)-3-N.N'-bis-(3,3-tert-butyl ester)-hydrazino-5-formyl-3-oxo-
1,2,3,5,6,11b-hexahydro-indolizino[8,7-b]indole-11-carboxylic acid tert-butyl ester 
(114) (5Q4 mg, 1.02 mmol) in acetonitrile (13 ml), tert-butanol (42 ml) and 1-methyl-1- . 
cyclohexene (13 ml) was stirred rapidly as it cooled to 0 ·c. A solution of sodium 
chlorite (884 g, 7.82 mmol) and sodium dihydrogen phosphate (853 g, 7.11 mmol) in 
water (26 ml) was added dropwise over a 10 min period and the reaction stirred at room 
temperature for 17 h. The reaction mixture was added to a solution of saturated 
brine/ethyl acetate (1:1) (50 ml) and product extracted with ethyl acetate (3 x 40 ml). 
Organics were combined and washed with a 1 M solution of sodium hydrosulfite, dried 
over anhydrous magnesium sulfate, filtered and evaporated to a crude brown residue. 
The crude product was adsorbed onto silica and chromatographed using silica gel as 
absorbent and 2:1 light petroleum/ethyl acetate as eluent to produce a yellow solid 
(517 mg, 85 %), Mp 125-126 ·c; [a]0 + 62.1 [c = 1.03 in CHCh]; Vmax (thin film, 
CH2Ch)/cm-1 1698 (NCO), 1737 (CO), 2980 (aliphatic CH), 3288 (NH) and 3409 (OH); 
oH (400 MHz, DMSO, 80 "C) 1.44 (9 H, s, COzC(CH3)3), 1.47 (9 H, s, COzC(CH3)3), 
1.69 (9 H, s, COzC(CH3)3), 2.18-2.32 (1 H, m, CH(H)CHCO), 2.84-2.99 (2 H, m, 
CH(H)CHCO and ArCH(H)CHN), 3.25 (1 H, d, J 16.4 Hz, ArCH(H)CHN), 4.58 (1 H, 
br, s, CHzCHCO), 5.12 (1 H, br, s, ArCH2CHN), 5.49 (1 H, br, s, NCHAr), 7.25 (1 H, t, 
J7.2 Hz, ArH), 7.32 (1 H, t, J7.2 Hz, ArH), 7.49 (1 H, d, J7.2 Hz, ArH), 8.01 (1 H, d, 
J7.2 Hz, ArH) and 8.64 (1 H, br, s, NH); oc (lOO MHz, DMSO, 80 "C) 24.1 (CH2), 28.2 
(COzC(CH3)3), 28.4 (COzC(CH3)3), 28.5 (COzC(CH3)3), 30.5 (CHz), 50.2 (CH), 52.5 
(CH), 60.0 (CH), 80.2 (C), 81.0 (C), 85.0 (C), 113.6 (C), 115.5 (CH), 118.8 (CH), 123.3 
(CH), 124.9 (CH), 128.9 (C), 135.0 (C), 135.9 (C), 149.7 (CO), 154.5 (CO), 156.1 
(CO), 170.0 (CO) and 172.0 (CO); MS (FAB) mlz 601 [MH+, 2.0 %] (MH+, 601.2863. 
C3oH42N409 requires 601.2874). 
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(2S,5S,11 bR, 1 'S)-2-N ,N' -Bis-(3,3-tert-butyl ester)-hydrazide-5-(1-methoxycarbonyl 
-2-phenyl-ethylcarbamoyl)-3-oxo-1,2,3,5,6,11 b-hexahydro-indolizino [8, 7 -b] indole-
11-carboxylic acid tert-:butyl ester (116). 
02 ~fl CO,Mo 
N ')(N'pO 
Bocl H '---\ 
NBoc · 
I 
NHBoc 
(2S,5S,1lbR)-2-N,N-Bis-(3,3-tert-butyl ester)-hydrazide-3-oxo-1 ,2,3,5,6,11 b-hexa 
hydro-indolizino[8, 7 -b ]indole-5, 11-dicarboxylic acid 11-tert-butyl ester (115) ( 429 mg, 
0.714 mmol) was dissolved in anhydrous dichloromethane (5 ml) and cooled to -15 ·c 
under a nitrogen atmosphere. 1-Hydroxyazabenzotriazole (1 07 mg, 0. 786 mmol) and 1-
ethyl-3-[(dimethylamino)propyl]carbodiimide hydrochoride (151 mg, 0.786 mmol) 
were added and reaction stirred for 20 min at -15 ·c. N-methyl morpholine (80 mg, 
0.09 ml, 0.786 mmol) and L-phenylalanine methyl ester hydrochloride (97) (170 mg, 
0.786 mmol) were added and reaction stirred for a further 3 h at -15 ·c. An ice cold 
1 M solution ofHCl (3 ml) was added and reaction extracted with dichloromethane (3 x 
10 ml). The organic phase was washed with saturated sodium bicarbonate, dried over 
anhydrous magnesium sulfate, filtered and solvent removed by rotary evaporation to 
yield a crude orange residue. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 1:1 ethyl acetate/light petroleum as 
eluent to isolate the target compound as a colourless solid (350 mg, 64 %), Mp 130-133 
·c; [a]o + 50.0 [c = 1.44 in CHCh]; Vmax (thin film, CH2Clz)/cm·1 1686 (NCO), 1736 
(CO), 2931 (aliphatic CH) and 3343 (NH); oH (400 MHz, DMSO, 80 "C) 1.47 (9 H, s, 
COzC(CH3)3), 1.48 (9 H, s, COzC(CH3)3), 1.69 (9 H, s, COzC(CH3)3), 2.18-2.26 (1 H, 
m, CH(H)CHCO), 2.75-2.79 (1 H, m, ArCH(H)CHN), 2.96-3.05 (2 H, m, CH(H)CHCO 
and CHCH(H)Ph), 3.17 (1 H, dd, J 5.6, 14.0 Hz, CHCH(H)Ph), 3.37 (1 H, d, J 15.6 Hz, 
ArCH(H)CHN), 3.56 (3 H, s, OCH3), 4.42-4.55 (2 H, m, CHzCHCO and CHCOzCH3), 
5.13 (1 H, d,J6.8 Hz, ArCH2CHN), 5.31-5.37 (1 H, br, m, NCHAr), 7.08-7.16 (5 H, m, 
ArH), 7.25 (1 H, t, J 6.8 Hz, Arl/), 7.32 (1 H, t, J 7.2 Hz, ArH), 7.48 (1 H, d, J 7.6 Hz, 
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ArH), 7.92 (1 H, br, s, NH), 8.01 (1 H, d, J 8.0 Hz, ArH) and 9.05 (1 H, br, s, NH); oc 
(100 MHz, DMSO, 80 "C) 22.3 (CHz), 28.2 (COzC(CH3)3), 28.4 (C02C(CH3)3), 28.5 
(COzC(CH3)3), 31.4 (CHz), 37.4 (CHz), 49.9 (CH), 52.2 (OCH3), 53.1 (CH), 54.6 (CH), 
60.1 (CH), 80.3 (C), 81.4 (C), 85.1 (C), 113.5 (C),·115.5 (CH), 118.9 (CH), 123.3 (CH), 
124.9 (CH), 126.7 (CH), 128.6 (CH), 128.6 (CH), 128.9 (C), 129.1 (CH), 129.1 (CH), 
134.3 (C), 135.9 (C), 137.8 (C), 149.6 (CO), 154.8 (CO), 155.8 (CO), 169.1 (CO), 
170.5 (CO) and 171.8 (CO); MS (FAB) m/z 762 [M+, 3.7 %] (M+, 762.3705. 
C4oHs1NsOJO requires 762.3714). 
3.4.5. The Syn-Pyrrolo[2,1-a]isoquinoline Polypeptide 
(5S,1 ObR)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-1,5,6,1 Ob-tetrahydro-2H-
pyrrolo[2,1-a]isoquinolin-3-one (117). 
OTBS qto 
Imidazole (750 mg, 11.01 mmol), 4-dimethylaminopyridine (1 04 mg, 0.849 mmol) and 
(SS, 1 ObR)-5-(hydroxymethyl)-1 ,2,3,5,6, 1 Ob-hexahydropyrrolo[2, 1-a J isoquino1in-3-one 
(10) (1.84 g, 8.45 mmol) were dissolved in anhydrous dichloromethane (20 ml) under 
nitrogen. To this solution, tert-buty!dimethylsilylchloride (1.60 g, 10.6 mmol) was 
added and the solution was stirred at room temperature for 4 h. The resulting mixture 
was filtered to remove the solid phase and concentrated under reduced pressure. The 
crude product was chromatographed using silica gel as absorbent and 10 % 
methanol/dichloromethane as eluent to isolate the target compound as a blue oil (2.88 g, 
99 %), [a]o + 33.0 [c = 1.12 in CHzCh]; Vmax (thin film, CHzClz)/cm"1 1702 (NCO); OH 
( 400 MHz, CDCh) -0.02 (3 H, s, SiCH3), 0.00 (3 H, s, SiCH3), 0.82 (9 H, s, 
SiC(CH3)3), 1.90-2.00 (1 H, m, CH(H)CH2CO), 2.42-2.49 (1 H, m, CHzCH(lf)CO), 
2.54-2.70 (2 H, m, CH(J:OCH2CO and CH2CH(H)CO), 2.89 (1 H, dd, J 3.2, 16.4 Hz, 
ArCH(H)CHN), 3.02 (1 H, dd, J 6.8, 16.4 Hz, ArCH(H)CHN), 3.65 (1 H, dd, J 5.8, 
10.4 Hz, CH(H)OSi), 3.74 (1 H, dd, J6.2, 10.4 Hz, CH(H)OSi), 4.46-4.51 (1 H, m, 
ArCH2CHN), 4.79 (1 H, t, J 8.0 Hz, NCHAr) and 7.10-7.28 (4 H, m, ArH); oc (100 
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MHz, CDCh) -5.57 (SiCH3), -5.50 (SiCH3), 18.0 (C), 25.7 (SiC(CH3)3), 26.9 (CHz), 
29.3 (CHz), 31.8 (CHz), 48.0 (CH), 54.8 (CH), 62.7 (CHz), 124.2 (CH), 126.5 (CH), 
127.0 (CH), 129.2 (CH), 132.8 {C), 137.1 (C) and 173.7 (CO); MS (El) mlz 331 [M+, 
22.1 %] (M+, 331.1963. C19H29NOzSi requires 331.1968). 
(2S,5S,1 ObR)-2-N ,N'-Bis-(3,3-tert-b utyl ester)-hydrazino-5-(tert-butyl-dimethyl-
silanyloxymethyl)-1,5,6, 1 Ob-tetrahydro-2H-pyrrolo [2,1-a] isoq uinolin-3-one (118). 
ci:s 
NBoc 
I 
NHBoc 
n-Butyl lithium (4.3 ml, 10.6 mmol) was added dropwise to a stirred solution of 
diisopropylamine (1.09 g, 1.51 ml, 10.6 mmol) in anhydrous tetrahydofuran (15 ml) at 
0 ·c under nitrogen. The reaction was stirred at 0 ·c for 15 min then cooled to -78 ·c. 
(SS, 1 ObR)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-1 ,5,6, 1 Ob-tetrahydro-2H-pyrrolo 
[2,1-a]isoquinolin-3-one (117) (2.55 g, 7.68 mmol) in anhydrous tetrahydofuran (20 ml) 
was added dropwise and the reaction stirred for 15 min at -78 ·c. Di-tert-butyl 
azodicarboxylate (2.30 g, 9.98 mmol) in anhydrous tetrahydofuran (15 ml) was then 
added dropwise at -78 ·c and the reaction was allowed to warm to room temperature 
overnight. The reaction was quenched with saturated ammonium chloride and the 
product was extracted with ethyl acetate (3 x 60 ml). The organic phase was then dried 
over anhydrous magnesium sulfate and the solvent removed on the rotary evaporator to 
yield the target compound as a 15:1 mixture of diastereoisomers, which were separated 
by column chromatography using silica gel as absorbent and 2:1 light petroleum/ethyl 
acetate as eluent (3.80 g, 88 %), Mp 70-72 ·c; [a] 0 - 16.3 [c = 1.08 in CHzCh]; Vmax 
(thin film, CH2Clz)/cm·1 1682 (NCO), 1715 (CO) and 3271 (NH); DH (400 MHz, 
DMSO, 100 ·c) 0.01 (3 H, s, SiCH3), 0.02 (3 H, s, SiCH3), 0.85 (9 H, s, SiC(CH3)3), 
1.42 (9 H, s, C02C(CH3)3), 1.45 (9 H, s, COzC(CH3)3), 2.30-2.37 (1 H, m, 
CH(H)CHCO), 2.70-2.76 (1 H, m, CH(lf)CHCO), 2.85-3.01 (2 H, m, ArCH2CHN), 
3.69 (2 H, dd, J 6.8, 10.0 Hz, CH(H)OSi), 3.79 (2 H, dd, J 4.4, 10.0 Hz, CH(H)OSi), 
4.17-4.20 (1 H, m, ArCH2CHN), 4.55 (1 H, dd, J 6.0, 8.4 Hz, CHzCHCO), 4.76 (1 H, t, 
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J 7.2 Hz, NCHAr), 7.18-7.25 (4 H, m, ArH) and 8.34 (1 H, br, s, NH); oc (100 MHz, 
DMSO, 100 ·c) -6.19 (SiCH3), -6.19 (SiCH3), 17.1 {C), 25.1 (SiC(CH3)3), 27.4 
(C02C(CH3)3), 27.5 (C02C(CH3)3), 28.4 (CH2), 28.9 (CH2), 48.2 (CH), 51.9 (CH), 59.0 
(CH), 62.8 (CH2), 79.1 (C), 80.0 (C), 123.2 (CH), 125.7 (CH), 126.2 (CH), 128.1 (CH), 
132.7 (C), 136.7 (C), 153.5 (CO), 155.0 (CO) and 168.1 (CO); MS (FAB) m/z 562 
[MH\ 19.5 %] (MH+, 562.3304. C29H47N306Si requires 562.3312). The 
Stereochemistry at C-2, C-5 and C-11 b was determined by nOe studies. 
(2S,5S,10bR)-2-N,N'-Bis-(3,3-tert-butyl ester)-hydrazino-5-hydroxymethyl-1,5,6, 
1 Ob-tetrahydro-2H-pyrrolo [2,1-a]isoquinolin-3-one (119). 
~0 
NBoc 
I 
NHBoc 
To a solution of (2S,5S, 1 ObR)-2-N ,N-bis-(3,3-tert-butyl ester)-hydrazino-5-{tert-butyl-
dimethyl-silanyloxymethyl)-1 ,5,6,1 Ob-tetrahydro-2H-pyrrolo[2, 1-a ]isoquinolin-3-one 
(118) (1.0 g, 1.78 mmol) in tetrahydrofuran (30 ml) was added tetrabutylammonium 
fluoride (1 M solution in tetrahydrofuran, 1.78 ml, 1.78 Ihmol) and the reaction stirred 
for 5 min at room temperature. The resultant solution was concentrated and 
chromatographed through a pad of silica using 2:1 light petroleum/ethyl acetate as 
eluent to yield the target compound as a yellow solid (319 mg, 40 %), Mp 92-95 ·c; 
[a]o + 16.8 [c = 1.00 in CH2Ch]; Vmax {thin film, CH2Ch)/cm·1 1697 (CO), 1715 (CO), 
2977 (aliphatic CH), 3273 (NH) and 3409 (OH); oH (400 MHz, DMSO, 100 ·q 1.45 
(9 H, s, C02C(CH3)3), 1.46 (9 H, s, C02C(CH3)3), 2.31-2.35 (1 H, m, CH(H)CHCO), 
2.72-2.78 (1 H, m, CH(H)CHCO), 2.85-3.02 (2 H, m, ArCH2CHN), 3.50-3.59 (2 H, m, 
CH20H), 4.15-4.18 (1 H, m, ArCH2CHN), 4.41 (1 H, t, J 6.0 Hz,. OH), 4.53 (1 H, dd, 
J 4.4, 8.4 Hz, CH2CHCO), 4.79 (1 H, t, J 6.8 Hz, NCHAr), 7.18-7.26 (4 H, m, ArH) and 
8.40 (1 H, br, s, NH); oc (100 MHz, DMSO, 100 ·c) 28.4 (C02C(CH3) 3), 28.5 
(C02C(CH3)3), 29.4 (CH2), 30.3 (CH2), 49.9 (CH), 52.7 (CH), 60.4 (CH), 61.7 (CH2), 
80.3 (C), 81.2 (C), 124.3 (CH), 126.8 (CH), 127.3 (CH), 129.4 (CH), 133.8 (C), 137.8 
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(C), 154.6 (CO), 156.0 (CO) and 164.9 (CO); MS (El) m/z 448 [MH+, 4.3 %] (MH+, 
448.2441. Cz3H33N306 requires 448.2449). 
(2S,5S,lObR)-2-N,N'-Bis-(3,3-tert-butyl ester)-hydrazino-3-oxo-1,2,3,5,6,10b-hexa 
hydro-pyrrolo [2,1-a ]isoquinoline-5-carbaldehyde (120) 
0 
~: 
NBoc 
' NHBoc 
o-lodoxybenzoic acid (221 mg, 0.794 mmol) was added to a solution of (2S,5S,10bR)-
2-N ,N-bis-(3,3-tert-butyl ester)-hydrazino-5-hydroxymethyl-1 ,5,6, 1 Ob-tetrahydro-2H-
pyrro1o[2,1-a]isoquino1in-3-one (119) (237 mg, 0.530 mmol) in dimethyl sulfoxide 
(20 ml) and the reaction stirred for 24 h at room temperature. The reaction mixture was 
added to a solution of ethyl acetate/water and product extracted with ethyl acetate (3 x 
30 ml). The organic layer was washed with water (3 x 30 ml), dried over anhydrous 
magnesium sulfate, filtered and evaporated to a crude yellow solid. The crude product 
was adsorbed onto silica and chromatographed using silica gel as absorbent and 1:1 
ethyl acetate/light petroleum as eluent to isolate the target compound as a colourless 
solid (144 mg, 61 %), Mp 84-87 ·c; [a]0 - 8.80 [c = 1.00 in CH2Ch]; Vmax (thin film, 
CH2Clz)/cm·1 1700 (CO), 1700 (CO), 2977 {aliphatic CH) and 3281 (NH); oH . 
(400 MHz, DMSO, 100 "C) 1.46 (18 H, s, 2 x C02C(CH3)3), 2.31-2.38 (1 H, m, 
CH(H)CHCO), 2.83-3.07 (2 H, m, CH(H)CHCO and ArCH(H)CHN), 3.17 (1 H, dd, 
J 4.8, 16.4 Hz, ArCH(H)CHN), 4.65 (1 H, dd, J 3.2, 9.2 Hz, CHzCHCO), 4.72 (1 H, dd, 
J 5.2, 7.6 Hz, ArCH2CHN), 4.89 (1 H, t, J 7.2 Hz, NCHAr), 7.17-7.36 (4 H, m, ArH), 
8.57 (1 H, br, s, NH) and 9.64 (1 H, s, CHO); oc (100 MHz, DMSO, 100 ·c) 26.9 
(CHz), 28.4 (COzC(CH3)3), 28.5 (C02C(CHJ)J), 31.2 (CHz), 53.3 (CH), 56.7 (CH), 60.0 
(CH), 80.4 (C), 81.3 (C), 124.7 (CH), 127.4 (CH), 127.5 (CH), 129.1 (CH), 132.3 (C), 
137.4 (C), 154.5 (CO), 156.0 (CO), 170.0 (CO) and 200.0 (CHO); MS (ES) m/z 446 
[MH+, 100 %] (MH+, 446.2364. C23H31N306 requires 446.2291). 
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(2S,5S,10bR)-2-N,N'-Bis-(3,3-tert-butyl ester)-hydrazino-3-oxo-1,2,3,5,6,10b-hexa 
hydro-pyrrolo[2,1-a]isoquinoline-5-carboxylic acid (121). 
0 
~OH lJ;~o 
NBoc 
I 
NHBoc 
A solution of (2S,5S, 1 ObR)-2-N,N-bis-(3,3-tert-butyl ester)-hydrazino-3-oxo-1 ,2,3,5,6, 
1 Ob-hexahydro-pyrrolo[2, l-a ]isoquinoline-5-carbaldehyde (120) (862 mg, 1.94 mmol) 
in acetonitrile (28 ml), tert-butanol (80 ml) and 1-methyl-1-cyclohexene (28 ml) was 
stirred rapidly as it cooled to 0 ·c. A solution of sodium chlorite (1.68 g, 14.9 mmol) 
and sodium dihydrogen phosphate (1.63 g, 13.5 mmol) in water (55 ml) was added 
dropwise over a 10 min period and the reaction stirred at room temperature for 17 h. 
The reaction mixture was added to a solution of saturated brine/ethyl acetate (1: 1) 
(50 ml) and product extracted with ethyl acetate (3 x 50 ml). Organics were combined 
and washed with a 1 M solution of sodium hydrosulfite, dried over anhydrous 
magnesium sulfate, filtered and evaporated to a crude brown residue. The crude product 
was adsorbed onto silica and chromatographed using silica gel as absorbent and 2:1 
light petroleum/ethyl acetate as eluent to produce a yellow solid (713 mg, 80 %). 
Product still contained impurities which we were unable to remove by chromatography. 
For this reason, the_ intermediate carboxylic acid was reacted crude and purified at a 
later stage. 
(2S,5S,1 ObR,3 'S)-2-N ,N'-Bis-(3,3-tert-butyl ester )-hydrazino-2-[ (3-oxo-1,2,3,5,6, 
10 b-hexahydro-pyrrolo [2,1-a] isoquinoline-5-carbonyl)-amino ]-3-phenyl-propionic 
acid methyl ester (122). 
Experimental 
{) 
0 f_~_ ~"fi C02Me U;~o 
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I 
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(2S,5S, 1 ObR)-2-N ,N-Bis-(3,3-tert-butyl ester)-hydrazino-3-oxo-1 ,2,3,5,6, 1 Ob-hexa 
hydro-pyrrolo[2, 1-a ]isoquinoline-5-carboxylic acid (121) (713 mg, 1.55 mmol) was 
dissolved in anhydrous dichloromethane (30 ml) and cooled to -15 ·c under nitrogen. 
1-Hydroxyazabenzotriazole (231 mg, 1.70 mmol) and 1-ethyl-3-[(dimethylamino) 
propyl]carbodiimide hydrochoride (326 mg, 1.70 mmol) were added and reaction stirred 
for 20 min at -15 ·c. N-methyl morpholine (172 mg, 0.19 ml, 1. 70 mmol) and 
L-phenylalanine methyl ester hydrochloride (97) (366 mg, 1.70 mmol) were added and 
reaction stirred for a further 3 hat -15 ·c. An ice cold solution of 1 M HCl (6 ml) was 
added and reaction extracted with dichloromethane (3 x 30 ml). The organic phase was 
washed with saturated sodium bicarbonate, dried over anhydrous magnesium su1fate, 
filtered and solvent removed by rotary evaporation to yield a crude orange residue. The 
crude product was adsorbed onto silica and chromatographed using silica gel as 
absorbent and 1: 1 ethyl acetate/light petroleum as eluent to isolate the target compound 
as a colourless solid (549 mg, 57%), Mp 89-92 ·c; [a]0 - 28.0 [c = 1.10 in CH2Ch]; 
Vmax (thin film, CH2Ch)/cm·1 1699 (NCO), 1738 (CO), 2977 (aliphatic CH) and 3342 
(NH); oH (400 MHz, DMSO, 100 ·c) 1.48 (18 H, s, 2 x C02C(CH3)3), 2.34 (1 H, ddd, 
J6.0, 10.0, 13.6 Hz, CH(H)CHCO), 2.76-2.82 (1 H, m, CH(lf)CHCO), 2.91-3.05 (2 H, 
m, ArCH(lf)CHN and CHCH(H)Ph), 3.07-3.23 (2 H, m, ArCH(H)CHN and 
CHCH(lf)Ph), 3.60 (3 H, s, OCH3), 4.48 (1 H, dd, J 4.4, 9.6 Hz, CH2CHCO), 4.59-4.64 
(1 H, m, CHC02CH3), 4.67-4.72 (1 H, m, NCHAr), 4.76 (1 H, dd, J 3.6, 7.2 Hz, 
ArCH2CHN), 7.05-7.26 (9 H, m, ArH), 7.75 (1 H, d, J8.0 Hz, NH) and 8.62 (1 H, br, s, 
NH); oc (100 MHz, DMSO, 100 ·q 28.4 (C02C(CH3)3), 28.6 (C02C(CH3)3), 29.8 
(CH2), 30.5 (CH2), 37.4 (CH2), 50.8 (CH), 52.1 (OCH3), 52.9 (CH), 54.1 (CH), 60.9 
(CH), 80.4 (C), 81.5 (C), 124.7 (CH), 126.9 (CH), 126.9 (CH), 127.2 (CH), 128.5 (CH), 
128.5 (CH), 129.0 (CH), 129.3 (CH), 129.3 (CH), 132.7 (C), 137.4 (C), 137.6 (C), 
154.8 (CO), 155.9 (CO), 169.6 (CO), 169.8 (CO) and 171.9 (CO); MS (ES) m/z 623 
[MH\ 100 %] (MH+, 623.3077. C33H42N40s requires 623.3081). 
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3.5. Application Toward the Synthesis of Cephalotaxine 
3.5.1. Stereoselective Synthesis of a Tetracyclic Model System 
Methyl-3-(2-oxocyclopen tyl)-propionate (132). 39 
0 
~CO,Mo 
A solution of cyclopentanone pyrrolidine enamine (131) (4.55 g, 33.2 mmol) and 
methyl acrylate (5.50 g, 63.9 mmol) in dioxane (13 ml) was heated under reflux for 
3.5 h. The addition of water (5 ml) and reflux for a further 30 min was followed by the 
removal of most of the solvent under pressure. The product was extracted with ethyl 
acetate and washed with a 5 % solution of HCl. ·The organic phase was dried over 
anhydrous magnesium sulfate, filtered and evaporated to dryness. The crude product 
was purified by distillation to yield a clear yellow oil (4.50 g, 79 %), Bp 130-132 ·c, 
Lit: Bp 127-130 ·c; Vmax (thin film, CH2Cb)/cm·1 1739 (CO) and 2954 (aliphatic CH); 
oH (400 MHz, CDCh) 1.51-2.45 (11 H, m, 5 x CH2 and CH) and 3.67 (3 H, s, OCH3); 
oc (100 MHz, CDCh) 20.5 (CH2), 24.7 (CHz), 29.4 (CH2), 31.6 (CH2), 37.7 (CH2), 48.1 
(CH), 51.4 (OCH3), 173.5 (CO) and 173.8 (CO); MS (El) m/z 170 [M+, 21.5 %] (M+, 
· 170.0940. C9H1403 requires 170.0943). 
3-(2-0xo-cyclopentyl)-propionic acid (133). 
Methyl 3-(2-oxocyclopentyl)-propionate (132) (3.63 g, 21.3 mmol) was dissolved in a 
mixture of tetrahydrofuran (140 ml) and water (62 ml). Lithium hydroxide (770 mg, 
32.0 mmol) was added and mixture stirred for 20 h at room temperature. The reaction 
mixture was concentrated, re-suspended in water (200 ml) and acidified with a 1 M 
solution of HCI. The aqueous layer was extracted with ethyl acetate (3 x 50 ml), dried 
over anhydrous magnesium sulfate, filtered and evaporated to a yellow oil (3.29 g, 
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99 %); Vmax (thin film, CH2Ch)/cm·1 1734 (CO), 2959 (aliphatic CH) and 3255 (OH); oH 
(400 MHz, CDCh) 1.36-2.40 (11 H, m, 5 x CH2 and CH) and 10.10 (1 H, br, s, OH); oc 
(100 MHz, CDCh) 25.2 (CH2), 25.2 (CHz), 27.3 (CHz), 27.3 (CHz), 31.8 (CH2), 48.4 
(CH), 175.4 (CO) and 221.1 (CO); MS (El) mlz 156 [M+, 30.9 %] (M+, 156.0785. 
CsH1203 requires 156.0787). 
(3S,6aS,l OaR)-3-(3,4-Dimethoxy-benzyl)-hexahydro-1-oxa-3a-aza-cyclopenta [d) 
inden-5-one (134). 
rl~OMo ()o_l ~OMe 
(2S)-2-Amino-3-(3,4-dimethyloxy)phenyl)propan-1-ol (62) (900 mg, 4.26 mmol) and 
3-(2-oxo-cyclopentyl)-propionic acid (133) (798 mg, 5.11 mmol) were dissolved in 
toluene (60 ml) and refluxed under Dean-Stark conditions for 48 h. The reaction was 
allowed to cool to room temperature and solvent removed by rotary evaporation. The 
crude product was adsorbed onto silica and chromatographed using silica gel as 
absorbent and 3 % methanolldichloromethane as eluent to produce the target compound 
as a yellow oil (1.07 g, 76 %), [a]o + 80.8 [c = 1.00 in CHzCh]; Vmax (thin film, 
CHzClz)/cm·1 1648 (NCO) and 2950 (aliphatic CH); oH (400 MHz, CDCh) 1.37-1.46 
(2 H, m, NCCHzCH(H)CHz and NCCHzCH2CH(H)), 1.59-1.66 (2 H, m, 
NCCH(H)CH2CH2 and CHCH(lf)CH2CO), 1.74-1.81 (2 H, m, NCCH(H)CH2CH2 and 
CHCH(H)CHzCO), 1.87-1.90 (1 H, m, NCCH2CH(H)CH2), 2.01-2.15 (2 H, m, 
NCCHzCHzCH(H) and CHCHzCHzCO), 2.34-2.37 (2 H, m, CHCH2CH2CO), 2.66 (1 H, 
dd, J 10.0, 13.4 Hz, ArCH(H)CHN), 3.32 (1 H, dd, J3.6, 13.3 Hz, ArCH(H)CHN), 3.69 
(1 H, dd, J 8.0, 9.1 Hz, ArCH2CHCH(H)O), 3.86 (3 H, s, OCH3), 3.88 (3 H, s, OCH3), 
3.96 (1 H, dd, J 7.8, 9.2 Hz, ArCH2CHCH(H)O), 4.39-4.47 (1 H, m, ArCH2CHN) and 
6.73-6.80 (3 H, m, ArH); oc (100 MHz, CDCh) 21.8 (CHz), 24.9 (CHz), 29.3 (CHz), 
30.6 (CHz), 36.0 (CHz), 38.8 (CHz), 42.1 (CH), 55.9 (OCH3), 55.9 (OCH3), 56.1 (CH), 
67.2 (CHz), 102.0 (C), 111.1 (CH), 112.4 (CH), 121.3 (CH), 129.7 (C), 147.7 (C), 148.9 
(C) and 169.6 (CO); MS (El) m/z 331 [M\ 28.5 %] (M+, 331.1782. C19H2sN04 requires 
331.1784). 
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(SS, 10 bS, 13aS)-5-Hydroxymethyl-8,9-dimethoxy-1,2,5,6, 11,12,13, 13a-octahydro-
cyclopenta[2,3]pyrido[2,1-a ]isoquinolin-3-one (130). 
OH 
(3S, 7 aS, 1 OaR)-3-(3,4-Dimethoxy-benzyl)-hexahydro-1-oxa-3a-aza-cyclopenta[ d]inden-
5-one (134) ( 438 mg, 1.32 mmol) was dissolved in anhydrous dichloromethane (25 ml) 
under nitrogen. The mixture was cooled to -78 ·c and titanium tetrachloride (752 mg, 
0.43 ml, 3.97 mmol) was added dropwise. After stirring at -78 ·c for 10 min, reaction 
was allowing to warm to room temperature and stirred for 48 h. The reaction mixture 
was quenched with saturated ammonium chloride (50 ml), extracted with 
dichloromethane (3 x 50 ml) and dried over anhydrous magnesium sulfate. The product 
was filtered and the solvent removed by rotary evaporation to yield the target compound 
as a single diastereoisomer, which were purified by column chromatography using silica 
gel as absorbent and ethyl acetate as eluent to yield a colourless solid (300 mg, 68 %); 
Mp 138-141 ·c; [a]o- 136.8 [c = 5.00 in CHzCh]; Vrnax (thin film, CH2Ch)/cm"1 1620 
(NCO), 2947 (aliphatic CH) and 3376 (OH); oH (400 MHz, CDCh) 1.70-1.82 (5 H, m, 
NCCHzCHzCH(lf), NCCH2CH2CHz and CHCH2CH2CO), 1.95-2.02 (1 H, m, 
NCCH(H)CH2CH2), 2.14-2.25 (2 H, m, NCCH(fflCH2CHz and NCCHzCHzCH(ffl), 
2.29-2.36 (1 H, m, CHCH2CH(H)CO), 2.52-2.57 (1 H, m, CHCH2CH(fflCO), 2.69-2.80 
(2 H, m, CHCH2CH2CO and ArCH(H)CHN), 3.24 (1 H, dd, J 9.4, 16.2 Hz 
ArCH(H)CHN), 3.71-3.75 (2 H, m, CH20H), 3.87 (3 H, s, OCH3), 3.88 (3 H, s, OCH3), 
4.07-4.13 (1 H, m, ArCH2CHN), 4.72 (1 H, br, s, OH), 6.64 (1 H, s, ArH) and 6.69 
(1 H, s, ArH); oc (100 MHz, CDCh) 22.7 (C1lz), 23.9 (CHz), 30.1 (CHz), 30.2 (CHz), 
-30.4 (CHz), 43.1 (CH), 43.9 (CH2), 55.9 (OCH3), 56.3 (OCH3), 56.5 (CH), 63.7 (CHz), 
72.0 (C), 108.5 (CH), 112.0 (CH), 127.9 (C), 134.0 (C), 147.2 (C), 147.9 (C) and 173.1 
(CO); MS (El) rn/z 331 [M+, 46.5 %] (M+, 331.1782. C19Hz5N04 requires 331.1784). 
The product was recrystallised from dichloromethane/hexane via vapour diffusion to 
produce clear, colourless crystals. Relative stereochemistry was confirmed by single 
crystal X-ray analysis. 
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(2R)-2-Amino-3-(3,4-dimethyloxy)phenyl)propan-1-ol (136). 3 
OH 
M~Om I : 
MeO 0 NH2 
Trimethylsilylchloride (1.54 g, 1.80 ml, 14.2 mmol) was added under nitrogen to a 
solution oflithium borohydride (2.0 M solution in tetrahydrofuran, 3.55 ml, 7.10 mmol) 
over a 2 min period. 3-(3,4-Dimethoxyphenyl)-D-alanine (800 mg, 3.55 mmol) was 
cautiously added to the resultant mixture over a 5 min period and the reaction stirred at 
room temperature for 24 h. Methanol (20 ml) was cautiously added and volatiles were 
removed. by rotary evaporation. The residue was treated with 20% potassium·hydroxide 
solution and extracted with dichloromethane (3 x 20 ml). The organic extracts were 
combined, dried over anhydrous magnesium sulfate, filtered and solvent was evaporated 
under reduced pressure resulting in a colourless crystalline solid (615 mg, 82 %), Mp 
82-83 "C; [a]o + 21.7 [c = 1.27 in EtOH]; Vmax (thin film, CH2Ch)/cm·1 2838 (OCH3), 
2938 (aliphatic CH) and 3385 (OH); oH (400 MHz, CDCh) 2.44 (1 H, dd, J 8.8, 
13.6 Hz, CH(l()CHNH2), 2.62 (3 H, br, s, OH and NH2), 2.73 (1 H, dd, J 4.9, 13.5 Hz, 
CH(H)CHNH2), ~.09-3.13 (1 H, m, CHNH2), 3.42 (1 H, dd, J7.1, 10.6 Hz, CH(l()OH), 
3.63 (1 H, dd, J 3.6, 10.7 Hz, CH(JOOH), 3.87 (3 H, s, OCH3), 3.88 (3 H, s, OCH3), 
6.72-6.75 (2 H, m, ArH) and 6.79-6.81 (1 H, m, ArH); oc (100 MHz, CDCh) 40.5 
(CH2), 54.2 (CH), 55.8 (OCH3), 55.9 (OCH3), 65.9 (CH2), 111.3 (CH), 112.3 (CH), 
121.2 (CH), 131.2 (C), 147.6 (C) and 149.0 (C); MS (El) mlz 211 [M+, 1.2 %] (M+, 
211.1134. CIIH17N03 requires 211.1130). 
(3R,6aR,1 OaS)-3-(3,4-Dimethoxy-benzyl)-hexahydro-1-oxa-3a-aza-cyclopen ta[ d] 
inden-5-one (137). 
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(2R)-2-Amino-3-(3,4-dimethyloxy)phenyl)propan-1-ol (136) (584 mg, 2.77 mmol) and 
3-(2-oxo-cyclopentyl)-propionic acid (133) (518 mg, 3.32 mmol) were dissolved in 
toluene (60 ml) and refluxed under Dean-Stark conditions for 48 h. The reaction was 
allowed to cool to room temperature and solvent removed by rotary evaporation. Crude 
product was adsorbed onto silica and chromatographed using silica gel as absorbent and 
3 % methanol in dichloromethane as eluent to produce a yellow oil (652 mg, 71 %), 
[a]o- 86.3 [c = 1.05 in CH2Ch]; Vmax (thin film, CH2Ch)/cm"1 1651 (NCO) and 2950 
(aliphatic CH); oH (400 MHz, CDCh) 1.37-1.46 (2 H, m, NCCH2CH(H)CH2 and 
NCCH2CH2CH(H)), 1.60-1.66 (2 H, m, NCCH(H)CH2CH2 and CHCH(H)CH2CO), 
1.73-1.80 (2 H, m, NCCH(H)CH2CH2 and CHCH(H)CH2CO), 1.87-1.91 (1 H, m, 
NCCH2CH(H)CH2), 2.01-2.16 (2 H, m, NCCH2CH2CH(H) and CHCH2CH2CO), 2.34-
2.37 (2 H, m, CHCH2CH2CO), 2.67 (1 H, dd, J 10.0, 13.4 Hz, ArCH(H)CHN), 3.31 
(1 H, dd, J 3.6, 13.3 Hz, ArCH(H)CHN), 3.70 (1 H, dd, J 8.0, 9.1 Hz, 
ArCH2CHCH(H)O), 3.86 (3 H, s, OCH3), 3.88 (3 H, s, OCH3), 3.96 (1 H, dd, J 7.8, 
9.2 Hz, ~rCH2CHCH(H)O), 4.39-4.48 (1 H, m, ArCH2CHN) and 6.74-6.81 (3 H, m, 
ArH); oc (lOO MHz, CDCh) 21.9 (CH2), 25.0 (CH2), 29.~ (CH2), 30.6 (CH2), 36.1 
(CH2), 38.8 (CH2), 42.1 (CH), 56.0 (OCH3), 55.9 (OCH3), 56.2 (CH), 67.3 (CH2), 102.1 
(C), 111.2 (CH), 112.5 (CH), 121.3 (CH), 129.7 (C), 147.7 (C), 148.9 (C) and 169.8 
(CO); MS (El) m/z 331 [M+, 28.5 %] (M+, 331.1782. C19H2sN04 requires 331.1784). 
(5R,lObR,13aR)-5-Hydroxymethyl-8,9-dimethoxy-1,2,5,6,11,12,13,13a-octahydro 
cyclopenta[2,3]pyrido[2,1-a]isoquinolin-3-one (138). 
OH 
I MeOXX)'-':: ,,,, 
0 ~''XN~ 
MeO 
(3R, 7aR, 1 OaS)-3-(3,4-Dimethoxy-benzyl)-hexahydro-1-oxa-3a-aza-cyclopenta[ d]inden-
5-one (137) ( 426 mg, 1.29 mmol) was dissolved in dry dichloromethane (25 ml) under 
nitrogen. The mixture was cooled to -78 ·c and titanium tetrachloride (732 mg, 
0.43 ml, 3.86 mmol) was dropwise. After stirring at -78 ·c for 10 min, reaction was 
allowing to warm to room temperature and stirred for 48 h. The reaction mixture was 
quenched with saturated aqueous ammonium chloride (50 ml), extracted with 
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dichloromethane (3 x 50 ml) and dried over anhydrous magnesium sulfate. The product 
was filtered and the solvent removed by rotary evaporation to yield the target compound 
as a single diastereoisomer, which were purified by column chromatography using silica 
gel as absorbent and ethyl acetate as eluent to yield a colourless solid (31 0 mg, 73 % ), 
Mp 138-141 ·c; [a]o + 141.2 [c = 1.01 in CH2Ch]; Vmax (thin film, CH2Ch)/cm-1 1621 
(NCO), 2947 (aliphatic CH) and 3379 (OH); oH (400 MHz, CDCh) 1.70-1.82 (5 H, m, 
NCCH2CH2CH(H), NCCH2CH2CH2 and CHCH2CH2CO), 1.95-2.02 (1 H, m, 
NCCH(H)CH2CH2), 2.14-2.25 (2 H, m, NCCH(H)CH2CH2 and NCCH2CH2CH(H)), 
2.29-2.36 (1 H, m, CHCH2CH(H)CO), 2.52-2.57 (1 H, m, CHCH2CH(H)CO), 2.69-2.80 
(2 H, m, CHCH2CH2CO and ArCH(H)CHN), 3.24 (1 H, dd, J 9.4, 16.2 Hz 
ArCH(H)CHN), 3.71-3.75 (2 H, m, CH20H), 3.87 (3 H, s, OCH3), 3.88 (3 H, s, OCH3), 
4.07-4.13 (1 H, m, ArCH2CHN), 4.72 (1 H, br, s, OH), 6.64 (1 H, s, ArH) and 6.69 
(1 H, s, ArH); oc (100 MHz, CDCh) 22.7 (Cl-h), 23.9 (Cfh), 30.( (CI-12), 30.2 (CI-12), 
30.4 (CH2), 43.1 (CH), 43.9 (CH2), 55.9 (OCH3), 56.3 (OCH3), 56.5 (CH), 63.7 (CI-12), 
72.0 (C), 108.5 (CH), 112.0 (CH), 127.9 (C), 134.0 (C), 147.2 (C), 147.9 (C) and 173.1 
(CO); MS (El) m/z 331 [M+, 46.5 %] (M+, 331.1784. C19H2sN04 requires 331.1784). 
The product was recrystallised from dichloromethane/hexane via vapour diffusion to 
produce clear, colourless crystals. The relative stereochemistry was confirmed by single 
crystal X-ray analysis. 
3.5.2. Synthesis of an Appropriate Keto-Acid Substrate 
3-Methoxy-cyclopent-2-enone (148). 
0 p 
M eO 
A mixture of 1,3-cyclopentanedione (147) (1.0 g, 10.2 mmol), p-toluenesulfonic acid 
(48 mg, 0.255 mmol), methanol (5 ml) and trimethyl orthoformate (1.08 g, 1.12 ml, 
10.2 mmol) was heated under reflux in toluene (30 ml) for 80 min. Solvent was 
removed under pressure and the resultant residue was dissolved in ethyl acetate. The 
organic phase was washed with 10 % sodium hydroxide solution (2 x 30 ml) and 
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saturated brine (30 ml), dried over magnesium sulfate and evaporated to a brown oil 
(822 mg, 72 %); Vmax (thin film, CHzCh)/cm·1 1692 (CO); oH (400 MHz, CDCh) 2.45-
2.48 (2 H, m, CH2CHzCO), 2.61-2.64 (2 H, m, CHzCH2CO), 3.86 (3 H, s, OCH3) and 
5.33 (1 H, t, J 1.2 Hz, C=CHCO); oc (100 MHz, CDCb) 28.3 (CH2), 34.3 (CH2), 58.8 
(OCH3), 104.5 (CH), 191.2 (C) and 205.9 (CO). 
3-(4-Methoxy-2-oxo-cyclopent-3-enyl)-propionic acid methyl ester (149). 
0 
~CO,Mo 
M eO 
n-Butyl lithium (5.90 ml, 14.8 mmol) was added dropwise to a stirred solution of 
' ' 
diisopropylamine (1.50 g, 2.10 ml, 14.8 mmol) in anhydrous tetrahydrofuran (10 ml) at 
0 ·c under nitrogen. The reaction was stirred at 0 ·c for 15 min then cooled to -78 ·c. 
3-Methoxy-cyclopent-2-enone (148) (663 mg, 5.91 mmol) in dry tetrahydrofuran 
(10 ml) was added dropwise and reaction stirred for 15 min at -78 ·c. Methyl-3-
bromopropionate (1.98 g, 1.30 ml, 11.8 mmol) was added dropwise at -78 ·c and the 
reaction allowed to warm to room temperature overnight. The resulting mixture was 
quenched with saturated ammonium chloride and product was extracted with ethyl 
acetate (3 x 40 ml). Organic phases were combined and washed with saturated brine 
( 40 ml) and dried over anhydrous magnesium sulfate. Organic phase was then filtered 
and solvent removed on the rotary evaporator to give the target compound, which was 
purified by column chromatography using silica gel as absorbent and 1: 1 ethyl 
acetate/light petroleum as eluent to yield a colourless oil (257 mg, 22 %), Vmax (thin 
film, CHzCh)/cm·1 1731 (CO); oH ( 400 MHz, CDCb) 1. 73-1.81 (1 H, m, 
CH(H)CHzCOzCH3), 2.05-2.15 (1 H, m, CH(lf)CHzC02CH3), 2.29 (1 H, ddd, J 1.2, 
3.2, 17.6 Hz, C=CHCH(H)), 2.45 (2 H, t, J 7.6 Hz, CHzCH2COzCH3), 2.50-2.55 (1 H, 
m, CHCHzCHzCOzCH3), 2.80 (1 H, ddd, J 1.2, 7.6, 17.6 Hz, C=CHCH(H)), 3.67 (3 H, 
s, OCH3), 3.86 (3 H, s, OCH3) and 5.28 (1 H, t, J 1.2 Hz, HC=COCH3); oc (100 MHz, 
CDCl3) 25.6 (CHz), 30.5 (CH2), 33.8 (CHz), 43.4 (CH), 50.7 (OCH3), 57.8 (OCH3), 
102.6 (HC=C), 172.5 (COCH3), 188.7 (CO) and 205.9 (CO); MS (El) m/z 198 [M\ 
2.0 %] (M+, 198.0891. C10H140 4 requires 198.0892). 
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3-(4-Hydroxy-2-oxo-cyclopent-3-enyl)-propionic acid (150). 
0 
~CO,H 
HO 
Methyl 3-(2-oxocyclopentyl)-propionate (149) (608 mg, 3.07 mmol) was dissolved in a 
mixture of tetrahydrofuran ( 4 ml) and water (2 ml). Lithium hydroxide (322 mg, 
7.67 mmol) was added and mixture stirred for 20 h. The mixture was concentrated, 
re-suspended in water (1 0 ml) and acidified with a 1 M solution of HCI. The aqueous 
layer was extracted with ethyl acetate (3 x 10 ml), dried over anhydrous magnesium 
sulfate, filtered and evaporated to a yellow oil (288 mg, 55 %); Vmax (thin film, 
CHzCh)/cm-1 1732 (CO), 2959 (aliphatic CH) and 3281 (OH); oH (400 MHz, CDCh) 
1.36-2.40 (7 H, m, 3 x CH2 and CH), 6.11 (1 H, t, J 1.4 Hz, HC=COH) and 10.23 (1 H, 
br, s, OH); oc (100 MHz, CDCh) 25.4 (Clh), 31.3 (CHz), 33.8 (CHz), 44.9 (CH), 104.0 
(HC=C), 173.0 (COH), 189.2 (C02H) and 205.9 (CO); MS (FAB) mlz 171 [M+, 19.5 %] 
(M+, 171.0653. C8H100 4 requires 171.0657). 
· 3.5.3. An Alternate Approach Towards a Tetracyclic Diol 
1,4-Dioxa-spiro[4.4]nonane-6,7-diol (162).44 
2-Cyclopenten-1-one ethylene ketal (161) (1.0 g, 0.94 ml, 7.93 mmol) was dissolved in 
ethanol (48 ml) and cooled to -78 ·c. A solution of potassium permanganate (1.25 g, 
7.93 mmol) and magnesium sulfate (1.5 g) in water (48 ml) was added rapidly while 
maintaining the temperature below 0 ·c. The reaction was stirred overnight at room 
temperature then filtered through charcoal. Filtrate was evaporated to a colourless solid, 
which was dissolved in water (3 ml) and extracted with dichloromethane (3 x 50 ml). 
Organic phase was dried over magnesium sulfate, filtered and evaporated to a colourless 
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oil (523 mg, 41 %), Vmax (thin film, neat)/cm-1 2947 (aliphatic CH) and 3363 (OH); OH 
' (400 MHz, CDCI)) 1.73-1.85 (2 H, m, CH2CH(H)COO) and CH(H)CH2COO), 1.91-
2.10 (2 H, m, CH2CH(H)COO) and CH(J-:OCH2COO), 2.46 (1 H, br, s, OH), 2.77 (1 H, 
br, s, OH), 3.78 (1 H, d, J 4.8 Hz, CH(OH)COO), 3.91-4.07 (4 H, m, OCH2CH20) and 
4.10-4.14 (1 H; m, CH(OH)CH(OH)COO); oc (100 MHz, CDCI)) 28.3 (CH2), 31.6 
(CH2), 64.9 (CH2), 65.5 (CH2), 71.4 (CH), 75.9 (CH) and 114.4 (C); MS (FAB) mlz 161 
[MH+, 10.9 %] (MH+, 161.0812. C7H1204 requires 161.0814). 
(6S,7S)-1,4-Dioxa-spiro[4.4]nonane-6,7-diol (162). 
A 500 ml round bottom flask was charged with tert-butyl alcohol (150 ml), water (150 
ml) and AD-mix-13 (60.9 g). Stirring at room temperature produced two clear phases; the 
lower aqueous phase appears bright yellow. Methanesulfonamide (5.79 g, 60.90 mmol) 
was added and the mixture cooled to 0 ·c. 2-Cyclopenten-1-one ethylene ketal (161) 
(5.0 g, 5.10 ml, 60.9 mmol) was added at once and the heterogeneous slurry was stirred 
vigorously at 0 ·c for 25 h. Solid sodium sulfite (36.0 g) was added and the mixture 
warmed to room temperature for 60 min. The reaction was extracted with ethyl acetate 
(3 x 80 ml) and organics washed with 2 M potassium hydroxide. The organic layers 
were combined and dried over magnesium sulfate and concentrated to give the crude 
dial, which was purified by column chromatography using silica gel as absorbent and 
ethyl acetate as eluent to yield a colourless oil (6.62 g, 94 %), [a] 0 + 6.8 [c = 1.12 in 
CH2Ch]; Vmax (thin film, neat)/cm-1 2947 (aliphatic CH) and 3363 (OH); OH (400 MHz, 
CDCl3) 1.70-1.82 (2 H, m, CH2CH(H)COO) and CH(H)CH2COO), 1.88-1.95 (1 H, m, 
CH(H)CH2COO), 2.04-2.12 (1 H, m, CH2CH(H)COO), 3.38 (2 H, br, s, OH), 3.74 (1 H, 
d, J 5.2 Hz, CH(OH)COO), 3.93-4.04 (4 H, m, OCH2CH20) and 4.09-4.13 (1 H, m, 
CH(OH)CH(OH)COO); oc (100 MHz, CDCI)) 28.5 (CH2), 31.8 (CH2), 64.9 (CH2), 
65.6 (CH2), 71.4 (CH), 76.1 (CH) and 114.7 (C); MS (FAB) mlz 161 [MH+, 22.3 %] 
(MH+, 161.0812. C7H 1204 requires 161.0814). 
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6, 7-Isopropylidene-1,4-dioxa-spiro[ 4.4 ]nonane-6, 7 -diol (164). 
oil 
·xO· .. Ao 
O'.J_) 
1,4-Dioxa-spiro[4.4]nonane-6,7-dio1 (162) (1.16 g, 7.23 mmol) was dissolved in neat 
dimethoxypropane (7.53 g, 9.0 ml, 72.3 mmol) and boron trifluoride diethyl etherate 
(103 mg, 0.09 ml, 0.723 mmol) was added. The reaction was stirred for 30 min at room 
temperature then purified by column chromatography using silica gel as absorbent and 
2:1 ethyl acetate/light petroleum as eluent to yield a colourless oil (1.14 g, 79 %), Vmax 
(thin film, neat)/cm-1 2950 (aliphatic CH); oH (400 MHz, CDCh) 1.31 (3 H, s, CH3), 
1.51 (3 H, s, CH3), 1.60-1.64 (1 H, m, CH(H)CHzCOO), 1.70-1.82 (2 H, m, 
CH2CH2COO), 2.07-2.18 (1 H, m, CH(H)CH2COO), 3.91-4.08 (5 H, m, OCH2CH20 
and CH(O)COO) and 4.68-4.70 (1 H, m, CH(O)CH(O)COO); De (100 MHz, CDCh) 
24.0 (CH3), 26.2 (CH3), 28.2 (CHz), 30.4 (CHz), 64.2 (CHz), 65.6 (CHz), 79.2 (CH), 
80.9 (CH), 110.8 (C) and 115.0 (C); MS (El) mlz 200 [M+, 10.7 %] (Nr, 200.1046. 
C10H1604 requires 200.1045). 
Cyclopent-2-enol (166).45 
OH 
0 
At -78 oc, pre-cooled tetrahydrofuran ( 48 ml), diisopropylamine ( 4.81 g, 6.66 ml, 
47.6 mmol) and potassium tert-butoxide (5.34 g, 47.6 mmol) was consecutively added 
to n-Butyl lithium (19.02 ml, 47.6 mmol). After 15 min of vigorous stirring a 
homogeneous solution was obtained, to which cyclopentane oxide (167) (4.0 g, 4.12 ml, 
47.6 mmol) was added. The mixture was allowed to warm to 0 OC and stirred for 
90 min. The volatiles were removed by evaporation and the residue treated with water 
and extracted with hexane (3 x 50 ml). The organics were dried over magnesium sulfate 
and evaporated to an orange oil (3.54 g, 88 %), Vmax (thin film, neat)/cm-1 2952 
(aliphatic CH) and 3388 (OH); DH (400 MHz, CDCh) 1.56 (1 H, br, s, OH), 1.66-1.73 
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(1 H, m, CH2CH(H)CHOH), 2.21-2.32 (2 H, m, CH2CH(H)CHOH and 
CH(H)CH2CHOH), 2.47-2.55 (1 H, m, CH(H)CH2CHOH), 4.88 (1 H, br, d, J 4.8 Hz 
CHOH) and 5.83-5.86 (1 H, m, HC=CHCHOH), 5.98-6.01 (1 H, m, HC=CHCH(OH)); 
oc (100 MHz, CDCh) 31.0 (CH2), 31.2 (CH), 33.3 (CH2), 133.3 (CH) and 135.2 (CH). 
6-0xa-bicyclo[3.l.O]hexan-2-ol (167). 
02) 
Cyclopent-2-enol (168) (1.0 g, 11.9 mmol) was dissolved in anhydrous dichloromethane 
(15 ml). m-Chloroperbenzoic acid (77 %) (3.08 g, 17.8 mmol) was dissolved in 
anhydrous dichloromethane (40 ml) and dried over anhydrous magnesium sulfate. The 
m-chloroperbenzoic acid solution was then added in one portion to the reaction mixture 
and stirred at room temperature for 2 h. The solvent was removed under reduced 
pressure and the crude product was purified by column chromatography using silica gel 
treated with triethylamine as absorbent and 2:1 light petroleum/ethyl acetate as eluent to 
produce a yellow oil (807 mg, 68 %), Vmax (thin film, neat)/cm·1 1067 (CO), 2952 
(aliphatic CH) and 3388 (OH); oH (400 MHz, CDCh) 1.22-1.32 (1 H, m, 
CH2CH(H)CHOH), 1.59-1.70 (1 H, m, CH(H)CH2CHOH), 1.94 (1 H, dt, J 6.4, 
16.4 Hz, CH2CH(H)CHOH), 2.11 (1 H, dd, J 8.0, 14.0 Hz, CH(H)CH2CHOH), 2.30 
(1 H, d, J 7.6 Hz OH), 3.47-3.50 (2 H, m, (Cl/)20) and 4.28 (1 H, dd, J 7.6, 14.8 Hz 
CHOH); oc (100 MHz, CDCh) 25.9 (CH2), 27.0 (CH2)~ 56.2 (CH), 58.9 (CH) and 73.6 
(CHOH). 
2,2-Dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4-ol (168). 
To a stirred solution of 6-oxa-bicyclo[3.1.0]hexan-2-ol (167) (3.40 g, 34.0 mmol) in 
acetone (70 ml), boron trifluoride diethyl etherate (963 mg, 0.83 ml, 6. 78 mmol) was 
added at 0 ·c. After 1 h of stirring, a saturated solution of sodium bicarbonate ( 40 ml) 
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was added and the product extracted with dichloromethane (3 x 40 ml). The combined 
organic layers were dried over anhydrous magnesium sulfate and evaporated to yield the 
crude product, which was purified by column chromatography using silica gel treated 
with triethylamine as absorbent and 3:1 light petroleum/ethyl acetate as eluent to 
produce a colourless oil (4.36 g, 81 %), Vmax (thin film, neat)/cm-1 2936 (aliphatic CH) 
and 3419 (OH); oH (400 MHz, CDCh) 1.30 (3 H, s, CH3), 1.42 (3 H, s, CH3), 1.61-1.65 
(1 H, m, CH(lf)CH2CHOH), 1.69 (1 H, br, s, OH), 1.80-1.89 (1 H, m, 
CHzCH(lf)CHOH), 1.91-2.00 (2 H, m, CHzCH(lf)CHOH and CH(H)CHzCHOH), 4.18 
(1 H, d, J3.6 Hz, CHOH), 4.36 (1 H, dd, J 1.6, 5.6 Hz, CH(O)CHOH) and 4.76 (1 H, t, 
J 5.2 Hz, CH(O)CH(O)CHOH); oc (100 MHz, CDCh) 23.8 (Gh), 26.2 (CH3), 30.0 
(CHz), 30.8 (CHz), 76.6 (CH), 80.4 (CH), 86.6 (CH) and 109.8 (C). 
2,2-Dimethyl-tetrahydro-cyclopenta [1,3] dioxol-4-one (153). 
At 0 ·c, Dess-Martin periodinane (5.41 g, 12.8 mmol) was added to a solution of 
2,2-dimethyl-tetrahydro-cyclopenta[1,3]dioxol-4-ol (168) (1.26 g, 7.97 mmol) in 
dichloromethane (20 ml). The mixture was stirred for 1 hat 0 ·c then stirred for 3 h at 
room temperature. The resulting solution was evaporated to dryness to yield a 
colourless oil, which was purified by column chromatography using silica gel as 
· absorbent and 3:1 light petroleum/ethyl acetate as eluent to produce a colourless oil 
(1.11 g, 90 %), Vmax (thin film, neat)/cm-1 1751 (CO) and 2937 (aliphatic CH); OH (400 
MHz, CDCh) 1.37 (3 H, s, CH3), 1.43 (3 H, s, CH3), 2.01-2.13 (1 H, m, 
CH(H)CHzCO), 2.24-2.33 (2 H, m, CH(H)CHzCO and CHzCH(lf)CO), 2.55-2.65 (1 H, 
m, CH1CH(H)CO), 4.20 (1 H, d, J 5.2 Hz, CH(O)CO) and 4.84 (1 H, t, J 4.8 Hz, 
CH(O)CH(O)CO); oc (100 MHz, CDCh) 23.5 (CHz), 25.0 (CH3), 26.9 (CH3), 33.1 
(CHz), 77.5 (CH), 79.1 (CH), 112.2 (C) and 215.1 (CO). 
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3.5.4. Manipulation of the Keto-ester Test Substrate 
3-(2-Trimethylsilanyloxy-cyclopent-2-enyl)-propionic acid methyl ester (173). 
n-Butyl lithium (2.47 ml, 6.17 mmol) was added dropwise to a stirred solution of 
diisopropylamine (624 mg, 0.87 ml, 6.17 mmol) in anhydrous tetrahydrofuran (10 ml) 
at 0 ·c under nitrogen. The resulting solution was stirred at 0 ·c for 15 min then cooled 
to -78 ·c. Methyl-3-(2-oxocyclopentyl)-propionate (132) (1.0 g, 5.88 mmol) in 
anhydrous tetrahydrofuran (10 ml) was added dropwise and the reaction stirred for 
15 min at -78 ·c. Trimethylsilylchloride (766 mg, 0.90 ml, 7.05 mmol) was added 
dropwise at -78 ·c and the reaction allowed to warm to room temperature over 4 h. The 
volatiles were then removed by evaporation and the resultant residue dissolved in 
chloroform and filtered. Organics were then reduced to dryness to yield the desired 
product as a crude orange oil (1.43 g, 99 %), which was reacted without purification. 
3-(2-0xy-cyclopent-3-enyl)-propionic acid methyl ester (171 ). 
To a solution of palladium (II) acetate (662 mg, 2.95 mmol) and 1,4-benzoquinone 
. . 
(319 mg, 2.95 mmol) in acetonitrile (24 ml), 3-(2-trimethylsilanyloxy-cyclopent-2-
enyl)-propionic acid methyl ester (173) (1.43 g, 5.90 mmol) was added with stirring 
under a nitrogen atmosphere at room temperature. The reaction was stirred for 4 h at 
room temperature and then filtered through a pad of celite and evaporated to yield a 
yellow oil, which was purified by column chromatography using silica gel as absorbent 
and 3:1 light petroleum/ethyl acetate as eluent to produce a yellow oil (386 mg, 39 %), 
Vmax (thin film, neat)/cm·1 1737 (CO) and 2950 (aliphatic CH); OH (400 MHz, CDCh) 
1.72-1.79 (1 H, m, CH(H)CH2C02CH3), 2.05-2.13 (1 H, m, CH(H)CH2C02CH3), 2.33-
2.39. (2 H, m, CHCH2CH2C02CH3 and HC=CHCH(H)), 2.47 (2 H, t, J 7.6 Hz 
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CH2CH2COzCH3), 2.88-2.96 (1 H, m, HC=CHCH(H)), 3.68 (3 H, s, OCH3), 6.19 (1 H, 
dt, J2.0, 5.6 Hz, COCH=CH), 7.70 (1 H, dt, J2.8, 5.6 Hz, COCH=CH); oc (100 MHz, 
CDCh) 24.1 (CHz), 29.4 (CH2), 33.3 (CHz), 41.5 (CH), 49.4 (OCH3), 131.5 (CH), 161.1 
(CH), 171.3 (CO) and 209.3 (CO); MS (FAB) m/z 169 [MH+, 19.8 %] (MH\ 169.0868. 
C9H1203 requires 169.0864). 
3.5.5. Synthesis of a Tetracyclic Olefm via a Diels-Alder Strategy 
2,3,3a,4, 7, 7 a-Hexahydro-4, 7-methano-inden-1-one (179).49 
aP 
H 
To a mixture of 2-cyclopenten-1-one (152) (5.0 g, 5.10 ml, 60.9 mmol) and 
cyclopentadiene (6.03 g, 6.10 ml, 91.4 mmol) in diethyl ether (61 ml) at 0 ·c, was 
added a catalytic amount of boron trifluoride diethyl etherate (3.46 g, 3.00 ml, 
24.4 mmol) over a 5 min period. The reaction mixture was stirred while the cooling bath 
warmed to room temperature then stirred for a further 24 h. Water (60 ml) was added 
and the product was extracted with diethyl ether (3 x 40 ml), washed with saturated 
brine and dried over anhydrous magnesium sulfate. The resulting yellow oil was 
purified by column chromatography using silica gel as absorbent and 2 % ethyl 
acetate/light petroleum as eluent to produce a yellow oil (9.02 g, 99 %), Vmax (thin film, 
neat)/cm·1 1730 (CO) and 2960 (aliphatic CH); oH (400 MHz, CDCh) 1.41-1.44 (1 H, 
m, CHCH(If)CH), 1.48-1.57 (2 H, m, CHCH(If)CH and CH(If)CHzCO), 1.94-2.06 
(2 H, m, CH(H)CH2CO and CH2CH(H)CO), 2.08-2.21 (1 H, m, CHzCH(H)CO), 2.86 
(1 H, ddd, J 1.6, 4.8, 8.8 Hz, CH(CHz)CHCO), 2.93-3.01 (2 H, m, CH(CHz)CHCHz and 
CH(CHz)CHCHz), 3.19-3.22 (1 H, m, CH(CHz),CHCO), 6.12 (1 H, dd, J 2.8, 5.6 Hz, 
C=CHCHCHCO) and 6.23 (1 H, dd, J 2.8, 5.6 Hz, C=CHCHCHCH2); oc (100 MHz, 
CDCh) 22.7 (CH2), 40.6 (CH2), 41.2 (CH), 47.1 (CH), 47.5 (CH), 52.3 (Clh), 54.4 
(CH), 134.8 (CH), 136.2 (CH) and 222.5 (CO); MS (FAB) mlz 148 [M+, 16.0 %] (M+, 
148.0886. C10HI20 requires 148.0888). 
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3-(1-0xo-2,3,3a,4, 7, 7 a-hexahydro-1H-4, 7-methano-inden-2-yl)-propionic acid 
methyl ester (180). 
n-Butyl lithium (2.97 ml, 7.42 mmol) was added dropwise to a stirred solution of 
diisopropylamine (751 mg, 1.05 ml, 7.42 mmol) in anhydrous tetrahydrofuran (20 ml) 
at 0 ·c under nitrogen. The reaction was stirred at 0 ·c for 15 min then cooled to 
-78 ·c. 2,3,3a,4,7,7a-Hexahydro-4,7-methano-inden-1-one (179) (1.00 g, 6.75 mmol) in 
dry tetrahydrofuran (20 ml) was added dropwise and the reaction stirred for 15 min at 
-78 ·c. Methyl-3-bromopropionate (1.35 g, 0.86 ml, 8.10 mmol) was added dropwise at 
-78 ·c and the reaction allowed to warm to room temperature overnight. The resulting 
mixture was quenched with saturated ammonium chloride and product was extracted 
with ethyl acetate (3 x 40 ml). Organic phases were combined and washed with 
saturated brine ( 40 ml) and dried over anhydrous magnesium sulfate. Organic phase was 
then filtered and solvent removed on the rotary evaporator to give the target compound, 
which was purified by column chromatography using silica gel as absorbent and 6 % 
ethyl acetate/light petroleum as eluent to yield a colourless oil (1.03 g, 66 %), Vmax (thin 
film, neat)/cm·1 1732 (CO) and 2950 (aliphatic CH); oH (400 MHz, CDCh) 1.38-1.41 
(1 H, m, CHCH(H)CH), 1.42-1.53 (2 H, m, CHCH(H)CH and CH(H)CH2C02CH3), 
1.58-1.67 (1 H, m, CHCH(H)CHCO), 1.79-1.85 (1 H, m, CHCH(H)CHCO), 1.89-1.97 
(2 H, m, CHCHzCHCO and CH(H)CHzCOzCH3), 2.28-2.32 (2 H, m, CHzCH2COzCH3), 
2.83-2.91 (2 H, m, CH(CHz)CHCHz and CH(CH2)CHCO), 2.99-3.03 (1 H, m, 
CH(CH2)CHCH2), 3.21-3.23 (1 H, m, CH(CH2)CHCO), 3.65 (3 H, s, OCH3), 6.06 (1 H, 
dd, J 3.2, 6.0 Hz, C=CHCHCHCO) and 6.26 (1 H, dd, J 3.2, 6.0 Hz, C=CHCHCHCHz); 
oc (100 MHz, CDCh) 26.0 (CH2), 29.9 (CH2), 31.9 (CH2), 38.9 (CH), 47.5 (CH), 47.8 
(CH), 49.5 (CH), 51.6 (CH), 52.3 (CH2), 54.6 (CH), 135.0 (CH), 136.3 (CH), 173.7 
(CO) and 222.3 (CO); MS (FAB) m/z 235 [MH+, 18.0 %] (MH+, 235.1339. C14H1s03 
requires 235.1334). 
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3-(1-0xo-2,3,3a,4, 7, 7 a-hexahydro-1H-4, 7-methano-inden-2-yl)-propionic acid 
(181). 
H 0 atYC~H 
H 
3-(1-0xo-2,3,3a,4, 7, 7a-hexahydro-1H-4, 7-methano-inden-2-yl)-propionic acid methyl 
ester (180) (5.09 g, 21.7 mmol) was dissolved in a mixture oftetrahydrofuran (147 ml)" 
and water (59 ml). Lithium hydroxide (1.37 g, 32.6 mmol) was added and mixture 
stirred for 90 min at room temperature. The reaction mixture was concentrated, 
re-suspended in water (200 ml) and acidified with a 1 M solution of HCl. The aqueous 
layer was extracted with ethyl acetate (3 x 50 ml), dried over anhydrous magnesium 
sulfate, filtered and evaporated to the target compound as a 1: 1 mixture of inseperable 
diastereoisomers (4.74 g, 99 %), Vmax (thin film, CH2C}z)/cm"1 1718 (CO), 2961 
(aliphatic CH) and 3369 (OH); Diastereoisomer 1; oH (400 MHz, CDCh) 1.39-1.52 
(3 H, m, CHCH2CH and CH(mCHzCOzCH3), 1.55-1.67 (1 H, m, CHCH(H)CHCO), 
1.79-1.85 (1 H, m, CHCH(H)CHCO), 1.80-2.02 (1 H, m, CH(H)CHzCOzCH3), 2.34-
2.46 (3 H, m, CHzCH2COzCH3 and CHCHzCHCO), 2.82-2.92 (2 H, m, 
CH(CHz)CHCHz and CH(CH2)CHCO), 2.99-3.03 (1 H, m, CH(CH2)CHCHz), 3.20-
3.24 (1 H, m, CH(CH2)CHCO), 6.05-6.08 (1 H, m, C=CHCHCHCO} and 6.26 (1 H, dd, 
J 2.8, 5.6 Hz, C=CHCHCHCH2); oc (100 MHz, CDC13) 25.7 (CHz), 30.6 (CHz), 32.0 
(CH2), 38.9 (CH), 47.5 (CH), 47.9 (CH), 51.2 (CH), 52.5 (CH2), 54.6 (CH), 135.0 (CH), 
135.2 (CH), 179.2 (CO) and 222.5 (CO); Diastereoisomer 2; oH (400 MHz, CDCh) 
1.39-1.52 (3 H, m, CHCH2CH and CH(mCHzCOzCH3), 1.55-1.67 (1 H, m, 
CHCH(H)CHCO), 1.79-1.85 (1 H, m, CHCH(H)CHCO), 1.80-2.02 (2 H, m, 
CHCHzCHCO and CH(H)CH2C02CH3), 2.35-2.46 (2 H, m, CHzCH2COzCH3), 2.95-
3.01 (3 H, m, CH(CHz)CHCHz, CH(CHz)CHCO) and CH(CHz)CHCHz), 3.13-3.17 
(1 H, m, CH(CH2)CHCO), 6.05-6.08 (1 H, m, C=CHCHCHCO) and 6.17 (1 H, dd, 
J2.8, 5.6 Hz, C=CHCHCHCH2); oc (100 MHz, CDCh) 23.5 (CHz), 29.9 (CHz), 30.6 
(CH2), 38.6 (CH), 44.4 (CH), 46.0 (CH), 49.4 (CH), 52.2 (CHz), 54.8 (CH), 136.3 (CH), 
137.5 (CH), 179.0 (CO) and 219.0 (CO); MS (FAB) mlz 221 [MH+, 17.9 %] (MH+, 
221.1182. C 13H 1603 requires 221.1178). 
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(3S,6aR, 1 OaS)-3-(3,4-D imethoxy-benzyl)-octahydro-1-oxa-3a-aza-cyclopenta [ d] 
inden-4-one-8,9-bicyclo[2.2.1]hept-2-ene (182). 
(2S)-2-Amino-3-(3,4-dimethyloxy)phenyl)propan-1-ol (62) (1.88 g, 8.91 rnmol) and 
3-(1-oxo-2,3,3a,4, 7, 7a-hexahydro-1H-4, 7-methano-inden-2-yl)-propionic acid (181) 
(1.96 g, .8.91 mmol) were dissolved in toluene (50 ml) and refluxed under Dean-Stark 
conditions for 48 h. The reaction was allowed to cool to room temperature and solvent 
removed by rotary evaporation. The crude product was adsorbed onto silica and 
chromatographed using silica gel as absorbent and 3:2 ethyl acetate/light petroleum as 
eluent to produce the single diastereoisomer as a yellow oil (1.59 g, 45 %), [a]0 - 34.1 
[c = 1.08 in CHCh]; Vma" (thin film, neat)/cm-1 1650 (NCO) and 2956 (aliphatic CH); oH 
(400 MHz, CDCh) 1.38-1.46 (2 H, m, CHCH(H)CH and CH(H)CHCH2CH2CO), 1.56-
1.73 (3 H, m, CHCH(H)CH, CH(H)CHCH2CH2CO and CHCH(H)CH2CO), 1.77-1.85 
(1 H, m, CHCH(H)CH2CO), 2.05-2.09 (1 H, m, CHCH2CH2CO), 2.28-2.37 (1 H, m, 
CHCH2CH(H)CO), 2.54 (1 H, dt, J 5.6, 18.0 Hz, CHCH2CH(H)CO), 2.68-2.77 (3 H, m •. 
NCCHCH(CH2), NCCHCH(CH2) and ArCH(H)CHN), 2.98-3.05 (2 H, m, 
C=CHCH(CH2)CHCH2 and C=CHCH(CH2)CHCH2), 3.41 (1 H, dd, J 4.0, 13.2 Hz, 
ArCH(H)CHN), 3.75 (1 H, dd, J 7.6, 8.8 Hz, ArCH2CHCH(H)O), 3.83-3.88 (4 H, m, 
ArCH2CHCH(lf)O and OCH3), 3.90 (3 H, s, OCH3), 4.56-4.60 (1 H, m, ArCH2CHN), 
6.12 (1 H, dd, J 3.2, 6.0 Hz, C=CHCH(CH2)CHCH2), 6.23 (1 H, dd, J 2.8, 5.6 Hz, 
C=CHCH(CH2)CHCN), 6.81 (2 H, s, ArH) and 6.84 (1 H, s, ArH); oc (100 MHz, 
CDCh) 24.1 (CH2), 30.3 (CH2), 31.8 (CH2), 39.5 (CH2), 44.8 (CH), 45.2 (CH), 46.7 
(CH), 47.2 (CH), 53.8 (CH2), 55.9 (OCH3), 55.9 (OCH3), 56.1 (CH), 57.1 (CH), 67.6 
(CH2), 101.3 (C), 111.2 (CH), 112.2 (CH), 121.1 (CH), 130.0 (C), 133.7 (CH), 137.0· 
(CH), 147.9 (C), 149.1 (C) and 170.1 (CO); MS (FAB) mlz 396 [MH+, 0.4 %] (MH+, 
396.2181. C24H29N04 requires 396.2175). 
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(SS, 10 bR,13aR)-(8,9-dimethoxy-1,2,5,6,13, 13a-hexahydro-cyclopen ta[ e] oxazolo 
[3,2-a]pyrido[2,1-a]isoquinolinylium; tetrafluoro borate (186). 
To a stirred solution of (3S,6aR, 1 OaS)-3-(3,4-dimethoxy-benzyl)-octahydro-1-oxa-3a-
aza-cyclopenta[d]inden-4-one-8,9-bicyclo[2.2.1]hept-2-ene (182) (723 mg, 1.83 rnrnol) 
in anhydrous dichloromethane (15 ml), boron trifluoride diethyl etherate (778 mg, 
0.68 ml, 5.48 rnrnol) was added dropwise at room temperature and the resultant solution 
was heated under reflux. After 15 h, the reaction was cooled to room temperature and 
quenched with a saturated solution of ammonium chloride (15 ml). The product was 
then extracted with dichloromethane (3 x 20 ml), dried over anhydrous magnesium 
sulfate and evaporated to yield the crude product, which was recrystallised from 
dichloromethanelhexane to yield a colourless crystalline solid (664 g, 91 %), Mp 206-
207 ·c; [a]o- 286.3 [c = 1.01 in CHzClz]; Vmax (thin film, CH2Clz)/cm"1 1652 (NCO) 
and 2942 (aliphatic CH); oH (400 MHz, CDCh) 2.01-2.13 (2 H, m, CHCH2CH2CO), 
2.55-2.62 (I H, m, C=CCH(H)CH), 2.81-2.88 (2 H, m, CHCH2CH2CO), 2.98 (1 H, ddt, 
J 2.4, 9.2, 18.0 Hz, C=CHCH(H)CH), 3.17-3.23 (3 H, m, CHCH2CHzCO and 
ArCH2CHN), 3.84 (3 H, s, OCH3), 3.86 (3 H, s, OCH1), 4.78-4.87 (1 H, m, 
ArCHzCHN), 4.95 (1 H, dd, J 4.4, 9.6 Hz, CHCH(H)O+), 5.30 (1 H, dd, J 6.0, 9.2 Hz, 
CHCH(H)O+), 5.87-5.90 (1 H, m, C=CHCAr), 6.15-6.17 (1 H, m, C=CHCHzCH), 6.53 
(1 H, s, ArH) and 6.61 (1 H, s, ArH); oc (100 MHz, CDCh) 20.1 (CH2), 22.1 (CHz), 
33.8 (CHz), 37.3 (CHz), 42.9 (CH), 56.1 (CH), 56.1 (OCH3), 56.2 (OCH3), 74.1 (C), 
77.7 (CHz), 108.3 (CH), 111.6 (CH), 122.9 (C), 128.3 (C), 132.9 (CH), 135.2 (CH), 
148.9 (C), 149.1 (C) and 175.2 (CO); MS (El) m/z 312 [M+, 3.4 %] (M\ 312.1595. 
C19HzzN03 requires 312.1600). The product was recrystallised from dichloromethane/ 
hexane via vapour diffusion to produce clear, colourless crystals. The relative 
stereochemistry was confirmed by single crystal X-ray analysis. 
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( SS,1 0 bR,13aR)-(8,9-Dimethoxy-2,3,5,6,13,13a-hexahydro-1H-cyclopen ta [2,3] · 
pyrido[2,1-a]isoquinolin-5-yl)-methanol (174). 
OH 
(SS, 1 ObR, 13aR)-(8,9-dimethoxy-1 ,2,5,6, 13, 13a-hexahydro-cyclopenta[ e ]oxazolo[3 ,2-a] 
pyrido[2,1-a]isoquinolinylium; tetrafluoro borate (186) (612 mg, 1.53- mmol) was 
dissolved in anhydrous dichloromethane (5 ml) under nitrogen and cooled to 0 ·c in an 
ice bath. Diisobutylaluminium hydride (1 M solution in hexane, 3.83 ml, 3.83 mmol) 
was added dropwise at 0 ·c and the reaction was heated under reflux for 5 h. The 
reaction was then cooled to 0 ·c and methanol (5 ml) followed by saturated ammonium 
chloride (10 ml) was added carefully. Organics were washed with water (5 ml), dried 
over magnesium sulfate and concentrated to give an oily residue, which was purified by 
column chromatography using silica gel as absorbent and 3:2 ethyl acetate/light 
petroleum as eluent to yield a yellow oil (315 mg, 65 %), Vmax (thin film, CH2Ch)/cm"1 
2930 (aliphatic CH) and 3389 (OH); oH (400 MHz, CDCh) 1.42-1.54 (2 H, m, 
CHCH(H)CHzCHzN and CHCH2CH(H)CH2N), 1.70-1.77 (2 H, m, 
CHCH(H)CHzCH2N and CHCH2CH(H)CH2N), 2.14-2.20 (1 H, m, 
CHCHzCHzCH(H)N), 3.32-2.43 (2 H, m, ArCH(H)CHN and C=CCH(H)CH), 2.64-
2.71 (3 H, m, CHCHzCHzCH(H)N, ArCH(H)CHN and C=CCH(H)CH), 2.75-2.82 (1 H, 
m, CHCHzCHzCH2N), 3.40-3.46 (1 H, m, ArCHzCHN), 3.52-3.63 (2 H, m, CH20H), 
3.85 (3 H, s, OCH3), 3.86 (3 H, s, OCH3), 5.89-5.91 (1 H, m, C=CHCAr), 5.94-5.98 (1 
H, m, C=CHCHzCH), 6.58 (1 H, s, ArH) and 6.76 (1 H, s, ArH); oc (100 MHz, CDCh) 
21.3 (CI-{z), 24.0 (CI-Iz), 25.5 (CI-lz), 35.7 (CHz), 38.0 (CH2), 44.0 (CH), 54.9 (CH), 55.8 
(OCH3), 56.0 (OCH3), 60.8 (CHz), 70.6 (C), 109.7 (CH), 111.7 (CH), 126.6 (C), 131.0 
(C), 132.7 (CH), 139.9 (CH), 147.4 (C) and 147.7 (C); MS (FAB) mlz 316 (MH+, 
316.1920. C19HzsN03 requires 316.1913). 
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CHAPTER FOUR: 
APPENDIX 
4.1. X-Ray Crystallography Data 
4.2. Publications 
4.1. X-Ray Cry tallography Data 
(5S,11bR}-5-Hydroxymethyl-1,2,5,6,11,11b-hexahydro-indolizino[8,7-b]indol-3-one 
(21). 
Table 1. Crystal data and structure refinement for (21). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient IJ. 
F(OOO) 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
Appendix 
sma39 
C1 sH16N202 
256.30 
120(2) K 
MoKa, 0.71073 A 
orthorhombic, P212121 
a = 9.5570(7) A 
b = 11. 0909(7) A 
c = 11.5449(5) A 
1223.71(13) fi,_J 
4 
1.391 g/cm3 
0.094 mm- 1 
544 
a = 90° 
colourless, 0.10 x 0.07 x 0.07 mm3 
9900 (8 range 2.91 to 27.10°) 
Bruker -Nonius KappaCCD 
<I> & ro scans 
213 
e range for data collection 
Index ranges 
Completeness to 8 = 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Extinction coefficient 
Largest and mean shift/su 
Largest diff. peak and hole 
3.32 to 27.29° 
h - !I to 12, k -12 to 14, l - 14 to 13 
99.8% 
0% 
11883 
2685 (Rint = 0.1304) 
1866 
semi-empirical from equivalents 
0.9907 and 0.9935 
direct methods 
Full-matrix least-squares on F2 
0.0374, 0.5159 
2685 I 0 I 179 
R1 = 0.0602, wR2 = 0.1147 
R1 = 0.1051, wR2 = 0.1299 
1.039 
-1 (2) 
0.005(2) 
0.002 and 0.000 
0.199 and -0.245 eA - J 
Table 2. Hydrogen bonds for sma39 [A and 0 ]. 
D- H ... A 
0(2)-H(13 ) ... 0( lA) 
N(ll)-H(ll) ... 0(2B) 
d(D-H) 
0.94(4) 
0.94(4) 
Symmetry operations for equivalent atoms 
d(H ... A) 
1.73(4) 
1.95(4) 
A -x+2,y-112,-z+3/2 B -x+l,y+l /2,-z+312 
Appendix 
d(D ... A) 
2.649(3) 
2.842(3) 
<(DHA) 
169(3) 
159(3) 
214 
(2S,SS,11 bS)-11-Beozyl-5-benzyloxymetbyl-2,11 b-dimetbyl-1,2,5,6,11 ,11 b-
hexabydro-iodolizino[8,7-b]iodol-3-ooe (85a). 
0~ 
oV 
Table 1. Crystal data and structure refinement for (85a). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
sma36 
C31H32N20 2 
464.59 
150(2) K 
MoKa, 0.71073 A 
monoclinic, P2 1 
a = 90° a = 10.8211(5) A 
b = 14.7247(7) A 
c = 15.8061(7) A 
2515.1(2) A3 
~ = 92.979(2)0 
Cell volume 
z 
Calculated density 
Absorption coefficient 1-1 
F(OOO) 
Crystal colour and size 
Reflections for cell refinement 
Appendix 
4 
1.227 g/cm3 
0.076 mm- 1 
992 
y = 90° 
colourless, 0.81 x 0.60 x 0.40 mm3 
10772 (8 range 2.34 to 28.32°) 
215 
Data collection method 
e range for data collection 
Index ranges 
Completeness to 8 = 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refmement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Largest and mean shiftlsu 
Largest diff. peak and hole 
Appendix 
Bruker SMART 1000 CCD diffractometer 
eo rotation with narrow frames 
1.88 to 29.03° 
h -13 to 13, k -18 to 19, 1-20 to 20 
99.9 % 
0% 
22419 
11286 (Rint = 0.0155) 
9859 
semi-empirical from equivalents 
0.941 and 0.970 
direct methods 
Full-matrix least-squares on F2 
0.0606, 0.3552 
11286 1 1 1 635 
RI = 0.0422, wR2 = 0.1042 
Rl = 0.0511 , wR2 = 0.1111 
1.050 
0.3(8) 
0.000 and 0.000 
0.505 and -0.216 e A - J 
216 
(2S,SS,ll bS)-11-Benzyi-S-benzyloxymetbyl-2-isopropyl-11 b-methyl-1 ,2,5,6,11, 11 b-
hexahydro-indolizino[8,7-b]indol-3-one (87b). 
0~ 
0 V Cl91 
Table 1. Crystal data and structure refinement for (87b ). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient J..l 
F(OOO) 
Appendix 
sma38 
C33H36Nz0 2 
492.64 
120(2) K 
MoKa, 0.71073 A 
orthorhombic, P212121 
a = 14.6043(4) A 
b = 16.6815(3) A 
c = 10.9921(3) A 
2677.91 (11) A3 
4 
1.222 g/cm3 
0.076 mm-1 
1056 
a = 90° 
f3 = 90° 
y = 90° 
Cl291 
217 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
8 range for data collection 
Index ranges 
Completeness to 8 = 26.50° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr) 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Extinction coefficient 
Largest and mean shiftlsu 
Largest diff. peak and hole 
Appendix 
Colourless, 0.32 x 0.16 x 0.14 mrn3 
24590 (8 range 2.91 to 27.48°) 
EnrafNonius KappaCCD area detector 
phi and omega scans to fill Ewald sphere 
3.05 to 27.48° 
h -18 to 16, k -21 to 19, 1-14 to 14 
99.5% 
0% 
29931 
6109 (Rint = 0.0825) 
5213 
semi-empirical from equivalents 
0.9762 and 0.9895 
direct methods 
Full-matrix least-squares on F2 
0.0235, 0.9331 
6109 1 0 1 338 
R1 = 0.0449, wR2 = 0.0922 
R1 = 0.0573 , wR2 = 0.0975 
1.071 
0.5(12) 
0.0049(7) 
0.000 and 0.000 
0.182 and -0.165 e A-3 
218 
(2R,SS,ll bS)-2,11-Dibenzyl-5-benzyloxymetbyl-11 b-methyl-1,2,5,6,11,11 b-
hexahydro-indolizino[8, 7 -b] indol-3-one (88b ). 
C(18J 
0~ 
0 V Cl91 
Table 1. Crystal data and structure refmement for (88b). 
Identification code 
Chemical formula 
Fonnula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient 1-l 
F(OOO) 
Crystal colour and size 
Appendix 
sma40 
C37H36N20 2 
540.68 
120(2) K 
MoKa, 0.71073 A 
orthorhombic, P2 t2 t2 t 
a = 8.3134(17) A 
b = 16.342(3) A 
c = 21.244(4) A 
2886.2(10) A3 
4 
1.244 g/cm3 
0.077mm- 1 
1152 
a = 90° 
y = 90° 
Colourless, 0.28 x 0.14 x 0.04 mm3 
Cl331 
219 
Reflections for cell refinement 
Data collection method 
8 range for data collection 
Index ranges 
Completeness to 8 = 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Extinction coefficient 
Largest and mean shiftlsu 
Largest diff. peak and hole 
Appendix 
36987 (8 range 2.91 to 27.48°) 
Bruker- onius KappaCCD 
<I> & eo scans 
3.11 to 27.53° 
h -10 to 9, k -21 to 18, l-21 to 27 
97.9% 
0% 
23603 
6242 (Rint = 0.1235) 
3721 
semi-empirical from equivalents 
0.9789 and 0.9969 
direct methods 
Full-matrix least-squares on F2 
0.0397, 1.4907 
6242 10 1372 
Rl = 0.0811 , wR2 = 0.1343 
Rl = 0.1533, wR2 = 0.1550 
1.045 
-1(2) 
0.0059(8) 
0.000 and 0.000 
0.215 and -0.186 e A-3 
220 
( SS,l ObS,13aS)-5-Byd roxy methyl-8,9-dim eth oxy-1,2,5,6,11,12,13,13a-octa hydro-
cyclopenta[2,3] pyrido[2,1-a] isoquinolin-3-one (130). 
OH 
M eO 
M eO 
Table 1. Crystal data and structure refinement for (130). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient 1..1. 
F(OOO) 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
Appendix 
sma51 
C2oll21Cl2~()4 
416.33 
150(2) K 
MoKa, 0. 71073 A 
monoclinic, p21 
a = 7.5974(6) A 
b = 8.9918(7) A J3 = 94.5680(10)0 
c = 14.6880(12) A 
1000.21(14) A3 
2 
1.382 g/cm3 
0.350mm- 1 
440 
y = 900 
colourless, 1.51 x 0.30 x 0.11 mm3 
6175 ce range 5.317 to 56.455°) 
Bruker SMART 1000 CCD diffractometer 
eo rotation with narrow frames 
221 
8 range for data collection 
Index ranges 
Completeness to 8 = 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Largest and mean shiftlsu 
Largest diff. peak and hole 
2.66 to 28 .79° 
h -9 to 9, k -11 to 1 l , I - 19 to 19 
100.0% 
0% 
8843 
4570 (Rim= 0.0147) 
4298 
semi-empirical from equivalents 
0.620 and 0.963 
direct methods 
Full-matrix least-squares on F2 
0.0507, 0.2973 
4570 I 1 I 249 
R1 = 0.0347, wR2 = 0.0884 
R1 = 0.0375, wR2 = 0.0908 
1.036 
-0.03(5) 
0.001 and 0.000 
0.255 and -0.275 e A-3 
Table 2. Hydrogen bonds for sma51 [A and 0 ). 
D-H ... A 
0(2)-H(2) .. . 0(1A) 
d(D- H) 
0.82(3) 
Symmetry operations for equivalent atoms 
A -x,y-112,-z+ 1 
Appendix 
d(H ... A) 
1.90(3) 
d(D ... A) <(DHA) 
2.7171(19) 172(3) 
222 
(5R,10bR,13aR)-5-Bydroxymethyl-8,9-dimethoxy-1,2,5,6,11,12,13,13a-octahydro 
cyclopenta[2,3]pyrido[2,1-a]isoquinolin-3-one (138). 
OH 
I MeO~,,·' O 
Mo0~?9 
ctSJ 
Table 1. Crystal data and structure refinement for (138). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient J..l. 
F(OOO) 
sma52 
C19.33H2s.67Clo.6?N04 
359.71 
150(2) K 
MoKa., 0.71073 A 
monoclinic, P2I 
a = 1 1.0731(9) A 
b = 9.0461(7) A 
c = 27.116(2) A 
2700.0(4) A3 
6 
1.327 g/cm3 
0.187 mm- 1 
1152 
a. = 90° 
p = 96.247(2)0 
y = 900 
Colourless, 0.42 x 0.11 x 0.03 mrn3 
3981 (8 range 4.516 to 52.827°) 
DIU 
Crystal colour and size 
Reflections for cell refinement 
Data collection method Bruker SMART 1000 CCD diffractometer 
Appendix 223 
8 range for data collection 
Index ranges 
Completeness to 8 = 26.00° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Absolute structure parameter 
Extinction coefficient 
Largest and mean shiftlsu 
Largest diff. peak and hole 
w rotation with narrow fram s 
1.85 to 28.64° 
h - 14 to 14, k -12 to 11 , l - 3 4 to 3 3 
100.0 % 
0% 
23177 
11816 (Rint = 0.0655) 
5847 
semi-empirical from equivalents 
0.9257 and 0.9944 
direct methods 
Full-matrix least-squares on F2 
0.0479, 0.0299 
11816 1 1 1 687 
R1 = 0.0565, wR2 = 0.1022 
R1 = 0.1595, wR2 = 0.1368 
0.988 
0.01(8) 
0.0040(5) 
0.000 and 0.000 
0.282 and -0.350 e A-3 
Table 2. Hydrogen bonds for sma52 [A and 0 ]. 
D-H .. . A 
0(2)-H(2) ... 0(5) 
0(6)-H(6) ... 0(1A) 
0(1 O)-H(10A) ... 0(9B) 
d(D-H) 
0.84 
0.84 
0.84 
Symmetry operations for equivalent atoms 
A x,y-1 ,z B - x+2,y+ l l2,-z+2 
Appendix 
d(H ... A) 
1.88 
1.88 
1.90 
d(D ... A) 
2.716(4) 
2.700(4) 
2.703(4) 
<(DHA) 
172.6 
165.9 
159.5 
224 
(5S,1 ObR,13aR)-(8,9-di metb oxy-1 ,2,5,6,13,13a-bexabyd ro-cyclopenta [ e] oxazolo 
[3,2-a]pyrido[2,1-a)isoquinolinylium; tetrafluoro borate (186). 
MeO:o.:g~ + O _ 
~ _ BF4 
MeO ,,'' 
~-j 
Table 1. Crystal data and structure refinement for (186). 
Identification code 
Chemical formula 
Formula weight 
Temperature 
Radiation, wavelength 
Crystal system, space group 
Unit cell parameters 
Cell volume 
z 
Calculated density 
Absorption coefficient 1..1. 
F(OOO) 
Crystal colour and size 
Reflections for cell refinement 
Data collection method 
Appendix 
smadl3 
C 19H22BF4N03 
399.19 
150(2) K 
synchrotron, 0.6904 A 
orthorhombic, P212121 
a = 7.3197(5)A 
b = 9.0804(6) A 
c = 28.5357(18) A 
1896.6(2) A3 
4 
1.398 g/cm3 
0.119 mm- 1 
832 
a. = 90° 
y= 900 
colourless, 0.19 x 0.05 x 0.05 mm3 
6221 ce range 4.05 to 30.77°) 
Bruker APEX 2 CCD diffractometer 
Fl" 
225 
e range for data collection 
Index ranges 
Completeness to 8 = 27.50° 
Intensity decay 
Reflections collected 
Independent reflections 
Reflections with F2>2cr 
Absorption correction 
Min. and max. transmission 
Structure solution 
Refinement method 
Weighting parameters a, b 
Data I restraints I parameters 
Final R indices [F2>2cr] 
R indices (all data) 
Goodness-of-fit on F2 
Largest and mean shiftlsu 
Largest diff. peak and hole 
Appendix 
eo rotation with narrow frames 
4.05 to 27.50° 
h -7 to 9, k -12 to 11, I - 3 3 to 3 8 
97.6% 
11 % 
12211 
2672 (Rint = 0.0645) 
2489 
semi-empirical from equivalents 
0.978 and 0.994 
direct methods 
Full-matrix least-squares on F2 
0.1086, 0.0340 
2672 I 0 I 255 
R1 = 0.0524, wR2 = 0.1483 
Rl = 0.0549, wR2 = 0.1519 
1.113 
0.001 and 0.000 
0.389 and -0.365 eA -J 
226 
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A new asymmetric synthesis of the natural enantiomer of the 
indolizidino[8, 7 -h]indole alkaloid ( + )-harmicine 
Steven M. Allin,a•* Sean N. Gaskell,a Mark R. J. Elsegooda and William P. Martinb 
a Department of Chemistry, Loughborough University, Loughborough, Leicestershire LEJJ 3TU, UK 
bSynthetic Chemistry, GlaxoSmithKline Pharmaceuticals, Gunnels Wood Road, Stevenage, Herts SGJ 2NY, UK 
Received 22 March 2007; revised I June 2007; accepted 6 June 2007 
Available online 9 June 2007 
Abstract-We report a novel, facile and asymmetric approach for the synthesis of the indole alkaloid (+)-harmicine via a highly 
diastereoselective N-acyliminium cyclization reaction as a key synthetic step, and verify the relative stereochemistry of the key syn-
thetic intermediate in this approach through X-ray crystallography. 
Crown Copyright © 2007 Published by Elsevier Ltd. All rights reserved. 
Leishmaniasis, a disease spread by the bite of the sand 
fly, is found in tropical and sub-tropical regions, affect-
ing some 12 million people in 88 countries. Symptoms 
of this disease vary from skin sores to fever, anaemia 
and damage to the spleen and liver. Common therapies 
have included the use of antimony-containing drugs, 
although less toxic treatments are currently in develop-
ment. 1 Screening of the leaf extract of the Malaysian 
plant Kopsia griffithii by Kam and Sim showed strong 
anti-leishmania activity that was traced back to the frac-
tion containing the indolizidino[8,7-b]indole alkaloid, 
( +)-harmicine, 1.2 
~ '~-\J\ .... xk_, 
H H. \._j 
(+)-Harmicine, 1 
(+)-Harmicine has previously been prepared in racemic 
form by Knolker and Agarwal,3 and asymmetric routes 
to (S)-ent-harmicine have been achieved by Ohsawa and 
eo-workers, who were also able to establish that the 
absolute configuration of the naturally occurring com-
pound was R.4 Our research group has had considerable 
success in the development of asymmetric routes to sev-
eral important heterocyclic templates over recent years, 
based around the development of a highly diastereo-
selective N-acyliminium cyclization strategy.5 Our recent 
applications of this methodology in natural product syn-
*Corresponding author. E-mail: S.M.Allin@lboro.ac.uk 
thesis has included targets from the erythrina group of 
alkaloids, sr,i and several indole alkaloids, including dep-
lancheine. sa,d.e,g In this Letter we report the successful 
application of our N-acyliminium strategy in a new 
asymmetric synthesis of (R)-(+)-harmicine, 1, the 
naturally occurring enantiomer. 
Our approach to (+)-harmicine began with the synthesis 
of imide 2, prepared from the ~-amino alcohol deriva-
tive of (S)-tryptophan. Subjecting imide 2 to sodium 
borohydride reduction, as described in Scheme 1, 
resulted in a direct and highly diastereoselective cycliza-
tion to give the indolizidino[8, 7-b ]indole derivative 3 as a 
9:1 mixture of diastereoisomers in 43% yield (Scheme 1). 
The major isomer was isolated by recrystallization from 
ethanol and its relative stereochemistry was confirmed 
by X-ray crystallographic analysis6 (Scheme 1 ). Presum-
ably, under the acidic reaction conditions, the electron-
rich indole moiety is able to cyclize onto the N-acylimin-
ium intermediate that is generated in situ. 
The stereochemical outcome of the reaction can be 
rationalized based on models previously proposed by 
our group for similar types of substrates.5k The high 
degree of stereocontrol arises from a preferred confor-
mation, shown in Scheme I, having minimal A0 ·3> strain 
between the H-atom at the stereogenic centre of the 
tryptophanol moiety and the Jactam carbonyl group in 
the transition state. 
To complete the synthesis of (+)-harmicine we were 
required to remove the hydroxymethyl auxiliary group 
0040-4039/$ - see front matter Crown Copyright © 2007 Published by Elsevier Ltd. All rights reserved. 
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Scheme 2. Reagents and conditions: (i) IBX, DMSO, rt, 24 h (72%); (ii) Et3N, (Boc)20, DMAP, THF, rt, 4 h (73%); (iii) NaCI02, NaH2PO •• 
CH3CN, t-BuOH, cyclohexene, 0 octo rt, 18 h (79%); (iv) (PhSeh, PBu3, CH2CI2, 0 octo rt, 18 h (66%); (v) n-Bu3SnH, AIBN, toluene, 1\,2 h (90%); 
(vi) TBAF, THF, 1\, 2 h then at rt, 9 h (69%); (vii) LiAIH4 , THF, 1\, 3 h (80"/o). 
from compound 3. Previous methods applied within our 
group to remove the hydroxymethyl 'auxiliary' substitu-
ent from other heterocyclic templates have involved a 
rhodium-induced decarbonylation sequence.5r Due to 
the rather long reaction times generally needed for sub-
strates in this decarbonylation protocol we have now 
applied a more facile approach that relies upon a 
decarboxylation strategy (Scheme 2), used successfully 
by our group in recent natural product syntheses. Sa,d,e 
Compound 3 was oxidized to the carboxylic acid deriva-
tive 4 through the corresponding aldehyde; from 4 we 
generated the acyl selenide derivative and subsequently 
performed a tin-mediated deacylation to yield the core 
indolizidino[8, 7 -b ]indole ring system 5. Deprotection of 
the indole nitrogen gave 6, from which reductive 
removal of the lactam carbonyl group completed the 
synthesis of the natural product, 1, (R)-(+)-harmicine, 
in 80% yield by LAH reduction in THF (Scheme 2). 
The optical rotation of our target compound, (R)-(+)-1, 
was determined to be +118.2 (c 1.6, CHCh) and was 
comparable to that reported by Kam and Sim for the 
isolated natural product[+ 119; (c 0.086, CHC13)].2 
In summary we have reported a new and highly stereo-
selective synthesis of the indolizidino[8, 7-b ]indole 
Appendix 
alkaloid (R)-(+)-harmicine from a readily available, 
enantiomerically pure imide substrate.? Following 
acceptance of this Letter, our attention was brought 
to a recent asymmetric synthesis of (+)-harmicine by 
Czarnocki and Drabowicz that gave the natural product 
in 79% ee.8 
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6. Crystallographic data (excluding structure factors) for 
structure 3 (R = 0.0464) have been deposited with the 
Cambridge Crystallographic Data Centre as supplementary 
publication no. CCDC 641155. Copies of the data can be 
obtained, free of charge, on application to CCDC, 12 
Union Road, Cambridge CB2 IEZ, UK (fax: +44 (0)1223 
336033 or e-mail: deposit@ccdc.cam.ac.uk). 
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4 steps M eO~ A) ... )(.N.) 
MeO H' \_j 
(R)-(+)-Crispine A 
We report a novel, facile, and asymmetric approach for the 
synthesis of the anti-tumor alkaloid {+)-crispine A via a 
highly diastereoselective N-acyliminium cyclization reaction 
as a key synthetic step. 
The pyrroloisoquinoline alkaloid (+)-crispine A, 1, isolated 
in 2002 from Clathrus crispus by Zhao and eo-workers, shows 
important biological activity against SKOV3, KB, and HeLa 
human cancer celllines.1 To date, syntheses of racemic crispine 
A have been achieved by Knolker and Agarwal,2 Meyer and 
Opatz,3 and more recently, by King.4 The first enantioselective 
synthesis of this alkaloid was reported by Czarnocki and eo-
workers on the basis of the use of asymmetric transfer 
hydrogenation as a key synthetic step.5 
MeO~ ;J ... :;(N') 
MeO H' \_} 
Crispine A, 1 
Our own group has had considerable success in the develop-
ment of asymmetric routes to several important heterocyclic 
templates, including the pyrroloisoquinoline system.6 There has 
t Department of Chemistry, Loughborough University. 
I Department of Chemical Engineering, Loughborough University. 
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been considerable interest in the synthesis of the pyrroloiso-
quinoline core over recent years, with many approaches involv-
ing N-acyliminium chemistry in the key ring-forming step, of 
which several have also addressed the important question of 
stereocontrol in the cyclization.7 In this current paper, we report 
the successful application of our own N-acyliminium strategy 
in an efficient new asymmetric synthesis of ( + )-crispine A, 1. 
Our approach to crispine A began with the synthesis of imide 
2, prepared as previously reported from (2S)-2-amino-3-(3,4-
dimethoxyphenyl)propan-I-ol and succinic anhydride.6 Subject-
ing imide 2 to sodium borohydride reduction, as described in 
Scheme I, resulted in direct and highly diastereoselective 
cyclization to give tricyclic lactam 3 as a single diastereoisomer 
(as determined by 400 MHz 1H NMR spectroscopy), in excellent 
yield (91 %). Presumably, under the acidic reaction conditions, 
the electron-rich methoxy-substituted aryl ring is able to cyclize 
onto the N-acyliminium intermediate that is generated in situ. 
We have been able to confirm the relative stereochemistry of 
this advanced intermediate by single-crystal X-ray analysis.6b 
The relative stereochemistry observed in product 3 is as expected 
on the basis of the conformational models previously proposed 
by our group to rationalize such highly diastereoselective 
cyclization reactions onto N-acyliminium intermediates.6 
Our completion of the total synthesis of crispine A required 
us to remove the hydroxymethyl auxiliary group, and to this 
end, we have investigated two alternative procedures. The most 
direct route to achieve this transformation would be the 
application of a method originally developed by Kraft, 8 and more 
recently applied by Martin,9 involving a Raney nickel induced 
decarbonylative removal of the hydroxymethyl functionality. 
Martin has successfully applied this methodology in the 
synthesis of pumiliotoxin 251D from an advanced bicyclic 
lactam intermediate.9 According to Kraft, primary alcohols 
undergo oxidation to aldehydes and are then subsequently 
decarbonylated when treated with Ra-Ni in refluxing toluene.8 
The quality of the Raney nickel used in this approach is known 
to be a critical factor in its success. In our hands, the Ra-Ni 
induced removal of the hydroxymethyl substituent from inter-
mediate 3 proceeded smoothly as reported, and in an excellent 
yield of 98%, to give the corresponding lactam, 4. Reductive 
(6) (a) Allin, S. M.; James, S. L.; Martin, W. P.; Smith, T. A. D. 
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removal of the lactam carbonyl group was achieved using LAH 
in THF, thus completing the synthesis of crispine A (Scheme 
2). In the recent enantioselective synthesis of this alkaloid, 
reported by Czamocki and Drabowicz,5 the enantiomeric excess 
of the alkaloid was determined by NMR spectroscopic methods 
using (R)-( + )-tert-butylphenylphosphinothiolic acid as a chiral 
additive. This research team were kind enough to furnish us 
with an amount of this chiral reagent for use in our own studies, 
and the detenninations of product ee described in this paper 
are thus based on an identical NMR spectroscopic procedure. 
Use of this thioacid as a chiral shift reagent allowed the 
determination of the ee of our product, which was shown to 
have a disappointingly low value of 50% ee. The diagnostic 
signal in the 1H NMR spectrum used in the determination is 
the aromatic C(IO) proton which, in the presence of the chiral 
shift reagent, shows distinct, well-separated singlet peaks for 
the enantiomers at 6.39 and 6.22 ppm. In our case, although 
the level of product ee was moderate, the major enantiomer 
was confirmed to be the desired (R)-crispine A, as expected. 
Although the use of Ra-Ni (W2) for removal of the hydroxy-
methyl group allows for rapid and relatively high-yielding access 
to crispine A, in only three synthetic steps from imide 2, 
epimerization of the benzylic stereocentre was occurring at some 
point in the two-step sequence shown in Scheme 2 and thus 
compromising the enantiomeric purity of the final product. 
As an alternative approach, we chose to reverse the order of 
synthetic transformations and first removed the lactam carbonyl 
Appendix 
using LAH to yield amine 5, followed by the Ra-Ni reaction. 
Unfortunately we were unable to achieve the removal of the 
hydroxymethyl group by following this alternative scheme of 
events, observing only decomposition of amine 5. 
As noted above, the literature precedent for the use of Ra-Ni 
is suggestive of an initial oxidation of the hydroxymethyl group 
to an aldehyde intermediate before subsequent decarbonylation. 8 
Based on this proposed mechanism, we decided to investigate 
the use of the aldehyde derivative 6 as a substrate for the Ra-
Ni reaction, reasoning that the aldehyde may undergo direct 
dccarbonylation. In our hands, however, compound 6 was simply 
reduced back to the hydroxymethylated substrate 3 under the 
usual reaction conditions. Since lactam removal to access 5 
proceeded without affecting the diastereoisomer ratio (i.e., 5 
was obtained as a single diastereoisomer), we propose that 
racemization of substrate 3 is taking place during the Ra-Ni 
procedure (step i, Scheme 2). 
This issue was ultimately overcome through the application 
of a Rh-induced decarbonylation sequence previously applied 
by us in our work on the Et:vthrina alkaloid scries.1° Compound 
3 was oxidized to aldehyde 6 in good yield using IBX in ethyl 
acetate, followed by Rh-induced decarbonylation using our 
previously developed procedure. 10 Amide 4 was again trans-
(10) Allin, S. M.; James, S. L.; Elscgood, M. R. J.; Martin, W. P. J. 
Org. Chem. 2002, 67, 9464-9467. Allin, S. M.; Streetley, G. B.; Slater, 
M.; Jamcs, S. L.; Martin, W. P. Tetrahedron Lett. 2004, 45, 5493-5496. 
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fonned into the target, (R)-(+)-crispine A, I, in 58% yield by 
LAH reduction in THF (Scheme 3). 
Compound 1, obtained as detailed in Scheme 3, was shown 
to have an cc of 95% by using the 1H NMR chiral shift 
experiment described above. The optical rotation of our product 
was detennined to be +95.2 (c 1.5, MeOH) and was comparable 
to that reported by Zhao and eo-workers for the natural product 
isolate [+91.0 (McOH)].I Czarnocki and Drabowicz observed 
a rotation of+ 100.4 (c 1) using chlorofonn as solvent, due to 
apparent problems of dissolution when using methanoJ.S 
In summary, we report a new, efficient, and highly stereo-
selective synthesis of the anti-tumor alkaloid (+)-crispine A in 
four synthetic steps from a readily available enantiomcrically 
pure imide substratc 2 in an overall yield of 24%. 
Experimental Section 
1 -(2S)-[2-(3,4-Dimethoxyphenyl)-1-hydroxymethylethyl)pyr-
rolidine-2,5-dione, 2. Succinic anhydride (2.56 g, 25.60 mmol) 
and (2S)-2-amino-3-(3,4-dimethyloxy )phenyl)propan-1-ol ( 4. 92, 
23.27 mmol) were stirred in toluene (100 mL) under an atmosphere 
of nitrogen. Triethylamine (4 mL) was added to the resultant 
solution and the mixture heated at reflux for 18 h. After 18 h, the 
reaction was cooled to room temperature and solvent removed by 
rotary evaporator to yield a yellow oil. The cmde product was 
adsorbcd onto silica gel and chromatographed using silica gel as 
absorbent and ethyl acetate as eluent to produce a colorless solid 
(4.87 g, 71%): mp 124-125 °C; [o.]0 -73.2 (c = 1.01 in CH2-
Ch); Vmax (thin film, CHzCh)/cm-1 1700 (CO), 2938 (aliphatic CH) 
and 3447 (OH); on (400 MHz, CDC13) 2.51-2.61 (4 H, m, 
COCH2CH2CO), 2.95-3.10 (2 H, m, ArCH2CHN), 3.79-3.85 (1 
H, m, CH(H)OH), 3.83 (3 H, s, OCH3), 3.84 (3 H, s, OCH3), 4.03 
(I H, dd, J 8.0, 11.6 Hz, CH(H)OH), 4.47-4.52 (I H, m, 
ArCH2CHN) and 6.67-6.80 (4 H, m, ArH); oc (100 MHz, CDCh) 
27.8 (CHz), 27.8 (CHz), 33.1 (CHz), 55.6 (CH), 55.8 (OCH3), 55.8 
(OCH3), 61.8 (CH2), 111.0 (CH), 111.9 (CH), 121.0 (CH), 129.6 
(C), 147.6 (C), 148.7 (C), 178.3 (CO) and 178.3 (CO); MS (FAB) 
m!: 294 [(M+ H)+, 4.0] ((M +H)+, 294.1344, C1 5H19NOs requires 
294.1342). 
(SS, 1 ObR)-5-Hydroxymethyl-8,9-dimethoxy-1,5,6, 1 Ob-tetrahy-
dro-2H-pyrrolo[2,1 -a)isoquinolin-3-one, 3. I-(2S)-[2-(3,4-Dimeth-
oxyphcnyl)-1-hydroxymethylethyl]pyrrolidine-2,5-dionc 2 (4.09 g, 
13.94 mmol) was dissolved in absolute ethanol (lOO mL) and cooled 
to 0 °C. Sodium borohydridc (5.28 g, 139.4 mmol) was then added 
with stirring. A 2 M solution ofHCl in absolute ethanol (6.97 mL, 
13.94 mmol) was then slowly added via syringe over a 3 h period. 
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The resultant solution was acidified to pH I-3 by the addition of 
a 2 M solution of HCI in absolute ethanol over a 15 min period. 
This afforded a white suspension, which was stirred for a further 
20 h. The reaction was quenched with sodium hydrogen carbonate 
and extracted with dichloromethane (3 x 40 mL). The dichlo-
romethane layers were then combined and dried over anhydrous 
magnesium sulfatc and solvent removed by rotary evaporation to 
yield the target cyclizcd compound as a single diastcrcoisomcr, 
which was purified by column chromatography using silica gel as 
absorbent and 5% methanol/dichloromethane as eluent to yield a 
white solid (3.01 g, 78%): mp 177-179 °C; [o.]o +133.6 (c = 
1.03 in CHzCh); Vmax (thin film, CH2Ch)/cm-l 1666 (CO), 2939 
(aliphatic CH) and 3369 (OH); on (400 MHz, CDC13) 1.91-1.98 
(I H, m, CH(H)CHzCO), 2.46-2.52 (I H, m, CH2CH(H)CO), 
2.61-2.69 (3 H, m, CH(H)CH2CO, CH2CH(H)CO and ArCH(H)-
CHN), 3.00 (1 H, dd, J 6.8, 16.0 Hz, ArCH(H)CHN), 3.62-3.73 
(2 H, m, CH:OH), 3.87 (3 H, s, OCH1), 3.88 (3 H, s, OCH3), 4.47-
4.50 (I H, m, ArCHzCHN), 4. 76 (I H, t, J 7.6 Hz, NCHAr), 6.59 
(I H, s, ArH) and 6.63 (I H, s, ArH), (OH not visible); Oc (100 
MHz, CDCh) 27.1 (CH2), 29.1 (CH2), 31.7 (CH2), 49.5 (CH), 54.2 
(CH), 55.9 (OCH3), 56.1 (OCH3), 63.2 (CH2), 107.3 (CH), 111.7 
(CH), 124.1 (C), 128.4 (C), 148.0 (C), 148.2 (C) and 175.1 (CO); 
MS (FAB) mlz 278 [(M+ H)+, 27.5] ((M +H)+, 278.1395, C15Hw 
N04 requires 278.1392). 
(1 ObR)-8,9-Dimethoxy-1 ,5,6, 1 Ob-tctrahydro-2H-pyrrolo [2, 1-
a)isoquinolin-3-one, 4, by Raney-Ni Route. Freshly prepared 
Raney nickel (W-2) (7.08 g) was washed with water (3 x 20 mL) 
followed by 2-propanol (2 x 20 mL). 2-Propanol was decanted, 
the Rancy nickel was taken up in toluene, and the residual water 
and 2-propanol were azcotropically removed using a Dean-Stark 
trap. A solution of (SS,IObR)-5-hydroxymcthyl-8,9-dimcthoxy-
1 ,5,6, !Ob-tetrahydro-2H-pyrrolo[2,1-a ]isoquinolin-3-one 3 (1.18 g, 
6.49 mmol) in toluene (60 mL) was added, and the reaction was 
rcfluxed under Dean-Stark conditions for 4 h. The resulting 
solution was filtered through a Celite pad, washed with methanol, 
and evaporated under reduced pressure to yield the target compound 
as a yellow oil (1.03 g, 98%): [o.]0 +175.8 (c = 3.09 in CHCh); 
Vmax (thin film, CHCh)/cm-l 1681 (CO) and 2934 (aliphatic CH); 
on (400 MHz, CDCh) 1.82-1.90 (1 H, m, CH(H)CH2CO), 2.45-
2.71 (4 H, m, CH(H)CH2CO, CH2CH2CO and ArCH(H)CH2N), 
2.85-2.93 (I H, m, ArCH(H)CH2N), 2.99-3.06 (I H, m, ArCH2-
CH(H)N), 3.87 (3 H, s, OCHJ), 3.88 (3 H, s, OCH3), 4.31 (I H, 
ddd, J 2.4, 6.0, 12.8 Hz, ArCH2CH(H)N), 4.74 (I H, t, J 8.0 Hz, 
NCHAr), 6.58 (I H, s, ArH) and 6.63 (I H, s, ArH); be (100 MHz, 
CDCb) 27.8 (CHz), 28.1 (CH2), 31.8 (CH2), 37.1 (CH2), 55.9 
(OCHJ), 56.0 (OCHJ), 56.6 (CH), 107.6 (CH), 111.6 (CH), 125.5 
(C), 129.3 (C), 147.9 (C), 148.0 (C) and 173.4 (CO); MS (FAB) 
mlz 248 [(M +H)+, 31.3] ((M +H)+, 248.1287, C14H11N03 
requires 248.1287). 
(R)-(+)-Crispine A, 1, by Raney-Ni Route. Lithium aluminum 
hydride (I M solution in tetrahydrofuran) (4.5 mL, 4.49 mmol) 
was added to a prcdricd flask fitted with a reflux condenser under 
a nitrogen atmosphere. Anhydrous tetrahydrofuran (I 00 mL) was 
added and the solution cooled to 0 °C. (IObR)-8,9-Dimcthoxy-
1,5,6, 1 Ob-tetrahydro-2H-pyrrolo[2, !-a ]isoquinolin-3-one 4 ( 1.05 g, 
4.49 mmol) in anhydrous tctrahydrofuran (50 mL) was added 
dropwise to the hydride solution at 0 °C and the resulting solution 
heated under reflux for 3 h and then stirred for a further 12 h at 
room temperature. Dicthyl ether (50 mL) was added, and reaction 
was quenched by the careful addition of saturated sodium potassium 
tartate. The mixture was stirred for a further I h before the addition 
of anhydrous magnesium sui fate prior to filtration through a Cc lite 
pad. The filtrate was evaporated under reduced pressure, and the 
resultant yellow solid was purified by column chromatography using 
silica gel as absorbent and I 0: I chloroform/methanol as eluent to 
yield a colorless solid (752 mg, 76%): mp 88-89 °C (Iit. 1 mp 
88-89 °C); [o.]o + 43.9 (c = 1.14 in CHJOH) [Iit.1 [o.]u +91.0 
(CH30H)]; Vmax (thin film, CH2Ciz)/cm-1 2934 (aliphatie CH); On 
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(400 MHz, CDCh) 1.72-1.79 (I H, m, CH(H)CHzCHzN), 1.86-
1 .96 (2 H, m, CH2CH2CHzN), 2.3 I -2.37 (I H, m, CH(H)CHz· 
CH2N), 2.60-2.79 (3 H, m, CHzCHzCH(H)N, ArCH(H)CHzN and 
ArCH2CH(H)N), 2.98-3.11 (2 H, m, CHzCH2CH(H)N and ArCH-
(H)CH2N), 3.18 (I H, ddd, J 2.8, 5.6, 10.8 Hz, ArCHzCH(H)N), 
3.50 (I H, t, J 8.4 Hz, NCHAr), 3.84 (3 H, s, OCHJ), 3.85 (3 H, 
s, OCH3), 6.57 (I H, s, ArH) and 6.61 (I H, s, ArH); Oc (lOO MHz, 
CDCh) 22.3 (CH2), 27.9 (CH2), 30.6 (CHz), 48.3 (CHz), 53.2 (CHz), 
55.9 (OCH3), 56.0 (OCH3), 62.9 (CH), 108.8 (CH), 111.3 (CH), 
126.1 (C), 130.5 (C), 147.3 (C) and 147.4 (C); MS (FAB) m/z232 
[MI, 66.6) (MI, 233.1419, C14H19N02 requires 233.1416). The ee 
of crispine A obtained via this method was determined to be ea 
50% by the 1H NMR chiral shift experiments described in the 
discussion. 
(1 ObR)-8,9-Dimethoxy-1 ,5,6,1 Ob-tetrahydro-2H-pyrrolo[2, 1· 
a)isoquinolin-3-one, 4, by Rh-Decarbonylation Route. Bis-
(triphenylphosphine)rhodium(l) carbonyl chloride (0.012 g, 0.018 
mmol) was added to anhydrous xylene (10 mL) under a nitrogen 
atmosphere. The mixture was then stirred at 80 oc for I 5 min. 
3-Bis(diphenylphosphino)propane (0.019 g, 0.046 mmol) was then 
added and the mixture stirred for a further 30 min at this 
temperature. To the stirred mixture was then added aldehyde 6 
(0.102 g, 0.371 mmol) in anhydrous xylene (10 mL), and the 
resulting mixture was heated under reflux for a further 240 h. The 
solvent was removed under reduced pressure. The crude product 
was then adsorbed onto silica and purified by flash column 
chromatography over silica with 3: I ethyl acctatc!hcxanc as the 
eluent to produce the 4 as an oil (0.042 g, 46%). Spectral analysis 
of compound 4 obtained via this route was identical to that reported 
above. 
(R)-(+)-Crispine A, 1, by Rh-Decarbonylation Route. Treat-
ment of amide 4, obtained via Rh-deearbonylation chemistry, as 
described above using LAH gave crispine A, 1, in 58% yield and 
was shown to have an cc of >95% by 1H NMR chiral shift 
experiments as described in the discussion. Spectral analysis of 
compound 1 obtained via this route was identical to that reported 
above. The optical rotation of this product was detennined to be 
+95.2 (c 1.5, M eO H) and was comparable to that reported by Zhao 
and eo-workers for the natural product isolate [+91.0 (MeOH)]. 1 
(SS,10bR)-(8,9-Dimethoxy-1,2,3,5,6,10b-hexahydropyrrolo· 
[2,1-a)isoquinolin-5-yl)methanol, 5. Lithium aluminum hydride 
(I M solution in tetrahydrofuran) (3.61 mL, 3.61 mrnol) was added 
to a predried flask fitted with a reflux condenser under a nitrogen 
atmosphere. Anhydrous tetrahydrofuran (50 mL) was added and 
the solution cooled to 0 °C. (5S,IObR)-8,9-Dimethoxy-1,5,6,10b-
tetrahydro-2H-pyrrolo[2, 1-a ]isoquinolin-3-one, 3 (500 mg, 1.80 
mmol), in anhydrous tetrahydrofuran (20 mL) was added dropwise 
to the hydride solution at 0 °C and the resulting solution heated 
under reflux for 3 h and then stirred for a further 12 h at room 
temperature. Diethyl ether (20 mL) was added, and the reaction 
was quenched by the careful addition of saturated sodium potassium 
tartrate. The mixture was stirred for a further I h before the addition 
of anhydrous magnesium sulfate prior to filtration through a Celite 
pad. The filtrate was evaporated under reduced pressure, and the 
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resultant yellow solid was purified by column chromatography using 
silica gel as absorbent and I 0: I chloroform/methanol as eluent to 
yield a colorless solid (460 mg, 97%): [a]o +79.1 (c = 1.83 in 
CHCh); Vm-. (thin film, ncat)lcm·t 2934 (aliphatic CH) and 3374 
(OH); On (400 MHz, CDCh) 1.78-1.89 (3 H, m, CH2CHzCH2N 
and CH2CH(H)CH2N), 2.41-2.46 (2 H, m,.CH2CH(H)CHzN and 
ArCH(H)CHN), 2.76-2.81 (I H, m, CHzCH2CH(H)N), 2.96 (I H, 
dd, J 5.2, 16.0 Hz, ArCH(H)CHN), 3.05-3.09 (I H, m, CHzCHz-
CH(H)N), 3.13-3.16 (I H, m, ArCH2CHN), 3.22 (I H, br, s, OH), 
3.42 (I H, dd, J 8.0, 10.4 Hz, CH(H)OH), 3.52 (I H, dd, J 5.2, 
10.4 Hz, CH(H)OH), 3.85 (3 H, s, OCHJ), 3.85 (3 H, s, OCH1), 
4.22 (I H, t, J 6.4 Hz, NCHAr) and 6.56 (2 H, s, ArH); Oc (100 
MHz, CDCh) 24.0 (CH2), 26.3 (CH2), 33.5 (CH2), 51.9 (CH2), 55.6 
(CH), 55.6 (OCH3), 55.8 (OCH3), 62.6 (CHz), 109.0 (CH), I 11.2 
(CH), 112.3 (CH), 124.9 (C), 130.9 (C), 147.3 (C) and 147.6 (C); 
MS (FAB) mlz 264 [(M+ H)+, 14.2] ((M+ H)+, 264.1596, CtsHw 
N03 requires 264. I 600). 
(SS, 1 ObR)-8,9-Dimethoxy-3-oxo-1 ,2,3,5,6, 1 Ob-hexahydropyr-
rolo[2,1-a)isoquinoline-5-carbaldehyde, 6. o-Iodoxybenzoic acid 
(4.48 g, 16.12 mmol) was added to a solution of (5S,IObR)-5-
hydroxymethyl-8,9-dimethoxy-l ,5,6,1 Ob-tetrahydro-2H-pyrrolo[2,1-
a]isoquinolin-3-one, 3 (1.49 g, 5.37 mrnol), in ethyl acetate (75 
mL), and the reaction was heated under reflux for 4 h. The resulting 
mixture was cooled to room temperature, filtered through a sinter 
funnel, and evaporated to a crude brown residue. The crude product 
was adsorbed onto silica and chromatographed using silica gel as 
absorbent and 3:1 light petroleum/ethyl acetate as eluent to isolate 
the target compound as a yellow foam (1.46 g, 99%): [a)0 +66.5 
(c = 1.3 in CHCI3); Vmax (thin film, CHzCh)/cm·t 1672 (CO) and 
2937 (aliphatic CH); on (400 MHz, CDCI3) 1.85-1.93 (I H, m, 
CH(H)CH2CO), 2.47-2.55 (I H, m, CH2CH(H)CO), 2.68-2.75 
(2 H, m, CH(H)CH2CO and CH2CH(H)CO), 3.06 (I H, dd, J 7.2, 
16.0 Hz, ArCH(H)CHN), 3.22 (I H, dd, J 2.4, 16.4 Hz, ArCH-
(H)CHN), 3.85 (3 H, s, OCH3), 3.86 (3 H, s, OCH1), 4.91 (I H, t, 
J 6.8 Hz, NCHAr), 5.01 (I H, dd, J 2.4, 7.2 Hz, ArCH2CHN), 
6.53 (I H, s, ArH), 6.65 (I H, s, ArH) and 9.62 (I H, s, CHO); oc 
(lOO MHz, CDCh) 26.5 (CH2), 28.2 (CHz), 31.4 (CHz), 54.7 (CH), 
55.7 (CH), 56.0 (OCHJ), 56.1 (OCH3), 107.5 (CH), 111.5 (C.l-1), 
122.3 (C), 128.1 (C), 148.2 (C), 148.5 (C), 174.4 (CO) and 198.9 
(CHO); MS (FAB) mlz 276 [(M+ H)+, 22.2] ((M+ H)+, 276.1240, 
CtsH11N04 requires 276.1236). 
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